2	Detailed information on changes in leukocyte counts in milk , lymph and blood is reported by Lun et al. [ CIT ] .	[('Detailed', 'Detailed', 'JJ', 'B-NP', 'O'), ('information', 'information', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('leukocyte', 'leukocyte', 'NN', 'B-NP', 'O'), ('counts', 'count', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('milk', 'milk', 'NN', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('lymph', 'lymph', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('blood', 'blood', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Lun', 'Lun', 'NNP', 'B-NP', 'B-protein'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	As judged from post-mortem records , the panorama of necropsy diagnoses did not differ between infested and non-infested animals , and was similar to that found in the material of Swedish moose necropsied at SVA 1986-1991 [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('judged', 'judge', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('post-mortem', 'post-mortem', 'JJ', 'B-NP', 'O'), ('records', 'record', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('panorama', 'panorama', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('necropsy', 'necropsy', 'NN', 'B-NP', 'O'), ('diagnoses', 'diagnosis', 'NNS', 'I-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('differ', 'differ', 'VB', 'I-VP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('infested', 'infested', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('non-infested', 'non-infested', 'JJ', 'I-NP', 'O'), ('animals', 'animal', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('material', 'material', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Swedish', 'Swedish', 'JJ', 'B-NP', 'O'), ('moose', 'moose', 'NN', 'I-NP', 'O'), ('necropsied', 'necropsie', 'VBN', 'B-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('SVA', 'SVA', 'NN', 'B-NP', 'O'), ('1986-1991', '1986-1991', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Our sequencing results of the mutant FXI allele were consistent with prior report [ CIT ] of the FXI gene deficiency .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('sequencing', 'sequencing', 'NN', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutant', 'mutant', 'JJ', 'I-NP', 'B-DNA'), ('FXI', 'FXI', 'NN', 'I-NP', 'I-DNA'), ('allele', 'allele', 'NN', 'I-NP', 'I-DNA'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('prior', 'prior', 'JJ', 'B-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('FXI', 'FXI', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('deficiency', 'deficiency', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	FXI deficiency in cattle has been reported in many different countries , such as the USA [ CIT ] .	[('FXI', 'FXI', 'NN', 'B-NP', 'O'), ('deficiency', 'deficiency', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cattle', 'cattle', 'NNS', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('many', 'many', 'JJ', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('countries', 'country', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('USA', 'USA', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The prevalence ratio found in this study is similar to those reports in Canadian Holstein cattle ( 1.2 % ) [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('prevalence', 'prevalence', 'NN', 'I-NP', 'O'), ('ratio', 'ratio', 'NN', 'I-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Canadian', 'Canadian', 'NNP', 'B-NP', 'O'), ('Holstein', 'Holstein', 'NNP', 'I-NP', 'O'), ('cattle', 'cattle', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('1.2', '1.2', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	The usefulness in using β-glucuronidase activity for identification of E. coli has been confirmed by Schraft and coworkers who reported almost identical colony counts based on β-glucuronidase activity and on classical biochemical reactions [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('usefulness', 'usefulness', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('β-glucuronidase', 'β-glucuronidase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('identification', 'identification', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Schraft', 'Schraft', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('coworkers', 'coworker', 'NNS', 'B-NP', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('almost', 'almost', 'RB', 'B-NP', 'O'), ('identical', 'identical', 'JJ', 'I-NP', 'O'), ('colony', 'colony', 'NN', 'I-NP', 'O'), ('counts', 'count', 'NNS', 'I-NP', 'O'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('β-glucuronidase', 'β-glucuronidase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('classical', 'classical', 'JJ', 'B-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('reactions', 'reaction', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In a previous study , a one to five log2 dilution increased in MICs of E. coli to tetracycline was observed when Mueller-Hinton broth was supplemented with 5 mg calcium and 2.5 mg magnesium per dl , confirming that tetracycline is bound to divalent cations , and therefore have reduced antibacterial activity [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('to', 'to', 'TO', 'I-NP', 'O'), ('five', 'five', 'CD', 'I-NP', 'O'), ('log2', 'log2', 'NN', 'I-NP', 'O'), ('dilution', 'dilution', 'NN', 'I-NP', 'O'), ('increased', 'increase', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('MICs', 'MIC', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('tetracycline', 'tetracycline', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('Mueller-Hinton', 'Mueller-Hinton', 'JJ', 'B-NP', 'O'), ('broth', 'broth', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('supplemented', 'supplement', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('mg', 'mg', 'NN', 'I-NP', 'O'), ('calcium', 'calcium', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('2.5', '2.5', 'CD', 'B-NP', 'O'), ('mg', 'mg', 'NN', 'I-NP', 'O'), ('magnesium', 'magnesium', 'NN', 'I-NP', 'O'), ('per', 'per', 'IN', 'B-PP', 'O'), ('dl', 'dl', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('confirming', 'confirm', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('tetracycline', 'tetracycline', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('bound', 'bind', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('divalent', 'divalent', 'JJ', 'B-NP', 'O'), ('cations', 'cation', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('therefore', 'therefore', 'RB', 'B-ADVP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('reduced', 'reduce', 'VBN', 'I-VP', 'O'), ('antibacterial', 'antibacterial', 'JJ', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	According to descriptions published [ CIT ] , the third instar larvae of C. ulrichii is distinguished from C. stimulator and C. trompe by having spines irregularly placed on the anterior dorsal side .	[('According', 'Accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('descriptions', 'description', 'NNS', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('third', 'third', 'JJ', 'I-NP', 'O'), ('instar', 'instar', 'NN', 'I-NP', 'O'), ('larvae', 'larva', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('C.', 'C.', 'NNP', 'B-NP', 'O'), ('ulrichii', 'ulrichii', 'NNP', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('distinguished', 'distinguish', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('C.', 'C.', 'FW', 'B-NP', 'O'), ('stimulator', 'stimulator', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('C.', 'C.', 'NN', 'I-NP', 'O'), ('trompe', 'trompe', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('having', 'have', 'VBG', 'B-VP', 'O'), ('spines', 'spine', 'NNS', 'B-NP', 'O'), ('irregularly', 'irregularly', 'RB', 'B-VP', 'O'), ('placed', 'place', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('anterior', 'anterior', 'JJ', 'I-NP', 'O'), ('dorsal', 'dorsal', 'JJ', 'I-NP', 'O'), ('side', 'side', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	In continental Europe , several large surveys on the throat bot flies on roe deer have been performed ( e.g. [ CIT ] ) , but only C. stimulator has been reported .	[('In', 'In', 'IN', 'B-PP', 'O'), ('continental', 'continental', 'JJ', 'B-NP', 'O'), ('Europe', 'Europe', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('large', 'large', 'JJ', 'I-NP', 'O'), ('surveys', 'survey', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('throat', 'throat', 'NN', 'I-NP', 'O'), ('bot', 'bot', 'NN', 'I-NP', 'O'), ('flies', 'fly', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('roe', 'roe', 'NN', 'B-NP', 'O'), ('deer', 'deer', 'NN', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('e.g.', 'e.g.', 'FW', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('C.', 'C.', 'FW', 'I-NP', 'O'), ('stimulator', 'stimulator', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Alignment of the deduced protein sequences to published sequences of S. Typhimurium [ CIT ] showed only three variable positions between the three sequences .	[('Alignment', 'Alignment', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('deduced', 'deduce', 'VBN', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('S.', 'S.', 'NNP', 'B-NP', 'O'), ('Typhimurium', 'Typhimurium', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('variable', 'variable', 'JJ', 'I-NP', 'O'), ('positions', 'position', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
3	The survival percentage of 63 for all colic cases in the present study is on the same level as reported from other studies on hospitalised colic cases [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('survival', 'survival', 'NN', 'I-NP', 'O'), ('percentage', 'percentage', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('63', '63', 'CD', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('colic', 'colic', 'JJ', 'I-NP', 'O'), ('cases', 'case', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('level', 'level', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('hospitalised', 'hospitalised', 'JJ', 'B-NP', 'O'), ('colic', 'colic', 'JJ', 'I-NP', 'O'), ('cases', 'case', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The probabilities of survival in surgically and medically colic cases ( 48 and 78 % , respectively ) also correspond to previous studies [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('probabilities', 'probability', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('survival', 'survival', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('surgically', 'surgically', 'RB', 'B-ADVP', 'O'), ('and', 'and', 'CC', 'I-ADVP', 'O'), ('medically', 'medically', 'RB', 'B-NP', 'O'), ('colic', 'colic', 'JJ', 'I-NP', 'O'), ('cases', 'case', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('48', '48', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('78', '78', 'CD', 'I-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), (')', ')', ')', 'O', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('correspond', 'correspond', 'VBP', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In the present study there was no association between age and gender and outcome while some studies have reported that older horses have a higher risk of non-survival [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('association', 'association', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('age', 'age', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('gender', 'gender', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('outcome', 'outcome', 'NN', 'I-NP', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('older', 'old', 'JJR', 'B-NP', 'O'), ('horses', 'horse', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('higher', 'high', 'JJR', 'I-NP', 'O'), ('risk', 'risk', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('non-survival', 'non-survival', 'JJ', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In line with the present study , [ CIT ] and Thoefner et al. ( 2000 ) reported no association between age and the outcome in colic cases .	[('In', 'In', 'IN', 'B-PP', 'O'), ('line', 'line', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Thoefner', 'Thoefner', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2000', '2000', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('association', 'association', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('age', 'age', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('outcome', 'outcome', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('colic', 'colic', 'JJ', 'B-NP', 'O'), ('cases', 'case', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	[ CIT ] reported an increased risk of death in cold-blooded ponies compared to a heterogeneous group of warm-blooded horses .	[('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('increased', 'increase', 'VBN', 'I-NP', 'O'), ('risk', 'risk', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('death', 'death', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cold-blooded', 'cold-blooded', 'JJ', 'B-NP', 'O'), ('ponies', 'pony', 'NNS', 'I-NP', 'O'), ('compared', 'compare', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('heterogeneous', 'heterogeneous', 'JJ', 'I-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('warm-blooded', 'warm-blooded', 'JJ', 'B-NP', 'O'), ('horses', 'horse', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	In agreement with [ CIT ] no association between gender and outcome was found .	[('In', 'In', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'I-PP', 'O'), ('with', 'with', 'IN', 'I-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('association', 'association', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('gender', 'gender', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('outcome', 'outcome', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
7	This is in disagreement with [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('disagreement', 'disagreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	[ CIT ] found that a temperature deviation from 38°C was a significant variable in the multivariable logistic regression model expressing the outcome of a colic case .	[('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('deviation', 'deviation', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('38°C', '38°C', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('variable', 'variable', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('multivariable', 'multivariable', 'JJ', 'I-NP', 'O'), ('logistic', 'logistic', 'JJ', 'I-NP', 'O'), ('regression', 'regression', 'NN', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('expressing', 'express', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('outcome', 'outcome', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('colic', 'colic', 'JJ', 'I-NP', 'O'), ('case', 'case', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in agreement with [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	[ CIT ] , however , found that D-dimer was included in the final logistic model together with the variables heart rate and chloride .	[('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('D-dimer', 'D-dimer', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('included', 'include', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('final', 'final', 'JJ', 'I-NP', 'O'), ('logistic', 'logistic', 'JJ', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('together', 'together', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('variables', 'variable', 'NNS', 'I-NP', 'O'), ('heart', 'heart', 'NN', 'I-NP', 'O'), ('rate', 'rate', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('chloride', 'chloride', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Different editions revealed an extended or modified definition of health [ CIT ] .	[('Different', 'Different', 'JJ', 'B-NP', 'O'), ('editions', 'edition', 'NNS', 'I-NP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('extended', 'extend', 'VBN', 'I-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('modified', 'modify', 'VBN', 'I-NP', 'O'), ('definition', 'definition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('health', 'health', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	There were found no discrepancies between the phenotypic character demonstrated for present isolates and the ones outlined for the different Mannheimia species by Angen et al. [ CIT ] .	[('There', 'There', 'EX', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('discrepancies', 'discrepancy', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('phenotypic', 'phenotypic', 'JJ', 'I-NP', 'O'), ('character', 'character', 'NN', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('present', 'present', 'JJ', 'B-NP', 'O'), ('isolates', 'isolate', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ones', 'one', 'NNS', 'I-NP', 'O'), ('outlined', 'outline', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('Mannheimia', 'Mannheimia', 'NNP', 'I-NP', 'O'), ('species', 'specie', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Angen', 'Angen', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Different editions revealed an extended or modified definition of health [ CIT ] .	[('Different', 'Different', 'JJ', 'B-NP', 'O'), ('editions', 'edition', 'NNS', 'I-NP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('extended', 'extend', 'VBN', 'I-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('modified', 'modify', 'VBN', 'I-NP', 'O'), ('definition', 'definition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('health', 'health', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	There were found no discrepancies between the phenotypic character demonstrated for present isolates and the ones outlined for the different Mannheimia species by Angen et al. [ CIT ] .	[('There', 'There', 'EX', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('discrepancies', 'discrepancy', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('phenotypic', 'phenotypic', 'JJ', 'I-NP', 'O'), ('character', 'character', 'NN', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('present', 'present', 'JJ', 'B-NP', 'O'), ('isolates', 'isolate', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ones', 'one', 'NNS', 'I-NP', 'O'), ('outlined', 'outline', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('Mannheimia', 'Mannheimia', 'NNP', 'I-NP', 'O'), ('species', 'specie', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Angen', 'Angen', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	PMWS was confirmed as the cause of death in all these three pigs ( Table 2 ) according to international standards [ CIT ] , which apart from wasting included enlarged lymph nodes macroscopically with typical histological lesions and the presence of an abundance of PCV2 antigen in these lesions .	[('PMWS', 'PMWS', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cause', 'cause', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('death', 'death', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('all', 'all', 'PDT', 'B-NP', 'O'), ('these', 'these', 'DT', 'I-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('pigs', 'pig', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('international', 'international', 'JJ', 'B-NP', 'O'), ('standards', 'standard', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('apart', 'apart', 'VBP', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('wasting', 'wasting', 'NN', 'B-NP', 'O'), ('included', 'include', 'VBD', 'B-VP', 'O'), ('enlarged', 'enlarged', 'JJ', 'B-NP', 'O'), ('lymph', 'lymph', 'NN', 'I-NP', 'O'), ('nodes', 'node', 'NNS', 'I-NP', 'O'), ('macroscopically', 'macroscopically', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('typical', 'typical', 'JJ', 'B-NP', 'O'), ('histological', 'histological', 'JJ', 'I-NP', 'O'), ('lesions', 'lesion', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('abundance', 'abundance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('PCV2', 'PCV2', 'NN', 'B-NP', 'B-protein'), ('antigen', 'antigen', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('lesions', 'lesion', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	HEK293 cell lines have been used by others to overexpress these enzymes [ CIT ] .	[('HEK293', 'HEK293', 'NN', 'B-NP', 'B-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('lines', 'line', 'NNS', 'I-NP', 'I-cell_line'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('others', 'other', 'NNS', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('overexpress', 'overexpress', 'VB', 'I-VP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Removal of N-linked oligosacharides increased the relative mobility of ASP-2 from 65-80-k to 50-60-k , a size resembling the estimated molecular weights of the core protein confirming glycosylation as reported by others either by suppression of N-glycosylation or deglycosylation [ CIT ] .	[('Removal', 'Removal', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('N-linked', 'N-linked', 'JJ', 'B-NP', 'O'), ('oligosacharides', 'oligosacharide', 'NNS', 'I-NP', 'O'), ('increased', 'increase', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('relative', 'relative', 'JJ', 'I-NP', 'O'), ('mobility', 'mobility', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ASP-2', 'ASP-2', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('65-80-k', '65-80-k', 'CD', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('50-60-k', '50-60-k', 'JJ', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('size', 'size', 'NN', 'I-NP', 'O'), ('resembling', 'resemble', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('estimated', 'estimate', 'VBN', 'I-NP', 'O'), ('molecular', 'molecular', 'JJ', 'I-NP', 'O'), ('weights', 'weight', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('core', 'core', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('confirming', 'confirm', 'VBG', 'B-VP', 'O'), ('glycosylation', 'glycosylation', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('others', 'other', 'NNS', 'B-NP', 'O'), ('either', 'either', 'CC', 'B-PP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('suppression', 'suppression', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('N-glycosylation', 'N-glycosylation', 'NN', 'B-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('deglycosylation', 'deglycosylation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We investigated the processing of ASP-2 at different pH values , since self-activation of other aspartic proteases such as pepsinogen [ CIT ] has been shown to be sensitive to pH .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('investigated', 'investigate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('processing', 'processing', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ASP-2', 'ASP-2', 'NN', 'B-NP', 'B-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('since', 'since', 'IN', 'B-PP', 'O'), ('self-activation', 'self-activation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('aspartic', 'aspartic', 'JJ', 'I-NP', 'B-protein'), ('proteases', 'protease', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('pepsinogen', 'pepsinogen', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('sensitive', 'sensitive', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('pH', 'pH', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The fact that PNGase did not reduce the ASP-2 protein to a single band of the unmodified protein is probably due to other modifications mentioned earlier , such as palmitoylation [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('PNGase', 'PNGase', 'NN', 'B-NP', 'B-protein'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('reduce', 'reduce', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ASP-2', 'ASP-2', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('band', 'band', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('unmodified', 'unmodified', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('probably', 'probably', 'RB', 'B-ADVP', 'O'), ('due', 'due', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('modifications', 'modification', 'NNS', 'I-NP', 'O'), ('mentioned', 'mention', 'VBN', 'B-VP', 'O'), ('earlier', 'earlier', 'RBR', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('palmitoylation', 'palmitoylation', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The intron borders are defined by the common " GT-AG " consensus ( Figure 1A ) [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('intron', 'intron', 'NN', 'I-NP', 'O'), ('borders', 'border', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('defined', 'define', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('common', 'common', 'JJ', 'I-NP', 'O'), ('``', '``', '``', 'I-NP', 'O'), ('GT-AG', 'GT-AG', 'NN', 'I-NP', 'B-protein'), ('``', '``', '``', 'I-NP', 'O'), ('consensus', 'consensus', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Prediction of the disorder and globularity [ CIT ] of hARD1 and hARD2 indicates that the C-terminal part of these two proteins to some extent diverge ( data not shown ) .	[('Prediction', 'Prediction', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('disorder', 'disorder', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('globularity', 'globularity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('hARD1', 'hARD1', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('hARD2', 'hARD2', 'NN', 'I-NP', 'O'), ('indicates', 'indicate', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('part', 'part', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('extent', 'extent', 'NN', 'I-NP', 'O'), ('diverge', 'diverge', 'VBP', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The interaction between hARD1 and HIF-1α has been described [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('hARD1', 'hARD1', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('HIF-1α', 'HIF-1α', 'NN', 'I-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Similarly to hARD1 [ CIT ] , hARD2-V5 was present both in the cytoplasm and in the nucleus , but the majority of the protein appeared to be located in the cytoplasm .	[('Similarly', 'Similarly', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('hARD1', 'hARD1', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('hARD2-V5', 'hARD2-V5', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytoplasm', 'cytoplasm', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nucleus', 'nucleus', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('majority', 'majority', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('appeared', 'appear', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('located', 'locate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytoplasm', 'cytoplasm', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been demonstrated that mARD1 and mNAT1 mRNAs are downregulated during neuronal differentiation of P19 cells [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('mARD1', 'mARD1', 'NN', 'B-NP', 'B-RNA'), ('and', 'and', 'CC', 'I-NP', 'I-RNA'), ('mNAT1', 'mNAT1', 'NN', 'I-NP', 'I-RNA'), ('mRNAs', 'mRNA', 'NNS', 'I-NP', 'I-RNA'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('downregulated', 'downregulate', 'VBN', 'I-VP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('neuronal', 'neuronal', 'JJ', 'B-NP', 'O'), ('differentiation', 'differentiation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('P19', 'P19', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These screens resulted in only two interaction partners , Snu71 and Luc7 , two other known components of the U1 snRNP [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('screens', 'screen', 'NNS', 'I-NP', 'O'), ('resulted', 'result', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('partners', 'partner', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Snu71', 'Snu71', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Luc7', 'Luc7', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('components', 'component', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('U1', 'U1', 'NN', 'I-NP', 'O'), ('snRNP', 'snRNP', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	PL transfer was determined after 30 minutes of incubation because Tall et al. [ CIT ] have demonstrated that PL net transfer reaches the maximum after this incubation period .	[('PL', 'PL', 'NN', 'B-NP', 'O'), ('transfer', 'transfer', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('30', '30', 'CD', 'B-NP', 'O'), ('minutes', 'minute', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('incubation', 'incubation', 'NN', 'B-NP', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('Tall', 'Tall', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('PL', 'PL', 'NN', 'B-NP', 'O'), ('net', 'net', 'JJ', 'I-NP', 'O'), ('transfer', 'transfer', 'NN', 'I-NP', 'O'), ('reaches', 'reach', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('maximum', 'maximum', 'NN', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('incubation', 'incubation', 'NN', 'I-NP', 'O'), ('period', 'period', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Table 3 shows that 14C-PL transfer from lipid emulsion to human HDL was reduced 40 % ( p < 0.005 ) when CETP activity was inhibited 58 % , indicating that CETP has PL transfer activity as previously reported [ CIT ] .	[('Table', 'Table', 'JJ', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), ('shows', 'show', 'NNS', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-NP', 'O'), ('14C-PL', '14C-PL', 'NN', 'B-NP', 'O'), ('transfer', 'transfer', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('lipid', 'lipid', 'NN', 'B-NP', 'O'), ('emulsion', 'emulsion', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('HDL', 'HDL', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reduced', 'reduce', 'VBN', 'I-VP', 'O'), ('40', '40', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('p', 'p', 'NN', 'B-NP', 'O'), ('<', '<', 'SYM', 'B-NP', 'O'), ('0.005', '0.005', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('CETP', 'CETP', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('inhibited', 'inhibit', 'VBN', 'I-VP', 'O'), ('58', '58', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('CETP', 'CETP', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('PL', 'PL', 'NN', 'B-NP', 'O'), ('transfer', 'transfer', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To support the observation that HDAC1 degrades to short peptide fragments in the presence of trypsin , the predicted sites of HDAC1 trypsin cleavage were determined using the program Peptide Cutter [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('support', 'support', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('HDAC1', 'HDAC1', 'NN', 'B-NP', 'O'), ('degrades', 'degrade', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('short', 'short', 'JJ', 'B-NP', 'B-DNA'), ('peptide', 'peptide', 'NN', 'I-NP', 'I-DNA'), ('fragments', 'fragment', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('trypsin', 'trypsin', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('predicted', 'predict', 'VBN', 'I-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'B-NP', 'B-protein'), ('trypsin', 'trypsin', 'NN', 'I-NP', 'I-protein'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ('Peptide', 'Peptide', 'NN', 'I-NP', 'O'), ('Cutter', 'Cutter', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous work showed that the HDAC1 S421A / S423A and HDAC1 E424A / E426A mutants behave similarly ; both mutants are unable to interact with RbAp48 , Sin3A , MTA2 , and CoREST and are catalytically inactive , demonstrating 22.9 ± 3.1 % and 30.9 ± 1.6 % of wild type activity , respectively [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'I-NP', 'O'), ('S421A', 'S421A', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('S423A', 'S423A', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'I-NP', 'O'), ('E424A', 'E424A', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-VP', 'O'), ('E426A', 'E426A', 'NN', 'B-NP', 'B-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), ('behave', 'behave', 'VBP', 'B-VP', 'O'), ('similarly', 'similarly', 'RB', 'B-ADVP', 'O'), (';', ';', ':', 'O', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('unable', 'unable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('RbAp48', 'RbAp48', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Sin3A', 'Sin3A', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('MTA2', 'MTA2', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('CoREST', 'CoREST', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('catalytically', 'catalytically', 'RB', 'B-ADJP', 'O'), ('inactive', 'inactive', 'JJ', 'I-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('22.9', '22.9', 'CD', 'B-NP', 'O'), ('±', '±', 'HYPH', 'O', 'O'), ('3.1', '3.1', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('30.9', '30.9', 'CD', 'B-NP', 'O'), ('±', '±', 'HYPH', 'I-NP', 'O'), ('1.6', '1.6', 'CD', 'I-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The experiments demonstrated that the HDAC1 S421A / S423A and HDAC1 E424A / E426A mutant proteins display equivalent concentration-dependent trypsin digestion , consistent with previous results showing that they maintain similar deacetylase activity and complex forming ability [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'I-NP', 'O'), ('S421A', 'S421A', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('S423A', 'S423A', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'I-NP', 'O'), ('E424A', 'E424A', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('E426A', 'E426A', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'JJ', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('display', 'display', 'VBP', 'B-VP', 'O'), ('equivalent', 'equivalent', 'JJ', 'B-NP', 'B-protein'), ('concentration-dependent', 'concentration-dependent', 'JJ', 'I-NP', 'I-protein'), ('trypsin', 'trypsin', 'NN', 'I-NP', 'I-protein'), ('digestion', 'digestion', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('maintain', 'maintain', 'VBP', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('deacetylase', 'deacetylase', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('complex', 'complex', 'JJ', 'B-NP', 'O'), ('forming', 'form', 'VBG', 'I-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with the proposal , mutation of H141 results in loss of HDAC1 deacetylase activity [ CIT ] .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proposal', 'proposal', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('mutation', 'mutation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('H141', 'H141', 'NN', 'B-NP', 'B-cell_line'), ('results', 'result', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('loss', 'loss', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HDAC1', 'HDAC1', 'NN', 'B-NP', 'B-protein'), ('deacetylase', 'deacetylase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Because of heterogeneous nature of glycosylation [ CIT ] , prorenin and renin migrated on the SDS-PAGE gel as broad bands of around 50 kDa and 42 kDa , respectively ( molecular weight of the DNA-deduced polypeptides of prorenin and renin were 42,319 and 37,233 , respectively , see Table 1 ) .	[('Because', 'Because', 'IN', 'B-PP', 'O'), ('of', 'of', 'IN', 'I-PP', 'O'), ('heterogeneous', 'heterogeneous', 'JJ', 'B-NP', 'O'), ('nature', 'nature', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('glycosylation', 'glycosylation', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('prorenin', 'prorenin', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('renin', 'renin', 'NN', 'I-NP', 'B-protein'), ('migrated', 'migrate', 'VBD', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SDS-PAGE', 'SDS-PAGE', 'NN', 'I-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('broad', 'broad', 'JJ', 'B-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('around', 'around', 'IN', 'B-NP', 'O'), ('50', '50', 'CD', 'I-NP', 'B-protein'), ('kDa', 'kDa', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('42', '42', 'CD', 'B-NP', 'O'), ('kDa', 'kDa', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('molecular', 'molecular', 'JJ', 'B-NP', 'O'), ('weight', 'weight', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DNA-deduced', 'DNA-deduced', 'JJ', 'I-NP', 'O'), ('polypeptides', 'polypeptide', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('prorenin', 'prorenin', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('renin', 'renin', 'NN', 'I-NP', 'B-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('42', '42', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('319', '319', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('37', '37', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('233', '233', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('Table', 'Table', 'NNP', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The catalytic activity was measured using the commercially available substrate , DABCYL-γAbu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS , which is based on the angiotensinogen sequence [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('measured', 'measure', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('commercially', 'commercially', 'RB', 'I-NP', 'O'), ('available', 'available', 'JJ', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('DABCYL-γAbu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS', 'DABCYL-γAbu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('angiotensinogen', 'angiotensinogen', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This value is similar to the KM of 1.5 μM reported in the literature based on the FRET assay [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('KM', 'KM', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('1.5', '1.5', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('literature', 'literature', 'NN', 'I-NP', 'O'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('FRET', 'FRET', 'NN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This value is close to the published catalytic efficiency of 6.9 × 105 M-1s-1 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('close', 'close', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('efficiency', 'efficiency', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('6.9', '6.9', 'CD', 'B-NP', 'O'), ('×', '×', 'HYPH', 'I-NP', 'O'), ('105', '105', 'CD', 'I-NP', 'O'), ('M-1s-1', 'M-1s-1', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The maximum activity was observed at pH 6.5 , similar to purified human renin [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('maximum', 'maximum', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('pH', 'pH', 'NN', 'B-NP', 'O'), ('6.5', '6.5', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('purified', 'purify', 'VBN', 'B-NP', 'B-protein'), ('human', 'human', 'JJ', 'I-NP', 'I-protein'), ('renin', 'renin', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The peak and the shoulder of the pH profile were similar to those observed for purified human renin cleaving partially purified human angiotensinogen with the maxima at ~6.5 and 8 [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('peak', 'peak', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('shoulder', 'shoulder', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('profile', 'profile', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('purified', 'purify', 'VBN', 'B-NP', 'B-protein'), ('human', 'human', 'JJ', 'I-NP', 'I-protein'), ('renin', 'renin', 'NN', 'I-NP', 'I-protein'), ('cleaving', 'cleave', 'VBG', 'B-VP', 'O'), ('partially', 'partially', 'RB', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'O'), ('angiotensinogen', 'angiotensinogen', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('maxima', 'maximum', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('~6.5', '~6.5', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('8', '8', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The comparison of these values with the parameters of the native BDH bound to the inner mitochondrial membrane [ CIT ] shows small differences in the KM values .	[('The', 'The', 'DT', 'B-NP', 'O'), ('comparison', 'comparison', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('parameters', 'parameter', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('native', 'native', 'JJ', 'I-NP', 'O'), ('BDH', 'BDH', 'NN', 'I-NP', 'O'), ('bound', 'bind', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inner', 'inner', 'JJ', 'I-NP', 'O'), ('mitochondrial', 'mitochondrial', 'JJ', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('shows', 'show', 'VBZ', 'B-VP', 'O'), ('small', 'small', 'JJ', 'B-NP', 'O'), ('differences', 'difference', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('KM', 'KM', 'NN', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is close to 37°C for BDH from Camelus dromedaries [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('close', 'close', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('37°C', '37°C', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('BDH', 'BDH', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Camelus', 'Camelus', 'NN', 'B-NP', 'O'), ('dromedaries', 'dromedary', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	BDH activity dependence on temperature discontinuity was previously found for native BDH in the heavy mitochondria fraction from Jerboa liver [ CIT ] .	[('BDH', 'BDH', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('dependence', 'dependence', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('temperature', 'temperature', 'NN', 'B-NP', 'O'), ('discontinuity', 'discontinuity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('native', 'native', 'JJ', 'B-NP', 'O'), ('BDH', 'BDH', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('heavy', 'heavy', 'JJ', 'I-NP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'I-NP', 'O'), ('fraction', 'fraction', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Jerboa', 'Jerboa', 'NNP', 'B-NP', 'O'), ('liver', 'liver', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similar results were found for rat [ CIT ] .	[('Similar', 'Similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The sequenced clone ( GenBank accession # bankit 1072824 EU563473 ) was aligned and compared with other BDHs , from several species , including the mammalian vertebrate phyla and bacterial species , using the BioEdit program [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('sequenced', 'sequence', 'VBN', 'I-NP', 'O'), ('clone', 'clone', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('GenBank', 'GenBank', 'NN', 'B-NP', 'O'), ('accession', 'accession', 'NN', 'I-NP', 'O'), ('#', '#', '#', 'B-NP', 'O'), ('bankit', 'bankit', 'NN', 'I-NP', 'O'), ('1072824', '1072824', 'CD', 'I-NP', 'O'), ('EU563473', 'EU563473', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('aligned', 'align', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('compared', 'compare', 'VBN', 'B-PP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('BDHs', 'BDH', 'NNS', 'I-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('species', 'specie', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mammalian', 'mammalian', 'JJ', 'I-NP', 'O'), ('vertebrate', 'vertebrate', 'NN', 'I-NP', 'O'), ('phyla', 'phyla', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('bacterial', 'bacterial', 'JJ', 'B-NP', 'O'), ('species', 'specie', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('BioEdit', 'BioEdit', 'NN', 'I-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A very brief description of the procedure for generating BnDGAT1 ( 1-116 ) His6 was presented previously in a conference proceeding document [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('very', 'very', 'RB', 'I-NP', 'O'), ('brief', 'brief', 'JJ', 'I-NP', 'O'), ('description', 'description', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('procedure', 'procedure', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('generating', 'generate', 'VBG', 'B-VP', 'O'), ('BnDGAT1', 'BnDGAT1', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('1-116', '1-116', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('His6', 'His6', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('presented', 'present', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('conference', 'conference', 'NN', 'I-NP', 'O'), ('proceeding', 'proceeding', 'NN', 'I-NP', 'O'), ('document', 'document', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A hydropathy plot [ CIT ] indicated that the N-terminal region of the enzyme was relatively hydrophilic compared to the rest of the protein .	[('A', 'A', 'DT', 'B-NP', 'O'), ('hydropathy', 'hydropathy', 'NN', 'I-NP', 'O'), ('plot', 'plot', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'B-protein'), ('region', 'region', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('relatively', 'relatively', 'RB', 'B-ADJP', 'O'), ('hydrophilic', 'hydrophilic', 'JJ', 'I-ADJP', 'O'), ('compared', 'compare', 'VBN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rest', 'rest', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	In a previous study , we demonstrated that [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Binding experiments with BSA , which is known to interact with acyl-CoAs [ CIT ] , demonstrated that the Lipidex-1000 assay was effective and thus served as a positive control ( data not shown ) .	[('Binding', 'Binding', 'NN', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('BSA', 'BSA', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('acyl-CoAs', 'acyl-CoAs', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Lipidex-1000', 'Lipidex-1000', 'NN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('effective', 'effective', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('thus', 'thus', 'RB', 'B-VP', 'O'), ('served', 'serve', 'VBD', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('positive', 'positive', 'JJ', 'I-NP', 'O'), ('control', 'control', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast , we have previously shown that ovalbumin does not bind acyl-CoA using this assay [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('ovalbumin', 'ovalbumin', 'NN', 'B-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('acyl-CoA', 'acyl-CoA', 'NN', 'B-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Analysis of the binding data using Scatchard plots [ CIT ] is depicted in Figures 2C and 2D .	[('Analysis', 'Analysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('Scatchard', 'Scatchard', 'NN', 'B-NP', 'O'), ('plots', 'plot', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('depicted', 'depict', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figures', 'Figure', 'NNS', 'B-NP', 'O'), ('2C', '2C', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('2D', '2D', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	A previous study indicated that micromolar concentrations of CoA were effective in stimulating microsomal DGAT activity from microspore-derived cell suspension cultures of oilseed rape [ CIT ] , so it seemed logical to test the possible effect of these compounds on the binding of thioester .	[('A', 'A', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('micromolar', 'micromolar', 'JJ', 'B-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CoA', 'CoA', 'NN', 'B-NP', 'B-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('effective', 'effective', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('stimulating', 'stimulate', 'VBG', 'B-VP', 'O'), ('microsomal', 'microsomal', 'JJ', 'B-NP', 'O'), ('DGAT', 'DGAT', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('microspore-derived', 'microspore-derived', 'JJ', 'B-NP', 'B-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('suspension', 'suspension', 'NN', 'I-NP', 'I-cell_line'), ('cultures', 'culture', 'NNS', 'I-NP', 'I-cell_line'), ('of', 'of', 'IN', 'B-PP', 'O'), ('oilseed', 'oilseed', 'NN', 'B-NP', 'O'), ('rape', 'rape', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('so', 'so', 'IN', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('seemed', 'seem', 'VBD', 'B-VP', 'O'), ('logical', 'logical', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('test', 'test', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('possible', 'possible', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('compounds', 'compound', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('thioester', 'thioester', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This molecular mass was in close agreement with the molecular mass of 56.9 kDa calculated from the deduced amino acid sequence of BnDGAT1 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('molecular', 'molecular', 'JJ', 'I-NP', 'O'), ('mass', 'mass', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('close', 'close', 'JJ', 'B-NP', 'O'), ('agreement', 'agreement', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('molecular', 'molecular', 'JJ', 'I-NP', 'O'), ('mass', 'mass', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('56.9', '56.9', 'CD', 'B-NP', 'B-RNA'), ('kDa', 'kDa', 'NN', 'I-NP', 'I-RNA'), ('calculated', 'calculate', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('deduced', 'deduce', 'VBN', 'I-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('BnDGAT1', 'BnDGAT1', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We previously showed that taurine-conjugated bile acids , such as taurocholic ( TCA ) and taurochenodeoxycholic ( TCDCA ) acids , were well tolerated by McNtcp.24 cells [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('taurine-conjugated', 'taurine-conjugated', 'JJ', 'B-NP', 'O'), ('bile', 'bile', 'NN', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('taurocholic', 'taurocholic', 'JJ', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('TCA', 'TCA', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('taurochenodeoxycholic', 'taurochenodeoxycholic', 'JJ', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('TCDCA', 'TCDCA', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('acids', 'acid', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('well', 'well', 'RB', 'I-VP', 'O'), ('tolerated', 'tolerate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('McNtcp.24', 'McNtcp.24', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In contrast , glycine-conjugated bile acids , such as glycocholic ( GCA ) and glycochenodeoxycholic ( GCDCA ) acids , were cytotoxic to McNtcp.24 cells [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('glycine-conjugated', 'glycine-conjugated', 'JJ', 'B-NP', 'O'), ('bile', 'bile', 'NN', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('glycocholic', 'glycocholic', 'JJ', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('GCA', 'GCA', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('glycochenodeoxycholic', 'glycochenodeoxycholic', 'JJ', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('GCDCA', 'GCDCA', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('acids', 'acid', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('cytotoxic', 'cytotoxic', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('McNtcp.24', 'McNtcp.24', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	There is considerable evidence to suggest that bile acids activate a variety of cellular signaling pathways in liver cells [ CIT ] .	[('There', 'There', 'EX', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('considerable', 'considerable', 'JJ', 'B-NP', 'O'), ('evidence', 'evidence', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('suggest', 'suggest', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('bile', 'bile', 'NN', 'B-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('activate', 'activate', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('variety', 'variety', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cellular', 'cellular', 'JJ', 'B-NP', 'O'), ('signaling', 'signaling', 'NN', 'I-NP', 'O'), ('pathways', 'pathway', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('liver', 'liver', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In addition , several studies have shown the activation of the caspase cascade by toxic bile acids in hepatocytes [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('caspase', 'caspase', 'NN', 'I-NP', 'O'), ('cascade', 'cascade', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('toxic', 'toxic', 'JJ', 'B-NP', 'O'), ('bile', 'bile', 'NN', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('hepatocytes', 'hepatocyte', 'NNS', 'B-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Using a human IRBP cDNA as a probe , we previously isolated by low stringency hybridization screening a Xenopus IRBP cDNA ( XenB1 ) corresponding to the fourth ( C-terminal ) module of the protein [ CIT ] .	[('Using', 'Use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'B-DNA'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-DNA'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'I-DNA'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('probe', 'probe', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('isolated', 'isolate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('stringency', 'stringency', 'NN', 'I-NP', 'O'), ('hybridization', 'hybridization', 'NN', 'I-NP', 'O'), ('screening', 'screen', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'I-NP', 'B-DNA'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-DNA'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('XenB1', 'XenB1', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fourth', 'fourth', 'JJ', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'B-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('module', 'module', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with Northern blot studies showing that the mRNA for Xenopus IRBPis approximately 4.2 kb in size [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('Northern', 'Northern', 'NN', 'B-NP', 'O'), ('blot', 'blot', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'B-RNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NNP', 'B-NP', 'O'), ('IRBPis', 'IRBPis', 'NNP', 'I-NP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('4.2', '4.2', 'CD', 'I-NP', 'O'), ('kb', 'kb', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('size', 'size', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These observations are consistent with the suggestion that the middle two modules of teleost IRBP were lost during the evolution of the ray-finned fish ( actinopterygii ) [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('suggestion', 'suggestion', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('middle', 'middle', 'JJ', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('modules', 'module', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('teleost', 'teleost', 'NN', 'B-NP', 'B-protein'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('lost', 'lose', 'VBN', 'I-VP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('evolution', 'evolution', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ray-finned', 'ray-finned', 'JJ', 'I-NP', 'O'), ('fish', 'fish', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('actinopterygii', 'actinopterygii', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In addition , each of the modules showed similarity with C-terminal processing proteases ( CtpAs ) [ CIT ] ( data not illustrated ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('modules', 'module', 'NNS', 'I-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('similarity', 'similarity', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'B-NP', 'B-protein'), ('processing', 'processing', 'NN', 'I-NP', 'I-protein'), ('proteases', 'protease', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('CtpAs', 'CtpA', 'NNS', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('illustrated', 'illustrate', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These observations taken together with X-ray crystallographic data from the second module of Xenopus IRBP suggest that IRBP belongs to the CptA / crotonase superfamily , and shares with other members of the family a common ligand-binding domain to stabilize unique hydrophobic molecules [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('taken', 'take', 'VBN', 'B-VP', 'O'), ('together', 'together', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('X-ray', 'X-ray', 'NN', 'B-NP', 'O'), ('crystallographic', 'crystallographic', 'JJ', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('second', 'second', 'JJ', 'I-NP', 'O'), ('module', 'module', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'B-protein'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-protein'), ('suggest', 'suggest', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('IRBP', 'IRBP', 'NN', 'B-NP', 'B-protein'), ('belongs', 'belong', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CptA', 'CptA', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('crotonase', 'crotonase', 'NN', 'I-NP', 'I-protein'), ('superfamily', 'superfamily', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('shares', 'share', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('members', 'member', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('family', 'family', 'NN', 'I-NP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('common', 'common', 'JJ', 'I-NP', 'O'), ('ligand-binding', 'ligand-binding', 'JJ', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('to', 'to', 'TO', 'B-VP', 'O'), ('stabilize', 'stabilize', 'VB', 'I-VP', 'O'), ('unique', 'unique', 'JJ', 'B-NP', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'I-NP', 'B-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This observation is consistent with the fact that bovine IRBP contains asparagine-linked sialoligosaccharides [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('bovine', 'bovine', 'JJ', 'B-NP', 'B-protein'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-protein'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('asparagine-linked', 'asparagine-linked', 'JJ', 'B-NP', 'O'), ('sialoligosaccharides', 'sialoligosaccharide', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Glycosylation differences between species could explain why Xenopus IRBP ( Mr = 124 kDa ) [ CIT ] .	[('Glycosylation', 'Glycosylation', 'NN', 'B-NP', 'O'), ('differences', 'difference', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('species', 'specie', 'NNS', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('explain', 'explain', 'VB', 'I-VP', 'O'), ('why', 'why', 'WRB', 'B-ADVP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'B-protein'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Mr', 'Mr', 'NN', 'B-NP', 'O'), ('=', '=', 'JJ', 'B-VP', 'O'), ('124', '124', 'CD', 'B-NP', 'O'), ('kDa', 'kDa', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
8	The role of IRBP 's sugar moieties , which appear unnecessary for its elongated shape , secretion , or ability to bind retinoids , is presently unknown [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('IRBP', 'IRBP', 'NN', 'B-NP', 'B-protein'), ("'s", "'s", 'POS', 'B-NP', 'I-protein'), ('sugar', 'sugar', 'NN', 'I-NP', 'I-protein'), ('moieties', 'moiety', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('appear', 'appear', 'VBP', 'B-VP', 'O'), ('unnecessary', 'unnecessary', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('elongated', 'elongate', 'VBN', 'I-NP', 'O'), ('shape', 'shape', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('secretion', 'secretion', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('ability', 'ability', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('retinoids', 'retinoid', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('presently', 'presently', 'RB', 'B-ADJP', 'O'), ('unknown', 'unknown', 'JJ', 'I-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The use of alternative signal sequences for in IRBP has been shown in the rat retina where two IRBP mRNAs of different lengths are expressed [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('use', 'use', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('alternative', 'alternative', 'JJ', 'B-NP', 'B-DNA'), ('signal', 'signal', 'NN', 'I-NP', 'I-DNA'), ('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('IRBP', 'IRBP', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rat', 'rat', 'NN', 'I-NP', 'O'), ('retina', 'retina', 'NN', 'I-NP', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'B-RNA'), ('mRNAs', 'mRNA', 'NNS', 'I-NP', 'I-RNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('lengths', 'length', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The use of thioredoxin as a fusion partner was previously found to significantly enhance the soluble expression of X4IRBP [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('use', 'use', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('thioredoxin', 'thioredoxin', 'NN', 'B-NP', 'B-protein'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('fusion', 'fusion', 'NN', 'I-NP', 'B-protein'), ('partner', 'partner', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('significantly', 'significantly', 'RB', 'I-VP', 'O'), ('enhance', 'enhance', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('soluble', 'soluble', 'JJ', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('X4IRBP', 'X4IRBP', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	This effect , which is related to the reduced aggregation of recombinant proteins at lower expression temperatures , has been used to improve the solubility of a variety proteins in E. coli [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('related', 'related', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reduced', 'reduce', 'VBN', 'I-NP', 'O'), ('aggregation', 'aggregation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('recombinant', 'recombinant', 'JJ', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('temperatures', 'temperature', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('improve', 'improve', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('solubility', 'solubility', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('variety', 'variety', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The method utilizes changes in quantum yield occurring during ligand binding [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('utilizes', 'utilize', 'VBZ', 'B-VP', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('quantum', 'quantum', 'NN', 'B-NP', 'O'), ('yield', 'yield', 'NN', 'I-NP', 'O'), ('occurring', 'occur', 'VBG', 'B-VP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('ligand', 'ligand', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A nonspecific decrease in fluorescence at this wavelength , which is largely due to the inner filter effect , is accounted for by graphical correction ( dashed line ) as previously described [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('nonspecific', 'nonspecific', 'JJ', 'I-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('wavelength', 'wavelength', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('largely', 'largely', 'RB', 'B-ADJP', 'O'), ('due', 'due', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inner', 'inner', 'JJ', 'I-NP', 'O'), ('filter', 'filter', 'NN', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('accounted', 'account', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('graphical', 'graphical', 'JJ', 'B-NP', 'O'), ('correction', 'correction', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('dashed', 'dash', 'VBN', 'B-NP', 'O'), ('line', 'line', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	9-AS has been previously used to study the fatty-acid binding properties of native bovine IRBP [ CIT ] .	[('9-AS', '9-AS', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('study', 'study', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fatty-acid', 'fatty-acid', 'JJ', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('native', 'native', 'JJ', 'B-NP', 'O'), ('bovine', 'bovine', 'JJ', 'I-NP', 'O'), ('IRBP', 'IRBP', 'NN', 'I-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , site II , delineated by residues Pro62 , Arg63 , Val65 , Lys67 , Asp71 , Thr72 , Leu73 , Ser239 , Gly240 , Met243 , His244 , Ser245 , Val247 , Thr258 , Leu273 , Gly274 and Gly275 , has a number of polar side chains and is situated at the interface between the A and the C-terminal B domains [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('site', 'site', 'NN', 'B-NP', 'B-DNA'), ('II', 'II', 'CD', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('delineated', 'delineate', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('Pro62', 'Pro62', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Arg63', 'Arg63', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Val65', 'Val65', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Lys67', 'Lys67', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Asp71', 'Asp71', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Thr72', 'Thr72', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Leu73', 'Leu73', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Ser239', 'Ser239', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Gly240', 'Gly240', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Met243', 'Met243', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('His244', 'His244', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Ser245', 'Ser245', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Val247', 'Val247', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Thr258', 'Thr258', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Leu273', 'Leu273', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Gly274', 'Gly274', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Gly275', 'Gly275', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('polar', 'polar', 'JJ', 'B-NP', 'B-protein'), ('side', 'side', 'NN', 'I-NP', 'I-protein'), ('chains', 'chain', 'NNS', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('situated', 'situate', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interface', 'interface', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('B', 'B', 'NN', 'I-NP', 'I-protein'), ('domains', 'domain', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Site II , the hydrophobic region between the two domains was previously thought to represent the putative ligand-binding site within X2IRBP [ CIT ] .	[('Site', 'Site', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'I-NP', 'B-protein'), ('region', 'region', 'NN', 'I-NP', 'I-protein'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('domains', 'domain', 'NNS', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('thought', 'think', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('represent', 'represent', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'B-DNA'), ('ligand-binding', 'ligand-binding', 'JJ', 'I-NP', 'I-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('within', 'within', 'IN', 'B-PP', 'O'), ('X2IRBP', 'X2IRBP', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The sizes of plaques were evaluated [ CIT ] λ red-gam-χ0 formed small plaques , λ red-gam-χ+ formed medium plaques , and λ red+gam+ formed large plaques .	[('The', 'The', 'DT', 'B-NP', 'O'), ('sizes', 'size', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('plaques', 'plaque', 'NNS', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('evaluated', 'evaluate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'I-NP', 'O'), ('λ', 'λ', 'NN', 'I-NP', 'O'), ('red-gam-χ0', 'red-gam-χ0', 'NN', 'I-NP', 'O'), ('formed', 'form', 'VBD', 'B-VP', 'O'), ('small', 'small', 'JJ', 'B-NP', 'O'), ('plaques', 'plaque', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('λ', 'λ', 'VBP', 'B-VP', 'O'), ('red-gam-χ+', 'red-gam-χ+', 'JJ', 'B-NP', 'O'), ('formed', 'form', 'VBN', 'I-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('plaques', 'plaque', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('λ', 'λ', 'VB', 'B-VP', 'O'), ('red+gam+', 'red+gam+', 'JJ', 'B-NP', 'O'), ('formed', 'form', 'VBN', 'I-NP', 'O'), ('large', 'large', 'JJ', 'I-NP', 'O'), ('plaques', 'plaque', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , EGFP-cPLA2 is functional since it dose-dependently catalyzes release of AA when expressed in cells that lack endogenous cPLA2 , such as Sf9 cells [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('EGFP-cPLA2', 'EGFP-cPLA2', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('functional', 'functional', 'JJ', 'B-ADJP', 'O'), ('since', 'since', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('dose-dependently', 'dose-dependently', 'RB', 'B-ADVP', 'O'), ('catalyzes', 'catalyze', 'VBZ', 'B-VP', 'O'), ('release', 'release', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('AA', 'AA', 'NN', 'B-NP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('expressed', 'express', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('lack', 'lack', 'VBP', 'B-VP', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'B-protein'), ('cPLA2', 'cPLA2', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('Sf9', 'Sf9', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In order to enhance AA release in cells containing endogenous cPLA2 , it is necessary to over-express the enzyme several fold as previously reported [ CIT ] .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('enhance', 'enhance', 'VB', 'I-VP', 'O'), ('AA', 'AA', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'B-protein'), ('cPLA2', 'cPLA2', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('necessary', 'necessary', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('over-express', 'over-express', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'O'), ('several', 'several', 'JJ', 'B-ADJP', 'O'), ('fold', 'fold', 'RB', 'I-ADJP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Cytosolic PLA2 has been shown to mediate Ca2+-induced AA release in MDCK cells treated with ATP and IONO in experiments using the group IV cPLA2α-specific inhibitor pyrrolidine-1 [ CIT ] .	[('Cytosolic', 'Cytosolic', 'JJ', 'B-NP', 'B-protein'), ('PLA2', 'PLA2', 'NN', 'I-NP', 'I-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('mediate', 'mediate', 'VB', 'I-VP', 'O'), ('Ca2+-induced', 'Ca2+-induced', 'JJ', 'B-NP', 'O'), ('AA', 'AA', 'NN', 'I-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('MDCK', 'MDCK', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('treated', 'treat', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('ATP', 'ATP', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('IONO', 'IONO', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('experiments', 'experiment', 'NNS', 'B-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('IV', 'IV', 'CD', 'I-NP', 'O'), ('cPLA2α-specific', 'cPLA2α-specific', 'JJ', 'I-NP', 'O'), ('inhibitor', 'inhibitor', 'NN', 'I-NP', 'O'), ('pyrrolidine-1', 'pyrrolidine-1', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	AA release was measured at 3 min because we have shown that ATP- and IONO-stimulated AA release peaks between 3 to 5 min post-stimulation [ CIT ] .	[('AA', 'AA', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('measured', 'measure', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('min', 'min', 'NN', 'I-NP', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('ATP-', 'ATP-', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('IONO-stimulated', 'IONO-stimulated', 'JJ', 'B-NP', 'O'), ('AA', 'AA', 'NN', 'I-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('peaks', 'peak', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('to', 'to', 'TO', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), ('min', 'min', 'NN', 'I-NP', 'O'), ('post-stimulation', 'post-stimulation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Work in our laboratory has shown that recognition of ERK by anti-phospho-ERK antibodies correlates with an increase in ERK activity [ CIT ] .	[('Work', 'Work', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('laboratory', 'laboratory', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('recognition', 'recognition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ERK', 'ERK', 'NN', 'B-NP', 'B-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('anti-phospho-ERK', 'anti-phospho-ERK', 'JJ', 'B-NP', 'B-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('correlates', 'correlate', 'VBZ', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ERK', 'ERK', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We have previously reported that p38 is also selectively activated in anisomycin-treated macrophages [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('p38', 'p38', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('selectively', 'selectively', 'RB', 'B-VP', 'O'), ('activated', 'activate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('anisomycin-treated', 'anisomycin-treated', 'JJ', 'B-NP', 'B-cell_type'), ('macrophages', 'macrophage', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	This observation is consistent with our previous results [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These studies show extensive translocation to the endoplasmic reticulum ( ER ) , nuclear envelope and Golgi [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('show', 'show', 'VBP', 'B-VP', 'O'), ('extensive', 'extensive', 'JJ', 'B-NP', 'O'), ('translocation', 'translocation', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('endoplasmic', 'endoplasmic', 'JJ', 'I-NP', 'O'), ('reticulum', 'reticulum', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('ER', 'ER', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('nuclear', 'nuclear', 'JJ', 'B-NP', 'O'), ('envelope', 'envelope', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Golgi', 'Golgi', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Translocation of cPLA2 S505A in CHO cells has been reported in response to ionophore stimulation [ CIT ] , but the effect of Ser505 phosphorylation on the kinetics of translocation , targeting , and in response to a physiological agonist was not investigated .	[('Translocation', 'Translocation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cPLA2', 'cPLA2', 'NN', 'B-NP', 'B-protein'), ('S505A', 'S505A', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('CHO', 'CHO', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('response', 'response', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('ionophore', 'ionophore', 'NN', 'B-NP', 'O'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ser505', 'Ser505', 'NN', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('kinetics', 'kinetic', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('translocation', 'translocation', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('targeting', 'targeting', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('response', 'response', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('physiological', 'physiological', 'JJ', 'I-NP', 'O'), ('agonist', 'agonist', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('investigated', 'investigate', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously reported [ CIT ] , the cPLA2 S727A mutation has a similar phenotype on AA release as the S505A mutation and Ser727 was found to be phosphorylated in tandem with Ser505 .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cPLA2', 'cPLA2', 'NN', 'I-NP', 'O'), ('S727A', 'S727A', 'NN', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('phenotype', 'phenotype', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('AA', 'AA', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('S505A', 'S505A', 'NN', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Ser727', 'Ser727', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('tandem', 'tandem', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('Ser505', 'Ser505', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	To produce Thr160-phosphorylated Cdk2 ( [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('produce', 'produce', 'VB', 'I-VP', 'O'), ('Thr160-phosphorylated', 'Thr160-phosphorylated', 'JJ', 'B-NP', 'B-protein'), ('Cdk2', 'Cdk2', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously reported [ CIT ] Cdk2 by itself displays a low but detectable histone H1 kinase activity ( Fig. 1A-B ) .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('Cdk2', 'Cdk2', 'NN', 'B-NP', 'B-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('itself', 'itself', 'PRP', 'B-NP', 'O'), ('displays', 'display', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('low', 'low', 'JJ', 'I-NP', 'O'), ('but', 'but', 'CC', 'I-NP', 'O'), ('detectable', 'detectable', 'JJ', 'I-NP', 'O'), ('histone', 'histone', 'NN', 'I-NP', 'B-protein'), ('H1', 'H1', 'NN', 'I-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1A-B', '1A-B', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have found that the previously reported mammalian Speedy / Ringo protein , Spy1 , is expressed as two closely related proteins resulting from alternative splicing [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('mammalian', 'mammalian', 'JJ', 'I-NP', 'O'), ('Speedy', 'Speedy', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('Ringo', 'Ringo', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('Spy1', 'Spy1', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('closely', 'closely', 'RB', 'I-NP', 'O'), ('related', 'related', 'JJ', 'I-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('resulting', 'result', 'VBG', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('alternative', 'alternative', 'JJ', 'B-NP', 'O'), ('splicing', 'splicing', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We next evaluated the substrate specificity of Cdk2-Speedy / Ringo A2 at the +3 position in more detail using a panel of GST-KSPRX substrates [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('next', 'next', 'RB', 'B-ADVP', 'O'), ('evaluated', 'evaluate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('specificity', 'specificity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cdk2-Speedy', 'Cdk2-Speedy', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('Ringo', 'Ringo', 'NN', 'I-NP', 'I-protein'), ('A2', 'A2', 'NN', 'I-NP', 'I-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('+3', '+3', 'NN', 'I-NP', 'B-DNA'), ('position', 'position', 'NN', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('more', 'more', 'JJR', 'B-NP', 'O'), ('detail', 'detail', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('panel', 'panel', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('GST-KSPRX', 'GST-KSPRX', 'NN', 'B-NP', 'B-protein'), ('substrates', 'substrate', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Although [ CIT ] .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	These results differ significantly from those obtained using Cdk2-cyclin A , which has a KM for phosphorylation of histone H1 of 0.8 μM [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('differ', 'differ', 'VBP', 'B-VP', 'O'), ('significantly', 'significantly', 'RB', 'B-ADVP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('Cdk2-cyclin', 'Cdk2-cyclin', 'NN', 'B-NP', 'B-protein'), ('A', 'A', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('KM', 'KM', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('histone', 'histone', 'NN', 'B-NP', 'B-protein'), ('H1', 'H1', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('0.8', '0.8', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Autoamplification of Cdc2 activity at the G2 / M transition was proposed more than a decade ago [ CIT ] .	[('Autoamplification', 'Autoamplification', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cdc2', 'Cdc2', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('G2', 'G2', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('M', 'M', 'NN', 'I-NP', 'O'), ('transition', 'transition', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('proposed', 'propose', 'VBN', 'I-VP', 'O'), ('more', 'more', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('decade', 'decade', 'NN', 'I-NP', 'O'), ('ago', 'ago', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	All three mammalian Cdc25 isoforms ( A , B , and C ) can be phosphorylated on multiple sites by CDK-cyclin complexes ( reviewed in [ CIT ] ) .	[('All', 'All', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('mammalian', 'mammalian', 'JJ', 'I-NP', 'B-protein'), ('Cdc25', 'Cdc25', 'NN', 'I-NP', 'I-protein'), ('isoforms', 'isoform', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('A', 'A', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('B', 'B', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('C', 'C', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('multiple', 'multiple', 'JJ', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('CDK-cyclin', 'CDK-cyclin', 'JJ', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('reviewed', 'review', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In addition , like Cdk2-Speedy / Ringo A2 , monomeric [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('like', 'like', 'IN', 'B-PP', 'O'), ('Cdk2-Speedy', 'Cdk2-Speedy', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('Ringo', 'Ringo', 'NN', 'B-NP', 'B-protein'), ('A2', 'A2', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('monomeric', 'monomeric', 'JJ', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Structural studies indicate that the activation loop in monomeric [ CIT ] .	[('Structural', 'Structural', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('indicate', 'indicate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('monomeric', 'monomeric', 'JJ', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Finally , we examined the T-loop conformation in the Cdk2-Speedy / Ringo A2 complex using serine / threonine protein phosphatase type 2C ( PP2C ) [ CIT ] .	[('Finally', 'Finally', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('T-loop', 'T-loop', 'JJ', 'I-NP', 'O'), ('conformation', 'conformation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Cdk2-Speedy', 'Cdk2-Speedy', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('Ringo', 'Ringo', 'NN', 'I-NP', 'B-protein'), ('A2', 'A2', 'NN', 'I-NP', 'I-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('serine', 'serine', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('threonine', 'threonine', 'NN', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('phosphatase', 'phosphatase', 'NN', 'I-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'O'), ('2C', '2C', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('PP2C', 'PP2C', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As described previously [ CIT ] , cyclin A fully blocked the dephosphorylation of Cdk2 ( Fig. 7C , compare lanes 3 and 4 ) .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('cyclin', 'cyclin', 'NN', 'B-NP', 'B-protein'), ('A', 'A', 'NN', 'I-NP', 'I-protein'), ('fully', 'fully', 'RB', 'B-ADVP', 'O'), ('blocked', 'block', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dephosphorylation', 'dephosphorylation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cdk2', 'Cdk2', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('7C', '7C', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('compare', 'compare', 'NN', 'B-NP', 'O'), ('lanes', 'lane', 'NNS', 'I-NP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
8	RAD51 unwinds dsDNA [ CIT ] , but the underlying mechanism of this process with respect to biochemical reaction conditions is far from clear .	[('RAD51', 'RAD51', 'NN', 'B-NP', 'B-protein'), ('unwinds', 'unwind', 'VBZ', 'B-VP', 'O'), ('dsDNA', 'dsDNA', 'NN', 'B-NP', 'B-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('underlying', 'underlie', 'VBG', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('respect', 'respect', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('biochemical', 'biochemical', 'JJ', 'B-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('far', 'far', 'RB', 'B-ADVP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('clear', 'clear', 'JJ', 'B-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Thus unwinding appears to be ATP binding but not hydrolysis dependent , as not only ATP but also its non-hydrolysable analogs support the process , which is in congruence with previously published reports [ CIT ] .	[('Thus', 'Thus', 'RB', 'B-NP', 'O'), ('unwinding', 'unwinding', 'NN', 'I-NP', 'O'), ('appears', 'appear', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('ATP', 'ATP', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('but', 'but', 'CC', 'B-NP', 'O'), ('not', 'not', 'RB', 'I-NP', 'O'), ('hydrolysis', 'hydrolysis', 'NN', 'B-NP', 'O'), ('dependent', 'dependent', 'JJ', 'B-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('not', 'not', 'RB', 'B-CONJP', 'O'), ('only', 'only', 'RB', 'I-CONJP', 'O'), ('ATP', 'ATP', 'NN', 'B-NP', 'O'), ('but', 'but', 'CC', 'B-CONJP', 'O'), ('also', 'also', 'RB', 'I-CONJP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('non-hydrolysable', 'non-hydrolysable', 'JJ', 'I-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('support', 'support', 'VBP', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('congruence', 'congruence', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	But in fact , even this observation is consistent with earlier result that RAD51 binds ssDNA sufficiently well that it promotes strand annealing even in ADP conditions , a property starkly contrasting with that of well studied E. coli RecA protein [ CIT ] .	[('But', 'But', 'CC', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fact', 'fact', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('even', 'even', 'RB', 'B-NP', 'O'), ('this', 'this', 'DT', 'I-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('earlier', 'early', 'JJR', 'B-ADJP', 'O'), ('result', 'result', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RAD51', 'RAD51', 'NN', 'B-NP', 'B-protein'), ('binds', 'bind', 'VBZ', 'B-VP', 'O'), ('ssDNA', 'ssDNA', 'NN', 'B-NP', 'O'), ('sufficiently', 'sufficiently', 'RB', 'B-ADVP', 'O'), ('well', 'well', 'RB', 'I-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('promotes', 'promote', 'VBZ', 'B-VP', 'O'), ('strand', 'strand', 'NN', 'B-NP', 'O'), ('annealing', 'anneal', 'VBG', 'B-VP', 'O'), ('even', 'even', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ADP', 'ADP', 'NN', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('property', 'property', 'NN', 'I-NP', 'O'), ('starkly', 'starkly', 'RB', 'B-VP', 'O'), ('contrasting', 'contrast', 'VBG', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('well', 'well', 'RB', 'B-ADVP', 'O'), ('studied', 'study', 'VBN', 'B-VP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('RecA', 'RecA', 'NN', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This was so in all nucleotide conditions , suggesting RAD51 binding to dsDNA was not dependent on nucleotide cofactor conditions ( lanes 2-4 & 8-10 , Panel A : lanes 1-3 & 7-9 , Panels B & C , Fig. 4 ) which is consistent with previously published reports [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('so', 'so', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('RAD51', 'RAD51', 'NN', 'B-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('dsDNA', 'dsDNA', 'NN', 'B-NP', 'B-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('dependent', 'dependent', 'JJ', 'B-ADJP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('nucleotide', 'nucleotide', 'NN', 'B-NP', 'O'), ('cofactor', 'cofactor', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('lanes', 'lane', 'NNS', 'B-NP', 'O'), ('2-4', '2-4', 'CD', 'B-NP', 'O'), ('&', '&', 'CC', 'I-NP', 'O'), ('8-10', '8-10', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Panel', 'Panel', 'NNP', 'B-NP', 'O'), ('A', 'A', 'NNP', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('lanes', 'lane', 'NNS', 'B-NP', 'O'), ('1-3', '1-3', 'CD', 'B-NP', 'O'), ('&', '&', 'CC', 'I-NP', 'O'), ('7-9', '7-9', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Panels', 'Panel', 'NNPS', 'B-NP', 'O'), ('B', 'B', 'NNP', 'I-NP', 'O'), ('&', '&', 'CC', 'I-NP', 'O'), ('C', 'C', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Under same conditions , binding of RAD52 alone to dsDNA generated large protein-DNA complexes that failed to enter the gel ( Panel D , Fig. 4 ) as reported earlier [ CIT ] .	[('Under', 'Under', 'IN', 'B-PP', 'O'), ('same', 'same', 'JJ', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('RAD52', 'RAD52', 'NN', 'B-NP', 'B-protein'), ('alone', 'alone', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('dsDNA', 'dsDNA', 'NN', 'B-NP', 'B-DNA'), ('generated', 'generate', 'VBD', 'B-VP', 'O'), ('large', 'large', 'JJ', 'B-NP', 'B-protein'), ('protein-DNA', 'protein-DNA', 'JJ', 'I-NP', 'I-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('failed', 'fail', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('enter', 'enter', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Panel', 'Panel', 'NNP', 'B-NP', 'O'), ('D', 'D', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('earlier', 'earlier', 'RBR', 'B-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We speculate that these complexes in fact , may represent " co-aggregates " as both proteins are known to interact with each other in these reaction conditions [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('speculate', 'speculate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('complexes', 'complex', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fact', 'fact', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('represent', 'represent', 'VB', 'I-VP', 'O'), ('``', '``', '``', 'O', 'O'), ('co-aggregates', 'co-aggregate', 'NNS', 'B-NP', 'O'), ('``', '``', '``', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Actually , it has been reported that a protein 's resistance to proteolysis increases with its conformational stability [ CIT ] .	[('Actually', 'Actually', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ("'s", "'s", 'POS', 'B-NP', 'O'), ('resistance', 'resistance', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('proteolysis', 'proteolysis', 'NN', 'B-NP', 'O'), ('increases', 'increase', 'VBZ', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('conformational', 'conformational', 'JJ', 'I-NP', 'O'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Thiol-disulfide interchanges have been reported in proteins [ CIT ] .	[('Thiol-disulfide', 'Thiol-disulfide', 'JJ', 'B-NP', 'O'), ('interchanges', 'interchange', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('proteins', 'protein', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To test the relevance of this phenomenon for stability , we used the " foot printing system " of Tullius and Dombrowski [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('test', 'test', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('relevance', 'relevance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('phenomenon', 'phenomenon', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('stability', 'stability', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('``', '``', '``', 'I-NP', 'O'), ('foot', 'foot', 'NN', 'I-NP', 'O'), ('printing', 'printing', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('``', '``', '``', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Tullius', 'Tullius', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Dombrowski', 'Dombrowski', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	As increasing the hydrophobicity of buried residues usually increases the stabilityof proteins [ CIT ] , we may hypothesize that this rule applied here .	[('As', 'As', 'IN', 'B-PP', 'O'), ('increasing', 'increase', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrophobicity', 'hydrophobicity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('buried', 'bury', 'VBN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('usually', 'usually', 'RB', 'B-ADVP', 'O'), ('increases', 'increase', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('stabilityof', 'stabilityof', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('hypothesize', 'hypothesize', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('rule', 'rule', 'NN', 'I-NP', 'O'), ('applied', 'apply', 'VBN', 'B-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been demonstrated that polyamines cause a decrease in the E. coli ODC mRNA and protein levels and that the specific activity of ODC decreases significantly more than its protein levels , due to its post-translational inhibition by antizyme ( s ) [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('polyamines', 'polyamine', 'NNS', 'B-NP', 'O'), ('cause', 'cause', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('ODC', 'ODC', 'NN', 'I-NP', 'B-RNA'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA'), ('and', 'and', 'CC', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ODC', 'ODC', 'NN', 'B-NP', 'B-cell_type'), ('decreases', 'decrease', 'VBZ', 'B-VP', 'O'), ('significantly', 'significantly', 'RB', 'B-NP', 'O'), ('more', 'more', 'JJR', 'I-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('due', 'due', 'JJ', 'B-PP', 'O'), ('to', 'to', 'TO', 'I-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('post-translational', 'post-translational', 'JJ', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('antizyme', 'antizyme', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('s', 's', 'NNS', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Since growth of E. coli cells in the presence of polyamines results in decreased ODC protein levels [ CIT ] , it was investigated whether the reduced ODC activity in extracts from polyamine analogue-exposed cells ( Table 3 ) similarly resulted from such a reduction .	[('Since', 'Since', 'IN', 'B-PP', 'O'), ('growth', 'growth', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'B-cell_type'), ('coli', 'coli', 'FW', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('polyamines', 'polyamine', 'NNS', 'B-NP', 'O'), ('results', 'result', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('decreased', 'decrease', 'VBN', 'B-NP', 'O'), ('ODC', 'ODC', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('investigated', 'investigate', 'VBN', 'I-VP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reduced', 'reduce', 'VBN', 'I-NP', 'O'), ('ODC', 'ODC', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('extracts', 'extract', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('polyamine', 'polyamine', 'NN', 'B-NP', 'B-cell_line'), ('analogue-exposed', 'analogue-exposed', 'JJ', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('similarly', 'similarly', 'RB', 'B-ADVP', 'O'), ('resulted', 'result', 'VBD', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('a', 'a', 'DT', 'I-NP', 'O'), ('reduction', 'reduction', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Optimal activities were found at 0.01 % SDS in both yeast strains as reported by others [ CIT ] and that seemed to reflect a convergence ( Figs. 1A and 1B ) .	[('Optimal', 'Optimal', 'JJ', 'B-NP', 'O'), ('activities', 'activity', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('0.01', '0.01', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('SDS', 'SDS', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('yeast', 'yeast', 'NN', 'I-NP', 'O'), ('strains', 'strain', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('others', 'other', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('seemed', 'seem', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('reflect', 'reflect', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('convergence', 'convergence', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figs.', 'Figs.', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('1B', '1B', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The SDS appeared to inactivate LRR-activity as previously found by Thomas et al. ( Fig. 1C ) [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('SDS', 'SDS', 'NN', 'I-NP', 'O'), ('appeared', 'appear', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('inactivate', 'inactivate', 'VB', 'I-VP', 'O'), ('LRR-activity', 'LRR-activity', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Thomas', 'Thomas', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'FW', 'B-NP', 'O'), ('1C', '1C', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The polyunsaturated fatty acid , linolenic acid , is another well-known activator of the 20S proteasome [ CIT ] and its effect on hydrolysis of peptidyl substrates was also evaluated ( Fig. 2 ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('polyunsaturated', 'polyunsaturated', 'JJ', 'I-NP', 'O'), ('fatty', 'fatty', 'JJ', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('linolenic', 'linolenic', 'JJ', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('another', 'another', 'DT', 'B-NP', 'O'), ('well-known', 'well-known', 'JJ', 'I-NP', 'O'), ('activator', 'activator', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('hydrolysis', 'hydrolysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('peptidyl', 'peptidyl', 'NN', 'B-NP', 'B-protein'), ('substrates', 'substrate', 'NNS', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('evaluated', 'evaluate', 'VBN', 'I-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Our findings are similar to those of Thomas et al. [ CIT ] who reported linolenic acid-mediated stimulation of LLVY-activity and LLE-activity of the 20S proteasome from Ostrich skeletal muscle at pH 9.0 , and inactivation of LRR-activity by the same acid .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Thomas', 'Thomas', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('linolenic', 'linolenic', 'JJ', 'B-NP', 'O'), ('acid-mediated', 'acid-mediated', 'JJ', 'I-NP', 'O'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LLVY-activity', 'LLVY-activity', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('LLE-activity', 'LLE-activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Ostrich', 'Ostrich', 'JJ', 'B-NP', 'O'), ('skeletal', 'skeletal', 'JJ', 'I-NP', 'O'), ('muscle', 'muscle', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('pH', 'pH', 'NN', 'B-NP', 'O'), ('9.0', '9.0', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('inactivation', 'inactivation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LRR-activity', 'LRR-activity', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This observation is similar to the findings of Yanagawa et al. [ CIT ] who conducted a comparative study of the effect of reaction pH on three peptidase activities of the 20S proteasome from rice and spinach .	[('This', 'This', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Yanagawa', 'Yanagawa', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('conducted', 'conduct', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('comparative', 'comparative', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('reaction', 'reaction', 'NN', 'B-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('peptidase', 'peptidase', 'NN', 'I-NP', 'O'), ('activities', 'activity', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('rice', 'rice', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('spinach', 'spinach', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Hoffman et al. [ CIT ] identified two electrophoretic forms of the 20S proteasome from rabbit reticulocytes , a slow form ( 20SS ) and a fast form ( 20SF ) , and demonstrated the latter to be less active in the hydrolysis of the fluorogenic peptide Suc-LLVY-MCA .	[('Hoffman', 'Hoffman', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('electrophoretic', 'electrophoretic', 'JJ', 'I-NP', 'O'), ('forms', 'form', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('rabbit', 'rabbit', 'NN', 'B-NP', 'B-cell_type'), ('reticulocytes', 'reticulocyte', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('slow', 'slow', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('20SS', '20SS', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('fast', 'fast', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('20SF', '20SF', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('latter', 'latter', 'JJ', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('active', 'active', 'JJ', 'I-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrolysis', 'hydrolysis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fluorogenic', 'fluorogenic', 'JJ', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('Suc-LLVY-MCA', 'Suc-LLVY-MCA', 'NNP', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Groll et al. [ CIT ] demonstrated that the channel of the 20S proteasome is too narrow for substrate entry , but that the proteasome may become active when the channel is open .	[('Groll', 'Groll', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('channel', 'channel', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('too', 'too', 'RB', 'B-ADJP', 'O'), ('narrow', 'narrow', 'JJ', 'I-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('substrate', 'substrate', 'NN', 'B-NP', 'O'), ('entry', 'entry', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'B-protein'), ('may', 'may', 'MD', 'B-VP', 'O'), ('become', 'become', 'VB', 'I-VP', 'O'), ('active', 'active', 'JJ', 'B-ADJP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('channel', 'channel', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('open', 'open', 'JJ', 'B-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Phosphorylation of the proteasome has been reported to modulate a number of functions including catalytic activity [ CIT ] .	[('Phosphorylation', 'Phosphorylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('modulate', 'modulate', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('functions', 'function', 'NNS', 'B-NP', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('catalytic', 'catalytic', 'JJ', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Iwafune et al. [ CIT ] demonstrated that the α7-subunit in yeast is a major phosphorylatable subunit .	[('Iwafune', 'Iwafune', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α7-subunit', 'α7-subunit', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('major', 'major', 'JJ', 'I-NP', 'B-protein'), ('phosphorylatable', 'phosphorylatable', 'JJ', 'I-NP', 'I-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	Regulation of the proteasome complex by phosphorylation of the α7-subunit in COS-7 cells has been demonstrated by Rivett and colleagues [ CIT ] .	[('Regulation', 'Regulation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α7-subunit', 'α7-subunit', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('COS-7', 'COS-7', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Rivett', 'Rivett', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('colleagues', 'colleague', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Tokumoto et al. [ CIT ] detected a high molecular weight phosphorylated α4-subunit in the 26S proteasome from immature Xenopus oocyte .	[('Tokumoto', 'Tokumoto', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('detected', 'detect', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('high', 'high', 'JJ', 'I-NP', 'B-protein'), ('molecular', 'molecular', 'JJ', 'I-NP', 'I-protein'), ('weight', 'weight', 'NN', 'I-NP', 'I-protein'), ('phosphorylated', 'phosphorylated', 'JJ', 'I-NP', 'I-protein'), ('α4-subunit', 'α4-subunit', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('26S', '26S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('immature', 'immature', 'JJ', 'B-NP', 'B-cell_type'), ('Xenopus', 'Xenopus', 'NN', 'I-NP', 'I-cell_type'), ('oocyte', 'oocyte', 'NN', 'I-NP', 'I-cell_type'), ('.', '.', '.', 'O', 'O')]
2	The rpt6-1 mutant arrests cell division within one cycle at the restrictive temperature [ CIT ] and under normal growth conditions , we found changes in the α1- and α7-subunits of the 20S proteasome in the rpt6-1 mutant .	[('The', 'The', 'DT', 'B-NP', 'O'), ('rpt6-1', 'rpt6-1', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('arrests', 'arrest', 'VBZ', 'B-VP', 'O'), ('cell', 'cell', 'NN', 'B-NP', 'O'), ('division', 'division', 'NN', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('cycle', 'cycle', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('restrictive', 'restrictive', 'JJ', 'I-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('normal', 'normal', 'JJ', 'B-NP', 'O'), ('growth', 'growth', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α1-', 'α1-', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('α7-subunits', 'α7-subunit', 'NNS', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rpt6-1', 'rpt6-1', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	An earlier report [ CIT ] demonstrated that testosterone increased the high-affinity transport of aspartate in the rat ventral prostate cells .	[('An', 'An', 'DT', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('testosterone', 'testosterone', 'NN', 'B-NP', 'O'), ('increased', 'increase', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('high-affinity', 'high-affinity', 'JJ', 'I-NP', 'O'), ('transport', 'transport', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('aspartate', 'aspartate', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rat', 'rat', 'NN', 'I-NP', 'B-cell_type'), ('ventral', 'ventral', 'JJ', 'I-NP', 'I-cell_type'), ('prostate', 'prostate', 'NN', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('.', '.', '.', 'O', 'O')]
1	In addition to testosterone , prolactin also regulates citrate production and key metabolic genes , including mAAT gene expression [ CIT ] ; which caused us to consider the possibility that prolactin might also be important in the regulation of aspartate transport .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('testosterone', 'testosterone', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('prolactin', 'prolactin', 'NN', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('regulates', 'regulate', 'VBZ', 'B-VP', 'O'), ('citrate', 'citrate', 'NN', 'B-NP', 'B-DNA'), ('production', 'production', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'I-DNA'), ('key', 'key', 'JJ', 'B-NP', 'I-DNA'), ('metabolic', 'metabolic', 'JJ', 'I-NP', 'I-DNA'), ('genes', 'gene', 'NNS', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('mAAT', 'mAAT', 'NN', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('caused', 'cause', 'VBD', 'B-VP', 'O'), ('us', 'us', 'PRP', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('consider', 'consider', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('prolactin', 'prolactin', 'NN', 'B-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('aspartate', 'aspartate', 'NN', 'B-NP', 'O'), ('transport', 'transport', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	The effects of testosterone corroborate our earlier report [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('testosterone', 'testosterone', 'NN', 'B-NP', 'O'), ('corroborate', 'corroborate', 'VBP', 'B-VP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It is important to note that the level of hormonal stimulation is less than shown in figure 3 , which is a reflection of the endogenous hormonal effect in the normal animals [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('note', 'note', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('level', 'level', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('hormonal', 'hormonal', 'JJ', 'B-NP', 'O'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('less', 'less', 'JJR', 'B-ADJP', 'O'), ('than', 'than', 'IN', 'B-SBAR', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('figure', 'figure', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('reflection', 'reflection', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('endogenous', 'endogenous', 'JJ', 'I-NP', 'O'), ('hormonal', 'hormonal', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('normal', 'normal', 'JJ', 'I-NP', 'O'), ('animals', 'animal', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have shown that prolactin regulation of metabolic genes in prostate cells is mediated via direct stimulation of the PKC signalling pathway and is mimicked by phorbol ester [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('prolactin', 'prolactin', 'NN', 'B-NP', 'O'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('metabolic', 'metabolic', 'JJ', 'B-NP', 'B-DNA'), ('genes', 'gene', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('prostate', 'prostate', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('mediated', 'mediate', 'VBN', 'I-VP', 'O'), ('via', 'via', 'IN', 'B-PP', 'O'), ('direct', 'direct', 'JJ', 'B-NP', 'O'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PKC', 'PKC', 'NN', 'I-NP', 'B-protein'), ('signalling', 'signalling', 'NN', 'I-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('mimicked', 'mimic', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('phorbol', 'phorbol', 'NN', 'B-NP', 'O'), ('ester', 'ester', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Another approach taken in these rebinding experiments involved treatment of mitochondria with DCCD , which has been previously shown to block site A for HK-I binding [ CIT ] .	[('Another', 'Another', 'DT', 'B-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('taken', 'take', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('rebinding', 'rebind', 'VBG', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('involved', 'involve', 'VBD', 'B-VP', 'O'), ('treatment', 'treatment', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('DCCD', 'DCCD', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('block', 'block', 'VB', 'I-VP', 'O'), ('site', 'site', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('HK-I', 'HK-I', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To analyze these changes in affinity more precisely , the data have been plotted on an average receptor affinity graph as described by DeMeyts and Roth [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('analyze', 'analyze', 'VB', 'I-VP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('changes', 'change', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('affinity', 'affinity', 'NN', 'B-NP', 'O'), ('more', 'more', 'RBR', 'B-ADVP', 'O'), ('precisely', 'precisely', 'RB', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('plotted', 'plot', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('average', 'average', 'JJ', 'I-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('graph', 'graph', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('DeMeyts', 'DeMeyts', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Roth', 'Roth', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Also the RING finger mutant POSHV14A , which is inactive as an E3 ligase and was previously shown to function in a dominant-negative manner [ CIT ] , was efficiently co-immunoprecipitated using anti-ALIX antibodies ( Figure 1A ) .	[('Also', 'Also', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RING', 'RING', 'NN', 'I-NP', 'B-protein'), ('finger', 'finger', 'NN', 'I-NP', 'I-protein'), ('mutant', 'mutant', 'JJ', 'I-NP', 'I-protein'), ('POSHV14A', 'POSHV14A', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('inactive', 'inactive', 'JJ', 'B-ADJP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('E3', 'E3', 'NN', 'I-NP', 'B-protein'), ('ligase', 'ligase', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('function', 'function', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dominant-negative', 'dominant-negative', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('efficiently', 'efficiently', 'RB', 'I-VP', 'O'), ('co-immunoprecipitated', 'co-immunoprecipitate', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('anti-ALIX', 'anti-ALIX', 'JJ', 'B-NP', 'B-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('1A', '1A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The C-terminal PRR of ALIX was the most promising candidate to be targeted by POSH as it was shown to interact with SH3-domains [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('PRR', 'PRR', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ALIX', 'ALIX', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('most', 'most', 'RBS', 'I-NP', 'O'), ('promising', 'promising', 'JJ', 'I-NP', 'O'), ('candidate', 'candidate', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('targeted', 'target', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('POSH', 'POSH', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('SH3-domains', 'SH3-domain', 'NNS', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recent studies demonstrated that overexpression of ALIX can rescue the production of an HIV-1ΔPTAP mutant virus , that otherwise is severely attenuated due to its L-domain deficiency [ CIT ] .	[('Recent', 'Recent', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('overexpression', 'overexpression', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ALIX', 'ALIX', 'NN', 'B-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('rescue', 'rescue', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('production', 'production', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('HIV-1ΔPTAP', 'HIV-1ΔPTAP', 'NN', 'I-NP', 'O'), ('mutant', 'mutant', 'JJ', 'I-NP', 'O'), ('virus', 'virus', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('otherwise', 'otherwise', 'RB', 'B-ADVP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('severely', 'severely', 'RB', 'I-VP', 'O'), ('attenuated', 'attenuate', 'VBN', 'I-VP', 'O'), ('due', 'due', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('L-domain', 'L-domain', 'NN', 'I-NP', 'B-protein'), ('deficiency', 'deficiency', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The overexpression of POSH alone slightly enhanced both the expression of Gag and the release of virus particles ( Figure 4 , lane 2 ) , while overexpression of ALIX dramatically stimulated virus release by approximately 10-fold ( Figure 4 , lane 3 ) as described previously [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('overexpression', 'overexpression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('POSH', 'POSH', 'NN', 'B-NP', 'B-protein'), ('alone', 'alone', 'RB', 'B-ADVP', 'O'), ('slightly', 'slightly', 'RB', 'I-ADVP', 'O'), ('enhanced', 'enhance', 'VBD', 'B-VP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Gag', 'Gag', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('virus', 'virus', 'NN', 'B-NP', 'O'), ('particles', 'particle', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lane', 'lane', 'NN', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('overexpression', 'overexpression', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ALIX', 'ALIX', 'NN', 'B-NP', 'B-protein'), ('dramatically', 'dramatically', 'RB', 'B-ADVP', 'O'), ('stimulated', 'stimulate', 'VBD', 'B-VP', 'O'), ('virus', 'virus', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('10-fold', '10-fold', 'RB', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lane', 'lane', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies already indicated that POSH did not directly interact with HIV-1 Gag [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('already', 'already', 'RB', 'B-ADVP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('POSH', 'POSH', 'NN', 'B-NP', 'B-protein'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('directly', 'directly', 'RB', 'I-VP', 'O'), ('interact', 'interact', 'VBP', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('Gag', 'Gag', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with previous results [ CIT ] , the secondary ΔYP mutation further reduced HIV-1 release and infectivity by an additional 5-fold ( Figure 6 , lanes 1 and 3 ) as this mutation blocks ALIX-Gag interaction and as a result , the ability of ALIX to stimulate virus release .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('secondary', 'secondary', 'JJ', 'I-NP', 'O'), ('ΔYP', 'ΔYP', 'NN', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('further', 'further', 'RBR', 'B-ADVP', 'O'), ('reduced', 'reduce', 'VBD', 'B-VP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('infectivity', 'infectivity', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('additional', 'additional', 'JJ', 'I-NP', 'O'), ('5-fold', '5-fold', 'JJ', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NNP', 'B-NP', 'O'), ('6', '6', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lanes', 'lane', 'NNS', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('blocks', 'block', 'VBZ', 'B-VP', 'O'), ('ALIX-Gag', 'ALIX-Gag', 'NN', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ALIX', 'ALIX', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('virus', 'virus', 'NN', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similar results were obtained when the POSH deficient H310A HeLa cell line was employed [ CIT ] and the ability of ALIX to rescue the release HIV-1 L-domain mutants in these cells was compared to the control cell line H314A ( data no shown ) .	[('Similar', 'Similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('POSH', 'POSH', 'NN', 'I-NP', 'B-cell_line'), ('deficient', 'deficient', 'JJ', 'I-NP', 'I-cell_line'), ('H310A', 'H310A', 'NN', 'I-NP', 'I-cell_line'), ('HeLa', 'HeLa', 'NN', 'I-NP', 'I-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('line', 'line', 'NN', 'I-NP', 'I-cell_line'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('employed', 'employ', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ALIX', 'ALIX', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-VP', 'O'), ('rescue', 'rescue', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('L-domain', 'L-domain', 'NN', 'I-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('compared', 'compare', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('control', 'control', 'NN', 'I-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('line', 'line', 'NN', 'I-NP', 'O'), ('H314A', 'H314A', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('shown', 'show', 'VBN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	HeLa cells have been reported to be resistant to α-sarcin activity [ CIT ] .	[('HeLa', 'HeLa', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('resistant', 'resistant', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This was consistent with reported catalytic activities of α-sarcin and ricin , with ricin demonstrating approximately 100-fold greater catalytic activity than α-sarcin [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('reported', 'report', 'VBN', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activities', 'activity', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('ricin', 'ricin', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('ricin', 'ricin', 'NN', 'B-NP', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('100-fold', '100-fold', 'RB', 'I-NP', 'O'), ('greater', 'great', 'JJR', 'I-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Based on in vitro biochemical assays and cell culture experiments performed with purified α-sarcin , it has been reported that α-sarcin 's toxicity is due to its catalytic ability to inactivate the ribosome and inhibit protein synthesis [ CIT ] .	[('Based', 'Base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('in', 'in', 'FW', 'B-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('assays', 'assay', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('cell', 'cell', 'NN', 'B-NP', 'O'), ('culture', 'culture', 'NN', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('performed', 'perform', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('purified', 'purify', 'VBN', 'B-NP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ("'s", "'s", 'POS', 'B-NP', 'O'), ('toxicity', 'toxicity', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('due', 'due', 'IN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('inactivate', 'inactivate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ribosome', 'ribosome', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('inhibit', 'inhibit', 'VB', 'B-VP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Arginine 121 is located near the catalytic site and although it is not directly involved in catalysis , it is thought to help position the substrate in the correct orientation for cleavage [ CIT ] .	[('Arginine', 'Arginine', 'NN', 'B-NP', 'B-protein'), ('121', '121', 'CD', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('near', 'near', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('directly', 'directly', 'RB', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('catalysis', 'catalysis', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('thought', 'think', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('help', 'help', 'VB', 'I-VP', 'O'), ('position', 'position', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('correct', 'correct', 'JJ', 'I-NP', 'O'), ('orientation', 'orientation', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('cleavage', 'cleavage', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The α-sarcin-R121Q mutant is catalytically attenuated based on in vitro biochemical assays [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('α-sarcin-R121Q', 'α-sarcin-R121Q', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('catalytically', 'catalytically', 'RB', 'I-VP', 'O'), ('attenuated', 'attenuate', 'VBN', 'I-VP', 'O'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('in', 'in', 'FW', 'B-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('assays', 'assay', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Measurement of GFP fluorescence in α-sarcin-R121Q transfected cells revealed that the mutant was attenuated with respect to its ability to inhibit GFP expression , which is consistent with data implicating R121Q involvement in catalysis ( Figure 2a ) [ CIT ] .	[('Measurement', 'Measurement', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('GFP', 'GFP', 'NN', 'B-NP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('α-sarcin-R121Q', 'α-sarcin-R121Q', 'NN', 'B-NP', 'B-cell_line'), ('transfected', 'transfecte', 'VBN', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutant', 'mutant', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('attenuated', 'attenuate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('respect', 'respect', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('inhibit', 'inhibit', 'VB', 'I-VP', 'O'), ('GFP', 'GFP', 'NN', 'B-NP', 'B-protein'), ('expression', 'expression', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('implicating', 'implicate', 'VBG', 'B-VP', 'O'), ('R121Q', 'R121Q', 'NN', 'B-NP', 'O'), ('involvement', 'involvement', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('catalysis', 'catalysis', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2a', '2a', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	The finding that α-sarcin-R121Q retained toxicity is contrary to the widely held view that ribotoxins induce apoptosis by blocking protein synthesis [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('α-sarcin-R121Q', 'α-sarcin-R121Q', 'NN', 'B-NP', 'B-protein'), ('retained', 'retain', 'VBN', 'I-NP', 'O'), ('toxicity', 'toxicity', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('contrary', 'contrary', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('widely', 'widely', 'RB', 'I-NP', 'O'), ('held', 'held', 'JJ', 'I-NP', 'O'), ('view', 'view', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('ribotoxins', 'ribotoxin', 'NNS', 'B-NP', 'B-protein'), ('induce', 'induce', 'VBP', 'B-VP', 'O'), ('apoptosis', 'apoptosis', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('blocking', 'block', 'VBG', 'B-VP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As discussed , Histidine-137 is essential for catalytic activity of α-sarcin , acting as a general acid in the initial transphosphorylation step of the hydrolysis reaction [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('discussed', 'discuss', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('Histidine-137', 'Histidine-137', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('essential', 'essential', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('catalytic', 'catalytic', 'JJ', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('acting', 'act', 'VBG', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('general', 'general', 'JJ', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('initial', 'initial', 'JJ', 'I-NP', 'O'), ('transphosphorylation', 'transphosphorylation', 'NN', 'I-NP', 'O'), ('step', 'step', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrolysis', 'hydrolysis', 'NN', 'I-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The H137Q has been shown to be catalytically inactive against ribosomes and dinucleotide substrates in vitro [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('H137Q', 'H137Q', 'NN', 'I-NP', 'B-DNA'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('catalytically', 'catalytically', 'RB', 'B-ADJP', 'O'), ('inactive', 'inactive', 'JJ', 'I-ADJP', 'O'), ('against', 'against', 'IN', 'B-PP', 'O'), ('ribosomes', 'ribosome', 'NNS', 'B-NP', 'B-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('dinucleotide', 'dinucleotide', 'NN', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	Our results are in contrast with a previous study using the H137Q mutant that concluded that α-sarcin toxicity was dependent upon its catalytic activity [ CIT ] .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('H137Q', 'H137Q', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('concluded', 'conclude', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'O'), ('toxicity', 'toxicity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('dependent', 'dependent', 'JJ', 'B-ADJP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The 28S rRNA has been proposed to act as a sensor for ribotoxic stress ; α-sarcin has been shown to induce Jun N-terminal kinase ( JNK ) activation and phosphorylation through damage to the sarcin-ricin loop of the 28S rRNA [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('28S', '28S', 'NN', 'I-NP', 'B-RNA'), ('rRNA', 'rRNA', 'NN', 'I-NP', 'I-RNA'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('proposed', 'propose', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('act', 'act', 'VB', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('sensor', 'sensor', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('ribotoxic', 'ribotoxic', 'JJ', 'B-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('induce', 'induce', 'VB', 'I-VP', 'O'), ('Jun', 'Jun', 'NN', 'B-NP', 'B-protein'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('JNK', 'JNK', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('activation', 'activation', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'B-NP', 'O'), ('through', 'through', 'IN', 'B-PP', 'O'), ('damage', 'damage', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sarcin-ricin', 'sarcin-ricin', 'NN', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('28S', '28S', 'NN', 'I-NP', 'B-RNA'), ('rRNA', 'rRNA', 'NN', 'I-NP', 'I-RNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with the notion that 28S rRNA damage is responsible for initiating this stress response [ CIT ] and rules out the possible explanation that the mutants retain sufficient activity against the sarcin-ricin loop to induce apoptosis through a JNK mediated stress response .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('notion', 'notion', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('28S', '28S', 'NN', 'B-NP', 'O'), ('rRNA', 'rRNA', 'NN', 'I-NP', 'O'), ('damage', 'damage', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('responsible', 'responsible', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('initiating', 'initiate', 'VBG', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('rules', 'rule', 'VBZ', 'B-VP', 'O'), ('out', 'out', 'RP', 'B-PRT', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('possible', 'possible', 'JJ', 'I-NP', 'O'), ('explanation', 'explanation', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('retain', 'retain', 'VBP', 'B-VP', 'O'), ('sufficient', 'sufficient', 'JJ', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('against', 'against', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sarcin-ricin', 'sarcin-ricin', 'NN', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('induce', 'induce', 'VB', 'I-VP', 'O'), ('apoptosis', 'apoptosis', 'NN', 'B-NP', 'O'), ('through', 'through', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('JNK', 'JNK', 'NN', 'I-NP', 'B-protein'), ('mediated', 'mediated', 'JJ', 'I-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recent studies have shown that α-sarcin binds to the ribosome through electrostatic interactions that lie outside of the catalytic site [ CIT ] .	[('Recent', 'Recent', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ('binds', 'bind', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ribosome', 'ribosome', 'NN', 'I-NP', 'O'), ('through', 'through', 'IN', 'B-PP', 'O'), ('electrostatic', 'electrostatic', 'JJ', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('lie', 'lie', 'VBP', 'B-VP', 'O'), ('outside', 'outside', 'IN', 'B-ADVP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	α-Sarcin has been shown to kill cells by apoptotic induction [ CIT ] .	[('α-Sarcin', 'α-Sarcin', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('kill', 'kill', 'VB', 'I-VP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('apoptotic', 'apoptotic', 'JJ', 'B-NP', 'O'), ('induction', 'induction', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with reports on the cytotoxicity of N-glycosidase ribosome inactivating proteins , abrin and ricin [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('reports', 'report', 'NNS', 'B-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytotoxicity', 'cytotoxicity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('N-glycosidase', 'N-glycosidase', 'NN', 'B-NP', 'B-protein'), ('ribosome', 'ribosome', 'NN', 'I-NP', 'I-protein'), ('inactivating', 'inactivate', 'VBG', 'B-VP', 'I-protein'), ('proteins', 'protein', 'NNS', 'B-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('abrin', 'abrin', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('ricin', 'ricin', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Abrin has been shown to interact with and inhibit anti-oxidant protein-1 ( AOP-1 ) [ CIT ] .	[('Abrin', 'Abrin', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('inhibit', 'inhibit', 'VB', 'B-VP', 'O'), ('anti-oxidant', 'anti-oxidant', 'JJ', 'B-NP', 'B-protein'), ('protein-1', 'protein-1', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('AOP-1', 'AOP-1', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similarly , in a yeast expression screen , Li et al. identified mutants of ricin , which although catalytically active , were not cytotoxic to yeast cells [ CIT ] .	[('Similarly', 'Similarly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('yeast', 'yeast', 'NN', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('screen', 'screen', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Li', 'Li', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('identified', 'identify', 'VBN', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ricin', 'ricin', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('catalytically', 'catalytically', 'RB', 'B-ADVP', 'O'), ('active', 'active', 'JJ', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('cytotoxic', 'cytotoxic', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with this hypothesis , Garcia-Ortega et al. have shown that deletion of the entire β-hairpin produces a catalytically active toxin that is non-toxic [ CIT ] .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('hypothesis', 'hypothesis', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Garcia-Ortega', 'Garcia-Ortega', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('deletion', 'deletion', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('entire', 'entire', 'JJ', 'I-NP', 'O'), ('β-hairpin', 'β-hairpin', 'NN', 'I-NP', 'O'), ('produces', 'produce', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('catalytically', 'catalytically', 'RB', 'I-NP', 'B-protein'), ('active', 'active', 'JJ', 'I-NP', 'I-protein'), ('toxin', 'toxin', 'NN', 'I-NP', 'I-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('non-toxic', 'non-toxic', 'JJ', 'B-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	This resembles a sequence found in elongation factors [ CIT ] , which is further suggestive that this region may be important in targeting α-sarcin to the ribosome .	[('This', 'This', 'DT', 'B-NP', 'O'), ('resembles', 'resemble', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('elongation', 'elongation', 'NN', 'B-NP', 'B-protein'), ('factors', 'factor', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('further', 'further', 'RBR', 'B-ADJP', 'O'), ('suggestive', 'suggestive', 'JJ', 'I-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('targeting', 'target', 'VBG', 'B-VP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ribosome', 'ribosome', 'NN', 'I-NP', 'B-DNA'), ('.', '.', '.', 'O', 'O')]
1	The large-scale mutagenesis approach used by Li et al. to isolate catalytically active , non-toxic ricin mutants based on their inability to kill yeast cells , would be ideally suited for identifying residues that are required for α-sarcin cytotoxicity but not for cleavage of the sarcin-ricin loop [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('large-scale', 'large-scale', 'JJ', 'I-NP', 'O'), ('mutagenesis', 'mutagenesis', 'NN', 'I-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Li', 'Li', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('isolate', 'isolate', 'VB', 'I-VP', 'O'), ('catalytically', 'catalytically', 'RB', 'B-NP', 'O'), ('active', 'active', 'JJ', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('non-toxic', 'non-toxic', 'JJ', 'I-NP', 'B-protein'), ('ricin', 'ricin', 'NN', 'I-NP', 'I-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('inability', 'inability', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('kill', 'kill', 'VB', 'I-VP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('ideally', 'ideally', 'RB', 'I-VP', 'O'), ('suited', 'suit', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('identifying', 'identify', 'VBG', 'B-VP', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('required', 'require', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('α-sarcin', 'α-sarcin', 'NN', 'B-NP', 'O'), ('cytotoxicity', 'cytotoxicity', 'NN', 'I-NP', 'O'), ('but', 'but', 'CC', 'B-PP', 'O'), ('not', 'not', 'RB', 'B-PP', 'O'), ('for', 'for', 'IN', 'I-PP', 'O'), ('cleavage', 'cleavage', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sarcin-ricin', 'sarcin-ricin', 'NN', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Since residues at these positions are in a close proximity to chromophore ( Fig. 2A , 2B ) [ CIT ] , it is reasonable to presume that they can participate in the determination of the state ( fluorescent or non-fluorescent ) of a particular protein .	[('Since', 'Since', 'IN', 'B-SBAR', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('positions', 'position', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('close', 'close', 'JJ', 'I-NP', 'O'), ('proximity', 'proximity', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('chromophore', 'chromophore', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('2B', '2B', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reasonable', 'reasonable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('presume', 'presume', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('participate', 'participate', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('determination', 'determination', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('state', 'state', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('fluorescent', 'fluorescent', 'JJ', 'B-ADJP', 'O'), ('or', 'or', 'CC', 'I-ADJP', 'O'), ('non-fluorescent', 'non-fluorescent', 'JJ', 'I-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('particular', 'particular', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	Earlier , we demonstrated for several CPs that Ser-148 containing mutants possess red fluorescence [ CIT ] .	[('Earlier', 'Earlier', 'RBR', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('CPs', 'CP', 'NNS', 'I-NP', 'B-DNA'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('Ser-148', 'Ser-148', 'NN', 'B-NP', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('mutants', 'mutant', 'NNS', 'B-NP', 'O'), ('possess', 'possess', 'VBP', 'B-VP', 'O'), ('red', 'red', 'JJ', 'B-NP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In previous studies we observed that cardiac MLCL AT activity was elevated when the cardiac CL content and CL synthase activity were elevated in hyperthyroid rats [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('observed', 'observe', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('cardiac', 'cardiac', 'JJ', 'B-NP', 'O'), ('MLCL', 'MLCL', 'NN', 'I-NP', 'O'), ('AT', 'AT', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('elevated', 'elevate', 'VBN', 'I-VP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cardiac', 'cardiac', 'JJ', 'I-NP', 'O'), ('CL', 'CL', 'NN', 'I-NP', 'O'), ('content', 'content', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('CL', 'CL', 'NN', 'B-NP', 'O'), ('synthase', 'synthase', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('elevated', 'elevate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('hyperthyroid', 'hyperthyroid', 'JJ', 'B-NP', 'O'), ('rats', 'rat', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	This protocol was shown to produce decreased serum thyroid hormone levels and result in cardiac atrophy in the rat [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('protocol', 'protocol', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('produce', 'produce', 'VB', 'I-VP', 'O'), ('decreased', 'decrease', 'VBN', 'B-NP', 'O'), ('serum', 'serum', 'NN', 'I-NP', 'O'), ('thyroid', 'thyroid', 'NN', 'I-NP', 'O'), ('hormone', 'hormone', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('result', 'result', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cardiac', 'cardiac', 'JJ', 'B-NP', 'O'), ('atrophy', 'atrophy', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rat', 'rat', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These are documented characteristics of hypothyroidism [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('documented', 'document', 'VBN', 'I-VP', 'O'), ('characteristics', 'characteristic', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('hypothyroidism', 'hypothyroidism', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously we showed that cardiac phosphatidylglycerol levels were reduced in streptozotocin-induced diabetic rats but CL synthase activity and CL content were unaltered [ CIT ] .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('cardiac', 'cardiac', 'JJ', 'B-NP', 'O'), ('phosphatidylglycerol', 'phosphatidylglycerol', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('reduced', 'reduce', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('streptozotocin-induced', 'streptozotocin-induced', 'JJ', 'B-NP', 'B-protein'), ('diabetic', 'diabetic', 'JJ', 'I-NP', 'I-protein'), ('rats', 'rat', 'NNS', 'I-NP', 'I-protein'), ('but', 'but', 'CC', 'O', 'I-protein'), ('CL', 'CL', 'NN', 'B-NP', 'I-protein'), ('synthase', 'synthase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('CL', 'CL', 'NN', 'B-NP', 'O'), ('content', 'content', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('unaltered', 'unaltered', 'JJ', 'B-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously shown CL content , MLCL AT and PLA2 activities were unaltered during P19 cell differentiation into cardiac myocytes [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('shown', 'show', 'VBN', 'I-NP', 'O'), ('CL', 'CL', 'NN', 'I-NP', 'O'), ('content', 'content', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('MLCL', 'MLCL', 'NN', 'B-NP', 'O'), ('AT', 'AT', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('PLA2', 'PLA2', 'NN', 'I-NP', 'B-protein'), ('activities', 'activity', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('unaltered', 'unaltered', 'JJ', 'B-ADJP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('P19', 'P19', 'NN', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('differentiation', 'differentiation', 'NN', 'I-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('cardiac', 'cardiac', 'JJ', 'B-NP', 'B-cell_type'), ('myocytes', 'myocyte', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	Although it is not possible to calculate a Kd for profilin I by this method [ CIT ] , from the obtained RU-values we can deduce relative affinities for the mutants as compared to wild type profilin I ( Table 1 ) .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('possible', 'possible', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('calculate', 'calculate', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Kd', 'Kd', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'B-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('obtained', 'obtain', 'VBN', 'I-NP', 'O'), ('RU-values', 'RU-value', 'NNS', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('deduce', 'deduce', 'VB', 'I-VP', 'O'), ('relative', 'relative', 'JJ', 'B-NP', 'O'), ('affinities', 'affinity', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('compared', 'compare', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'B-protein'), ('type', 'type', 'NN', 'I-NP', 'I-protein'), ('profilin', 'profilin', 'NN', 'I-NP', 'I-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	These residues do , however , not directly contact the proline-rich peptide nor do they stabilize any of the crucial poly ( L-proline ) binding residues [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('do', 'do', 'VBP', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('directly', 'directly', 'RB', 'I-VP', 'O'), ('contact', 'contact', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proline-rich', 'proline-rich', 'JJ', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('nor', 'nor', 'CC', 'O', 'O'), ('do', 'do', 'VBP', 'B-VP', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('stabilize', 'stabilize', 'VBP', 'B-VP', 'O'), ('any', 'any', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crucial', 'crucial', 'JJ', 'I-NP', 'O'), ('poly', 'poly', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('L-proline', 'L-proline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In addition , mutations may inhibit or facilitate the previously observed conformational changes that occur in profilin upon binding of poly ( L-proline ) [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('mutations', 'mutation', 'NNS', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('inhibit', 'inhibit', 'VB', 'I-VP', 'O'), ('or', 'or', 'CC', 'I-VP', 'O'), ('facilitate', 'facilitate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('observed', 'observe', 'VBN', 'I-NP', 'O'), ('conformational', 'conformational', 'JJ', 'I-NP', 'O'), ('changes', 'change', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('occur', 'occur', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('L-proline', 'L-proline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Remarkably , mutations in this region in yeast profilin caused a similar phenotype [ CIT ] .	[('Remarkably', 'Remarkably', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('mutations', 'mutation', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('profilin', 'profilin', 'NN', 'I-NP', 'O'), ('caused', 'cause', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('phenotype', 'phenotype', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As determined from the crystal structure of the actin-profilin complex [ CIT ] , Arg74 is a crucial residue for actin binding , since it forms a salt bridge with the carboxyl group of Phe375 .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('determined', 'determine', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crystal', 'crystal', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('actin-profilin', 'actin-profilin', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('Arg74', 'Arg74', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('crucial', 'crucial', 'JJ', 'I-NP', 'O'), ('residue', 'residue', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('actin', 'actin', 'NN', 'B-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('since', 'since', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('forms', 'form', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('salt', 'salt', 'NN', 'I-NP', 'O'), ('bridge', 'bridge', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('carboxyl', 'carboxyl', 'NN', 'I-NP', 'B-protein'), ('group', 'group', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Phe375', 'Phe375', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	A further difference with invertebrate profilins is the observation that mutating Arg74 to leucine , glutamic acid or alanine ( this study and [ CIT ] ) does not significantly affect PI ( 4 , 5 ) -P2-binding .	[('A', 'A', 'DT', 'B-NP', 'O'), ('further', 'further', 'JJ', 'I-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('invertebrate', 'invertebrate', 'NN', 'B-NP', 'B-protein'), ('profilins', 'profilin', 'NNS', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('mutating', 'mutate', 'VBG', 'B-VP', 'O'), ('Arg74', 'Arg74', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('leucine', 'leucine', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('glutamic', 'glutamic', 'JJ', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('alanine', 'alanine', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('significantly', 'significantly', 'RB', 'I-VP', 'O'), ('affect', 'affect', 'VB', 'I-VP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2-binding', '-P2-binding', 'JJ', 'B-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously , it was shown that Arg88 is involved in PI ( 4 , 5 ) -P2-binding of human profilin I [ CIT ] .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Arg88', 'Arg88', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2-binding', '-P2-binding', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-protein'), ('profilin', 'profilin', 'NN', 'I-NP', 'I-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This seems , however , not to be the case ( data not shown ) , since we found for both wild type and mutant a ratio of ten profilin molecules per PI ( 4 , 5 ) -P2 micelle , suggesting a stoichiometry of 1 : 8 profilin : PI ( 4 , 5 ) -P2 molecules , consistent with a previous report [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('seems', 'seem', 'VBZ', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('case', 'case', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('since', 'since', 'IN', 'B-SBAR', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'B-NP', 'O'), ('wild', 'wild', 'JJ', 'I-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('mutant', 'mutant', 'NN', 'I-NP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('ratio', 'ratio', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ten', 'ten', 'CD', 'B-NP', 'O'), ('profilin', 'profilin', 'NN', 'I-NP', 'B-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('per', 'per', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('micelle', 'micelle', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('stoichiometry', 'stoichiometry', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), (':', ':', ':', 'O', 'O'), ('8', '8', 'CD', 'B-NP', 'O'), ('profilin', 'profilin', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('molecules', 'molecule', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Lassing and Lindberg [ CIT ] showed that the inhibition on actin polymerization of wild type human profilin I decreases in the presence of PI ( 4 , 5 ) -P2 .	[('Lassing', 'Lasse', 'VBG', 'B-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Lindberg', 'Lindberg', 'NNP', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('actin', 'actin', 'NN', 'B-NP', 'B-protein'), ('polymerization', 'polymerization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'B-protein'), ('type', 'type', 'NN', 'I-NP', 'I-protein'), ('human', 'human', 'JJ', 'I-NP', 'I-protein'), ('profilin', 'profilin', 'NN', 'I-NP', 'I-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('decreases', 'decrease', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently we demonstrated that profilin IIa has a lower affinity for PI ( 4 , 5 ) -P2 than profilin I [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'O'), ('IIa', 'IIa', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('lower', 'low', 'JJR', 'I-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'B-DNA'), ('I', 'I', 'CD', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Based on experiments with photoactivatable PI ( 4 , 5 ) -P2 analogues , Chaudhary and coworkers ( 1998 ) [ CIT ] suggested that hydrophobic residues in the amino terminal helix are involved in the interaction with PI ( 4 , 5 ) -P2 .	[('Based', 'Base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('experiments', 'experiment', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('photoactivatable', 'photoactivatable', 'JJ', 'B-NP', 'O'), ('PI', 'PI', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('analogues', 'analogue', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Chaudhary', 'Chaudhary', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('coworkers', 'coworker', 'NNS', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('1998', '1998', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('suggested', 'suggest', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'B-protein'), ('terminal', 'terminal', 'JJ', 'I-NP', 'I-protein'), ('helix', 'helix', 'NN', 'I-NP', 'I-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Given the profilin I W3A data presented here and in view of the conformational changes observed upon ligand binding [ CIT ] , we propose that mutating Trp3 in profilin IIa promotes / induces a conformation which is more competent for PI ( 4 , 5 ) -P2-binding ( see below ) .	[('Given', 'Give', 'VBN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('profilin', 'profilin', 'NN', 'I-NP', 'O'), ('I', 'I', 'CD', 'I-NP', 'O'), ('W3A', 'W3A', 'NN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('presented', 'present', 'VBN', 'B-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('view', 'view', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conformational', 'conformational', 'JJ', 'I-NP', 'O'), ('changes', 'change', 'NNS', 'I-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('ligand', 'ligand', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('propose', 'propose', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('mutating', 'mutate', 'VBG', 'B-VP', 'O'), ('Trp3', 'Trp3', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'O'), ('IIa', 'IIa', 'NN', 'I-NP', 'O'), ('promotes', 'promote', 'VBZ', 'B-VP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('induces', 'induce', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('conformation', 'conformation', 'NN', 'I-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('more', 'more', 'RBR', 'B-ADJP', 'O'), ('competent', 'competent', 'JJ', 'I-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2-binding', '-P2-binding', 'JJ', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('below', 'below', 'IN', 'B-PP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A partial overlap of actin- and PI ( 4 , 5 ) -P2-binding sites was also observed for actophorin [ CIT ] , suggesting this is the basis for a general regulatory mechanism for several actin binding proteins , whose function is inhibited by PI ( 4 , 5 ) -P2 .	[('A', 'A', 'DT', 'B-NP', 'O'), ('partial', 'partial', 'JJ', 'I-NP', 'O'), ('overlap', 'overlap', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('actin-', 'actin-', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('PI', 'PI', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2-binding', '-P2-binding', 'JJ', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('actophorin', 'actophorin', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('basis', 'basis', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('general', 'general', 'JJ', 'I-NP', 'O'), ('regulatory', 'regulatory', 'JJ', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('actin', 'actin', 'NN', 'I-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('whose', 'whose', 'WP$', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('inhibited', 'inhibit', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Our data thus offer an explanation for the previously observed competition between PI ( 4 , 5 ) -P2 and the two other profilin ligands : actin [ CIT ] .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('thus', 'thus', 'RB', 'B-ADVP', 'O'), ('offer', 'offer', 'VBP', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('explanation', 'explanation', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('observed', 'observe', 'VBN', 'I-NP', 'O'), ('competition', 'competition', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('profilin', 'profilin', 'NN', 'I-NP', 'O'), ('ligands', 'ligand', 'NNS', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('actin', 'actin', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	Since PI ( 4 , 5 ) -P2 inhibits both actin and poly ( L-proline ) binding [ CIT ] , it is conceivable that PI ( 4 , 5 ) -P2 may have a master regulatory function in the cell .	[('Since', 'Since', 'IN', 'B-SBAR', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'B-protein'), ('inhibits', 'inhibit', 'VBZ', 'B-VP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('actin', 'actin', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('L-proline', 'L-proline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('conceivable', 'conceivable', 'JJ', 'B-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('have', 'have', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('master', 'master', 'NN', 'I-NP', 'O'), ('regulatory', 'regulatory', 'JJ', 'I-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The concerted action in vivo of profilin-actin complexes with several proline-rich proteins such as Ena / VASP proteins , N-WASP and formins for the promotion of actin polymerization was suggested previously [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('concerted', 'concerted', 'JJ', 'I-NP', 'O'), ('action', 'action', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('profilin-actin', 'profilin-actin', 'NN', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('proline-rich', 'proline-rich', 'JJ', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('Ena', 'Ena', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('VASP', 'VASP', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('N-WASP', 'N-WASP', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('formins', 'formin', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('promotion', 'promotion', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('actin', 'actin', 'NN', 'B-NP', 'B-protein'), ('polymerization', 'polymerization', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These results suggest that the interaction of profilin with PI ( 4 , 5 ) -P2 and poly ( L-proline ) involve conformational changes , which have been experimentally observed before [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('suggest', 'suggest', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('profilin', 'profilin', 'NN', 'B-NP', 'B-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('PI', 'PI', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-P2', '-P2', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('L-proline', 'L-proline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('involve', 'involve', 'VBP', 'B-VP', 'O'), ('conformational', 'conformational', 'JJ', 'B-NP', 'O'), ('changes', 'change', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('experimentally', 'experimentally', 'RB', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similarly , mouse profilin IIb , which has six additional amino acids at its carboxy terminus , does not bind poly ( L-proline ) [ CIT ] .	[('Similarly', 'Similarly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'B-protein'), ('profilin', 'profilin', 'NN', 'I-NP', 'I-protein'), ('IIb', 'IIb', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('six', 'six', 'CD', 'B-NP', 'O'), ('additional', 'additional', 'JJ', 'I-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('carboxy', 'carboxy', 'NN', 'I-NP', 'B-protein'), ('terminus', 'terminus', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('L-proline', 'L-proline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In addition , it has been reported that both amino- and carboxy terminal GFP fusion proteins of mammalian profilins display a dramatic loss in poly ( Lproline ) binding [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('amino-', 'amino-', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('carboxy', 'carboxy', 'NN', 'B-NP', 'B-protein'), ('terminal', 'terminal', 'JJ', 'I-NP', 'I-protein'), ('GFP', 'GFP', 'NN', 'I-NP', 'I-protein'), ('fusion', 'fusion', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mammalian', 'mammalian', 'JJ', 'B-NP', 'B-protein'), ('profilins', 'profilin', 'NNS', 'I-NP', 'I-protein'), ('display', 'display', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dramatic', 'dramatic', 'JJ', 'I-NP', 'O'), ('loss', 'loss', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Lproline', 'Lproline', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As reported previously [ CIT ] , the N-terminal transesterification domain Top67 by itself did not exhibit any relaxation activity when assayed with negatively supercoiled plasmid DNA ( Figure 2a ) .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'B-protein'), ('transesterification', 'transesterification', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('Top67', 'Top67', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('itself', 'itself', 'PRP', 'B-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('exhibit', 'exhibit', 'VB', 'I-VP', 'O'), ('any', 'any', 'DT', 'B-NP', 'O'), ('relaxation', 'relaxation', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('assayed', 'assay', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('negatively', 'negatively', 'RB', 'B-NP', 'O'), ('supercoiled', 'supercoile', 'VBN', 'I-NP', 'O'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2a', '2a', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have shown that E. coli DNA topoisomerase I cleavage of single-stranded DNA occurs with selectivity for sites with the C nucleotide base at the - 4 position [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('topoisomerase', 'topoisomerase', 'NN', 'I-NP', 'O'), ('I', 'I', 'CD', 'I-NP', 'O'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('single-stranded', 'single-stranded', 'JJ', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('occurs', 'occur', 'VBZ', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('selectivity', 'selectivity', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('sites', 'site', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'O'), ('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O'), ('base', 'base', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('-', '-', 'SYM', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('position', 'position', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The results showed that with single-stranded substrates , Top67 also preferred cleavage sites with a C nucleotide base at the -4 position as reported for most of the type IA topoisomerases [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('single-stranded', 'single-stranded', 'JJ', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Top67', 'Top67', 'NN', 'B-NP', 'B-protein'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('preferred', 'prefer', 'VBD', 'B-VP', 'O'), ('cleavage', 'cleavage', 'NN', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'O'), ('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O'), ('base', 'base', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('-4', '-4', 'CD', 'I-NP', 'O'), ('position', 'position', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('most', 'most', 'JJS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'B-protein'), ('IA', 'IA', 'NN', 'I-NP', 'I-protein'), ('topoisomerases', 'topoisomeras', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with an early observation of dissociation of the enzyme-DNA complex in high salt upon addition of Mg2+ [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('early', 'early', 'JJ', 'I-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('dissociation', 'dissociation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme-DNA', 'enzyme-DNA', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('salt', 'salt', 'NN', 'I-NP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has also been reported [ CIT ] that addition of Mg2+ was apparently not required for observation of this reversal of cleavage .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('apparently', 'apparently', 'RB', 'I-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('required', 'require', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('observation', 'observation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('reversal', 'reversal', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cleavage', 'cleavage', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	However , it is possible that some enzyme preparations may contain bound Mg2+ and the low concentration of bound Mg2+ might have been sufficient for reversal of cleavage , as postulated previously to explain the data [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('possible', 'possible', 'JJ', 'B-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'O'), ('preparations', 'preparation', 'NNS', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('contain', 'contain', 'VB', 'I-VP', 'O'), ('bound', 'bind', 'VBN', 'B-NP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('low', 'low', 'JJ', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('bound', 'bind', 'VBN', 'B-NP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'I-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('have', 'have', 'VB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('sufficient', 'sufficient', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('reversal', 'reversal', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cleavage', 'cleavage', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('postulated', 'postulate', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('explain', 'explain', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Despite the uncertainty about the proximal mediator of IDO 's effect , it is known that alterations in cell adhesion and metalloproteinase activity are often associated with changes in prostaglandin synthesis [ CIT ] .	[('Despite', 'Despite', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('uncertainty', 'uncertainty', 'NN', 'I-NP', 'O'), ('about', 'about', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proximal', 'proximal', 'JJ', 'I-NP', 'O'), ('mediator', 'mediator', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('IDO', 'IDO', 'NN', 'B-NP', 'B-protein'), ("'s", "'s", 'POS', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('alterations', 'alteration', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cell', 'cell', 'NN', 'B-NP', 'O'), ('adhesion', 'adhesion', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('metalloproteinase', 'metalloproteinase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('often', 'often', 'RB', 'I-VP', 'O'), ('associated', 'associate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('prostaglandin', 'prostaglandin', 'NN', 'B-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	PG D2 was the major product of both vector-only controls and IDO-expressing clone 11 , consistent with reports that D2 production is typical of antigen-presenting cells [ CIT ] .	[('PG', 'PG', 'NN', 'B-NP', 'B-protein'), ('D2', 'D2', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('major', 'major', 'JJ', 'I-NP', 'O'), ('product', 'product', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('vector-only', 'vector-only', 'JJ', 'I-NP', 'O'), ('controls', 'control', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('IDO-expressing', 'IDO-expressing', 'JJ', 'B-NP', 'O'), ('clone', 'clone', 'NN', 'I-NP', 'O'), ('11', '11', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('reports', 'report', 'NNS', 'B-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('D2', 'D2', 'NN', 'B-NP', 'O'), ('production', 'production', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('typical', 'typical', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('antigen-presenting', 'antigen-presenting', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	They are both located in the F helix of the E. coli enzyme , using the nomenclature given by Zhang et al. [ CIT ] .	[('They', 'They', 'PRP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('both', 'both', 'DT', 'B-ADJP', 'O'), ('located', 'located', 'JJ', 'I-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('F', 'F', 'NN', 'I-NP', 'O'), ('helix', 'helix', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'B-protein'), ('coli', 'coli', 'FW', 'I-NP', 'I-protein'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nomenclature', 'nomenclature', 'NN', 'I-NP', 'O'), ('given', 'give', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Zhang', 'Zhang', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The gene nadD has been shown essential in Salmonella typhimurium [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), ('nadD', 'nadD', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('essential', 'essential', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Salmonella', 'Salmonella', 'NNP', 'B-NP', 'O'), ('typhimurium', 'typhimurium', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	However , some conflicting data on this matter was recently published [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('conflicting', 'conflict', 'VBG', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('matter', 'matter', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('published', 'publish', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The final yield was typically 5-20 mg protein / l culture , similar to an earlier report [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('final', 'final', 'JJ', 'I-NP', 'B-protein'), ('yield', 'yield', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'I-protein'), ('typically', 'typically', 'RB', 'B-ADVP', 'I-protein'), ('5-20', '5-20', 'CD', 'B-NP', 'I-protein'), ('mg', 'mg', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-VP', 'O'), ('l', 'l', 'NN', 'B-NP', 'O'), ('culture', 'culture', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have earlier shown that the intracellular level of NAD+ correlates to growth ability on different media and at different temperatures [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('earlier', 'earlier', 'RBR', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('intracellular', 'intracellular', 'JJ', 'I-NP', 'O'), ('level', 'level', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NAD+', 'NAD+', 'NN', 'B-NP', 'B-protein'), ('correlates', 'correlate', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('growth', 'growth', 'NN', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('media', 'medium', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('temperatures', 'temperature', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been suggested that the C-terminus in human NMNAT plays a role in substrate recognition [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminus', 'C-terminus', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('NMNAT', 'NMNAT', 'NN', 'I-NP', 'O'), ('plays', 'play', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('substrate', 'substrate', 'NN', 'B-NP', 'O'), ('recognition', 'recognition', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It was also suggested by the same authors that the carboxylate oxygen of the residue might be involved in the coordination of a Mg2+ ion shown to be important for the enzyme function [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('authors', 'author', 'NNS', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('carboxylate', 'carboxylate', 'NN', 'I-NP', 'B-protein'), ('oxygen', 'oxygen', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('residue', 'residue', 'NN', 'I-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('coordination', 'coordination', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Mg2+', 'Mg2+', 'JJ', 'I-NP', 'O'), ('ion', 'ion', 'NN', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The explanation might be that the hydroxyl group of Thr-11 forms an H-bridge to Asn-40 , which has been shown to interact with 2'-hydroxyl group of NAMN-ribose [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('explanation', 'explanation', 'NN', 'I-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydroxyl', 'hydroxyl', 'NN', 'I-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Thr-11', 'Thr-11', 'NN', 'B-NP', 'B-protein'), ('forms', 'form', 'VBZ', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('H-bridge', 'H-bridge', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('Asn-40', 'Asn-40', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ("2'-hydroxyl", "2'-hydroxyl", 'JJ', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NAMN-ribose', 'NAMN-ribose', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The role of the second histidine ( His-19 ) in the conserved T / HXGH motif has been tested in several studies and been shown to play a role in ATP-binding and stabilization , but the role for the two histidine residues can vary between enzymes [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('second', 'second', 'JJ', 'I-NP', 'O'), ('histidine', 'histidine', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('His-19', 'His-19', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'O'), ('T', 'T', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('HXGH', 'HXGH', 'NN', 'I-NP', 'B-DNA'), ('motif', 'motif', 'NN', 'I-NP', 'I-DNA'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('tested', 'test', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('been', 'be', 'VBN', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('play', 'play', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ATP-binding', 'ATP-binding', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('stabilization', 'stabilization', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('histidine', 'histidine', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('vary', 'vary', 'VB', 'I-VP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('enzymes', 'enzyme', 'NNS', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Mutational studies on NMNAT from Methanobacterium thermoautotrophicum indicate that the archaeal enzyme is involved in the reaction merely by placing the substrates in an ideal position [ CIT ] .	[('Mutational', 'Mutational', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('NMNAT', 'NMNAT', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Methanobacterium', 'Methanobacterium', 'NN', 'B-NP', 'O'), ('thermoautotrophicum', 'thermoautotrophicum', 'NN', 'I-NP', 'O'), ('indicate', 'indicate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('archaeal', 'archaeal', 'JJ', 'I-NP', 'B-protein'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('merely', 'merely', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('placing', 'place', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('ideal', 'ideal', 'JJ', 'I-NP', 'O'), ('position', 'position', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A search for conserved domains [ CIT ] revealed a significant alignment with MIP domain , a feature of all aquaporins and aquaglyceroporins .	[('A', 'A', 'DT', 'B-NP', 'O'), ('search', 'search', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('conserved', 'conserve', 'VBN', 'B-NP', 'O'), ('domains', 'domain', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('alignment', 'alignment', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('MIP', 'MIP', 'NN', 'B-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('feature', 'feature', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('aquaporins', 'aquaporin', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('aquaglyceroporins', 'aquaglyceroporin', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in agreement with a recent study demonstrating AQP11 immunostaining in mouse kidney cortex proximal tubule but not in distal tubule [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('AQP11', 'AQP11', 'NN', 'B-NP', 'O'), ('immunostaining', 'immunostaining', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), ('kidney', 'kidney', 'NN', 'I-NP', 'O'), ('cortex', 'cortex', 'NN', 'I-NP', 'O'), ('proximal', 'proximal', 'JJ', 'I-NP', 'O'), ('tubule', 'tubule', 'NN', 'I-NP', 'O'), ('but', 'but', 'CC', 'B-PP', 'O'), ('not', 'not', 'RB', 'B-PP', 'O'), ('in', 'in', 'IN', 'I-PP', 'O'), ('distal', 'distal', 'JJ', 'B-NP', 'O'), ('tubule', 'tubule', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Biochemical and structural evidence shows that many mammalian aquaporins form tetramers [ CIT ] .	[('Biochemical', 'Biochemical', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('evidence', 'evidence', 'NN', 'I-NP', 'O'), ('shows', 'show', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('many', 'many', 'JJ', 'B-NP', 'O'), ('mammalian', 'mammalian', 'JJ', 'I-NP', 'B-protein'), ('aquaporins', 'aquaporin', 'NNS', 'I-NP', 'I-protein'), ('form', 'form', 'VBP', 'B-VP', 'O'), ('tetramers', 'tetramer', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In agreement with previous work , we detected AQP4 in fractions 10-23 , with a peak in fractions 13-15 [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'I-PP', 'O'), ('with', 'with', 'IN', 'I-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('detected', 'detect', 'VBD', 'B-VP', 'O'), ('AQP4', 'AQP4', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fractions', 'fraction', 'NNS', 'B-NP', 'O'), ('10-23', '10-23', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('peak', 'peak', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fractions', 'fraction', 'NNS', 'B-NP', 'O'), ('13-15', '13-15', 'CD', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A previous study reported that exogenous mouse AQP11 was not targeted to the plasma membrane in oocytes [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('that', 'that', 'DT', 'O', 'O'), ('exogenous', 'exogenous', 'JJ', 'B-NP', 'B-protein'), ('mouse', 'mouse', 'NN', 'I-NP', 'I-protein'), ('AQP11', 'AQP11', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('targeted', 'target', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('plasma', 'plasma', 'NN', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('oocytes', 'oocyte', 'NNS', 'B-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A previous study demonstrated AQP11 protein expression in mouse kidney [ CIT ] ; using our AQP11 antibodies we were unable to see staining in rat kidney ( not shown ) .	[('A', 'A', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('AQP11', 'AQP11', 'NN', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), ('kidney', 'kidney', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('AQP11', 'AQP11', 'NN', 'I-NP', 'B-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('unable', 'unable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('see', 'see', 'VB', 'I-VP', 'O'), ('staining', 'staining', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('kidney', 'kidney', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The authors of the previous study did not stain brain sections , but they did note that mice lacking AQP11 began dying 15 days after birth , with renal failure and polycystic kidneys [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('authors', 'author', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('stain', 'stain', 'VB', 'I-VP', 'O'), ('brain', 'brain', 'NN', 'B-NP', 'O'), ('sections', 'section', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('note', 'note', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('mice', 'mouse', 'NNS', 'B-NP', 'O'), ('lacking', 'lack', 'VBG', 'B-VP', 'O'), ('AQP11', 'AQP11', 'NN', 'B-NP', 'B-protein'), ('began', 'begin', 'VBD', 'B-VP', 'O'), ('dying', 'die', 'VBG', 'I-VP', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('days', 'day', 'NNS', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('birth', 'birth', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('renal', 'renal', 'JJ', 'B-NP', 'O'), ('failure', 'failure', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('polycystic', 'polycystic', 'JJ', 'B-NP', 'O'), ('kidneys', 'kidney', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	However , in the presence of seeds ( sonicated preformed fibers 2.5 % w / w ) , the lag phase was completely eliminated and fiber formation occurred rapidly ( Fig. 1A ) as reported previously [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('seeds', 'seed', 'NNS', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('sonicated', 'sonicate', 'VBN', 'B-VP', 'O'), ('preformed', 'preforme', 'VBN', 'B-NP', 'O'), ('fibers', 'fiber', 'NNS', 'I-NP', 'O'), ('2.5', '2.5', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lag', 'lag', 'NN', 'I-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('completely', 'completely', 'RB', 'I-VP', 'O'), ('eliminated', 'eliminate', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('fiber', 'fiber', 'NN', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('occurred', 'occur', 'VBD', 'B-VP', 'O'), ('rapidly', 'rapidly', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The appearance of strong and weak [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('appearance', 'appearance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('strong', 'strong', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('weak', 'weak', 'JJ', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The concept of yeast prion strain variants and their basis of structural variability has been studied extensively [ CIT ] and is presumably recapitulated with our repeat expansion chimeras .	[('The', 'The', 'DT', 'B-NP', 'O'), ('concept', 'concept', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-protein'), ('prion', 'prion', 'NN', 'I-NP', 'I-protein'), ('strain', 'strain', 'NN', 'I-NP', 'I-protein'), ('variants', 'variant', 'NNS', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('basis', 'basis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('structural', 'structural', 'JJ', 'B-NP', 'O'), ('variability', 'variability', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('studied', 'study', 'VBN', 'I-VP', 'O'), ('extensively', 'extensively', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('presumably', 'presumably', 'RB', 'I-VP', 'O'), ('recapitulated', 'recapitulate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('repeat', 'repeat', 'NN', 'I-NP', 'O'), ('expansion', 'expansion', 'NN', 'I-NP', 'O'), ('chimeras', 'chimera', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	These data also support the previous suggestion that co-aggregation of wild type PrP and ORE PrP is a plausible factor in prion disease progression [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('support', 'support', 'VBP', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('suggestion', 'suggestion', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('co-aggregation', 'co-aggregation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'B-protein'), ('type', 'type', 'NN', 'I-NP', 'I-protein'), ('PrP', 'PrP', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('ORE', 'ORE', 'NN', 'B-NP', 'B-protein'), ('PrP', 'PrP', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('plausible', 'plausible', 'JJ', 'I-NP', 'B-protein'), ('factor', 'factor', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('prion', 'prion', 'NN', 'B-NP', 'O'), ('disease', 'disease', 'NN', 'I-NP', 'O'), ('progression', 'progression', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	For A-431 cells ( human epidermoid carcinoma ) a dependence on the expression of the EGF receptor was shown [ CIT ] .	[('For', 'For', 'IN', 'B-PP', 'O'), ('A-431', 'A-431', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('epidermoid', 'epidermoid', 'JJ', 'I-NP', 'O'), ('carcinoma', 'carcinoma', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dependence', 'dependence', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('EGF', 'EGF', 'NN', 'I-NP', 'B-protein'), ('receptor', 'receptor', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To detect F-ATPase activity we used its specific inhibitors , azide or oligomycin [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('detect', 'detect', 'VB', 'I-VP', 'O'), ('F-ATPase', 'F-ATPase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('azide', 'azide', 'NN', 'B-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('oligomycin', 'oligomycin', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A slight inhibition of comparable size was also observed for the established inhibitor of V-ATPases , concanamycin A , corroborating the well known fact that plecomacrolidic antibiotics start to inhibit P-ATPases at concentrations in the micromolar range [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('slight', 'slight', 'JJ', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('comparable', 'comparable', 'JJ', 'B-NP', 'O'), ('size', 'size', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('established', 'established', 'JJ', 'I-NP', 'O'), ('inhibitor', 'inhibitor', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('V-ATPases', 'V-ATPas', 'NNS', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('concanamycin', 'concanamycin', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('corroborating', 'corroborate', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('well', 'well', 'RB', 'I-NP', 'O'), ('known', 'know', 'VBN', 'I-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('plecomacrolidic', 'plecomacrolidic', 'JJ', 'B-NP', 'O'), ('antibiotics', 'antibiotic', 'NNS', 'I-NP', 'O'), ('start', 'start', 'VBP', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('inhibit', 'inhibit', 'VB', 'I-VP', 'O'), ('P-ATPases', 'P-ATPas', 'NNS', 'B-NP', 'B-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('concentrations', 'concentration', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('micromolar', 'micromolar', 'JJ', 'I-NP', 'O'), ('range', 'range', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	To investigate the mode of V-ATPase inhibition in more detail , we used the semi synthetic derivative of concanamycin , 9-O- [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mode', 'mode', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('V-ATPase', 'V-ATPase', 'NN', 'B-NP', 'B-protein'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('more', 'more', 'JJR', 'B-NP', 'O'), ('detail', 'detail', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('semi', 'semi', 'NN', 'I-NP', 'O'), ('synthetic', 'synthetic', 'JJ', 'I-NP', 'O'), ('derivative', 'derivative', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('concanamycin', 'concanamycin', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('9-O-', '9-O-', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Following the nomenclature system proposed for these enzymes [ CIT ] , we have tentatively called this new polyserine protease polyserase-3 .	[('Following', 'Follow', 'VBG', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nomenclature', 'nomenclature', 'JJ', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('proposed', 'propose', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('tentatively', 'tentatively', 'RB', 'I-VP', 'O'), ('called', 'call', 'VBN', 'I-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('new', 'new', 'JJ', 'I-NP', 'O'), ('polyserine', 'polyserine', 'NN', 'I-NP', 'O'), ('protease', 'protease', 'NN', 'I-NP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	We also performed an analysis in the polyserase-3 sequence of molecular markers of serine protease evolution described by Krem and Di Cera [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('performed', 'perform', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('molecular', 'molecular', 'JJ', 'B-NP', 'O'), ('markers', 'marker', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('serine', 'serine', 'NN', 'B-NP', 'B-protein'), ('protease', 'protease', 'NN', 'I-NP', 'I-protein'), ('evolution', 'evolution', 'NN', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Krem', 'Krem', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Di', 'Di', 'NNP', 'I-NP', 'O'), ('Cera', 'Cera', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In fact , the length of the intron that separates the exons containing the His and Asp residues of the catalytic triad of the first protease domain of polyserase-3 , is similar to that found in the equivalent region of matriptase-2 [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('fact', 'fact', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('length', 'length', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('intron', 'intron', 'NN', 'I-NP', 'B-DNA'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('separates', 'separate', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('exons', 'exon', 'NNS', 'I-NP', 'B-DNA'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('His', 'His', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Asp', 'Asp', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('triad', 'triad', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'B-protein'), ('protease', 'protease', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('equivalent', 'equivalent', 'JJ', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('matriptase-2', 'matriptase-2', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	By contrast , only two coding exons are found in the equivalent region of α / β-tryptase genes [ CIT ] .	[('By', 'By', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('coding', 'cod', 'VBG', 'I-NP', 'O'), ('exons', 'exon', 'NNS', 'I-NP', 'B-DNA'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('equivalent', 'equivalent', 'JJ', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('α', 'α', 'NN', 'B-NP', 'B-DNA'), ('/', '/', 'SYM', 'O', 'I-DNA'), ('β-tryptase', 'β-tryptase', 'NN', 'B-NP', 'I-DNA'), ('genes', 'gene', 'NNS', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	This analysis revealed a significant degree of similarity between both domains of polyserase-3 and some members of the tryptase family , such as human β-tryptase II [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('degree', 'degree', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('similarity', 'similarity', 'NN', 'B-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('domains', 'domain', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('members', 'member', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('tryptase', 'tryptase', 'NN', 'I-NP', 'B-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-protein'), ('β-tryptase', 'β-tryptase', 'NN', 'I-NP', 'I-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This situation resembles that observed for polyserase-2 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('situation', 'situation', 'NN', 'I-NP', 'O'), ('resembles', 'resemble', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polyserase-2', 'polyserase-2', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with this , analysis of the polyserase-3 sequence using the NetNGlyc 1.0 Server [ CIT ] predicted that the only putative N-glycosylation site present in this protein ( Asn543 ) , would not be effectively glycosylated .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('analysis', 'analysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('NetNGlyc', 'NetNGlyc', 'NN', 'I-NP', 'O'), ('1.0', '1.0', 'CD', 'I-NP', 'O'), ('Server', 'Server', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('predicted', 'predict', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('only', 'only', 'JJ', 'I-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('N-glycosylation', 'N-glycosylation', 'NN', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Asn543', 'Asn543', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('effectively', 'effectively', 'RB', 'I-VP', 'O'), ('glycosylated', 'glycosylate', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Moreover , SDS-PAGE analysis of the recombinant polyserase-3 incubated for 16 h at 37°C also indicates that the enzyme is released from the GST-moiety ( data not shown ) , which could be due to an autoactivation process of polyserase-3 , similarly to fusion proteins containing the catalytic domain of matriptase-1 [ CIT ] .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('SDS-PAGE', 'SDS-PAGE', 'NN', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('recombinant', 'recombinant', 'JJ', 'I-NP', 'B-protein'), ('polyserase-3', 'polyserase-3', 'NN', 'I-NP', 'I-protein'), ('incubated', 'incubate', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('16', '16', 'CD', 'B-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('37°C', '37°C', 'NN', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('indicates', 'indicate', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('released', 'release', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GST-moiety', 'GST-moiety', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('due', 'due', 'JJ', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('autoactivation', 'autoactivation', 'NN', 'I-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('similarly', 'similarly', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('fusion', 'fusion', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('matriptase-1', 'matriptase-1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Moreover , other members of this group of serine proteases , such as mouse mast cell tryptase [ CIT ] , are able to degrade the α-chain of fibrinogen when forming tetramers in a similar manner to that shown herein for polyserase-3 .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('members', 'member', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('serine', 'serine', 'NN', 'B-NP', 'B-protein'), ('proteases', 'protease', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'B-protein'), ('mast', 'mast', 'NN', 'I-NP', 'I-protein'), ('cell', 'cell', 'NN', 'I-NP', 'I-protein'), ('tryptase', 'tryptase', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('degrade', 'degrade', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α-chain', 'α-chain', 'NN', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('fibrinogen', 'fibrinogen', 'NN', 'B-NP', 'B-protein'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('forming', 'form', 'VBG', 'B-VP', 'O'), ('tetramers', 'tetramer', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('herein', 'herein', 'RB', 'B-ADVP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The presence of two immunoreactive bands in native conditions and one band of the expected size in the sample containing the denaturing reagent suggested that polyserase-3 forms dimers which seems to be stabilized by disulfide bridges , as reported for the dog mast cell protease-3 [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('immunoreactive', 'immunoreactive', 'JJ', 'I-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('native', 'native', 'JJ', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('band', 'band', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('expected', 'expect', 'VBN', 'I-NP', 'O'), ('size', 'size', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sample', 'sample', 'NN', 'I-NP', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('denaturing', 'denature', 'VBG', 'I-NP', 'O'), ('reagent', 'reagent', 'NN', 'I-NP', 'O'), ('suggested', 'suggest', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('polyserase-3', 'polyserase-3', 'NN', 'B-NP', 'B-protein'), ('forms', 'form', 'NNS', 'I-NP', 'I-protein'), ('dimers', 'dimer', 'NNS', 'I-NP', 'I-protein'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('seems', 'seem', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('stabilized', 'stabilize', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('disulfide', 'disulfide', 'NN', 'B-NP', 'B-protein'), ('bridges', 'bridge', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dog', 'dog', 'NN', 'I-NP', 'O'), ('mast', 'mast', 'NN', 'I-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('protease-3', 'protease-3', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Bioinformatic analysis using different programs available at the NIX tool [ CIT ] , predicts a transcript of around 8 kb for this gene , suggesting that the higher band observed in Fig. 7 , likely corresponds to a full-length polyserase-3 transcript .	[('Bioinformatic', 'Bioinformatic', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('programs', 'program', 'NNS', 'I-NP', 'O'), ('available', 'available', 'JJ', 'B-ADJP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('NIX', 'NIX', 'NN', 'I-NP', 'O'), ('tool', 'tool', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('predicts', 'predict', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('transcript', 'transcript', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('around', 'around', 'IN', 'B-NP', 'O'), ('8', '8', 'CD', 'I-NP', 'O'), ('kb', 'kb', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('higher', 'high', 'JJR', 'I-NP', 'O'), ('band', 'band', 'NN', 'I-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('7', '7', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('likely', 'likely', 'RB', 'B-ADVP', 'O'), ('corresponds', 'correspond', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('full-length', 'full-length', 'JJ', 'I-NP', 'B-RNA'), ('polyserase-3', 'polyserase-3', 'NN', 'I-NP', 'I-RNA'), ('transcript', 'transcript', 'NN', 'I-NP', 'I-RNA'), ('.', '.', '.', 'O', 'O')]
1	This mRNA processing of a multidomain protease has also been described for polyserases -1 and -2 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'O'), ('processing', 'processing', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('multidomain', 'multidomain', 'JJ', 'I-NP', 'B-protein'), ('protease', 'protease', 'NN', 'I-NP', 'I-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polyserases', 'polyseras', 'NNS', 'B-NP', 'O'), ('-1', '-1', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('-2', '-2', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Charged residues in the headgroup of lipid molecules as well as attracted counter ions cause an electrical potential at the surface of the respective aggregates , the so-called Gouy-Chapman potential which decreases exponentially in the surrounding buffer ( for review see [ CIT ] ) .	[('Charged', 'Charge', 'VBN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('headgroup', 'headgroup', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('lipid', 'lipid', 'NN', 'B-NP', 'B-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('attracted', 'attract', 'VBN', 'B-NP', 'O'), ('counter', 'counter', 'NN', 'I-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('cause', 'cause', 'VBP', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('electrical', 'electrical', 'JJ', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('respective', 'respective', 'JJ', 'I-NP', 'O'), ('aggregates', 'aggregate', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('so-called', 'so-called', 'JJ', 'I-NP', 'O'), ('Gouy-Chapman', 'Gouy-Chapman', 'JJ', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('decreases', 'decrease', 'VBZ', 'B-VP', 'O'), ('exponentially', 'exponentially', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('surrounding', 'surround', 'VBG', 'I-NP', 'O'), ('buffer', 'buffer', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('review', 'review', 'NN', 'B-NP', 'O'), ('see', 'see', 'VBP', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The determination of the ζ-potential is based on the Smoluchowski approximation [ CIT ] assuming a homogenously charged , smooth surface .	[('The', 'The', 'DT', 'B-NP', 'O'), ('determination', 'determination', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ζ-potential', 'ζ-potential', 'JJ', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Smoluchowski', 'Smoluchowski', 'NNP', 'I-NP', 'O'), ('approximation', 'approximation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('assuming', 'assume', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('homogenously', 'homogenously', 'RB', 'I-NP', 'O'), ('charged', 'charge', 'VBN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('smooth', 'smooth', 'DT', 'B-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Aggregates formed by LPS are also described to be multilamellar in the presence of di- or polyvalent ions at a temperature of 25°C [ CIT ] .	[('Aggregates', 'Aggregate', 'NNS', 'B-NP', 'O'), ('formed', 'form', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('LPS', 'LPS', 'NN', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('multilamellar', 'multilamellar', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('di-', 'di-', 'JJ', 'B-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('polyvalent', 'polyvalent', 'JJ', 'I-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('25°C', '25°C', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The surface potential profiles of LPS aggregates can be calculated according to the Gouy-Chapman theory [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('profiles', 'profile', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LPS', 'LPS', 'NN', 'B-NP', 'O'), ('aggregates', 'aggregate', 'NNS', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('calculated', 'calculate', 'VBN', 'I-VP', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Gouy-Chapman', 'Gouy-Chapman', 'JJ', 'I-NP', 'O'), ('theory', 'theory', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As shown by Pasquale et al [ CIT ] , the planes of shear can be calculated from measured ζ-potentials and calculated surface potentials .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Pasquale', 'Pasquale', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('planes', 'plane', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('shear', 'shear', 'NN', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('calculated', 'calculate', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('measured', 'measure', 'VBN', 'B-NP', 'O'), ('ζ-potentials', 'ζ-potential', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('calculated', 'calculate', 'VBN', 'B-VP', 'O'), ('surface', 'surface', 'NN', 'B-NP', 'O'), ('potentials', 'potential', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Snyder et al. [ CIT ] concluded from electron density profiles of LPS R60 that its charges are located mainly in two distinct planes which are separated by a distance of 1.1 nm .	[('Snyder', 'Snyder', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('concluded', 'conclude', 'VBD', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('electron', 'electron', 'NN', 'B-NP', 'O'), ('density', 'density', 'NN', 'I-NP', 'O'), ('profiles', 'profile', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LPS', 'LPS', 'NN', 'B-NP', 'O'), ('R60', 'R60', 'NN', 'I-NP', 'B-protein'), ('that', 'that', 'IN', 'B-NP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('charges', 'charge', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('mainly', 'mainly', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('distinct', 'distinct', 'JJ', 'I-NP', 'O'), ('planes', 'plane', 'NNS', 'I-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('separated', 'separate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('distance', 'distance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('1.1', '1.1', 'CD', 'B-NP', 'O'), ('nm', 'nm', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	This value appeared lower than that reported by Skabkin et al [ CIT ] ( about 4 nm for monomeric YB-1 in solution of high ionic strength ) and probably resulted from YB-1 flattening on the mica surface .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('appeared', 'appear', 'VBD', 'B-VP', 'O'), ('lower', 'low', 'JJR', 'B-ADVP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Skabkin', 'Skabkin', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('about', 'about', 'RB', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('nm', 'nm', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('monomeric', 'monomeric', 'JJ', 'B-NP', 'O'), ('YB-1', 'YB-1', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('solution', 'solution', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('ionic', 'ionic', 'JJ', 'I-NP', 'O'), ('strength', 'strength', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('probably', 'probably', 'RB', 'B-VP', 'O'), ('resulted', 'result', 'VBD', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('YB-1', 'YB-1', 'NN', 'B-NP', 'B-protein'), ('flattening', 'flatten', 'VBG', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mica', 'mica', 'NN', 'I-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Tubulin appeared as particles with an average height of 3.7 nm ( Fig. 4 , middle panel ) in agreement with previous reports [ CIT ] .	[('Tubulin', 'Tubulin', 'NN', 'B-NP', 'B-protein'), ('appeared', 'appear', 'VBD', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('particles', 'particle', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('average', 'average', 'JJ', 'I-NP', 'O'), ('height', 'height', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('3.7', '3.7', 'CD', 'B-NP', 'O'), ('nm', 'nm', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('4', '4', 'CD', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('middle', 'middle', 'JJ', 'B-NP', 'O'), ('panel', 'panel', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	It is known that RNP saturated with YB-1 contains about one molecule of YB-1 per 25 RNA bases [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RNP', 'RNP', 'NN', 'B-NP', 'B-protein'), ('saturated', 'saturate', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('YB-1', 'YB-1', 'NN', 'B-NP', 'B-protein'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('about', 'about', 'IN', 'B-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('molecule', 'molecule', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('YB-1', 'YB-1', 'NN', 'B-NP', 'B-protein'), ('per', 'per', 'IN', 'B-PP', 'O'), ('25', '25', 'CD', 'B-NP', 'O'), ('RNA', 'RNA', 'NN', 'I-NP', 'O'), ('bases', 'base', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A similar kinetic pattern was observed for polyE4Y , a commonly used artificial substrate for PTK activity assays ( Figure 3B ) [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('kinetic', 'kinetic', 'JJ', 'I-NP', 'O'), ('pattern', 'pattern', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polyE4Y', 'polyE4Y', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('commonly', 'commonly', 'RB', 'I-NP', 'O'), ('used', 'use', 'VBN', 'I-NP', 'O'), ('artificial', 'artificial', 'JJ', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('PTK', 'PTK', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('assays', 'assay', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3B', '3B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	It is known that Csk activity is highly sensitive to ionic inhibition [ CIT ] , making it difficult to separate the effect of Mg2+ as an activator from ionic inhibition at high MgCl2 concentrations .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Csk', 'Csk', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('highly', 'highly', 'RB', 'B-ADJP', 'O'), ('sensitive', 'sensitive', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('ionic', 'ionic', 'JJ', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('making', 'make', 'VBG', 'B-VP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('difficult', 'difficult', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('separate', 'separate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('activator', 'activator', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('ionic', 'ionic', 'JJ', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('MgCl2', 'MgCl2', 'NN', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	All three residues are conserved among PTKs , corresponding to Asp332 , Glu236 and Asn319 in Csk [ CIT ] .	[('All', 'All', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('conserved', 'conserve', 'VBN', 'I-VP', 'O'), ('among', 'among', 'IN', 'B-PP', 'O'), ('PTKs', 'PTKs', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('Asp332', 'Asp332', 'NN', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('Glu236', 'Glu236', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Asn319', 'Asn319', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Csk', 'Csk', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous analysis has shown that daidzein , genistein , luteolin and apigenin are the main flavonoids present in Dpm- and SNP-elicited cotyledons [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('daidzein', 'daidzein', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('genistein', 'genistein', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('luteolin', 'luteolin', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('apigenin', 'apigenin', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('main', 'main', 'JJ', 'I-NP', 'O'), ('flavonoids', 'flavonoid', 'NNS', 'I-NP', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Dpm-', 'Dpm-', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('SNP-elicited', 'SNP-elicited', 'JJ', 'B-NP', 'O'), ('cotyledons', 'cotyledon', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	As it has been shown earlier under these conditions CSN1 and CSN3 protein levels were reduced below 40 % , which was paralleled by a similar reduction of the holocomplex [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('earlier', 'earlier', 'RBR', 'B-ADVP', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('CSN1', 'CSN1', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('CSN3', 'CSN3', 'NN', 'B-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('reduced', 'reduce', 'VBN', 'I-VP', 'O'), ('below', 'below', 'IN', 'B-PP', 'O'), ('40', '40', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('paralleled', 'parallel', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('reduction', 'reduction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('holocomplex', 'holocomplex', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This differs from CSN1 or CSN3 knockdowns where the amount of the CSN holocomplex decreased proportionally to the reduction of the CSN subunits [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('differs', 'differ', 'VBZ', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('CSN1', 'CSN1', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('CSN3', 'CSN3', 'NN', 'I-NP', 'B-protein'), ('knockdowns', 'knockdown', 'NNS', 'I-NP', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amount', 'amount', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CSN', 'CSN', 'NN', 'I-NP', 'B-protein'), ('holocomplex', 'holocomplex', 'NN', 'I-NP', 'I-protein'), ('decreased', 'decrease', 'VBD', 'B-VP', 'O'), ('proportionally', 'proportionally', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reduction', 'reduction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CSN', 'CSN', 'NN', 'I-NP', 'B-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown before that the CSN , most likely by the CSN-associated deubiquitinating enzyme USP15 , protects components of CRLs including the CRL RING-domain component , Rbx1 , against autoubiquitination and degradation [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('that', 'that', 'IN', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CSN', 'CSN', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('most', 'most', 'RBS', 'B-ADJP', 'O'), ('likely', 'likely', 'JJ', 'I-ADJP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CSN-associated', 'CSN-associated', 'JJ', 'I-NP', 'O'), ('deubiquitinating', 'deubiquitinate', 'VBG', 'I-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('USP15', 'USP15', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('protects', 'protect', 'VBZ', 'B-VP', 'O'), ('components', 'component', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CRLs', 'CRL', 'NNS', 'B-NP', 'B-protein'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CRL', 'CRL', 'NN', 'I-NP', 'B-protein'), ('RING-domain', 'RING-domain', 'NN', 'I-NP', 'I-protein'), ('component', 'component', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('Rbx1', 'Rbx1', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('against', 'against', 'IN', 'B-PP', 'O'), ('autoubiquitination', 'autoubiquitination', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('degradation', 'degradation', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	It can be called a substrate receptor of CSN interacting proteins including important regulators such as c-Jun and p27 ( for rev. see [ CIT ] ) .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('called', 'call', 'VBN', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CSN', 'CSN', 'NNP', 'B-NP', 'B-protein'), ('interacting', 'interact', 'VBG', 'B-VP', 'I-protein'), ('proteins', 'protein', 'NNS', 'B-NP', 'I-protein'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('important', 'important', 'JJ', 'B-NP', 'O'), ('regulators', 'regulator', 'NNS', 'I-NP', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('c-Jun', 'c-Jun', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('p27', 'p27', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('rev.', 'rev.', 'NN', 'B-NP', 'O'), ('see', 'see', 'VBP', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Therefore , siCSN1 cells were synchronized by serum-deprivation for 24 h and then driven into G1 phase of cell cycle by serum complementation as performed before [ CIT ] .	[('Therefore', 'Therefore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('siCSN1', 'siCSN1', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('synchronized', 'synchronize', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('serum-deprivation', 'serum-deprivation', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('24', '24', 'CD', 'B-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('then', 'then', 'RB', 'B-ADVP', 'O'), ('driven', 'drive', 'VBN', 'B-VP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('G1', 'G1', 'NN', 'B-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cell', 'cell', 'NN', 'B-NP', 'O'), ('cycle', 'cycle', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('serum', 'serum', 'NN', 'B-NP', 'O'), ('complementation', 'complementation', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('performed', 'perform', 'VBN', 'B-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A decreased phosphorylation in siCSN1 cells has been shown for the microtubule-end-binding protein 1 ( EB1 ) [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('decreased', 'decrease', 'VBN', 'I-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('siCSN1', 'siCSN1', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('microtubule-end-binding', 'microtubule-end-binding', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('EB1', 'EB1', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	AtSUC2 : : GUS was expressed in companion cells , consistent with previous immunolocalization studies [ CIT ] .	[('AtSUC2', 'AtSUC2', 'NN', 'B-NP', 'O'), (':', ':', ':', 'O', 'O'), (':', ':', ':', 'O', 'O'), ('GUS', 'GUS', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('companion', 'companion', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('immunolocalization', 'immunolocalization', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	The expression of SUT2 in companion cells is in disagreement with immunolocalization data in Arabidopsis [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('SUT2', 'SUT2', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('companion', 'companion', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('disagreement', 'disagreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('immunolocalization', 'immunolocalization', 'NN', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Arabidopsis', 'Arabidopsis', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A series of NubG-fusion proteins including membrane proteins of different compartments such as a the plasma membrane potassium channel AtKAT1 [ CIT ] , was used to probe the specificity of the interactions and possibly detect interactions between sucrose transporters and enzymes of sucrose metabolism ( Fig. 2 ) .	[('A', 'A', 'DT', 'B-NP', 'O'), ('series', 'series', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NubG-fusion', 'NubG-fusion', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('membrane', 'membrane', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('compartments', 'compartment', 'NNS', 'I-NP', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('the', 'the', 'DT', 'I-NP', 'O'), ('plasma', 'plasma', 'NN', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('potassium', 'potassium', 'NN', 'I-NP', 'O'), ('channel', 'channel', 'NN', 'I-NP', 'O'), ('AtKAT1', 'AtKAT1', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('probe', 'probe', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('specificity', 'specificity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('possibly', 'possibly', 'RB', 'B-VP', 'O'), ('detect', 'detect', 'VB', 'I-VP', 'O'), ('interactions', 'interaction', 'NNS', 'B-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('sucrose', 'sucrose', 'NN', 'B-NP', 'O'), ('transporters', 'transporter', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('sucrose', 'sucrose', 'NN', 'B-NP', 'O'), ('metabolism', 'metabolism', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Kinetic analysis ( data not shown ) revealed no significant difference between sucrose affinity of NubG-fusion proteins and published sucrose affinities [ CIT ] .	[('Kinetic', 'Kinetic', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('sucrose', 'sucrose', 'NN', 'B-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NubG-fusion', 'NubG-fusion', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('sucrose', 'sucrose', 'NN', 'I-NP', 'O'), ('affinities', 'affinity', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	No interactions were observed with the glucose transporter AtSTP1 and the potassium channel AtKAT1 [ CIT ] , demonstrating specificity of the interaction between the three different sucrose transporters ( Fig. 3 , 4 ) .	[('No', 'No', 'DT', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('glucose', 'glucose', 'NN', 'I-NP', 'B-protein'), ('transporter', 'transporter', 'NN', 'I-NP', 'I-protein'), ('AtSTP1', 'AtSTP1', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('potassium', 'potassium', 'NN', 'I-NP', 'O'), ('channel', 'channel', 'NN', 'I-NP', 'O'), ('AtKAT1', 'AtKAT1', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('specificity', 'specificity', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('sucrose', 'sucrose', 'NN', 'I-NP', 'O'), ('transporters', 'transporter', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Since soluble enzymes involved in sucrose metabolism , such as sucrose synthase and sucrose-6-phosphate phosphatase were found to be membrane-associated [ CIT ] .	[('Since', 'Since', 'IN', 'B-SBAR', 'O'), ('soluble', 'soluble', 'JJ', 'B-NP', 'B-protein'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'I-protein'), ('involved', 'involve', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('sucrose', 'sucrose', 'NN', 'B-NP', 'O'), ('metabolism', 'metabolism', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('sucrose', 'sucrose', 'NN', 'B-NP', 'B-protein'), ('synthase', 'synthase', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('sucrose-6-phosphate', 'sucrose-6-phosphate', 'NN', 'B-NP', 'B-protein'), ('phosphatase', 'phosphatase', 'NN', 'I-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('membrane-associated', 'membrane-associate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Therefore , we hypothesized that the conversion was on the ethanolamine moiety in AEA to form the glycine as was previously suggested [ CIT ] .	[('Therefore', 'Therefore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('hypothesized', 'hypothesize', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conversion', 'conversion', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ethanolamine', 'ethanolamine', 'NN', 'I-NP', 'O'), ('moiety', 'moiety', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('AEA', 'AEA', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('glycine', 'glycine', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In Xenopus , EF-1γ has been shown to be the major substrate for maturation-promoting factor ( MPF ) [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('EF-1γ', 'EF-1γ', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('major', 'major', 'JJ', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('maturation-promoting', 'maturation-promoting', 'JJ', 'B-NP', 'B-protein'), ('factor', 'factor', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('MPF', 'MPF', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	EF-1β and EF-1δ were shown to be phosphorylated by casein kinase II [ CIT ] .	[('EF-1β', 'EF-1β', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('EF-1δ', 'EF-1δ', 'NN', 'I-NP', 'B-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('casein', 'casein', 'NN', 'B-NP', 'B-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has also been reported that casein kinase II co-purified with the 20S proteasome [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('casein', 'casein', 'NN', 'B-NP', 'B-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('co-purified', 'co-purifie', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('20S', '20S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	According to previous results , EF-1γ in isolated EF-1 complex is phosphorylated by MPF [ CIT ] .	[('According', 'Accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('EF-1γ', 'EF-1γ', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('isolated', 'isolate', 'VBN', 'B-NP', 'O'), ('EF-1', 'EF-1', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('MPF', 'MPF', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Under low salt conditions , EF-1 complex was obtained in the fractions corresponding to the 26S proteasome on gel column chromatography as described previously [ CIT ] ( Data not shown ) .	[('Under', 'Under', 'IN', 'B-PP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('salt', 'salt', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('EF-1', 'EF-1', 'NN', 'B-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('26S', '26S', 'NN', 'I-NP', 'B-protein'), ('proteasome', 'proteasome', 'NN', 'I-NP', 'I-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('gel', 'gel', 'NN', 'B-NP', 'O'), ('column', 'column', 'NN', 'I-NP', 'O'), ('chromatography', 'chromatography', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Data', 'Data', 'NN', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with previous reports [ CIT ] , Dnmt1 is strongly stimulated by hemimethylated substrates showing approximately a 13-fold higher activity on these substrates than on fully unmethylated DNA and showed nearly no activity on fully methylated DNA ( Fig. 1A ) .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('strongly', 'strongly', 'RB', 'I-VP', 'O'), ('stimulated', 'stimulate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('hemimethylated', 'hemimethylate', 'VBN', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('a', 'a', 'DT', 'I-NP', 'O'), ('13-fold', '13-fold', 'RB', 'I-NP', 'O'), ('higher', 'high', 'JJR', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('unmethylated', 'unmethylated', 'JJ', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('nearly', 'nearly', 'RB', 'B-NP', 'O'), ('no', 'no', 'DT', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('methylated', 'methylate', 'VBN', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1A', '1A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Also consistent with the lack of in vitro site preference reported previously [ CIT ] , virtually no difference in Dnmt1 activity between the 30 bp and the 122 bp substrates was detected ( Fig. 1A ) .	[('Also', 'Also', 'RB', 'B-ADJP', 'O'), ('consistent', 'consistent', 'JJ', 'I-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lack', 'lack', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('in', 'in', 'FW', 'B-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('site', 'site', 'NN', 'I-NP', 'O'), ('preference', 'preference', 'NN', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('virtually', 'virtually', 'RB', 'B-NP', 'O'), ('no', 'no', 'DT', 'I-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('30', '30', 'CD', 'I-NP', 'B-DNA'), ('bp', 'bp', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('122', '122', 'CD', 'I-NP', 'O'), ('bp', 'bp', 'NN', 'I-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with previous reports [ CIT ] , Dnmt3a showed a very low activity on all of the 30 bp substrates , though the highest activity was detected with fully unmethylated DNA ( UM ) ; and nearly no activity was detected with fully methylated substrate ( DM ) ( Fig. 1B ) .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('very', 'very', 'RB', 'I-NP', 'O'), ('low', 'low', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('30', '30', 'CD', 'I-NP', 'B-DNA'), ('bp', 'bp', 'NN', 'I-NP', 'I-DNA'), ('substrates', 'substrate', 'NNS', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('though', 'though', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('highest', 'high', 'JJS', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('unmethylated', 'unmethylate', 'VBN', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('UM', 'UM', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('nearly', 'nearly', 'RB', 'B-NP', 'O'), ('no', 'no', 'DT', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('methylated', 'methylate', 'VBN', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('DM', 'DM', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('1B', '1B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A Dnmt3a catalytic mutant [ CIT ] showed background levels of radioactivity , confirming the activity of Dnmt3a ( data not shown ) .	[('A', 'A', 'DT', 'B-NP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'I-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('mutant', 'mutant', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('background', 'background', 'NN', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('radioactivity', 'radioactivity', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('confirming', 'confirm', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with our previous findings [ CIT ] and results using several other substrates ( data not shown ) , these findings suggest that Dnmt3a has substrate preferences while Dnmt1 does not .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('results', 'result', 'VBZ', 'B-VP', 'O'), ('using', 'use', 'VBG', 'I-VP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('suggest', 'suggest', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('substrate', 'substrate', 'NN', 'B-NP', 'O'), ('preferences', 'preference', 'NNS', 'I-NP', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'B-NP', 'B-protein'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A de novo methylation activity of Dnmt1 has been described as acting on single-stranded substrates at low efficiency in vitro [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('de', 'de', 'FW', 'I-NP', 'O'), ('novo', 'novo', 'FW', 'I-NP', 'O'), ('methylation', 'methylation', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('acting', 'act', 'VBG', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('single-stranded', 'single-stranded', 'JJ', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('efficiency', 'efficiency', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These findings are consistent with previous reports [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous work indicated that partially-purified human and mouse Dnmt1 has a higher level of methylation activity on partially-methylated plasmids than fully unmethylated plasmids in vitro [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('partially-purified', 'partially-purified', 'JJ', 'B-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('mouse', 'mouse', 'NN', 'I-NP', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('higher', 'high', 'JJR', 'I-NP', 'O'), ('level', 'level', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('methylation', 'methylation', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('partially-methylated', 'partially-methylated', 'JJ', 'B-NP', 'B-DNA'), ('plasmids', 'plasmid', 'NNS', 'I-NP', 'I-DNA'), ('than', 'than', 'IN', 'B-PP', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('unmethylated', 'unmethylate', 'VBN', 'I-NP', 'O'), ('plasmids', 'plasmid', 'NNS', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Another report indicated that hemimethylated CCG can stimulate Dnmt3a but not Dnmt1 ; fully methylated CCG fails to stimulate either enzyme ; and fully methylated CWG can stimulate both enzymes [ CIT ] .	[('Another', 'Another', 'DT', 'B-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hemimethylated', 'hemimethylate', 'VBN', 'B-NP', 'O'), ('CCG', 'CCG', 'NN', 'I-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'O'), ('but', 'but', 'CC', 'B-NP', 'O'), ('not', 'not', 'RB', 'I-NP', 'O'), ('Dnmt1', 'Dnmt1', 'NN', 'B-NP', 'B-protein'), (';', ';', ':', 'O', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('methylated', 'methylate', 'VBN', 'I-NP', 'O'), ('CCG', 'CCG', 'NN', 'I-NP', 'O'), ('fails', 'fail', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('either', 'either', 'CC', 'O', 'O'), ('enzyme', 'enzyme', 'NN', 'B-NP', 'B-protein'), (';', ';', ':', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('fully', 'fully', 'RB', 'B-NP', 'O'), ('methylated', 'methylate', 'VBN', 'I-NP', 'O'), ('CWG', 'CWG', 'NN', 'I-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To test whether pre-existing CpG methylation can stimulate Dnmt3a activity in vivo , a previously established assay system was used [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('test', 'test', 'VB', 'I-VP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('pre-existing', 'pre-existing', 'JJ', 'B-NP', 'O'), ('CpG', 'CpG', 'NN', 'I-NP', 'O'), ('methylation', 'methylation', 'NN', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('established', 'establish', 'VBN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	It has been described previously [ CIT ] , cotransfection of Dnmt3a expression vector with a target plasmid , such as p220.2 , into 293 / EBNA1 cells leads to methylation of the target plasmid while no methylation on the target plasmid was detected when the target plasmid was transfected alone or with a Dnmt3a catalytic mutant expression vector into 293 / EBNA1 cells .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('cotransfection', 'cotransfection', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'B-NP', 'B-DNA'), ('expression', 'expression', 'NN', 'I-NP', 'I-DNA'), ('vector', 'vector', 'NN', 'I-NP', 'I-DNA'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('p220.2', 'p220.2', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('293', '293', 'CD', 'B-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('EBNA1', 'EBNA1', 'NN', 'I-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('leads', 'lead', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('methylation', 'methylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('methylation', 'methylation', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('transfected', 'transfecte', 'VBN', 'I-VP', 'O'), ('alone', 'alone', 'RB', 'B-ADVP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Dnmt3a', 'Dnmt3a', 'NN', 'I-NP', 'B-DNA'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'I-DNA'), ('mutant', 'mutant', 'JJ', 'I-NP', 'I-DNA'), ('expression', 'expression', 'NN', 'I-NP', 'I-DNA'), ('vector', 'vector', 'NN', 'I-NP', 'I-DNA'), ('into', 'into', 'IN', 'B-PP', 'O'), ('293', '293', 'CD', 'B-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('EBNA1', 'EBNA1', 'NN', 'I-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('.', '.', '.', 'O', 'O')]
2	This finding suggests that cellular and mitochondrial uptake of thiamine may be mediated by the same transporter since TRMA is defined by mutation within the thiamine transporter located on the plasma membrane [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('suggests', 'suggest', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('cellular', 'cellular', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('mitochondrial', 'mitochondrial', 'JJ', 'I-NP', 'O'), ('uptake', 'uptake', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('thiamine', 'thiamine', 'NN', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('mediated', 'mediate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('transporter', 'transporter', 'NN', 'I-NP', 'O'), ('since', 'since', 'IN', 'B-PP', 'O'), ('TRMA', 'TRMA', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('defined', 'define', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('mutation', 'mutation', 'NN', 'B-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('thiamine', 'thiamine', 'NN', 'I-NP', 'O'), ('transporter', 'transporter', 'NN', 'I-NP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('plasma', 'plasma', 'NN', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We thus were interested in uptake of ThDP by mitochondria , a possibility demonstrated previously with rat liver [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('thus', 'thus', 'RB', 'B-ADVP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('interested', 'interested', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('uptake', 'uptake', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ThDP', 'ThDP', 'NN', 'B-NP', 'B-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('liver', 'liver', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous work has indicated that different cell types may differentially regulate intracellular pools of thiamine and/or its phosphorylated derivatives [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('indicated', 'indicate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('types', 'type', 'NNS', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('differentially', 'differentially', 'RB', 'I-VP', 'O'), ('regulate', 'regulate', 'VB', 'I-VP', 'O'), ('intracellular', 'intracellular', 'JJ', 'B-NP', 'O'), ('pools', 'pool', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('thiamine', 'thiamine', 'NN', 'B-NP', 'O'), ('and/or', 'and/or', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-NP', 'O'), ('derivatives', 'derivative', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	When suspended in a 0.3 M KCl medium , energized mitochondria were unable to accumulate Ca2+ after ETH-129 addition as measured by mitochondrial-targeted aequorin [ CIT ] or the presence of the Ca2+-indicating dye antipyrylazo III ( Figure 1A ) .	[('When', 'When', 'WRB', 'B-ADVP', 'O'), ('suspended', 'suspend', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('0.3', '0.3', 'CD', 'I-NP', 'O'), ('M', 'M', 'NN', 'I-NP', 'O'), ('KCl', 'KCl', 'NN', 'I-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('energized', 'energize', 'VBN', 'B-NP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('unable', 'unable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('accumulate', 'accumulate', 'VB', 'I-VP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('ETH-129', 'ETH-129', 'NN', 'B-NP', 'O'), ('addition', 'addition', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('measured', 'measure', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('mitochondrial-targeted', 'mitochondrial-targeted', 'JJ', 'B-NP', 'B-protein'), ('aequorin', 'aequorin', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Ca2+-indicating', 'Ca2+-indicating', 'JJ', 'I-NP', 'O'), ('dye', 'dye', 'NN', 'I-NP', 'O'), ('antipyrylazo', 'antipyrylazo', 'NN', 'I-NP', 'O'), ('III', 'III', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In a previous report a large decrease in the ΔΨ occured after ETH-129 addition to mitochondria suspended in a mannitol medium in the absence of BSA ( bovine serum albumin ) [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('large', 'large', 'JJ', 'I-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ΔΨ', 'ΔΨ', 'NN', 'I-NP', 'O'), ('occured', 'occur', 'VBN', 'B-VP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('ETH-129', 'ETH-129', 'NN', 'B-NP', 'O'), ('addition', 'addition', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'B-NP', 'O'), ('suspended', 'suspend', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('mannitol', 'mannitol', 'NN', 'I-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('BSA', 'BSA', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('bovine', 'bovine', 'JJ', 'B-NP', 'B-protein'), ('serum', 'serum', 'NN', 'I-NP', 'I-protein'), ('albumin', 'albumin', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is fairly consistent with a previously measured value of between 20 and 30 nmole Mg2+ / mg protein [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('fairly', 'fairly', 'RB', 'B-ADJP', 'O'), ('consistent', 'consistent', 'JJ', 'I-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('measured', 'measure', 'VBN', 'I-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('between', 'between', 'IN', 'B-NP', 'O'), ('20', '20', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('30', '30', 'CD', 'I-NP', 'O'), ('nmole', 'nmole', 'NN', 'I-NP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-VP', 'O'), ('mg', 'mg', 'NN', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This finding is consistent with previous results using mitochondrial-targeted aequorin indicating that free external and free mitochondrial Ca2+ levels equilibrate [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('mitochondrial-targeted', 'mitochondrial-targeted', 'JJ', 'B-NP', 'B-protein'), ('aequorin', 'aequorin', 'NN', 'I-NP', 'I-protein'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('free', 'free', 'JJ', 'B-NP', 'O'), ('external', 'external', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('free', 'free', 'JJ', 'I-NP', 'O'), ('mitochondrial', 'mitochondrial', 'JJ', 'I-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('equilibrate', 'equilibrate', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Our first approach was based on the glycoprotein properties of gp114 [ CIT ] .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('glycoprotein', 'glycoprotein', 'NN', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('gp114', 'gp114', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The conservation of gp114 across species is apparently not sufficient for an identification by cross-species matching of acquired tandem mass spectra matching using Mascot software [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('conservation', 'conservation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('gp114', 'gp114', 'NN', 'B-NP', 'B-protein'), ('across', 'across', 'IN', 'B-PP', 'O'), ('species', 'specie', 'NNS', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('apparently', 'apparently', 'RB', 'B-ADVP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('sufficient', 'sufficient', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('identification', 'identification', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('cross-species', 'cross-species', 'JJ', 'B-NP', 'O'), ('matching', 'matching', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('acquired', 'acquire', 'VBN', 'B-NP', 'O'), ('tandem', 'tandem', 'JJ', 'I-NP', 'O'), ('mass', 'mass', 'NN', 'I-NP', 'O'), ('spectra', 'spectrum', 'NNS', 'I-NP', 'O'), ('matching', 'match', 'VBG', 'B-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('Mascot', 'Mascot', 'NNP', 'B-NP', 'O'), ('software', 'software', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In addition , some CEACAM proteins are modified to include a glycophosphatidylinositol ( GPI ) anchor instead of a transmembrane domain ( reviewed in [ CIT ] ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('CEACAM', 'CEACAM', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('modified', 'modify', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('include', 'include', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('glycophosphatidylinositol', 'glycophosphatidylinositol', 'NN', 'I-NP', 'B-protein'), ('(', '(', '(', 'O', 'I-protein'), ('GPI', 'GPI', 'NN', 'B-NP', 'I-protein'), (')', ')', ')', 'O', 'I-protein'), ('anchor', 'anchor', 'NN', 'B-NP', 'I-protein'), ('instead', 'instead', 'RB', 'B-CONJP', 'O'), ('of', 'of', 'IN', 'I-CONJP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('transmembrane', 'transmembrane', 'JJ', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('reviewed', 'review', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	CEACAM 5 , 8 and 6 are GPI anchored proteins which have been reported to be expressed in humans only [ CIT ] .	[('CEACAM', 'CEACAM', 'NN', 'B-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('8', '8', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('6', '6', 'CD', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('GPI', 'GPI', 'NNP', 'B-NP', 'B-protein'), ('anchored', 'anchor', 'VBN', 'B-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('humans', 'human', 'NNS', 'B-NP', 'O'), ('only', 'only', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To identify potential physiological substrates of Dbf2-Mob1 , we first proceeded to determine an optimal substrate sequence by using an oriented degenerate peptide library technique [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('identify', 'identify', 'VB', 'I-VP', 'O'), ('potential', 'potential', 'JJ', 'B-NP', 'O'), ('physiological', 'physiological', 'JJ', 'I-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Dbf2-Mob1', 'Dbf2-Mob1', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('first', 'first', 'RB', 'B-ADVP', 'O'), ('proceeded', 'proceed', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('oriented', 'orient', 'VBN', 'I-NP', 'O'), ('degenerate', 'degenerate', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('library', 'library', 'NN', 'I-NP', 'O'), ('technique', 'technique', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The rationale for this is articulated in Songyang et. al. [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('rationale', 'rationale', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('articulated', 'articulate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Songyang', 'Songyang', 'NN', 'B-NP', 'O'), ('et.', 'et.', 'FW', 'B-ADVP', 'O'), ('al.', 'al.', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	While some of these bands have been shown to correspond to multistranded complexes [ CIT ] were drawn to our attention for two reasons .	[('While', 'While', 'IN', 'B-SBAR', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('correspond', 'correspond', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('multistranded', 'multistranded', 'JJ', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('drawn', 'draw', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('attention', 'attention', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('reasons', 'reason', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	But , after it was shown that the formation of multistranded structures by fragments containing a tract of poly ( CA ) · poly ( TG ) was correlated to some extent with the opening of the double helix [ CIT ] , we found that the most efficient way of producing Form X was to dissociate the DNA strands by thermal denaturation and to let them reassociate in the presence of protein HMG1 or HMG2 .	[('But', 'But', 'CC', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('after', 'after', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('multistranded', 'multistranded', 'JJ', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('fragments', 'fragment', 'NNS', 'B-NP', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('tract', 'tract', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('poly', 'poly', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('CA', 'CA', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('·', '·', 'NN', 'B-NP', 'O'), ('poly', 'poly', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('TG', 'TG', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('correlated', 'correlate', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('extent', 'extent', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('opening', 'opening', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('double', 'double', 'JJ', 'I-NP', 'O'), ('helix', 'helix', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('most', 'most', 'RBS', 'I-NP', 'O'), ('efficient', 'efficient', 'JJ', 'I-NP', 'O'), ('way', 'way', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('producing', 'produce', 'VBG', 'B-VP', 'O'), ('Form', 'Form', 'NN', 'B-NP', 'O'), ('X', 'X', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('dissociate', 'dissociate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('strands', 'strand', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('thermal', 'thermal', 'JJ', 'B-NP', 'O'), ('denaturation', 'denaturation', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('let', 'let', 'VB', 'I-VP', 'O'), ('them', 'them', 'PRP', 'B-NP', 'O'), ('reassociate', 'reassociate', 'VB', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('HMG1', 'HMG1', 'NN', 'I-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('HMG2', 'HMG2', 'NN', 'I-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
3	In addition , structures containing staggered single-stranded loops resulting from shifted reassociation in the repetitive region had to be considered [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('structures', 'structure', 'NNS', 'B-NP', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('staggered', 'staggered', 'JJ', 'B-NP', 'O'), ('single-stranded', 'single-stranded', 'JJ', 'I-NP', 'O'), ('loops', 'loop', 'NNS', 'I-NP', 'O'), ('resulting', 'result', 'VBG', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('shifted', 'shift', 'VBN', 'B-NP', 'O'), ('reassociation', 'reassociation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('repetitive', 'repetitive', 'JJ', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('considered', 'consider', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The possibility that two DNA duplexes might associate to form such junctions has been proposed previously [ CIT ] , and such structures have been termed ' hemicatenanes ' to reflect the fact that each duplex is linked to the other duplex by only one of its strands , although from an etymological point of view the term ' semicatenane ' formed with two Latin roots would seem more correct .	[('The', 'The', 'DT', 'B-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('duplexes', 'duplex', 'NNS', 'I-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('associate', 'associate', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('junctions', 'junction', 'NNS', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('proposed', 'propose', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('termed', 'term', 'VBN', 'I-VP', 'O'), ("'", "'", "''", 'O', 'O'), ('hemicatenanes', 'hemicatenane', 'NNS', 'B-NP', 'O'), ("'", "'", 'POS', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('reflect', 'reflect', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('duplex', 'duplex', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('linked', 'link', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('duplex', 'duplex', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('strands', 'strand', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('etymological', 'etymological', 'JJ', 'I-NP', 'O'), ('point', 'point', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('view', 'view', 'NN', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('term', 'term', 'NN', 'I-NP', 'O'), ("'", "'", '``', 'I-NP', 'O'), ('semicatenane', 'semicatenane', 'NN', 'I-NP', 'O'), ("'", "'", "''", 'O', 'O'), ('formed', 'form', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('Latin', 'Latin', 'JJ', 'I-NP', 'O'), ('roots', 'root', 'NNS', 'I-NP', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('seem', 'seem', 'VB', 'I-VP', 'O'), ('more', 'more', 'RBR', 'B-ADJP', 'O'), ('correct', 'correct', 'JJ', 'I-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in accordance with literature , amino acid substitution usually does not significantly affect the stability [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('accordance', 'accordance', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('literature', 'literature', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('amino', 'amino', 'NN', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('substitution', 'substitution', 'NN', 'I-NP', 'O'), ('usually', 'usually', 'RB', 'B-ADVP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('significantly', 'significantly', 'RB', 'I-VP', 'O'), ('affect', 'affect', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Thus , as with other S. pombe cullins [ CIT ] , Pcu3p undergoes covalent modification by ubiquitin-like Ned8p at lysine 729 .	[('Thus', 'Thus', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('S.', 'S.', 'FW', 'I-NP', 'O'), ('pombe', 'pombe', 'FW', 'I-NP', 'O'), ('cullins', 'cullin', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('Pcu3p', 'Pcu3p', 'NN', 'B-NP', 'O'), ('undergoes', 'undergo', 'VBZ', 'B-VP', 'O'), ('covalent', 'covalent', 'JJ', 'B-NP', 'O'), ('modification', 'modification', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('ubiquitin-like', 'ubiquitin-like', 'JJ', 'B-NP', 'B-protein'), ('Ned8p', 'Ned8p', 'NN', 'I-NP', 'I-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('lysine', 'lysine', 'NN', 'B-NP', 'B-DNA'), ('729', '729', 'CD', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
2	This indicates that the described phenotype of csn1 mutants [ CIT ] is unlikely to be a consequence of interference with Pcu3p activity .	[('This', 'This', 'DT', 'B-NP', 'O'), ('indicates', 'indicate', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('phenotype', 'phenotype', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('csn1', 'csn1', 'NN', 'B-NP', 'B-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('unlikely', 'unlikely', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('consequence', 'consequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('interference', 'interference', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('Pcu3p', 'Pcu3p', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
8	Lyapina et al. recently demonstrated that partially purified CSN promotes the cleavage of Pcu1p-Ned8p conjugates in vitro [ CIT ] , but it remained unclear whether the enzymatic activity is contained within one of the CSN subunits or a tightly associated peptidase .	[('Lyapina', 'Lyapina', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('recently', 'recently', 'RB', 'B-ADVP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('partially', 'partially', 'RB', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'O'), ('CSN', 'CSN', 'NN', 'I-NP', 'B-protein'), ('promotes', 'promote', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Pcu1p-Ned8p', 'Pcu1p-Ned8p', 'NN', 'B-NP', 'B-protein'), ('conjugates', 'conjugate', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('remained', 'remain', 'VBD', 'B-VP', 'O'), ('unclear', 'unclear', 'JJ', 'B-ADJP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzymatic', 'enzymatic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('contained', 'contain', 'VBN', 'I-VP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CSN', 'CSN', 'NN', 'I-NP', 'B-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('or', 'or', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('tightly', 'tightly', 'RB', 'I-NP', 'O'), ('associated', 'associate', 'VBN', 'I-NP', 'O'), ('peptidase', 'peptidase', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	All peptidases known to cleave ubiquitin- or SUMO-protein conjugates are cysteine-based proteases ( reviewed in ref. [ CIT ] ) .	[('All', 'All', 'DT', 'B-NP', 'O'), ('peptidases', 'peptidase', 'NNS', 'I-NP', 'O'), ('known', 'know', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('cleave', 'cleave', 'VB', 'I-VP', 'O'), ('ubiquitin-', 'ubiquitin-', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('SUMO-protein', 'SUMO-protein', 'NN', 'I-NP', 'O'), ('conjugates', 'conjugate', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('cysteine-based', 'cysteine-based', 'JJ', 'B-NP', 'B-protein'), ('proteases', 'protease', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('reviewed', 'review', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ref.', 'ref.', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In A. thaliana , CSN was shown to be required for the efficient nuclear accumulation of the putative RING-type ubiquitin ligase COP1 [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('A.', 'A.', 'NN', 'B-NP', 'O'), ('thaliana', 'thaliana', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('CSN', 'CSN', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('required', 'require', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('efficient', 'efficient', 'JJ', 'I-NP', 'O'), ('nuclear', 'nuclear', 'JJ', 'I-NP', 'O'), ('accumulation', 'accumulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('RING-type', 'RING-type', 'JJ', 'I-NP', 'O'), ('ubiquitin', 'ubiquitin', 'NN', 'I-NP', 'O'), ('ligase', 'ligase', 'NN', 'I-NP', 'O'), ('COP1', 'COP1', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	All human cullins have been shown to assemble into complexes possessing polyubiquitylation activity in vitro [ CIT ] .	[('All', 'All', 'DT', 'B-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'B-protein'), ('cullins', 'cullin', 'NNS', 'I-NP', 'I-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('assemble', 'assemble', 'VB', 'I-VP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('complexes', 'complex', 'NNS', 'B-NP', 'O'), ('possessing', 'possess', 'VBG', 'B-VP', 'O'), ('polyubiquitylation', 'polyubiquitylation', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	To determine whether Pcu3p is associated with such an activity and how it is affected by CSN , we developed a substrate-independent in vitro polyubiquitylation assay , similar to that originally reported by Lyapina et al. [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('Pcu3p', 'Pcu3p', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('associated', 'associate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('an', 'an', 'DT', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('how', 'how', 'WRB', 'B-ADVP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('affected', 'affect', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('CSN', 'CSN', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('developed', 'develop', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('substrate-independent', 'substrate-independent', 'JJ', 'I-NP', 'O'), ('in', 'in', 'FW', 'I-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('polyubiquitylation', 'polyubiquitylation', 'NN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('originally', 'originally', 'RB', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Lyapina', 'Lyapina', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As Pcu3p-associated ubiquitin ligase activity was not described before , we first needed to determine which of the fourteen different ubiquitin-conjugating enzymes ( UBCs ) present in the fission yeast genome associate with the RING domain protein Pip1p , an essential cofactor of cullin ubiquitin ligases [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('Pcu3p-associated', 'Pcu3p-associated', 'JJ', 'B-NP', 'B-protein'), ('ubiquitin', 'ubiquitin', 'NN', 'I-NP', 'I-protein'), ('ligase', 'ligase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('before', 'before', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('first', 'first', 'RB', 'B-ADVP', 'O'), ('needed', 'need', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fourteen', 'fourteen', 'CD', 'I-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('ubiquitin-conjugating', 'ubiquitin-conjugating', 'JJ', 'I-NP', 'B-protein'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('UBCs', 'UBC', 'NNS', 'B-NP', 'B-cell_type'), (')', ')', ')', 'O', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fission', 'fission', 'NN', 'I-NP', 'B-DNA'), ('yeast', 'yeast', 'NN', 'I-NP', 'I-DNA'), ('genome', 'genome', 'NN', 'I-NP', 'I-DNA'), ('associate', 'associate', 'VBP', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RING', 'RING', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('Pip1p', 'Pip1p', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('essential', 'essential', 'JJ', 'I-NP', 'O'), ('cofactor', 'cofactor', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cullin', 'cullin', 'NN', 'B-NP', 'B-protein'), ('ubiquitin', 'ubiquitin', 'NN', 'I-NP', 'I-protein'), ('ligases', 'ligas', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This value is further supported by dilution experiments monitoring tyrosine fluorescence as a function of protein concentration ( Inset , Figure 5A ) , a method previously used to probe the Kd [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('further', 'further', 'RBR', 'I-VP', 'O'), ('supported', 'support', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('dilution', 'dilution', 'NN', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('monitoring', 'monitor', 'VBG', 'B-VP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Inset', 'Inset', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('5A', '5A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('probe', 'probe', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Kd', 'Kd', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Therefore the respiration-induced YMUC does not transport solutes as large as previously reported ( ~1,000 Daltons ) [ CIT ] .	[('Therefore', 'Therefore', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('respiration-induced', 'respiration-induced', 'JJ', 'I-NP', 'O'), ('YMUC', 'YMUC', 'NN', 'I-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('transport', 'transport', 'VB', 'I-VP', 'O'), ('solutes', 'solute', 'NNS', 'B-NP', 'O'), ('as', 'as', 'RB', 'B-ADJP', 'O'), ('large', 'large', 'JJ', 'I-ADJP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('~1', '~1', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('000', '000', 'CD', 'B-NP', 'O'), ('Daltons', 'Dalton', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown that yeast mitochondria need greater than 1 mM phosphate to prevent YMUC opening and membrane potential dissipation when oxidizing ethanol [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'I-NP', 'O'), ('need', 'need', 'VBP', 'B-VP', 'O'), ('greater', 'great', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('mM', 'mM', 'NN', 'I-NP', 'O'), ('phosphate', 'phosphate', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('prevent', 'prevent', 'VB', 'I-VP', 'O'), ('YMUC', 'YMUC', 'NN', 'B-NP', 'O'), ('opening', 'opening', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('dissipation', 'dissipation', 'NN', 'I-NP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('oxidizing', 'oxidize', 'VBG', 'B-VP', 'O'), ('ethanol', 'ethanol', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A procedure that allows the formation of [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('procedure', 'procedure', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('allows', 'allow', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Such a figure is consistent with previously obtained data [ CIT ] , showing that the optimized conditions do not dilute the inorganic ( SO42- ) or the organic ( PAPS ) sulfate sources .	[('Such', 'Such', 'PDT', 'B-NP', 'O'), ('a', 'a', 'DT', 'I-NP', 'O'), ('figure', 'figure', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('obtained', 'obtain', 'VBN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('optimized', 'optimize', 'VBN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('do', 'do', 'VBP', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('dilute', 'dilute', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inorganic', 'inorganic', 'JJ', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('SO42-', 'SO42-', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('organic', 'organic', 'JJ', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('PAPS', 'PAPS', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('sulfate', 'sulfate', 'NN', 'B-NP', 'O'), ('sources', 'source', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Moreover , studies on the selectivity of a Nod factor binding site , associated to Medicago varia cell suspension cultures , revealed the importance of some structural elements for a high affinity binding [ CIT ] .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('studies', 'study', 'NNS', 'B-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('selectivity', 'selectivity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Nod', 'Nod', 'NN', 'I-NP', 'B-DNA'), ('factor', 'factor', 'NN', 'I-NP', 'I-DNA'), ('binding', 'binding', 'NN', 'I-NP', 'I-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('associated', 'associate', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('Medicago', 'Medicago', 'NNP', 'B-NP', 'B-cell_line'), ('varia', 'varia', 'NN', 'I-NP', 'I-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('suspension', 'suspension', 'NN', 'I-NP', 'I-cell_line'), ('cultures', 'culture', 'NNS', 'I-NP', 'I-cell_line'), (',', ',', ',', 'O', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('importance', 'importance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'B-DNA'), ('elements', 'element', 'NNS', 'I-NP', 'I-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('high', 'high', 'JJ', 'I-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	White and co-workers have previously pointed out that the interfacial width of ca. 1.5 nm is wide enough to accommodate a standard alpha-helix [ CIT ] .	[('White', 'White', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('co-workers', 'co-worker', 'NNS', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('pointed', 'point', 'VBN', 'I-VP', 'O'), ('out', 'out', 'RP', 'B-PRT', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interfacial', 'interfacial', 'JJ', 'I-NP', 'O'), ('width', 'width', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ca.', 'ca.', 'NN', 'B-NP', 'O'), ('1.5', '1.5', 'CD', 'I-NP', 'O'), ('nm', 'nm', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('wide', 'wide', 'JJ', 'B-ADJP', 'O'), ('enough', 'enough', 'RB', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('accommodate', 'accommodate', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('standard', 'standard', 'JJ', 'I-NP', 'O'), ('alpha-helix', 'alpha-helix', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been concluded from the crystallographic study that Arg41 , Lys44 and Asn53 of GST can interact with glutathione [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('concluded', 'conclude', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crystallographic', 'crystallographic', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-NP', 'O'), ('Arg41', 'Arg41', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'I-NP', 'O'), ('Lys44', 'Lys44', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Asn53', 'Asn53', 'NN', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('GST', 'GST', 'NN', 'B-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('glutathione', 'glutathione', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Moreover , Tyr6 , Trp7 and Leu12 of GST were shown to interact with glutathione [ CIT ] , and our results show that F1 peptide GYWKIKGLV contains Tyr6 , Trp7 and Leu12 ( indicated in bold letters ) .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Tyr6', 'Tyr6', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Trp7', 'Trp7', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('Leu12', 'Leu12', 'NN', 'B-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('GST', 'GST', 'NN', 'B-NP', 'B-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('glutathione', 'glutathione', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('show', 'show', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('F1', 'F1', 'NN', 'B-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('GYWKIKGLV', 'GYWKIKGLV', 'NN', 'I-NP', 'O'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('Tyr6', 'Tyr6', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'I-NP', 'O'), ('Trp7', 'Trp7', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Leu12', 'Leu12', 'NN', 'I-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('indicated', 'indicate', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('bold', 'bold', 'JJ', 'B-NP', 'O'), ('letters', 'letter', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The structure-function analysis has shown that GST contains one important binding site ( G-site ) for glutathione [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('structure-function', 'structure-function', 'JJ', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('GST', 'GST', 'NN', 'B-NP', 'B-protein'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('important', 'important', 'JJ', 'I-NP', 'O'), ('binding', 'bind', 'VBG', 'I-NP', 'O'), ('site', 'site', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('G-site', 'G-site', 'NN', 'B-NP', 'B-DNA'), (')', ')', ')', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('glutathione', 'glutathione', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Experiments based on kinetic and chemical modification techniques indicated that the active site might contain either His , Cys , Trp , Arg , or Asp [ CIT ] .	[('Experiments', 'Experiment', 'NNS', 'B-NP', 'O'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('kinetic', 'kinetic', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('chemical', 'chemical', 'JJ', 'I-NP', 'O'), ('modification', 'modification', 'NN', 'I-NP', 'O'), ('techniques', 'technique', 'NNS', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('active', 'active', 'JJ', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('might', 'might', 'MD', 'B-VP', 'O'), ('contain', 'contain', 'VB', 'I-VP', 'O'), ('either', 'either', 'CC', 'O', 'O'), ('His', 'His', 'NNP', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Cys', 'Cys', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Trp', 'Trp', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Arg', 'Arg', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('Asp', 'Asp', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It was shown that different extracellular molecules such as heparin sulphate proteoglycans were able to bind S100A12 and other S100 proteins [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('extracellular', 'extracellular', 'JJ', 'I-NP', 'B-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('heparin', 'heparin', 'NN', 'B-NP', 'O'), ('sulphate', 'sulphate', 'NN', 'I-NP', 'O'), ('proteoglycans', 'proteoglycan', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('S100A12', 'S100A12', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('S100', 'S100', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similar results were previously reported [ CIT ] .	[('Similar', 'Similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This result is consistent with the previously reported observation that towards carbamylphosphate the inhibition by UTP is of uncompetitive type [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-NP', 'O'), ('towards', 'towards', 'IN', 'B-PP', 'O'), ('carbamylphosphate', 'carbamylphosphate', 'NN', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('UTP', 'UTP', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('uncompetitive', 'uncompetitive', 'JJ', 'B-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Such mutants were previously described [ CIT ] .	[('Such', 'Such', 'JJ', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Three of these mutants were used in this study : Asn1094→Asp located in the CPSase domain ; Glu1933→Lys and Glu2182→Lys located in the ATCase domain [ CIT ] ( Table 1 ) .	[('Three', 'Three', 'CD', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('Asn1094→Asp', 'Asn1094→Asp', 'NN', 'B-NP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CPSase', 'CPSase', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), (';', ';', ':', 'O', 'O'), ('Glu1933→Lys', 'Glu1933→Ly', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Glu2182→Lys', 'Glu2182→Ly', 'NNS', 'I-NP', 'O'), ('located', 'locate', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ATCase', 'ATCase', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In previous studies on two-component systems it was shown that the individual domains can be expressed separately , thereby maintaining their biochemical function [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('two-component', 'two-component', 'JJ', 'B-NP', 'O'), ('systems', 'system', 'NNS', 'I-NP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('individual', 'individual', 'JJ', 'I-NP', 'O'), ('domains', 'domain', 'NNS', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('separately', 'separately', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('thereby', 'thereby', 'RB', 'B-VP', 'O'), ('maintaining', 'maintain', 'VBG', 'I-VP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast , wild type DokA , expressed under the control of the endogenous promoter , can not be detected by these methods , as it is only weakly expressed in vegetative cells and in the early stages of development [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'B-protein'), ('type', 'type', 'NN', 'I-NP', 'I-protein'), ('DokA', 'DokA', 'NNP', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('expressed', 'express', 'VBN', 'B-VP', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('control', 'control', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('endogenous', 'endogenous', 'JJ', 'I-NP', 'B-DNA'), ('promoter', 'promoter', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('methods', 'method', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('only', 'only', 'RB', 'I-VP', 'O'), ('weakly', 'weakly', 'RB', 'I-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('vegetative', 'vegetative', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('and', 'and', 'CC', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('early', 'early', 'JJ', 'I-NP', 'O'), ('stages', 'stage', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('development', 'development', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Because Dictyostelium cells lacking the dokA gene are sensitive to hyperosmotic stress , it was speculated that DokA is part of the osmotic response system of Dictyostelium [ CIT ] .	[('Because', 'Because', 'IN', 'B-SBAR', 'O'), ('Dictyostelium', 'Dictyostelium', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('lacking', 'lack', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dokA', 'dokA', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('sensitive', 'sensitive', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('hyperosmotic', 'hyperosmotic', 'JJ', 'B-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('speculated', 'speculate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('DokA', 'DokA', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('part', 'part', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('osmotic', 'osmotic', 'JJ', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Dictyostelium', 'Dictyostelium', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It was previously shown that mutation of two conserved glycine residues in the ATP-binding site of the eukaryotic histidine kinase homologue Etr1 suppresses ATP binding and thus prevents autophosphorylation of Etr1 on a histidine residue [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('mutation', 'mutation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'O'), ('glycine', 'glycine', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ATP-binding', 'ATP-binding', 'JJ', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('eukaryotic', 'eukaryotic', 'JJ', 'I-NP', 'B-protein'), ('histidine', 'histidine', 'NN', 'I-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('homologue', 'homologue', 'NN', 'I-NP', 'O'), ('Etr1', 'Etr1', 'NN', 'I-NP', 'B-protein'), ('suppresses', 'suppress', 'VBZ', 'B-VP', 'O'), ('ATP', 'ATP', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('thus', 'thus', 'RB', 'B-VP', 'O'), ('prevents', 'prevent', 'VBZ', 'I-VP', 'O'), ('autophosphorylation', 'autophosphorylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Etr1', 'Etr1', 'NN', 'B-NP', 'B-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('histidine', 'histidine', 'NN', 'I-NP', 'O'), ('residue', 'residue', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	As described previously [ CIT ] , similar results were obtained at pH 6.0 , 7.0 and 7.4 .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('pH', 'pH', 'NN', 'B-NP', 'O'), ('6.0', '6.0', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('7.0', '7.0', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('7.4', '7.4', 'CD', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Partitions performed with an upper to lower phase volume ratio of 20 : 1 yielded reproducible low 14C-PR from the 2nd through 5th cycle at all pH values studied , as described previously [ CIT ] .	[('Partitions', 'Partition', 'NNS', 'B-NP', 'O'), ('performed', 'perform', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('upper', 'upper', 'JJ', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('volume', 'volume', 'NN', 'I-NP', 'O'), ('ratio', 'ratio', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('20', '20', 'CD', 'B-NP', 'O'), (':', ':', ':', 'O', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('yielded', 'yield', 'VBD', 'B-VP', 'O'), ('reproducible', 'reproducible', 'JJ', 'B-NP', 'O'), ('low', 'low', 'JJ', 'I-NP', 'O'), ('14C-PR', '14C-PR', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('2nd', '2nd', 'NN', 'I-NP', 'O'), ('through', 'through', 'IN', 'B-PP', 'O'), ('5th', '5th', 'JJ', 'B-NP', 'O'), ('cycle', 'cycle', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('studied', 'study', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It is of interest that a recently published article [ CIT ] on Rhizopus oryzar found a second GA gene , amyB , lacks the N-terminal SBD .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('interest', 'interest', 'NN', 'B-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('recently', 'recently', 'RB', 'I-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('article', 'article', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Rhizopus', 'Rhizopus', 'NN', 'B-NP', 'B-protein'), ('oryzar', 'oryzar', 'NN', 'I-NP', 'I-protein'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('second', 'second', 'JJ', 'I-NP', 'O'), ('GA', 'GA', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('amyB', 'amyB', 'NN', 'B-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('lacks', 'lack', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'B-protein'), ('SBD', 'SBD', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
1	Potential N-glycosylation sites in RoGA analyzed using the on-line prediction server NetNGlyc version 1.0 [ CIT ] revealed that RoGA contained three putative N-linked glycosylation consensus sites , one ( Asn167-Ser-Thr ) located in the linker region and two ( Asn230-Thr-Thr and Asn236-Lys-Thr ) in the catalytic domain ( Figure 1 ) .	[('Potential', 'Potential', 'JJ', 'B-NP', 'O'), ('N-glycosylation', 'N-glycosylation', 'NN', 'I-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('RoGA', 'RoGA', 'NNP', 'B-NP', 'O'), ('analyzed', 'analyze', 'VBN', 'B-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('on-line', 'on-line', 'JJ', 'I-NP', 'O'), ('prediction', 'prediction', 'NN', 'I-NP', 'O'), ('server', 'server', 'NN', 'I-NP', 'O'), ('NetNGlyc', 'NetNGlyc', 'NN', 'I-NP', 'O'), ('version', 'version', 'NN', 'I-NP', 'O'), ('1.0', '1.0', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RoGA', 'RoGA', 'NNP', 'B-NP', 'O'), ('contained', 'contain', 'VBD', 'B-VP', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('N-linked', 'N-linked', 'JJ', 'I-NP', 'B-DNA'), ('glycosylation', 'glycosylation', 'NN', 'I-NP', 'I-DNA'), ('consensus', 'consensus', 'NN', 'I-NP', 'I-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Asn167-Ser-Thr', 'Asn167-Ser-Thr', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('linker', 'linker', 'NN', 'I-NP', 'B-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Asn230-Thr-Thr', 'Asn230-Thr-Thr', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Asn236-Lys-Thr', 'Asn236-Lys-Thr', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Although no specific consensus sequence for O-linked glycosylation has yet been reported [ CIT ] .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('consensus', 'consensus', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('O-linked', 'O-linked', 'JJ', 'B-NP', 'O'), ('glycosylation', 'glycosylation', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('yet', 'yet', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	T. harzianum 1051 growing in casein-containing liquid medium produces substantial proteolytic activity as previously reported [ CIT ] .	[('T.', 'T.', 'NN', 'B-NP', 'O'), ('harzianum', 'harzianum', 'NN', 'I-NP', 'O'), ('1051', '1051', 'CD', 'I-NP', 'O'), ('growing', 'grow', 'VBG', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('casein-containing', 'casein-containing', 'JJ', 'B-NP', 'O'), ('liquid', 'liquid', 'JJ', 'I-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('produces', 'produce', 'VBZ', 'B-VP', 'O'), ('substantial', 'substantial', 'JJ', 'B-NP', 'O'), ('proteolytic', 'proteolytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The enzyme sample resulting from pooling of fractions 30-37 contained a single protein as demonstrated by SDS-PAGE [ CIT ] analysis ( Fig. 2 ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'O'), ('sample', 'sample', 'NN', 'I-NP', 'O'), ('resulting', 'result', 'VBG', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('pooling', 'pooling', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('fractions', 'fraction', 'NNS', 'B-NP', 'O'), ('30-37', '30-37', 'CD', 'B-NP', 'O'), ('contained', 'contain', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('SDS-PAGE', 'SDS-PAGE', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('analysis', 'analysis', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	This optimal temperature value is very close to the optimal temperatures determined for the proteases from Streptomyces spp. G157 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('very', 'very', 'RB', 'B-ADJP', 'O'), ('close', 'close', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('temperatures', 'temperature', 'NNS', 'I-NP', 'O'), ('determined', 'determine', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteases', 'protease', 'NNS', 'I-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Streptomyces', 'Streptomyce', 'NNS', 'B-NP', 'O'), ('spp.', 'spp.', 'NN', 'I-NP', 'O'), ('G157', 'G157', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As much as 0.202 μg of protein / μL of reaction mixture , as measured by the method of Lowry et al. [ CIT ] were present in the reaction mixture 48 h after the beginning of the period of incubation of the purified native enzyme with the Crinipellis mycelium ( Tab. 2 ) .	[('As', 'As', 'RB', 'B-NP', 'O'), ('much', 'much', 'JJ', 'I-NP', 'O'), ('as', 'as', 'IN', 'I-NP', 'O'), ('0.202', '0.202', 'CD', 'I-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('μL', 'μL', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('reaction', 'reaction', 'NN', 'B-NP', 'O'), ('mixture', 'mixture', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('measured', 'measure', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Lowry', 'Lowry', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('mixture', 'mixture', 'NN', 'I-NP', 'O'), ('48', '48', 'CD', 'I-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('beginning', 'beginning', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('period', 'period', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('incubation', 'incubation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'B-protein'), ('native', 'native', 'JJ', 'I-NP', 'I-protein'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'I-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Crinipellis', 'Crinipellis', 'NNP', 'I-NP', 'O'), ('mycelium', 'mycelium', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Tab.', 'Tab.', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The effects of purified Trichoderma chitinase on the cell wall of Rhizoctonia solani and Sclerotium rolfsii [ CIT ] were reported before supporting the involvement of hydrolytic enzymes in the antagonistic process .	[('The', 'The', 'DT', 'B-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('purified', 'purify', 'VBN', 'B-NP', 'O'), ('Trichoderma', 'Trichoderma', 'NN', 'I-NP', 'B-protein'), ('chitinase', 'chitinase', 'NN', 'I-NP', 'I-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('wall', 'wall', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Rhizoctonia', 'Rhizoctonia', 'NNP', 'B-NP', 'O'), ('solani', 'solani', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Sclerotium', 'Sclerotium', 'NN', 'B-NP', 'O'), ('rolfsii', 'rolfsii', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('supporting', 'support', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('involvement', 'involvement', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('hydrolytic', 'hydrolytic', 'JJ', 'B-NP', 'B-protein'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('antagonistic', 'antagonistic', 'JJ', 'I-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	As a consequence , it has been claimed that hydrolytic enzymes and the genes encoding them may be useful for production of transgenic microorganisms with superior biocontrol capability and the development of transgenic plants with high resistance to pathogens [ CIT ] .	[('As', 'As', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('consequence', 'consequence', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('claimed', 'claim', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hydrolytic', 'hydrolytic', 'JJ', 'B-NP', 'B-protein'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('genes', 'gene', 'NNS', 'I-NP', 'O'), ('encoding', 'encode', 'VBG', 'B-VP', 'O'), ('them', 'them', 'PRP', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('useful', 'useful', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('production', 'production', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('transgenic', 'transgenic', 'JJ', 'B-NP', 'O'), ('microorganisms', 'microorganism', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('superior', 'superior', 'JJ', 'B-NP', 'O'), ('biocontrol', 'biocontrol', 'NN', 'I-NP', 'O'), ('capability', 'capability', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('development', 'development', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('transgenic', 'transgenic', 'JJ', 'B-NP', 'O'), ('plants', 'plant', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('resistance', 'resistance', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('pathogens', 'pathogen', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Purified ORC yielded 5 specific bands , corresponding to XOrc1 , 2 , 3 , 4 and 5 [ CIT ] ( Fig 2b ) .	[('Purified', 'Purify', 'VBN', 'B-VP', 'O'), ('ORC', 'ORC', 'NNP', 'B-NP', 'O'), ('yielded', 'yield', 'VBD', 'B-VP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('XOrc1', 'XOrc1', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('5', '5', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig', 'Fig', 'NNP', 'B-NP', 'O'), ('2b', '2b', 'NNP', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	ORC purified from HeLa cell chromatin has also been reported to lack Orc6 [ CIT ] .	[('ORC', 'ORC', 'NN', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('HeLa', 'HeLa', 'NN', 'B-NP', 'B-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('chromatin', 'chromatin', 'NN', 'I-NP', 'B-DNA'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('lack', 'lack', 'VB', 'I-VP', 'O'), ('Orc6', 'Orc6', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	These proteins were subjected to MALDI-TOF analysis and were identified as Xenopus Klp1 and Kcm1 [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('subjected', 'subject', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('MALDI-TOF', 'MALDI-TOF', 'NN', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('Klp1', 'Klp1', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Kcm1', 'Kcm1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Complexes of Xenopus Mcm ( 2+4+6+7 ) and Mcm ( 3+5 ) were purified from Xenopus egg extracts as described [ CIT ] ( Figs 2f and 2g ) .	[('Complexes', 'Complex', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NNP', 'B-NP', 'O'), ('Mcm', 'Mcm', 'NNP', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2+4+6+7', '2+4+6+7', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Mcm', 'Mcm', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('3+5', '3+5', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('purified', 'purify', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('egg', 'egg', 'NN', 'I-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Figs', 'Fig', 'NNS', 'B-NP', 'O'), ('2f', '2f', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('2g', '2g', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Recombinant geminin was prepared from E. coli as described ( Fig 2h ) [ CIT ] .	[('Recombinant', 'Recombinant', 'JJ', 'B-NP', 'B-protein'), ('geminin', 'geminin', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('prepared', 'prepare', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig', 'Fig', 'NNP', 'B-NP', 'O'), ('2h', '2h', 'NNP', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is close to the expected density of ORC on Xenopus sperm chromatin in the early embryo ( ~1 ORC per 10-15 kb ) [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('close', 'close', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('expected', 'expect', 'VBN', 'I-NP', 'O'), ('density', 'density', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ORC', 'ORC', 'NN', 'B-NP', 'B-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'B-DNA'), ('sperm', 'sperm', 'NN', 'I-NP', 'I-DNA'), ('chromatin', 'chromatin', 'NN', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('early', 'early', 'JJ', 'I-NP', 'O'), ('embryo', 'embryo', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('~1', '~1', 'CD', 'O', 'O'), ('ORC', 'ORC', 'NNP', 'O', 'O'), ('per', 'per', 'IN', 'B-PP', 'O'), ('10-15', '10-15', 'CD', 'B-NP', 'O'), ('kb', 'kb', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This suggests that , consistent with previous reports [ CIT ] , the recombinant protein is only partially active .	[('This', 'This', 'DT', 'B-NP', 'O'), ('suggests', 'suggest', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('recombinant', 'recombinant', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('only', 'only', 'RB', 'B-ADJP', 'O'), ('partially', 'partially', 'RB', 'I-ADJP', 'O'), ('active', 'active', 'JJ', 'I-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Fig. 2g shows that geminin inhibits origin licensing in whole egg extract at ~1.5 ng / μl , consistent with previous reports [ CIT ] .	[('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('2g', '2g', 'NN', 'I-NP', 'O'), ('shows', 'show', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('geminin', 'geminin', 'NN', 'B-NP', 'O'), ('inhibits', 'inhibit', 'VBZ', 'B-VP', 'O'), ('origin', 'origin', 'NN', 'B-NP', 'O'), ('licensing', 'licensing', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('whole', 'whole', 'JJ', 'B-NP', 'O'), ('egg', 'egg', 'NN', 'I-NP', 'O'), ('extract', 'extract', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('~1.5', '~1.5', 'CD', 'B-NP', 'O'), ('ng', 'ng', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('μl', 'μl', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous work has shown that under the assay conditions used , there is close correlation between the number of licensed origins and the degree of replication [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('close', 'close', 'JJ', 'B-NP', 'O'), ('correlation', 'correlation', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('licensed', 'licensed', 'JJ', 'B-NP', 'B-protein'), ('origins', 'origin', 'NNS', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('degree', 'degree', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('replication', 'replication', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Geminin has recently been shown to form a complex with RLF-B / Cdt1 and inhibit its function [ CIT ] .	[('Geminin', 'Geminin', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('complex', 'complex', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('RLF-B', 'RLF-B', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('Cdt1', 'Cdt1', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('inhibit', 'inhibit', 'VBP', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	LEXA-HSF1 is known from previous studies to be regulated similarly as HSF1 [ CIT ] .	[('LEXA-HSF1', 'LEXA-HSF1', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('regulated', 'regulate', 'VBN', 'I-VP', 'O'), ('similarly', 'similarly', 'RB', 'B-ADVP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('HSF1', 'HSF1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
4	This is a departure from several earlier studies relating to HSF1 phosphorylation , including one from our own group [ CIT ] , in which studies exogenous HSF1 forms were substantially overexpressed .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('departure', 'departure', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('relating', 'relate', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('HSF1', 'HSF1', 'NN', 'B-NP', 'B-protein'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('own', 'own', 'JJ', 'I-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('studies', 'study', 'VBZ', 'B-VP', 'O'), ('exogenous', 'exogenous', 'JJ', 'B-NP', 'O'), ('HSF1', 'HSF1', 'NN', 'I-NP', 'B-protein'), ('forms', 'form', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('substantially', 'substantially', 'RB', 'I-VP', 'O'), ('overexpressed', 'overexpresse', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
1	A known result of such overexpression is that a significant fraction of exogenous factor accumulates as DNA-binding trimers in the absence of a stress [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('overexpression', 'overexpression', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('fraction', 'fraction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('exogenous', 'exogenous', 'JJ', 'B-NP', 'B-protein'), ('factor', 'factor', 'NN', 'I-NP', 'I-protein'), ('accumulates', 'accumulate', 'VBZ', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('DNA-binding', 'DNA-binding', 'JJ', 'B-NP', 'B-protein'), ('trimers', 'trimer', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To examine the effects of substitution of Ser326 in an otherwise wildtype HSF1 background , use was made of an HSF1-negative mouse cell line prepared previously by McMillan et al. [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('examine', 'examine', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('substitution', 'substitution', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ser326', 'Ser326', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('otherwise', 'otherwise', 'RB', 'I-NP', 'O'), ('wildtype', 'wildtype', 'JJ', 'I-NP', 'O'), ('HSF1', 'HSF1', 'NN', 'I-NP', 'B-protein'), ('background', 'background', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('use', 'use', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('made', 'make', 'VBN', 'I-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('HSF1-negative', 'HSF1-negative', 'JJ', 'I-NP', 'B-cell_line'), ('mouse', 'mouse', 'NN', 'I-NP', 'I-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('line', 'line', 'NN', 'I-NP', 'I-cell_line'), ('prepared', 'prepare', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('McMillan', 'McMillan', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The sequence alignments and structural comparison of the three-dimensional models of fungal 17β-HSD [ CIT ] , aligned without gaps between residue number 15 to 222 in 17β-HSDcl and residues 26 to 233 in 3HNR ( 60 % of identical amino acids ) , identified strong hydrophobic and aromatic interactions across the Q-axis ( Phe120 , Phe124 , Phe132 , Phe133 , Phe177 ) and potential salt bridges / H-bonds between the αE and αF helices of the two subunits , all of which may stabilize dimerization ( Table 1 , Figure 1 ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('alignments', 'alignment', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('structural', 'structural', 'JJ', 'B-NP', 'O'), ('comparison', 'comparison', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('models', 'model', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('fungal', 'fungal', 'JJ', 'B-NP', 'O'), ('17β-HSD', '17β-HSD', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('aligned', 'align', 'VBN', 'B-VP', 'O'), ('without', 'without', 'IN', 'B-PP', 'O'), ('gaps', 'gap', 'NNS', 'B-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('residue', 'residue', 'NN', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('222', '222', 'CD', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('17β-HSDcl', '17β-HSDcl', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('26', '26', 'CD', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('233', '233', 'CD', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('3HNR', '3HNR', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('60', '60', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('identical', 'identical', 'JJ', 'B-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('strong', 'strong', 'JJ', 'B-NP', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('aromatic', 'aromatic', 'JJ', 'I-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('across', 'across', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Q-axis', 'Q-axis', 'NN', 'I-NP', 'B-DNA'), ('(', '(', '(', 'O', 'O'), ('Phe120', 'Phe120', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Phe124', 'Phe124', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Phe132', 'Phe132', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Phe133', 'Phe133', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Phe177', 'Phe177', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('potential', 'potential', 'JJ', 'B-NP', 'O'), ('salt', 'salt', 'NN', 'I-NP', 'O'), ('bridges', 'bridge', 'NNS', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('H-bonds', 'H-bond', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('αE', 'αE', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('αF', 'αF', 'NN', 'I-NP', 'O'), ('helices', 'helix', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('subunits', 'subunit', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('stabilize', 'stabilize', 'VB', 'I-VP', 'O'), ('dimerization', 'dimerization', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Figure', 'Figure', 'NNP', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To analyze the effect of loss of deneddylation in human cells , we utilized the doxycyline-inducible shRNA system developed by Clevers and colleagues [ CIT ] to conditionally down-regulate Csn5 protein levels .	[('To', 'To', 'TO', 'B-VP', 'O'), ('analyze', 'analyze', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('loss', 'loss', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('deneddylation', 'deneddylation', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('utilized', 'utilize', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('doxycyline-inducible', 'doxycyline-inducible', 'JJ', 'I-NP', 'O'), ('shRNA', 'shRNA', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('developed', 'develop', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Clevers', 'Clever', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('colleagues', 'colleague', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('conditionally', 'conditionally', 'RB', 'I-VP', 'O'), ('down-regulate', 'down-regulate', 'VB', 'I-VP', 'O'), ('Csn5', 'Csn5', 'NN', 'B-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with prior observations on normal diploid BJ1 fibroblasts depleted of Csn5 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('prior', 'prior', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('normal', 'normal', 'JJ', 'B-NP', 'B-cell_type'), ('diploid', 'diploid', 'JJ', 'I-NP', 'I-cell_type'), ('BJ1', 'BJ1', 'NN', 'I-NP', 'I-cell_type'), ('fibroblasts', 'fibroblast', 'NNS', 'I-NP', 'I-cell_type'), ('depleted', 'deplete', 'VBN', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Csn5', 'Csn5', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been proposed that loss of deneddylation could render F-box adaptor proteins unstable [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('proposed', 'propose', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('loss', 'loss', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('deneddylation', 'deneddylation', 'NN', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('render', 'render', 'VB', 'I-VP', 'O'), ('F-box', 'F-box', 'NN', 'B-NP', 'B-protein'), ('adaptor', 'adaptor', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('unstable', 'unstable', 'JJ', 'B-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Similar calculations were done for the other cell density ranges shown in Figure 1B , as well as for the extracellular CfaD concentrations shown in Figure 3 of [ CIT ] .	[('Similar', 'Similar', 'JJ', 'B-NP', 'O'), ('calculations', 'calculation', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('done', 'do', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('density', 'density', 'NN', 'I-NP', 'O'), ('ranges', 'range', 'NNS', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1B', '1B', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('extracellular', 'extracellular', 'JJ', 'I-NP', 'O'), ('CfaD', 'CfaD', 'NN', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Using the equation of Cheng and Prusoff [ CIT ] and the observed AprA concentration of 0.3 μg / ml in wild type conditioned growth medium from cells at 1.2 × 107 cells / ml , we found that native AprA had an inhibition constant ( Ki ) of 0.03 μg / ml , which is similar to the 0.03 μg / ml KD for the binding of rAprA to aprA- cells .	[('Using', 'Use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('equation', 'equation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cheng', 'Cheng', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Prusoff', 'Prusoff', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'I-NP', 'O'), ('AprA', 'AprA', 'NN', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('0.3', '0.3', 'CD', 'B-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('ml', 'ml', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('wild', 'wild', 'JJ', 'B-NP', 'O'), ('type', 'type', 'NN', 'I-NP', 'O'), ('conditioned', 'condition', 'VBD', 'B-VP', 'O'), ('growth', 'growth', 'NN', 'B-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('1.2', '1.2', 'CD', 'B-NP', 'O'), ('×', '×', 'HYPH', 'I-NP', 'B-cell_line'), ('107', '107', 'CD', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('/', '/', 'SYM', 'O', 'O'), ('ml', 'ml', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('native', 'native', 'JJ', 'B-NP', 'O'), ('AprA', 'AprA', 'NN', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('constant', 'constant', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Ki', 'Ki', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('0.03', '0.03', 'CD', 'B-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('ml', 'ml', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('0.03', '0.03', 'CD', 'I-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('ml', 'ml', 'NN', 'I-NP', 'O'), ('KD', 'KD', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('rAprA', 'rAprA', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('aprA-', 'aprA-', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('.', '.', '.', 'O', 'O')]
1	We used an IQ peptide from neuromodulin [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('IQ', 'IQ', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('neuromodulin', 'neuromodulin', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As has been noted for the neuromodulin IQ domain [ CIT ] , increasing the KCl concentration reduced binding to each IQ peptide .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('noted', 'note', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('neuromodulin', 'neuromodulin', 'NN', 'I-NP', 'B-protein'), ('IQ', 'IQ', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('increasing', 'increase', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('KCl', 'KCl', 'NN', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('reduced', 'reduce', 'VBD', 'B-VP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('IQ', 'IQ', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The partial specific volume of each protein complex was determined using the amino-acid composition of the constituent proteins ( Table 3 ; ref. [ CIT ] ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('partial', 'partial', 'JJ', 'I-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('volume', 'volume', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amino-acid', 'amino-acid', 'JJ', 'I-NP', 'O'), ('composition', 'composition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('constituent', 'constituent', 'JJ', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('ref.', 'ref.', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Fungal NAGK from S. cerevisiae [ CIT ] .	[('Fungal', 'Fungal', 'JJ', 'B-NP', 'B-protein'), ('NAGK', 'NAGK', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('S.', 'S.', 'FW', 'B-NP', 'O'), ('cerevisiae', 'cerevisiae', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The sequence of the argB gene product from X. campestris was aligned with mouse NAGS , NAGK with known three-dimensional structures from E. coli and T. maritima ( Figure 3B ) [ CIT ] , and fungal NAGS and NAGK from S. cerevisiae and S. pombe .	[('The', 'The', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('argB', 'argB', 'NN', 'I-NP', 'B-protein'), ('gene', 'gene', 'NN', 'I-NP', 'I-protein'), ('product', 'product', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('X.', 'X.', 'NN', 'B-NP', 'O'), ('campestris', 'campestris', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('aligned', 'align', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('NAGK', 'NAGK', 'NN', 'B-NP', 'B-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('known', 'known', 'JJ', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('T.', 'T.', 'FW', 'B-NP', 'O'), ('maritima', 'maritima', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3B', '3B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('fungal', 'fungal', 'JJ', 'B-NP', 'O'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('NAGK', 'NAGK', 'NN', 'I-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('S.', 'S.', 'FW', 'B-NP', 'O'), ('cerevisiae', 'cerevisiae', 'FW', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('S.', 'S.', 'FW', 'B-NP', 'O'), ('pombe', 'pombe', 'FW', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Based on this evidence we hypothesized that genes annotated as argB in Xanthomonadales encoded a dual-function enzyme that catalyzed the first two reactions of the arginine biosynthesis : formation of NAG from glutamate and AcCoA , and phosphorylation of NAG to form NAGP [ CIT ] .	[('Based', 'Base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('evidence', 'evidence', 'NN', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('hypothesized', 'hypothesize', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('genes', 'gene', 'NNS', 'B-NP', 'O'), ('annotated', 'annotate', 'VBN', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('argB', 'argB', 'NN', 'B-NP', 'B-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Xanthomonadales', 'Xanthomonadale', 'NNS', 'B-NP', 'O'), ('encoded', 'encode', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dual-function', 'dual-function', 'JJ', 'I-NP', 'B-protein'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'I-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('catalyzed', 'catalyze', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('reactions', 'reaction', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('arginine', 'arginine', 'NN', 'I-NP', 'O'), ('biosynthesis', 'biosynthesis', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('formation', 'formation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NAG', 'NAG', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('glutamate', 'glutamate', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('AcCoA', 'AcCoA', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NAG', 'NAG', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('NAGP', 'NAGP', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In contrast , presence of cholesterol leads to an increase of bound recoverin ( two columns on the right site of Fig. 1 ) , which is consistent with previous observations on the effect of cholesterol on membrane binding of recoverin [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('presence', 'presence', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cholesterol', 'cholesterol', 'NN', 'B-NP', 'O'), ('leads', 'lead', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('bound', 'bind', 'VBN', 'B-NP', 'O'), ('recoverin', 'recoverin', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('columns', 'column', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('right', 'right', 'JJ', 'I-NP', 'B-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cholesterol', 'cholesterol', 'NN', 'B-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('membrane', 'membrane', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('recoverin', 'recoverin', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The truncated mutant of recoverin Rc2-190 lacks this cluster of charges and its three-dimensional structure and some of its biochemcal properties have been previously reported by us [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('truncated', 'truncate', 'VBN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('recoverin', 'recoverin', 'NN', 'B-NP', 'O'), ('Rc2-190', 'Rc2-190', 'NN', 'I-NP', 'O'), ('lacks', 'lack', 'VBZ', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('cluster', 'cluster', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('charges', 'charge', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('biochemcal', 'biochemcal', 'JJ', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('us', 'us', 'PRP', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Composition of the lipid mixture was similar as in rod outer segment membranes and as used previously ( 40 % w / w PE , 40 % w / w PC , 15 % w / w PS ; 5 % w / w cholesterol ) [ CIT ] .	[('Composition', 'Composition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lipid', 'lipid', 'NN', 'I-NP', 'O'), ('mixture', 'mixture', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rod', 'rod', 'NN', 'B-NP', 'O'), ('outer', 'outer', 'JJ', 'I-NP', 'O'), ('segment', 'segment', 'NN', 'I-NP', 'O'), ('membranes', 'membrane', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('40', '40', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('PE', 'PE', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('40', '40', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('PC', 'PC', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('PS', 'PS', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('w', 'w', 'NN', 'I-NP', 'O'), ('cholesterol', 'cholesterol', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Recently , we attributed this effect to the decrease in Ca2+-affinity observed for Rc2-190 ( for experimental analysis and discussion on this point please refer to [ CIT ] ) .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('attributed', 'attribute', 'VBD', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Ca2+-affinity', 'Ca2+-affinity', 'NN', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('Rc2-190', 'Rc2-190', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('experimental', 'experimental', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('discussion', 'discussion', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('point', 'point', 'NN', 'I-NP', 'O'), ('please', 'please', 'NN', 'I-NP', 'O'), ('refer', 'refer', 'VBP', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Such an action of EGTA can not be explained only as a consequence of binding of endogenous ions of Ca2+ , and apparently , is also a result of a direct effect of EGTA on Na / K-ATPase [ CIT ] .	[('Such', 'Such', 'PDT', 'B-NP', 'O'), ('an', 'an', 'DT', 'I-NP', 'O'), ('action', 'action', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EGTA', 'EGTA', 'NN', 'B-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('explained', 'explain', 'VBN', 'I-VP', 'O'), ('only', 'only', 'RB', 'B-ADVP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('consequence', 'consequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('apparently', 'apparently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('direct', 'direct', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EGTA', 'EGTA', 'NN', 'B-NP', 'B-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Na', 'Na', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('K-ATPase', 'K-ATPase', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been earlier demonstrated [ CIT ] that in the absence of EGTA the dependence of inverse value of the Na / K-ATPase activity on the concentration of Ca2+ ions ( 10-5-10-3 M ) has a strictly linear character and the apparent inhibition constant is Ki = 0.30 ± 0.01 .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('earlier', 'earlier', 'RB', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EGTA', 'EGTA', 'NN', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dependence', 'dependence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('inverse', 'inverse', 'JJ', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Na', 'Na', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-VP', 'O'), ('K-ATPase', 'K-ATPase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('10-5-10-3', '10-5-10-3', 'CD', 'B-NP', 'O'), ('M', 'M', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('strictly', 'strictly', 'RB', 'I-NP', 'O'), ('linear', 'linear', 'JJ', 'I-NP', 'O'), ('character', 'character', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('apparent', 'apparent', 'JJ', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('constant', 'constant', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('Ki', 'Ki', 'NN', 'B-NP', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('0.30', '0.30', 'CD', 'B-NP', 'O'), ('±', '±', 'SYM', 'B-NP', 'O'), ('0.01', '0.01', 'CD', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been earlier demonstrated that in the absence of EGTA , addition of NA and SF into reaction medium does not alter the Ca2+ apparent inhibition constant [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('earlier', 'earlier', 'RB', 'B-ADVP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EGTA', 'EGTA', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NA', 'NA', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('SF', 'SF', 'NN', 'I-NP', 'B-protein'), ('into', 'into', 'IN', 'B-PP', 'O'), ('reaction', 'reaction', 'NN', 'B-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('alter', 'alter', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('apparent', 'apparent', 'JJ', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('constant', 'constant', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A potentially important biological role for Src in VEGF-dependent vascular permeability has been previously reported [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('potentially', 'potentially', 'RB', 'I-NP', 'O'), ('important', 'important', 'JJ', 'I-NP', 'O'), ('biological', 'biological', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('Src', 'Src', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('VEGF-dependent', 'VEGF-dependent', 'JJ', 'B-NP', 'O'), ('vascular', 'vascular', 'JJ', 'I-NP', 'O'), ('permeability', 'permeability', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Kinase reactions were also performed on Src optimal peptide substrate ( AEEEIYGEFEAKKKK [ CIT ] ) with similar results ( unpublished observations ) .	[('Kinase', 'Kinase', 'NN', 'B-NP', 'O'), ('reactions', 'reaction', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Src', 'Src', 'NN', 'B-NP', 'B-protein'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('AEEEIYGEFEAKKKK', 'AEEEIYGEFEAKKKK', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('unpublished', 'unpublished', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously , Cunningham et al. [ CIT ] have shown that tyrosine residues 801 ( juxtamembranal ) and 1175 ( C-terminal ) were phosphorylated on KDR / Flk-1 .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Cunningham', 'Cunningham', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('801', '801', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('juxtamembranal', 'juxtamembranal', 'JJ', 'B-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('1175', '1175', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'B-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('KDR', 'KDR', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'I-NP', 'O'), ('Flk-1', 'Flk-1', 'NN', 'I-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
2	Tyrosine residues 951 and 996 ( in the kinase insert domain ) , and 1054 and 1059 ( in the C-terminal kinase domain ) on KDR / Flk-1 have also been demonstrated to be phosphorylated [ CIT ] .	[('Tyrosine', 'Tyrosine', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('951', '951', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('996', '996', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('kinase', 'kinase', 'NN', 'I-NP', 'B-protein'), ('insert', 'insert', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('1054', '1054', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('1059', '1059', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('KDR', 'KDR', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'I-NP', 'O'), ('Flk-1', 'Flk-1', 'NN', 'I-NP', 'B-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Also , Takahashi and collaborators [ CIT ] have shown that in cultured endothelial cells , tyrosine residues 1175 and 1214 are major phosphorylation sites .	[('Also', 'Also', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Takahashi', 'Takahashi', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('collaborators', 'collaborator', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cultured', 'culture', 'VBN', 'B-NP', 'B-cell_line'), ('endothelial', 'endothelial', 'JJ', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), (',', ',', ',', 'O', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('1175', '1175', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('1214', '1214', 'CD', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('major', 'major', 'JJ', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'B-protein'), ('sites', 'site', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
7	In a recent study published by Meyer et al. [ CIT ] , VEGF activation of murine Flk-1 was found to stimulate Src activity ; however , mutational analysis of tyrosine 1212 ( homologous tyrosine in murine Flk-1 to tyrosine 1214 in human KDR ) did not impair Src activation , providing an important clue that tyrosine 1212 of murine Flk-1 might not be the major tyrosine involved in binding interactions with Src .	[('In', 'In', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('published', 'publish', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Meyer', 'Meyer', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('VEGF', 'VEGF', 'NN', 'B-NP', 'B-protein'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('murine', 'murine', 'JJ', 'B-NP', 'B-protein'), ('Flk-1', 'Flk-1', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('stimulate', 'stimulate', 'VB', 'I-VP', 'O'), ('Src', 'Src', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('mutational', 'mutational', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('1212', '1212', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('homologous', 'homologous', 'JJ', 'B-NP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('murine', 'murine', 'JJ', 'B-NP', 'O'), ('Flk-1', 'Flk-1', 'NN', 'I-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('1214', '1214', 'CD', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('KDR', 'KDR', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('impair', 'impair', 'VB', 'I-VP', 'O'), ('Src', 'Src', 'NN', 'B-NP', 'B-protein'), ('activation', 'activation', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('providing', 'provide', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('important', 'important', 'JJ', 'I-NP', 'O'), ('clue', 'clue', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('1212', '1212', 'CD', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('murine', 'murine', 'JJ', 'B-NP', 'B-protein'), ('Flk-1', 'Flk-1', 'NN', 'I-NP', 'I-protein'), ('might', 'might', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('major', 'major', 'JJ', 'I-NP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'I-NP', 'O'), ('involved', 'involve', 'VBN', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('Src', 'Src', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
5	These results are consistent with previous findings by Waltenberger and collaborators [ CIT ] who demonstrated that Fyn and Yes exhibited increased levels of tyrosine phosphorylation upon VEGF stimulation ( using stably transfected , VEGFR-overexpressing porcine aortic endothelial cell lines ) .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Waltenberger', 'Waltenberger', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('collaborators', 'collaborator', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Fyn', 'Fyn', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Yes', 'Ye', 'NNS', 'I-NP', 'B-protein'), ('exhibited', 'exhibit', 'VBD', 'B-VP', 'O'), ('increased', 'increase', 'VBN', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('VEGF', 'VEGF', 'NN', 'B-NP', 'B-protein'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('stably', 'stably', 'RB', 'B-VP', 'O'), ('transfected', 'transfecte', 'VBN', 'I-VP', 'O'), (',', ',', ',', 'O', 'O'), ('VEGFR-overexpressing', 'VEGFR-overexpressing', 'JJ', 'B-NP', 'B-cell_line'), ('porcine', 'porcine', 'JJ', 'I-NP', 'I-cell_line'), ('aortic', 'aortic', 'JJ', 'I-NP', 'I-cell_line'), ('endothelial', 'endothelial', 'JJ', 'I-NP', 'I-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('lines', 'line', 'NNS', 'I-NP', 'I-cell_line'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similar results have been observed for RGMc over-expressed in cell lines [ CIT ] .	[('Similar', 'Similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('RGMc', 'RGMc', 'NN', 'B-NP', 'B-protein'), ('over-expressed', 'over-expresse', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cell', 'cell', 'NN', 'B-NP', 'B-cell_line'), ('lines', 'line', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recent work has shown that delivery of iron to cultured cells resulted in a decline in abundance of extra-cellular RGMc 24 h later [ CIT ] .	[('Recent', 'Recent', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('delivery', 'delivery', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('iron', 'iron', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('cultured', 'culture', 'VBN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('resulted', 'result', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('decline', 'decline', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('abundance', 'abundance', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('extra-cellular', 'extra-cellular', 'JJ', 'B-NP', 'O'), ('RGMc', 'RGMc', 'NN', 'I-NP', 'O'), ('24', '24', 'CD', 'I-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('later', 'later', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In this regard , Silvestri et al have found that deferoxamine enhanced and iron loading decreased the abundance of furin in HeLa cells [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('regard', 'regard', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Silvestri', 'Silvestri', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('deferoxamine', 'deferoxamine', 'NN', 'B-NP', 'O'), ('enhanced', 'enhance', 'VBD', 'B-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('iron', 'iron', 'NN', 'B-NP', 'O'), ('loading', 'loading', 'NN', 'I-NP', 'O'), ('decreased', 'decrease', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('abundance', 'abundance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('furin', 'furin', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('HeLa', 'HeLa', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In addition , all analogs modified with fluorophores of high molecular weight and steric demands were reported to be potent PKA agonists [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('modified', 'modify', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('fluorophores', 'fluorophore', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('molecular', 'molecular', 'JJ', 'I-NP', 'O'), ('weight', 'weight', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('steric', 'steric', 'JJ', 'B-NP', 'O'), ('demands', 'demand', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('potent', 'potent', 'JJ', 'B-NP', 'O'), ('PKA', 'PKA', 'NN', 'I-NP', 'B-protein'), ('agonists', 'agonist', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In this respect , 8- [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('respect', 'respect', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('8-', '8-', 'CD', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has previously been shown that fluorescent cAMP analogs were able to label RIα aggregates , respectively [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('fluorescent', 'fluorescent', 'JJ', 'B-NP', 'O'), ('cAMP', 'cAMP', 'NN', 'I-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('label', 'label', 'VB', 'I-VP', 'O'), ('RIα', 'RIα', 'NN', 'B-NP', 'O'), ('aggregates', 'aggregate', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In lipophilicity measurements using reversed phase HPLC [ CIT ] , its logKw was determined to be 2.95 resulting in a more than 70 times increased lipophilicity compared to cAMP ( data not shown ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('lipophilicity', 'lipophilicity', 'NN', 'B-NP', 'O'), ('measurements', 'measurement', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('reversed', 'reverse', 'VBN', 'B-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('HPLC', 'HPLC', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('logKw', 'logKw', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('2.95', '2.95', 'CD', 'B-NP', 'O'), ('resulting', 'result', 'VBG', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('more', 'more', 'JJR', 'I-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('70', '70', 'CD', 'I-NP', 'O'), ('times', 'time', 'NNS', 'I-NP', 'O'), ('increased', 'increase', 'VBD', 'B-VP', 'O'), ('lipophilicity', 'lipophilicity', 'NN', 'B-NP', 'O'), ('compared', 'compare', 'VBN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('cAMP', 'cAMP', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In this respect the analog resembles highly membrane-permeant PKA agonists such as Sp-5 , 6-DCl-cBIMPS [ CIT ] , and surpasses all fluorescent cAMP analogs described so far .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('respect', 'respect', 'NN', 'I-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('analog', 'analog', 'NN', 'I-NP', 'O'), ('resembles', 'resemble', 'VBZ', 'B-VP', 'O'), ('highly', 'highly', 'RB', 'B-NP', 'O'), ('membrane-permeant', 'membrane-permeant', 'JJ', 'I-NP', 'O'), ('PKA', 'PKA', 'NN', 'I-NP', 'O'), ('agonists', 'agonist', 'NNS', 'I-NP', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('Sp-5', 'Sp-5', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('6-DCl-cBIMPS', '6-DCl-cBIMPS', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('surpasses', 'surpass', 'VBZ', 'B-VP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('fluorescent', 'fluorescent', 'JJ', 'I-NP', 'O'), ('cAMP', 'cAMP', 'NN', 'I-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('so', 'so', 'RB', 'B-ADVP', 'O'), ('far', 'far', 'RB', 'I-ADVP', 'O'), ('.', '.', '.', 'O', 'O')]
6	On the basis of the cAMP dose-FRET response curve [ CIT ] -cAMP is available to the intracellular fluorescent indicator .	[('On', 'On', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('basis', 'basis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cAMP', 'cAMP', 'NN', 'I-NP', 'O'), ('dose-FRET', 'dose-FRET', 'NN', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('curve', 'curve', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'I-NP', 'O'), ('-cAMP', '-cAMP', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('available', 'available', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('intracellular', 'intracellular', 'JJ', 'I-NP', 'O'), ('fluorescent', 'fluorescent', 'JJ', 'I-NP', 'O'), ('indicator', 'indicator', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The same experiments were performed using Sp-5 , 6-DCl-cBIMPS , a highly membrane permeable cAMP analog [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('Sp-5', 'Sp-5', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('6-DCl-cBIMPS', '6-DCl-cBIMPS', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('highly', 'highly', 'RB', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('permeable', 'permeable', 'JJ', 'I-NP', 'O'), ('cAMP', 'cAMP', 'NN', 'I-NP', 'O'), ('analog', 'analog', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been demonstrated before , that 8-modified cAMP analogs possess considerably high resistance towards PDE degradation [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('before', 'before', 'IN', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('8-modified', '8-modified', 'JJ', 'B-NP', 'O'), ('cAMP', 'cAMP', 'NN', 'I-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('possess', 'possess', 'VBP', 'B-VP', 'O'), ('considerably', 'considerably', 'RB', 'B-NP', 'O'), ('high', 'high', 'JJ', 'I-NP', 'O'), ('resistance', 'resistance', 'NN', 'I-NP', 'O'), ('towards', 'towards', 'IN', 'B-PP', 'O'), ('PDE', 'PDE', 'NN', 'B-NP', 'O'), ('degradation', 'degradation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Finally , we performed a bystander BRET test [ CIT ] , where COS-7 cells were transfected with a constant amount of donor-expression plasmid ( RIIα-RLuc , 0.5 μg ) and with increasing amounts of acceptor-expression plasmid ( GFP2-Cα , 0-2 μg ) .	[('Finally', 'Finally', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('performed', 'perform', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('bystander', 'bystander', 'NN', 'I-NP', 'O'), ('BRET', 'BRET', 'NN', 'I-NP', 'O'), ('test', 'test', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('COS-7', 'COS-7', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('transfected', 'transfecte', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('constant', 'constant', 'JJ', 'I-NP', 'O'), ('amount', 'amount', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('donor-expression', 'donor-expression', 'NN', 'B-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('RIIα-RLuc', 'RIIα-RLuc', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('0.5', '0.5', 'CD', 'B-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('increasing', 'increase', 'VBG', 'B-NP', 'O'), ('amounts', 'amount', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('acceptor-expression', 'acceptor-expression', 'NN', 'B-NP', 'B-DNA'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('GFP2-Cα', 'GFP2-Cα', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('0-2', '0-2', 'CD', 'B-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As already reported , the ectopic expression of full length POB1 had no influence on transferrin or EGF endocytosis [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('already', 'already', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ectopic', 'ectopic', 'JJ', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('full', 'full', 'JJ', 'B-NP', 'O'), ('length', 'length', 'NN', 'I-NP', 'O'), ('POB1', 'POB1', 'NN', 'I-NP', 'B-protein'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('influence', 'influence', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('transferrin', 'transferrin', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'O', 'O'), ('EGF', 'EGF', 'NN', 'B-NP', 'O'), ('endocytosis', 'endocytosis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The selected phage clones were sequenced and shown to encode either the Src homology 3 domain ( SH3 ) of Amphiphysin II or the carboxy-terminal SH3 domain of the molecular adaptor Grb2 , which was formerly shown to bind tagged POB1 in a GST pull-down assay [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('selected', 'select', 'VBN', 'I-NP', 'O'), ('phage', 'phage', 'NN', 'I-NP', 'O'), ('clones', 'clone', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('sequenced', 'sequence', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('encode', 'encode', 'VB', 'I-VP', 'O'), ('either', 'either', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Src', 'Src', 'NN', 'I-NP', 'B-protein'), ('homology', 'homology', 'NN', 'I-NP', 'I-protein'), ('3', '3', 'CD', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('SH3', 'SH3', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Amphiphysin', 'Amphiphysin', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('or', 'or', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('carboxy-terminal', 'carboxy-terminal', 'JJ', 'I-NP', 'B-protein'), ('SH3', 'SH3', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('molecular', 'molecular', 'JJ', 'I-NP', 'O'), ('adaptor', 'adaptor', 'NN', 'I-NP', 'O'), ('Grb2', 'Grb2', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('formerly', 'formerly', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('tagged', 'tag', 'VBN', 'B-NP', 'O'), ('POB1', 'POB1', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('GST', 'GST', 'NN', 'I-NP', 'B-protein'), ('pull-down', 'pull-down', 'JJ', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	Among the POB1 peptides the one showing the strongest signal ( indicated by a black triangle , peptide No.202 ) is 347KTHSRASpSLDLNKVF361 ( where pS represents phosphoserine 354 ) , although its sequence does not match a typical class 1 or class 2 14-3-3 consensus [ CIT ] .	[('Among', 'Among', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('POB1', 'POB1', 'NN', 'I-NP', 'B-protein'), ('peptides', 'peptide', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('one', 'one', 'NN', 'I-NP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('strongest', 'strong', 'JJS', 'I-NP', 'O'), ('signal', 'signal', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('indicated', 'indicate', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('black', 'black', 'JJ', 'I-NP', 'O'), ('triangle', 'triangle', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('peptide', 'peptide', 'NN', 'B-NP', 'O'), ('No.202', 'No.202', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('347KTHSRASpSLDLNKVF361', '347KTHSRASpSLDLNKVF361', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('pS', 'pS', 'NN', 'B-NP', 'B-protein'), ('represents', 'represent', 'VBZ', 'B-VP', 'O'), ('phosphoserine', 'phosphoserine', 'NN', 'B-NP', 'O'), ('354', '354', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('match', 'match', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('typical', 'typical', 'JJ', 'I-NP', 'O'), ('class', 'class', 'NN', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('class', 'class', 'NN', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('14-3-3', '14-3-3', 'CD', 'I-NP', 'O'), ('consensus', 'consensus', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The substitution of Ser354 with aspartate does not recapitulate binding , as often seen in 14-3-3 interactions with phosphorylated substrates , as , for example , RGS or keratin [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('substitution', 'substitution', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ser354', 'Ser354', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('aspartate', 'aspartate', 'NN', 'B-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('recapitulate', 'recapitulate', 'VB', 'I-VP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'RB', 'O', 'O'), ('often', 'often', 'RB', 'B-VP', 'O'), ('seen', 'see', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('14-3-3', '14-3-3', 'CD', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'B-NP', 'B-protein'), ('substrates', 'substrate', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), (',', ',', ',', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('example', 'example', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('RGS', 'RGS', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('keratin', 'keratin', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies demonstrated the purification of Cry1Aa binding proteins ( receptors ) , aminopeptidase N ( APN ) and cadherin-like receptor , from B. mori [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('purification', 'purification', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cry1Aa', 'Cry1Aa', 'NN', 'B-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('receptors', 'receptor', 'NNS', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('aminopeptidase', 'aminopeptidase', 'NN', 'B-NP', 'O'), ('N', 'N', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('APN', 'APN', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('cadherin-like', 'cadherin-like', 'JJ', 'B-NP', 'B-protein'), ('receptor', 'receptor', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('B.', 'B.', 'NNP', 'B-NP', 'O'), ('mori', 'mori', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The cadherin-like protein has been reported to be a functional Cry1Ab receptor [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('cadherin-like', 'cadherin-like', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('functional', 'functional', 'JJ', 'I-NP', 'O'), ('Cry1Ab', 'Cry1Ab', 'NN', 'I-NP', 'B-protein'), ('receptor', 'receptor', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	More recently an additional receptor , BR-270 , has been reported as an anionic brush border membrane glycoconjugate that show tight binding to a number of Cry toxins [ CIT ] .	[('More', 'More', 'RBR', 'B-ADVP', 'O'), ('recently', 'recently', 'RB', 'I-ADVP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('additional', 'additional', 'JJ', 'I-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('BR-270', 'BR-270', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('anionic', 'anionic', 'JJ', 'I-NP', 'O'), ('brush', 'brush', 'NN', 'I-NP', 'O'), ('border', 'border', 'NN', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('glycoconjugate', 'glycoconjugate', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('show', 'show', 'VBP', 'B-VP', 'O'), ('tight', 'tight', 'JJ', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cry', 'Cry', 'NNP', 'B-NP', 'B-protein'), ('toxins', 'toxin', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Or , perhaps a more complicated , multifaceted mechanism is involved , as proposed recently [ CIT ] .	[('Or', 'Or', 'CC', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('perhaps', 'perhaps', 'RB', 'B-ADVP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('more', 'more', 'RBR', 'I-NP', 'O'), ('complicated', 'complicated', 'JJ', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('multifaceted', 'multifaceted', 'JJ', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('proposed', 'propose', 'VBN', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	After the work on this paper was completed we became aware of a paper [ CIT ] reporting a B. thuringiensis strain , AF101 , which exhibited lower activity toward B. mori .	[('After', 'After', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('paper', 'paper', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('completed', 'complete', 'VBN', 'I-VP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('became', 'become', 'VBD', 'B-VP', 'O'), ('aware', 'aware', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('paper', 'paper', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('reporting', 'report', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('B.', 'B.', 'NNP', 'I-NP', 'O'), ('thuringiensis', 'thuringiensis', 'NN', 'I-NP', 'O'), ('strain', 'strain', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('AF101', 'AF101', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('exhibited', 'exhibit', 'VBD', 'B-VP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('toward', 'toward', 'IN', 'B-PP', 'O'), ('B.', 'B.', 'NNP', 'B-NP', 'O'), ('mori', 'mori', 'NNP', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Since Cry1Ab does not bind significantly to APN or cadherin [ CIT ] , one might speculate that F328 may also interact with other receptors .	[('Since', 'Since', 'IN', 'B-SBAR', 'O'), ('Cry1Ab', 'Cry1Ab', 'NN', 'B-NP', 'B-protein'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('significantly', 'significantly', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('APN', 'APN', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('cadherin', 'cadherin', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'PRP', 'B-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('speculate', 'speculate', 'VB', 'I-VP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('F328', 'F328', 'NN', 'I-NP', 'B-protein'), ('may', 'may', 'MD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('receptors', 'receptor', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	This principle was noted earlier in comparing the action of mutants of Cry1Ab and their action on Manduca sexta and Heliothis virescens [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('principle', 'principle', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('noted', 'note', 'VBN', 'I-VP', 'O'), ('earlier', 'earlier', 'RBR', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('comparing', 'compare', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('action', 'action', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mutants', 'mutant', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cry1Ab', 'Cry1Ab', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('action', 'action', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Manduca', 'Manduca', 'NNP', 'B-NP', 'O'), ('sexta', 'sexta', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Heliothis', 'Heliothis', 'NNP', 'B-NP', 'O'), ('virescens', 'virescens', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	Our understanding of certain aspects of the function of the B. thuringiensis insecticidal proteins , especially in the area of receptor binding has also been enhanced by protein engineering techniques [ CIT ] .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('understanding', 'understanding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('certain', 'certain', 'JJ', 'B-NP', 'O'), ('aspects', 'aspect', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('B.', 'B.', 'NNP', 'I-NP', 'O'), ('thuringiensis', 'thuringiensi', 'VBZ', 'B-VP', 'O'), ('insecticidal', 'insecticidal', 'JJ', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('especially', 'especially', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('area', 'area', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('receptor', 'receptor', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('enhanced', 'enhance', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('engineering', 'engineering', 'NN', 'I-NP', 'O'), ('techniques', 'technique', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Briefly , the previously described receptor-binding epitopes , best understood in Cry1Ac , are in the loops at the bottom of domain II , and N-acetylgalactosamine binding pocket in domain III [ CIT ] .	[('Briefly', 'Briefly', 'NNP', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('receptor-binding', 'receptor-binding', 'JJ', 'I-NP', 'B-protein'), ('epitopes', 'epitope', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('best', 'well', 'RBS', 'B-VP', 'O'), ('understood', 'understand', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Cry1Ac', 'Cry1Ac', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('loops', 'loop', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('bottom', 'bottom', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'B-DNA'), ('II', 'II', 'CD', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('N-acetylgalactosamine', 'N-acetylgalactosamine', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('pocket', 'pocket', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('III', 'III', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Improvements in toxicity against target pests , as much as 36-fold , have been reported for B. thuringiensis toxins [ CIT ] .	[('Improvements', 'Improvement', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('toxicity', 'toxicity', 'NN', 'B-NP', 'O'), ('against', 'against', 'IN', 'B-PP', 'O'), ('target', 'target', 'NN', 'B-NP', 'O'), ('pests', 'pest', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'RB', 'B-NP', 'O'), ('much', 'much', 'RB', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('36-fold', '36-fold', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('B.', 'B.', 'NNP', 'B-NP', 'O'), ('thuringiensis', 'thuringiensis', 'NN', 'I-NP', 'O'), ('toxins', 'toxin', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We followed the protocol [ CIT ] , as used by Volloch et al .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('followed', 'follow', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protocol', 'protocol', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Volloch', 'Volloch', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	This inability to detect AS globin RNA was in contrast to the reports of Volloch et al. who reported 1-3 % in spleen cells [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('inability', 'inability', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('detect', 'detect', 'VB', 'I-VP', 'O'), ('AS', 'AS', 'JJ', 'B-NP', 'B-RNA'), ('globin', 'globin', 'NN', 'I-NP', 'I-RNA'), ('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Volloch', 'Volloch', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('1-3', '1-3', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('spleen', 'spleen', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
4	It needs to be pointed out that Volloch et al. reported that their AS band was of a greater mobility than the mRNA [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('needs', 'need', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('pointed', 'point', 'VBN', 'I-VP', 'O'), ('out', 'out', 'RP', 'B-PRT', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Volloch', 'Volloch', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('AS', 'AS', 'JJ', 'I-NP', 'O'), ('band', 'band', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('greater', 'great', 'JJR', 'I-NP', 'O'), ('mobility', 'mobility', 'NN', 'I-NP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'B-RNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously reported , recombinant xEIAP / XLX is rapidly degraded by at least two distinct , consecutively acting proteolytic systems [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('recombinant', 'recombinant', 'JJ', 'B-NP', 'B-protein'), ('xEIAP', 'xEIAP', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('XLX', 'XLX', 'NN', 'I-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('rapidly', 'rapidly', 'RB', 'I-VP', 'O'), ('degraded', 'degrade', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('at', 'at', 'IN', 'B-NP', 'O'), ('least', 'least', 'JJS', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('distinct', 'distinct', 'JJ', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('consecutively', 'consecutively', 'RB', 'B-ADVP', 'O'), ('acting', 'act', 'VBG', 'B-VP', 'O'), ('proteolytic', 'proteolytic', 'JJ', 'B-NP', 'O'), ('systems', 'system', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Thus , we also used the C-terminally truncated stabilized forms of xEIAP / XLX [ CIT ] .	[('Thus', 'Thus', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminally', 'C-terminally', 'RB', 'I-NP', 'B-protein'), ('truncated', 'truncate', 'VBN', 'I-NP', 'I-protein'), ('stabilized', 'stabilize', 'VBN', 'I-NP', 'I-protein'), ('forms', 'form', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('xEIAP', 'xEIAP', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'O', 'O'), ('XLX', 'XLX', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously described , the time-dependent fragmentation of sperm nuclei is the hallmark of apoptosis execution in interphase egg extracts [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('time-dependent', 'time-dependent', 'JJ', 'I-NP', 'O'), ('fragmentation', 'fragmentation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('sperm', 'sperm', 'NN', 'B-NP', 'O'), ('nuclei', 'nucleus', 'NNS', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hallmark', 'hallmark', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('apoptosis', 'apoptosis', 'NN', 'B-NP', 'O'), ('execution', 'execution', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('interphase', 'interphase', 'NN', 'B-NP', 'O'), ('egg', 'egg', 'NN', 'I-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We named these clones α1-xl , α5-xl and α6-xl ( α1 , α5 and α6 subunits of Xenopus laevis ) according to a systematic nomenclature [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('named', 'name', 'VBD', 'B-VP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('clones', 'clone', 'NNS', 'I-NP', 'O'), ('α1-xl', 'α1-xl', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('α5-xl', 'α5-xl', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('α6-xl', 'α6-xl', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('α1', 'α1', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('α5', 'α5', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('α6', 'α6', 'CD', 'I-NP', 'O'), ('subunits', 'subunit', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NNP', 'B-NP', 'O'), ('laevis', 'laevis', 'NNP', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('systematic', 'systematic', 'JJ', 'I-NP', 'O'), ('nomenclature', 'nomenclature', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	With these antibodies and previously described monoclonal antibodies for subunits α2 and α4 [ CIT ] , changes to all α-type subunits during Xenopus meiotic maturation were analyzed .	[('With', 'With', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('monoclonal', 'monoclonal', 'JJ', 'I-NP', 'B-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('for', 'for', 'IN', 'B-PP', 'O'), ('subunits', 'subunit', 'NNS', 'B-NP', 'O'), ('α2', 'α2', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('α4', 'α4', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('α-type', 'α-type', 'JJ', 'I-NP', 'B-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('during', 'during', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('meiotic', 'meiotic', 'JJ', 'I-NP', 'O'), ('maturation', 'maturation', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('analyzed', 'analyze', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	It is suggested that the α4 subunit is phosphorylated in immature oocytes and dephosphorylated in mature oocytes [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α4', 'α4', 'CD', 'I-NP', 'B-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('immature', 'immature', 'JJ', 'B-NP', 'B-cell_type'), ('oocytes', 'oocyte', 'NNS', 'I-NP', 'I-cell_type'), ('and', 'and', 'CC', 'O', 'O'), ('dephosphorylated', 'dephosphorylate', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mature', 'mature', 'JJ', 'B-NP', 'B-cell_type'), ('oocytes', 'oocyte', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Furthermore , changes in proteasomal subunit composition under different physiological conditions and the likely existence of a different subpopulation of proteasomes have been reported [ CIT ] .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('changes', 'change', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('proteasomal', 'proteasomal', 'JJ', 'B-NP', 'O'), ('subunit', 'subunit', 'NN', 'I-NP', 'O'), ('composition', 'composition', 'NN', 'I-NP', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('physiological', 'physiological', 'JJ', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('likely', 'likely', 'JJ', 'I-NP', 'O'), ('existence', 'existence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('subpopulation', 'subpopulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('proteasomes', 'proteasome', 'NNS', 'B-NP', 'B-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Castaño et al. [ CIT ] ( 1996 ) identified the CKII phosphorylating subunit and its phosphorylation sites as the C8 component ( α7 subunit ) and serine-243 and serine-250 , respectively .	[('Castaño', 'Castaño', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('1996', '1996', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CKII', 'CKII', 'NN', 'I-NP', 'B-protein'), ('phosphorylating', 'phosphorylate', 'VBG', 'B-VP', 'I-protein'), ('subunit', 'subunit', 'NN', 'B-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'B-protein'), ('sites', 'site', 'NNS', 'I-NP', 'I-protein'), ('as', 'as', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C8', 'C8', 'NN', 'I-NP', 'B-protein'), ('component', 'component', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('α7', 'α7', 'CD', 'B-NP', 'B-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('serine-243', 'serine-243', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('serine-250', 'serine-250', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('.', '.', '.', 'O', 'O')]
2	CKII was also reported to phosphorylate the C2 component ( α6 subunit ) in rice [ CIT ] .	[('CKII', 'CKII', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('phosphorylate', 'phosphorylate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C2', 'C2', 'NN', 'I-NP', 'B-protein'), ('component', 'component', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('α6', 'α6', 'CD', 'B-NP', 'B-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rice', 'rice', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Mason et al. [ CIT ] .	[('Mason', 'Mason', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Calcium / calmodulin-dependent protein kinase II is shown to be involved in the exit from metaphase II arrest at fertilization in Xenopus [ CIT ] .	[('Calcium', 'Calcium', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'I-NP', 'I-protein'), ('calmodulin-dependent', 'calmodulin-dependent', 'JJ', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('exit', 'exit', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('metaphase', 'metaphase', 'NN', 'B-NP', 'O'), ('II', 'II', 'CD', 'I-NP', 'O'), ('arrest', 'arrest', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('fertilization', 'fertilization', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This pattern was similar in both plasma and serum , and similar to that previously described for rat and mouse serum [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('pattern', 'pattern', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('plasma', 'plasma', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('serum', 'serum', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), ('serum', 'serum', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	After this paper was submitted for publication , Jossin et al reported this same finding using a different C-terminal antibody [ CIT ] .	[('After', 'After', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('paper', 'paper', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('submitted', 'submit', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('publication', 'publication', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Jossin', 'Jossin', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('antibody', 'antibody', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These data confirm and extend the findings of Kubo et al. ( 2002 ) by showing that native reelin is a dimer not only in brain but also in plasma [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('confirm', 'confirm', 'VBP', 'B-VP', 'O'), ('and', 'and', 'CC', 'I-VP', 'O'), ('extend', 'extend', 'VBP', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Kubo', 'Kubo', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2002', '2002', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('native', 'native', 'JJ', 'B-NP', 'B-protein'), ('reelin', 'reelin', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dimer', 'dimer', 'NN', 'I-NP', 'B-protein'), ('not', 'not', 'RB', 'B-CONJP', 'O'), ('only', 'only', 'RB', 'I-CONJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('brain', 'brain', 'NN', 'B-NP', 'O'), ('but', 'but', 'CC', 'B-CONJP', 'O'), ('also', 'also', 'RB', 'I-CONJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('plasma', 'plasma', 'NN', 'B-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Persico et al. ( 2001 ) studied families with primary autistic probands , and found that even though most autistic patients do not possess long CGG repeats ( ≥ 11 repeats in at least one allele ) , the long alleles were preferentially passed to autistic offspring , such that the long CGG repeats were associated with a two-fold increase in the risk of autism [ CIT ] .	[('Persico', 'Persico', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2001', '2001', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('studied', 'study', 'VBN', 'B-NP', 'O'), ('families', 'family', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('primary', 'primary', 'JJ', 'B-NP', 'O'), ('autistic', 'autistic', 'JJ', 'I-NP', 'O'), ('probands', 'proband', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('even', 'even', 'RB', 'B-SBAR', 'O'), ('though', 'though', 'IN', 'I-SBAR', 'O'), ('most', 'most', 'JJS', 'B-NP', 'O'), ('autistic', 'autistic', 'JJ', 'I-NP', 'O'), ('patients', 'patient', 'NNS', 'I-NP', 'O'), ('do', 'do', 'VBP', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('possess', 'possess', 'VB', 'I-VP', 'O'), ('long', 'long', 'JJ', 'B-NP', 'B-DNA'), ('CGG', 'CGG', 'NN', 'I-NP', 'I-DNA'), ('repeats', 'repeat', 'NNS', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('≥', '≥', 'NN', 'B-NP', 'B-DNA'), ('11', '11', 'CD', 'B-NP', 'I-DNA'), ('repeats', 'repeat', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('at', 'at', 'IN', 'B-NP', 'O'), ('least', 'least', 'JJS', 'I-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('allele', 'allele', 'NN', 'I-NP', 'B-DNA'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('long', 'long', 'JJ', 'I-NP', 'B-DNA'), ('alleles', 'allele', 'NNS', 'I-NP', 'I-DNA'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('preferentially', 'preferentially', 'RB', 'I-VP', 'O'), ('passed', 'pass', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('autistic', 'autistic', 'JJ', 'B-NP', 'O'), ('offspring', 'offspring', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('long', 'long', 'JJ', 'I-NP', 'B-DNA'), ('CGG', 'CGG', 'NN', 'I-NP', 'I-DNA'), ('repeats', 'repeat', 'NNS', 'I-NP', 'I-DNA'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('associated', 'associate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('two-fold', 'two-fold', 'JJ', 'I-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('risk', 'risk', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('autism', 'autism', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently , Zhang et al. ( 2002 ) replicated this finding on a different set of North American multiplex autistic pedigrees [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Zhang', 'Zhang', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2002', '2002', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('replicated', 'replicate', 'VBD', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('set', 'set', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('North', 'North', 'JJ', 'B-NP', 'O'), ('American', 'American', 'JJ', 'I-NP', 'O'), ('multiplex', 'multiplex', 'JJ', 'I-NP', 'O'), ('autistic', 'autistic', 'JJ', 'I-NP', 'O'), ('pedigrees', 'pedigree', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Archival samples of plasma were studied which were characterized in the earlier study of Persico et al. ( 2001 ) [ CIT ] .	[('Archival', 'Archival', 'JJ', 'B-NP', 'O'), ('samples', 'sample', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('plasma', 'plasma', 'NN', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('studied', 'study', 'VBN', 'I-VP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('characterized', 'characterize', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Persico', 'Persico', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2001', '2001', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	From the known fragmentation [ CIT ] in the negative ion-mode , the first two represent Z1 and Y1 fragments comprising the GlcN I moiety consisting of one GlcN , one phosphate , one C16 : 0 , and one 3-OH-C16 : 0 without and with the oxygen atom joining it to GlcN II ( Fig. 1 ) .	[('From', 'From', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('known', 'know', 'VBN', 'I-NP', 'O'), ('fragmentation', 'fragmentation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('negative', 'negative', 'JJ', 'I-NP', 'O'), ('ion-mode', 'ion-mode', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('represent', 'represent', 'VBP', 'B-VP', 'O'), ('Z1', 'Z1', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Y1', 'Y1', 'NN', 'I-NP', 'B-DNA'), ('fragments', 'fragment', 'NNS', 'I-NP', 'I-DNA'), ('comprising', 'comprise', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GlcN', 'GlcN', 'NN', 'I-NP', 'O'), ('I', 'I', 'CD', 'I-NP', 'O'), ('moiety', 'moiety', 'NN', 'I-NP', 'O'), ('consisting', 'consist', 'VBG', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('GlcN', 'GlcN', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('phosphate', 'phosphate', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('C16', 'C16', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('3-OH-C16', '3-OH-C16', 'CD', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), ('without', 'without', 'IN', 'B-PP', 'O'), ('and', 'and', 'CC', 'I-PP', 'O'), ('with', 'with', 'IN', 'I-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('oxygen', 'oxygen', 'NN', 'I-NP', 'O'), ('atom', 'atom', 'NN', 'I-NP', 'O'), ('joining', 'join', 'VBG', 'B-VP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('GlcN', 'GlcN', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This peak and the other one at m / z 721.15 were interpreted to correspond to the B1 ions [ CIT ] containing one GlcN , one phosphate , one C16 : 0 , one 3-OH-C16 : 0 and one GlcN , one phosphate , one C15 : 0 , and one 3-OH-C16 : 0 , respectively ( Fig. 1 ) .	[('This', 'This', 'DT', 'B-NP', 'O'), ('peak', 'peak', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('m', 'm', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('z', 'z', 'NN', 'B-NP', 'B-protein'), ('721.15', '721.15', 'CD', 'I-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('interpreted', 'interpret', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('correspond', 'correspond', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('B1', 'B1', 'NN', 'I-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('GlcN', 'GlcN', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('phosphate', 'phosphate', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('C16', 'C16', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('3-OH-C16', '3-OH-C16', 'CD', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('one', 'one', 'CD', 'I-NP', 'O'), ('GlcN', 'GlcN', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('phosphate', 'phosphate', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('C15', 'C15', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('3-OH-C16', '3-OH-C16', 'CD', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('0', '0', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast , FGF-2 binding to heparin / HS depends on N-sulfation and iduronate-2-sulfation but not on 6-O-sulfation [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('FGF-2', 'FGF-2', 'NN', 'B-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('heparin', 'heparin', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('HS', 'HS', 'NN', 'I-NP', 'O'), ('depends', 'depend', 'VBZ', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('N-sulfation', 'N-sulfation', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('iduronate-2-sulfation', 'iduronate-2-sulfation', 'NN', 'I-NP', 'O'), ('but', 'but', 'CC', 'B-PP', 'O'), ('not', 'not', 'RB', 'B-PP', 'O'), ('on', 'on', 'IN', 'I-PP', 'O'), ('6-O-sulfation', '6-O-sulfation', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To confirm that the reductions in heparin binding were , in fact , due to Sulf-2 , we employed anti-HSulf-2 antibodies [ CIT ] for immunodepletion of Sulf-2 from MCF CM .	[('To', 'To', 'TO', 'B-VP', 'O'), ('confirm', 'confirm', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reductions', 'reduction', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('heparin', 'heparin', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fact', 'fact', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('due', 'due', 'IN', 'B-PP', 'O'), ('to', 'to', 'TO', 'I-PP', 'O'), ('Sulf-2', 'Sulf-2', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('employed', 'employ', 'VBD', 'B-VP', 'O'), ('anti-HSulf-2', 'anti-HSulf-2', 'JJ', 'B-NP', 'B-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('immunodepletion', 'immunodepletion', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Sulf-2', 'Sulf-2', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('MCF', 'MCF', 'NN', 'B-NP', 'B-protein'), ('CM', 'CM', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
1	In the absence of Mg2+ no FRET signal was detectable ( Fig. 3 ) confirming the finding in the literature that triplex formation with polypurine TFOs requires divalent cations [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'B-NP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('FRET', 'FRET', 'NN', 'I-NP', 'O'), ('signal', 'signal', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detectable', 'detectable', 'JJ', 'B-ADJP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('confirming', 'confirm', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('literature', 'literature', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('triplex', 'triplex', 'NN', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('polypurine', 'polypurine', 'NN', 'B-NP', 'O'), ('TFOs', 'TFO', 'NNS', 'I-NP', 'O'), ('requires', 'require', 'VBZ', 'B-VP', 'O'), ('divalent', 'divalent', 'JJ', 'B-NP', 'O'), ('cations', 'cation', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	We also did not observe a FRET signal in the presence of K+ions ( data not shown ) which are known to inhibit triple helix formation of G-rich TFOs by stabilization of quadruplex structures of the TFO [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('observe', 'observe', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('FRET', 'FRET', 'NN', 'I-NP', 'O'), ('signal', 'signal', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('K+ions', 'K+ion', 'NNS', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('inhibit', 'inhibit', 'VB', 'I-VP', 'O'), ('triple', 'triple', 'JJ', 'B-NP', 'O'), ('helix', 'helix', 'NN', 'I-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('G-rich', 'G-rich', 'JJ', 'B-NP', 'B-protein'), ('TFOs', 'TFO', 'NNS', 'I-NP', 'I-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('stabilization', 'stabilization', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('quadruplex', 'quadruplex', 'NN', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TFO', 'TFO', 'NN', 'I-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	This result confirms that the TFO binds to the DNA in an antiparallel orientation with respect to the polypurine strand [ CIT ] , because in a parallel orientation the distance between the donor and acceptor groups would not allow highly efficient FRET .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('confirms', 'confirm', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TFO', 'TFO', 'NN', 'I-NP', 'B-protein'), ('binds', 'bind', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('antiparallel', 'antiparallel', 'JJ', 'I-NP', 'O'), ('orientation', 'orientation', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('respect', 'respect', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('polypurine', 'polypurine', 'NN', 'I-NP', 'O'), ('strand', 'strand', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('parallel', 'parallel', 'JJ', 'I-NP', 'O'), ('orientation', 'orientation', 'NN', 'I-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('distance', 'distance', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('donor', 'donor', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('acceptor', 'acceptor', 'NN', 'I-NP', 'O'), ('groups', 'group', 'NNS', 'I-NP', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('allow', 'allow', 'VB', 'I-VP', 'O'), ('highly', 'highly', 'RB', 'B-NP', 'O'), ('efficient', 'efficient', 'JJ', 'I-NP', 'O'), ('FRET', 'FRET', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
3	They confirm similar results obtained by Beal and Dervan using the affinity cleavage method for a different TFO sequence [ CIT ] .	[('They', 'They', 'PRP', 'B-NP', 'O'), ('confirm', 'confirm', 'VBP', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Beal', 'Beal', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Dervan', 'Dervan', 'NNP', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('TFO', 'TFO', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We have used a normalised plot method , described by Bravo and colleagues [ CIT ] , to elucidate the kinetic mechanism of the PANAT-catalysed N-acetylation of 5-aminosalicylic acid with AcCoA as acetyl donor , and to measure the true kinetic parameters for the substrates .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('normalised', 'normalised', 'JJ', 'I-NP', 'O'), ('plot', 'plot', 'NN', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Bravo', 'Bravo', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('colleagues', 'colleague', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('elucidate', 'elucidate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('kinetic', 'kinetic', 'JJ', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PANAT-catalysed', 'PANAT-catalysed', 'JJ', 'I-NP', 'O'), ('N-acetylation', 'N-acetylation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('5-aminosalicylic', '5-aminosalicylic', 'JJ', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('AcCoA', 'AcCoA', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('acetyl', 'acetyl', 'NN', 'B-NP', 'O'), ('donor', 'donor', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('measure', 'measure', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('true', 'true', 'JJ', 'I-NP', 'O'), ('kinetic', 'kinetic', 'JJ', 'I-NP', 'O'), ('parameters', 'parameter', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	In order to determine by independent means whether mechanism 1P or 2P is most appropriate , the method described by Mannervik was used [ CIT ] , in which the quotient , Fexp ( eq. 4 ) is compared with the F-statistic : F ( pk - pj , n - pk ) , where SSj ( = 1.254 ) is the residual sum of squares from the simpler model ( mechanism 2P ) with pj ( = 4 ) parameters , SSk ( = 0.268 ) is the residual sum of squares from the more complex model ( mechanism 1P ) with pk ( = 5 ) parameters and n ( = 27 ) is the number of data points .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('independent', 'independent', 'JJ', 'B-NP', 'O'), ('means', 'mean', 'NNS', 'I-NP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('mechanism', 'mechanism', 'NN', 'B-NP', 'O'), ('1P', '1P', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('2P', '2P', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('most', 'most', 'RBS', 'B-ADJP', 'O'), ('appropriate', 'appropriate', 'JJ', 'I-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Mannervik', 'Mannervik', 'NNP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('quotient', 'quotient', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Fexp', 'Fexp', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('eq.', 'eq.', 'NN', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('compared', 'compare', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('F-statistic', 'F-statistic', 'JJ', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('F', 'F', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('pk', 'pk', 'NN', 'B-NP', 'O'), ('-', '-', 'HYPH', 'B-NP', 'O'), ('pj', 'pj', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('n', 'n', 'NN', 'B-NP', 'O'), ('-', '-', 'HYPH', 'I-NP', 'O'), ('pk', 'pk', 'NN', 'I-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('SSj', 'SSj', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('1.254', '1.254', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('residual', 'residual', 'JJ', 'I-NP', 'O'), ('sum', 'sum', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('squares', 'square', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('simpler', 'simpler', 'NN', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('mechanism', 'mechanism', 'NN', 'B-NP', 'O'), ('2P', '2P', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('pj', 'pj', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('parameters', 'parameter', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('SSk', 'SSk', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('0.268', '0.268', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('residual', 'residual', 'JJ', 'I-NP', 'O'), ('sum', 'sum', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('squares', 'square', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('more', 'more', 'RBR', 'I-NP', 'O'), ('complex', 'complex', 'JJ', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('mechanism', 'mechanism', 'NN', 'B-NP', 'O'), ('1P', '1P', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('pk', 'pk', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('parameters', 'parameter', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('n', 'n', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('27', '27', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('points', 'point', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	The proposed scheme is based both on this study and on previously described work with a eukaryotic NAT [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('proposed', 'propose', 'VBN', 'I-NP', 'O'), ('scheme', 'scheme', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('eukaryotic', 'eukaryotic', 'JJ', 'I-NP', 'O'), ('NAT', 'NAT', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Andres and colleagues noted marked product inhibition by CoA [ CIT ] .	[('Andres', 'Andre', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('colleagues', 'colleague', 'NNS', 'I-NP', 'O'), ('noted', 'note', 'VBD', 'B-VP', 'O'), ('marked', 'marked', 'JJ', 'B-NP', 'O'), ('product', 'product', 'NN', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('CoA', 'CoA', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In order to obtain the DNA sequences of the entire putative PST biosynthesis gene clusters in both A. circinalis AWQC131C and Aph. sp. NH-5 , a gene walking technique ( known as pan-handle PCR ) was employed [ CIT ] .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('obtain', 'obtain', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'B-DNA'), ('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('entire', 'entire', 'JJ', 'I-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('PST', 'PST', 'NN', 'I-NP', 'B-DNA'), ('biosynthesis', 'biosynthesis', 'NN', 'I-NP', 'I-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('clusters', 'cluster', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('A.', 'A.', 'NN', 'B-NP', 'O'), ('circinalis', 'circinalis', 'NN', 'I-NP', 'O'), ('AWQC131C', 'AWQC131C', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Aph.', 'Aph.', 'NNP', 'B-NP', 'O'), ('sp.', 'sp.', 'NN', 'I-NP', 'O'), ('NH-5', 'NH-5', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), ('walking', 'walk', 'VBG', 'B-VP', 'O'), ('technique', 'technique', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('known', 'know', 'VBN', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('pan-handle', 'pan-handle', 'JJ', 'B-NP', 'O'), ('PCR', 'PCR', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('employed', 'employ', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This value agrees with published data for this compound [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('agrees', 'agree', 'VBZ', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('compound', 'compound', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In general , however , receptor expression was similar to that reported by other laboratories [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('general', 'general', 'JJ', 'B-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('receptor', 'receptor', 'NN', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('laboratories', 'laboratory', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We lysed cells as described [ CIT ] in the presence of RNase inhibitors ( 100 U / ml SuperaseIn and 20 mM RVC ) , and spun the crude lysate at 1200 , 20000 and 200000 × g as indicated in Methods .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('lysed', 'lyse', 'VBD', 'B-VP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'I-PP', 'O'), ('presence', 'presence', 'NN', 'I-PP', 'O'), ('of', 'of', 'IN', 'I-PP', 'O'), ('RNase', 'RNase', 'NN', 'B-NP', 'B-protein'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('100', '100', 'CD', 'B-NP', 'O'), ('U', 'U', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('ml', 'ml', 'NN', 'B-NP', 'O'), ('SuperaseIn', 'SuperaseIn', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('20', '20', 'CD', 'B-NP', 'O'), ('mM', 'mM', 'NN', 'I-NP', 'O'), ('RVC', 'RVC', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('spun', 'spin', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crude', 'crude', 'JJ', 'I-NP', 'O'), ('lysate', 'lysate', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('1200', '1200', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('20000', '20000', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('200000', '200000', 'CD', 'I-NP', 'O'), ('×', '×', 'NN', 'I-NP', 'O'), ('g', 'g', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('indicated', 'indicate', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Methods', 'Method', 'NNS', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The IMP-specific 5'-nucleotidase purified as described previously [ CIT ] was submitted to EndoLysC proteolytic treatment .	[('The', 'The', 'DT', 'B-NP', 'O'), ('IMP-specific', 'IMP-specific', 'JJ', 'I-NP', 'O'), ("5'-nucleotidase", "5'-nucleotidase", 'NN', 'I-NP', 'O'), ('purified', 'purify', 'VBN', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('submitted', 'submit', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('EndoLysC', 'EndoLysC', 'VB', 'I-VP', 'O'), ('proteolytic', 'proteolytic', 'JJ', 'B-NP', 'O'), ('treatment', 'treatment', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Indeed , Yor155p was found to interact with itself in a systematic two hybrid analysis [ CIT ] .	[('Indeed', 'Indeed', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Yor155p', 'Yor155p', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('itself', 'itself', 'PRP', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('systematic', 'systematic', 'JJ', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('hybrid', 'hybrid', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , while the mutagenic effect of dIMP has been documented [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutagenic', 'mutagenic', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('dIMP', 'dIMP', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('documented', 'document', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Additionally , the secondary structure predictions of the FTO family showed high similarity with the known structures of AlkB , a member of the non-heme dioxygenase family [ CIT ] .	[('Additionally', 'Additionally', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('secondary', 'secondary', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('predictions', 'prediction', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('FTO', 'FTO', 'NN', 'I-NP', 'B-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('similarity', 'similarity', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('AlkB', 'AlkB', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('member', 'member', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('non-heme', 'non-heme', 'JJ', 'I-NP', 'B-protein'), ('dioxygenase', 'dioxygenase', 'NN', 'I-NP', 'I-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To investigate if FTO could be acting in a similar manner , we studied its sequence using an algorithm for prediction of protein cellular localization ( WolfPSORT ; [ CIT ] ) .	[('To', 'To', 'TO', 'B-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('if', 'if', 'IN', 'B-SBAR', 'O'), ('FTO', 'FTO', 'NNP', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('acting', 'act', 'VBG', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('studied', 'study', 'VBD', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('algorithm', 'algorithm', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('prediction', 'prediction', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('cellular', 'cellular', 'JJ', 'I-NP', 'O'), ('localization', 'localization', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('WolfPSORT', 'WolfPSORT', 'NN', 'B-NP', 'O'), (';', ';', ':', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In Figure 3 , hNaa15p and hNaa16p structural domains as identified by SMART [ CIT ] are presented .	[('In', 'In', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('hNaa15p', 'hNaa15p', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('hNaa16p', 'hNaa16p', 'NN', 'I-NP', 'B-protein'), ('structural', 'structural', 'JJ', 'I-NP', 'I-protein'), ('domains', 'domain', 'NNS', 'I-NP', 'I-protein'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('identified', 'identify', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('SMART', 'SMART', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('presented', 'present', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously , it was demonstrated that hNAA15 was overexpressed in papillary thyroid carcinomas as compared to non-neoplastic thyroid tissue [ CIT ] .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hNAA15', 'hNAA15', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('overexpressed', 'overexpresse', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('papillary', 'papillary', 'JJ', 'B-NP', 'O'), ('thyroid', 'thyroid', 'JJ', 'I-NP', 'O'), ('carcinomas', 'carcinoma', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('compared', 'compare', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('non-neoplastic', 'non-neoplastic', 'JJ', 'B-NP', 'O'), ('thyroid', 'thyroid', 'NN', 'I-NP', 'O'), ('tissue', 'tissue', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These results suggest that hNaa16p-hNaa10p and hNaa15p-hNaa10p have overlapping substrate specificities , since also the hNaa15p-hNaa10p complex showed a similar in vitro reactivity towards these peptides [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('suggest', 'suggest', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hNaa16p-hNaa10p', 'hNaa16p-hNaa10p', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('hNaa15p-hNaa10p', 'hNaa15p-hNaa10p', 'NN', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('overlapping', 'overlap', 'VBG', 'I-VP', 'O'), ('substrate', 'substrate', 'NN', 'B-NP', 'O'), ('specificities', 'specificity', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('since', 'since', 'IN', 'B-PP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hNaa15p-hNaa10p', 'hNaa15p-hNaa10p', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('in', 'in', 'FW', 'I-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('reactivity', 'reactivity', 'NN', 'I-NP', 'O'), ('towards', 'towards', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('peptides', 'peptide', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	The dependency of hNaa10p for hNaa15p has previously been described [ CIT ] , but the present results also indicate that a fraction of endogenous hNaa10p depend on hNaa16p for stability , albeit to a lesser extent as compared hNaa15p .	[('The', 'The', 'DT', 'B-NP', 'O'), ('dependency', 'dependency', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('hNaa10p', 'hNaa10p', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('hNaa15p', 'hNaa15p', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('indicate', 'indicate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('fraction', 'fraction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'O'), ('hNaa10p', 'hNaa10p', 'NN', 'I-NP', 'O'), ('depend', 'depend', 'VBP', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('hNaa16p', 'hNaa16p', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('stability', 'stability', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('albeit', 'albeit', 'IN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('lesser', 'less', 'JJR', 'I-NP', 'O'), ('extent', 'extent', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('compared', 'compare', 'VBN', 'B-NP', 'O'), ('hNaa15p', 'hNaa15p', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	That the m value for GdnHCl denaturation is about double that for urea denaturation is in agreement with general observation [ CIT ] .	[('That', 'That', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('m', 'm', 'NN', 'I-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('GdnHCl', 'GdnHCl', 'NN', 'B-NP', 'O'), ('denaturation', 'denaturation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('about', 'about', 'RB', 'B-NP', 'O'), ('double', 'double', 'RB', 'I-NP', 'O'), ('that', 'that', 'DT', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('urea', 'urea', 'NN', 'B-NP', 'O'), ('denaturation', 'denaturation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('general', 'general', 'JJ', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	According to the SMART program [ CIT ] , residues 1-26 of DSN form a signal sequence that allows for secretion , whereas residues 195-376 form a NUC domain characteristic of Serratia DNA-RNA non-specific endonucleases ( Figure 1 ) .	[('According', 'Accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SMART', 'SMART', 'NN', 'I-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('residues', 'residue', 'VBZ', 'B-VP', 'O'), ('1-26', '1-26', 'CD', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('DSN', 'DSN', 'NN', 'B-NP', 'B-protein'), ('form', 'form', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('signal', 'signal', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('allows', 'allow', 'VBZ', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('secretion', 'secretion', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('whereas', 'whereas', 'IN', 'O', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('195-376', '195-376', 'CD', 'B-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('NUC', 'NUC', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('characteristic', 'characteristic', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Serratia', 'Serratia', 'NNP', 'B-NP', 'O'), ('DNA-RNA', 'DNA-RNA', 'NNP', 'I-NP', 'O'), ('non-specific', 'non-specific', 'JJ', 'I-NP', 'O'), ('endonucleases', 'endonucleas', 'NNS', 'I-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously , Yang et al [ CIT ] have cloned and purified DNA topoisomerase I from M. tuberculosis Erdman strain in E. coli BL21 ( DE3 ) .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Yang', 'Yang', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('cloned', 'clone', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'B-protein'), ('topoisomerase', 'topoisomerase', 'NN', 'I-NP', 'I-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('M.', 'M.', 'NNP', 'B-NP', 'O'), ('tuberculosis', 'tuberculosis', 'NNP', 'I-NP', 'O'), ('Erdman', 'Erdman', 'NNP', 'I-NP', 'O'), ('strain', 'strain', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('BL21', 'BL21', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('DE3', 'DE3', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Difficulties have also been encountered by other researchers [ CIT ] .	[('Difficulties', 'Difficulty', 'NNS', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('encountered', 'encounter', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('researchers', 'researcher', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	We compared the ability of MtTOP with that of similarly purified E.coli topoisomerase I ( EcTOP ) [ CIT ] in relaxing negatively supercoiled DNA by agarose gel electrophoresis .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('compared', 'compare', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MtTOP', 'MtTOP', 'NN', 'B-NP', 'B-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('similarly', 'similarly', 'RB', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'O'), ('E.coli', 'E.coli', 'NNP', 'I-NP', 'O'), ('topoisomerase', 'topoisomerase', 'NN', 'I-NP', 'B-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('EcTOP', 'EcTOP', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('relaxing', 'relax', 'VBG', 'B-VP', 'O'), ('negatively', 'negatively', 'RB', 'B-NP', 'O'), ('supercoiled', 'supercoiled', 'JJ', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('agarose', 'agarose', 'NN', 'B-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('electrophoresis', 'electrophoresis', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	The optimal Mg2+ concentrations found here for MtTOP are higher than the 1 mM concentration determined in previous work [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('Mg2+', 'Mg2+', 'NN', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('MtTOP', 'MtTOP', 'NN', 'B-NP', 'B-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('higher', 'high', 'JJR', 'B-ADJP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('mM', 'mM', 'NN', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('determined', 'determine', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies elucidating the sequence specificity of topoisomerase I from M. smegmatis reported a strong topoisomerase I site ( STS ) , wherein the enzyme recognizes and cleaves the sequence CG / TCT↓T [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('elucidating', 'elucidate', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('specificity', 'specificity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('topoisomerase', 'topoisomerase', 'NN', 'B-NP', 'B-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('M.', 'M.', 'NNP', 'B-NP', 'O'), ('smegmatis', 'smegmatis', 'NNP', 'I-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('strong', 'strong', 'JJ', 'I-NP', 'O'), ('topoisomerase', 'topoisomerase', 'NN', 'I-NP', 'B-DNA'), ('I', 'I', 'NN', 'I-NP', 'I-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('STS', 'STS', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('wherein', 'wherein', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('recognizes', 'recognize', 'VBZ', 'B-VP', 'O'), ('and', 'and', 'CC', 'I-VP', 'O'), ('cleaves', 'cleave', 'VBZ', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('CG', 'CG', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('TCT↓T', 'TCT↓T', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	All of the cleavage sites for both enzymes were found to have a cytosine at the -4 position ( CXXX↓ ) as previously shown for many bacterial topoisomerase I enzymes [ CIT ] .	[('All', 'All', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('both', 'both', 'DT', 'B-NP', 'O'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'B-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('have', 'have', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('cytosine', 'cytosine', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('-4', '-4', 'CD', 'I-NP', 'O'), ('position', 'position', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('CXXX↓', 'CXXX↓', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('many', 'many', 'JJ', 'B-NP', 'O'), ('bacterial', 'bacterial', 'JJ', 'I-NP', 'O'), ('topoisomerase', 'topoisomerase', 'NN', 'I-NP', 'B-protein'), ('I', 'I', 'CD', 'B-NP', 'I-protein'), ('enzymes', 'enzyme', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These data correspond well with previously reported data for this compound [ CIT ] and verify the competitive antagonist action of lerisetron .	[('These', 'These', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('correspond', 'correspond', 'VBP', 'B-VP', 'O'), ('well', 'well', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('compound', 'compound', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('verify', 'verify', 'VB', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('competitive', 'competitive', 'JJ', 'I-NP', 'O'), ('antagonist', 'antagonist', 'NN', 'I-NP', 'O'), ('action', 'action', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('lerisetron', 'lerisetron', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Analogs of lerisetron have been shown to inhibit 5-HT3Rs in a similar manner [ CIT ] .	[('Analogs', 'Analog', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('lerisetron', 'lerisetron', 'NN', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('inhibit', 'inhibit', 'VB', 'I-VP', 'O'), ('5-HT3Rs', '5-HT3R', 'NNS', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These data agree well with previously reported values [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('agree', 'agree', 'VBP', 'B-VP', 'O'), ('well', 'well', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	The Km glyoxylate ( 70 μM ) , Km acetyl CoA ( 12 μM ) and Vmax ( 16.5 μmol / minutes / mg MSG ) of the P. aeruginosa PAO1 MSG are comparable to those of other malate synthases available from literature ( Table 1 , [ CIT ] ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('Km', 'Km', 'NN', 'I-NP', 'O'), ('glyoxylate', 'glyoxylate', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('70', '70', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('Km', 'Km', 'NN', 'B-NP', 'O'), ('acetyl', 'acetyl', 'NN', 'I-NP', 'O'), ('CoA', 'CoA', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('12', '12', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Vmax', 'Vmax', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('16.5', '16.5', 'CD', 'B-NP', 'O'), ('μmol', 'μmol', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('minutes', 'minute', 'NNS', 'I-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('mg', 'mg', 'NN', 'B-NP', 'O'), ('MSG', 'MSG', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('P.', 'P.', 'NNP', 'I-NP', 'O'), ('aeruginosa', 'aeruginosa', 'NN', 'I-NP', 'O'), ('PAO1', 'PAO1', 'NN', 'I-NP', 'O'), ('MSG', 'MSG', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('comparable', 'comparable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('malate', 'malate', 'NN', 'I-NP', 'B-protein'), ('synthases', 'synthas', 'NNS', 'I-NP', 'I-protein'), ('available', 'available', 'JJ', 'B-ADJP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('literature', 'literature', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NNP', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	After scaling of the profile [ CIT ] , and the uncharacterized human proteins C6.1A and KIAA1915 .	[('After', 'After', 'IN', 'B-PP', 'O'), ('scaling', 'scale', 'VBG', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('profile', 'profile', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('uncharacterized', 'uncharacterized', 'JJ', 'I-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('C6.1A', 'C6.1A', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('KIAA1915', 'KIAA1915', 'NN', 'I-NP', 'B-DNA'), ('.', '.', '.', 'O', 'O')]
1	In order to estimate the generality of the effect , two different substrates were used : a protein that is ubiquitinated by enzymes of the UFD ubiquitination pathway [ CIT ] .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('estimate', 'estimate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('generality', 'generality', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), (':', ':', ':', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('ubiquitinated', 'ubiquitinate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('enzymes', 'enzyme', 'NNS', 'B-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('UFD', 'UFD', 'NN', 'I-NP', 'O'), ('ubiquitination', 'ubiquitination', 'NN', 'I-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Four conserved motifs of the PHP ( polymerase and histidinol phosphatase ) domain identified by Aravind & Koonin [ CIT ] were located in the amino acid sequence of Wzb .	[('Four', 'Four', 'CD', 'B-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'B-DNA'), ('motifs', 'motif', 'NNS', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PHP', 'PHP', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('polymerase', 'polymerase', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('histidinol', 'histidinol', 'NN', 'B-NP', 'B-protein'), ('phosphatase', 'phosphatase', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('identified', 'identify', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Aravind', 'Aravind', 'NNP', 'B-NP', 'O'), ('&', '&', 'CC', 'I-NP', 'O'), ('Koonin', 'Koonin', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('located', 'locate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'B-protein'), ('acid', 'acid', 'NN', 'I-NP', 'I-protein'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Wzb', 'Wzb', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
5	The optimal conditions we found were 20-40 μCi [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('20-40', '20-40', 'CD', 'B-NP', 'O'), ('μCi', 'μCi', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	All results obtained with our new method were consistent with previously reported data on Rap2A [ CIT ] , demonstrating the functionality of the assay .	[('All', 'All', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('new', 'new', 'JJ', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('Rap2A', 'Rap2A', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('functionality', 'functionality', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Thus , we have shown with direct arguments that RasD2 is indeed a target for farnesylation [ CIT ] .	[('Thus', 'Thus', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('direct', 'direct', 'JJ', 'B-NP', 'O'), ('arguments', 'argument', 'NNS', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RasD2', 'RasD2', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('indeed', 'indeed', 'RB', 'B-ADVP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('farnesylation', 'farnesylation', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in accordance with the literature that RhoA is geranylgeranylated [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('accordance', 'accordance', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('literature', 'literature', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RhoA', 'RhoA', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('geranylgeranylated', 'geranylgeranylate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A GFP-fusion protein of RhoA63L , which has been shown to be a primary geranylgeranylation target and which has been previously used for localization studies [ CIT ] , was used to demonstrate the functionality of the GGTI treatment .	[('A', 'A', 'DT', 'B-NP', 'O'), ('GFP-fusion', 'GFP-fusion', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('RhoA63L', 'RhoA63L', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('primary', 'primary', 'JJ', 'I-NP', 'O'), ('geranylgeranylation', 'geranylgeranylation', 'NN', 'I-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('localization', 'localization', 'NN', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('demonstrate', 'demonstrate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('functionality', 'functionality', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GGTI', 'GGTI', 'NN', 'I-NP', 'O'), ('treatment', 'treatment', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
6	In support of our interpretation , Rilling et al. [ CIT ] reported that protein prenylation in Chinese hamster ovary cells can vary as a function of the extracellular mevalonate concentration .	[('In', 'In', 'IN', 'B-PP', 'O'), ('support', 'support', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('interpretation', 'interpretation', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Rilling', 'Rilling', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('prenylation', 'prenylation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Chinese', 'Chinese', 'JJ', 'B-NP', 'B-cell_type'), ('hamster', 'hamster', 'NN', 'I-NP', 'I-cell_type'), ('ovary', 'ovary', 'NN', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('can', 'can', 'MD', 'B-VP', 'O'), ('vary', 'vary', 'VB', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('extracellular', 'extracellular', 'JJ', 'I-NP', 'O'), ('mevalonate', 'mevalonate', 'NN', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	The hCD200R array was tested for reactivity with three different mAb : DX147 , and two previously reported [ CIT ] mAb DX136 and OX108 able to block ligand binding .	[('The', 'The', 'DT', 'B-NP', 'O'), ('hCD200R', 'hCD200R', 'NN', 'I-NP', 'O'), ('array', 'array', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('tested', 'test', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('reactivity', 'reactivity', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('mAb', 'mAb', 'NN', 'I-NP', 'B-protein'), (':', ':', ':', 'O', 'O'), ('DX147', 'DX147', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('[', '[', '(', 'I-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'I-NP', 'O'), ('mAb', 'mAb', 'NN', 'I-NP', 'O'), ('DX136', 'DX136', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('OX108', 'OX108', 'NN', 'B-NP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('block', 'block', 'VB', 'I-VP', 'O'), ('ligand', 'ligand', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have shown that the membrane distal N-terminal domain of CD200 is involved in binding its receptor [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'B-protein'), ('distal', 'distal', 'JJ', 'I-NP', 'I-protein'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CD200', 'CD200', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('binding', 'bind', 'VBG', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The binding sites of CD200 and of the OX108 mAb known to block ligand interaction to the hCD200R mutants , were shown to be on the GFCC ' face of the N-terminal IgSF domain [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('binding', 'bind', 'VBG', 'I-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CD200', 'CD200', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'B-PP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('OX108', 'OX108', 'NN', 'I-NP', 'B-protein'), ('mAb', 'mAb', 'NN', 'I-NP', 'I-protein'), ('known', 'know', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('block', 'block', 'VB', 'I-VP', 'O'), ('ligand', 'ligand', 'NN', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hCD200R', 'hCD200R', 'NN', 'I-NP', 'B-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GFCC', 'GFCC', 'NN', 'I-NP', 'O'), ("'", "'", 'POS', 'B-NP', 'O'), ('face', 'face', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'B-protein'), ('IgSF', 'IgSF', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	This presumably reflects variations in epitope availability due to direct immobilization of the mutant proteins on the array , which are less likely to occur in BIAcore studies where mutants were immobilized via OX68 mAb [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('presumably', 'presumably', 'RB', 'B-ADVP', 'O'), ('reflects', 'reflect', 'VBZ', 'B-VP', 'O'), ('variations', 'variation', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('epitope', 'epitope', 'NN', 'B-NP', 'O'), ('availability', 'availability', 'NN', 'I-NP', 'O'), ('due', 'due', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('direct', 'direct', 'JJ', 'B-NP', 'O'), ('immobilization', 'immobilization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutant', 'mutant', 'JJ', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('array', 'array', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('likely', 'likely', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('occur', 'occur', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('BIAcore', 'BIAcore', 'NN', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('mutants', 'mutant', 'NNS', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('immobilized', 'immobilize', 'VBN', 'I-VP', 'O'), ('via', 'via', 'IN', 'B-PP', 'O'), ('OX68', 'OX68', 'NN', 'B-NP', 'B-protein'), ('mAb', 'mAb', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Panel A shows the mutants affecting CD200 binding , as reported in [ CIT ] .	[('Panel', 'Panel', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('shows', 'show', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('affecting', 'affect', 'VBG', 'B-VP', 'O'), ('CD200', 'CD200', 'NN', 'B-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Furthermore , the microarray study confirms the results obtained by individual analysis of each mutant by surface plasmon resonance in terms of residues involved in OX108 binding ; the most critical amino acid appears to be R67 located in the B-C loop [ CIT ] .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('microarray', 'microarray', 'NN', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('confirms', 'confirm', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('individual', 'individual', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('mutant', 'mutant', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('surface', 'surface', 'NN', 'B-NP', 'O'), ('plasmon', 'plasmon', 'NN', 'I-NP', 'O'), ('resonance', 'resonance', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('terms', 'term', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('involved', 'involve', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('OX108', 'OX108', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('most', 'most', 'RBS', 'I-NP', 'O'), ('critical', 'critical', 'JJ', 'I-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('appears', 'appear', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('R67', 'R67', 'NN', 'B-NP', 'B-protein'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('B-C', 'B-C', 'NN', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The demonstration of Ca2+ binding to the ubiquitin-fused CR56 protein [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('demonstration', 'demonstration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ubiquitin-fused', 'ubiquitin-fused', 'JJ', 'I-NP', 'B-protein'), ('CR56', 'CR56', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	After affinity purification of ubiquitin-fused CR56 containing the authentic amino acid sequence , we liberated the CR56 domain pair from its fusion partner by factor Xa cleavage ( as described in ref. [ CIT ] ) .	[('After', 'After', 'IN', 'B-PP', 'O'), ('affinity', 'affinity', 'NN', 'B-NP', 'O'), ('purification', 'purification', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ubiquitin-fused', 'ubiquitin-fused', 'JJ', 'B-NP', 'B-protein'), ('CR56', 'CR56', 'NN', 'I-NP', 'I-protein'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('authentic', 'authentic', 'JJ', 'I-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('liberated', 'liberate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CR56', 'CR56', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('pair', 'pair', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('fusion', 'fusion', 'NN', 'I-NP', 'B-protein'), ('partner', 'partner', 'NN', 'I-NP', 'I-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('factor', 'factor', 'NN', 'B-NP', 'O'), ('Xa', 'Xa', 'NN', 'I-NP', 'O'), ('cleavage', 'cleavage', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ref.', 'ref.', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Ca2+ binding was measured using the microchamber rate dialysis technique [ CIT ] .	[('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('measured', 'measure', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('microchamber', 'microchamber', 'NN', 'I-NP', 'O'), ('rate', 'rate', 'NN', 'I-NP', 'O'), ('dialysis', 'dialysis', 'NN', 'I-NP', 'O'), ('technique', 'technique', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Secondly , the number is in accord with other data determining Ca2+ affinity to tandem CR-domain pair [ CIT ] .	[('Secondly', 'Secondly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('accord', 'accord', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('determining', 'determine', 'VBG', 'B-VP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'B-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('tandem', 'tandem', 'JJ', 'B-NP', 'O'), ('CR-domain', 'CR-domain', 'NN', 'I-NP', 'O'), ('pair', 'pair', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Bieri et al. found a similar stoichiometry ( n = 2.2 ) when they measured the Ca2+ binding to a concatemer of CR1LDLR-CR2LDLR , and neither solution nor crystal structure indicate that there is more than two Ca2+ binding sites within this fragment [ CIT ] .	[('Bieri', 'Bieri', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('stoichiometry', 'stoichiometry', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('n', 'n', 'NN', 'B-NP', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('2.2', '2.2', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('measured', 'measure', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('binding', 'bind', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('concatemer', 'concatemer', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CR1LDLR-CR2LDLR', 'CR1LDLR-CR2LDLR', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('neither', 'neither', 'CC', 'O', 'O'), ('solution', 'solution', 'NN', 'B-NP', 'O'), ('nor', 'nor', 'CC', 'O', 'O'), ('crystal', 'crystal', 'JJ', 'B-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('indicate', 'indicate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('more', 'more', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'B-DNA'), ('binding', 'binding', 'NN', 'I-NP', 'I-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('within', 'within', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('fragment', 'fragment', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The Ca2+ ions in the hitherto solved domain structures are located in identical Ca2+ cages as for CR5LDLR described previously by Fass and colleagues [ CIT ] ( Figure 1B ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('ions', 'ion', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hitherto', 'hitherto', 'NN', 'I-NP', 'O'), ('solved', 'solve', 'VBD', 'B-VP', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('identical', 'identical', 'JJ', 'B-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('cages', 'cage', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('CR5LDLR', 'CR5LDLR', 'NN', 'B-NP', 'B-protein'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Fass', 'Fass', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('colleagues', 'colleague', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1B', '1B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	In line with this our data suggest that two and only two Ca2+ are bound per tandem fragment as also reported for domain pairs from LDLR comprising CR1LDLR-CR2LDLR and CR5LDLR-CR6LDLR [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('line', 'line', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('our', 'our', 'PRP$', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('suggest', 'suggest', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('only', 'only', 'RB', 'I-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('bound', 'bind', 'VBN', 'I-VP', 'O'), ('per', 'per', 'IN', 'B-PP', 'O'), ('tandem', 'tandem', 'JJ', 'B-NP', 'B-DNA'), ('fragment', 'fragment', 'NN', 'I-NP', 'I-DNA'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('pairs', 'pair', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('LDLR', 'LDLR', 'NN', 'B-NP', 'B-protein'), ('comprising', 'comprising', 'NN', 'I-NP', 'O'), ('CR1LDLR-CR2LDLR', 'CR1LDLR-CR2LDLR', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('CR5LDLR-CR6LDLR', 'CR5LDLR-CR6LDLR', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In addition , especially the acidic residues is also involved in the intramolecular binding of CR-domains to the EGF-precursor homology domain at low pH , speculated to result in structural rearrangement and ligand release within endosomes , underscoring the importance of understanding the local environment around the Ca2+ binding site [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('especially', 'especially', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('acidic', 'acidic', 'JJ', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('intramolecular', 'intramolecular', 'JJ', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CR-domains', 'CR-domain', 'NNS', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('EGF-precursor', 'EGF-precursor', 'NN', 'I-NP', 'B-protein'), ('homology', 'homology', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('speculated', 'speculate', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('result', 'result', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('structural', 'structural', 'JJ', 'B-NP', 'O'), ('rearrangement', 'rearrangement', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('ligand', 'ligand', 'NN', 'I-NP', 'O'), ('release', 'release', 'NN', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('endosomes', 'endosome', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('underscoring', 'underscore', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('importance', 'importance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('understanding', 'understand', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('local', 'local', 'JJ', 'I-NP', 'O'), ('environment', 'environment', 'NN', 'I-NP', 'O'), ('around', 'around', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Ca2+', 'Ca2+', 'NN', 'I-NP', 'B-DNA'), ('binding', 'binding', 'NN', 'I-NP', 'I-DNA'), ('site', 'site', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We and Gregoire et al. had previously shown that the MEF2 family of transcription factors was efficiently sumoylated [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Gregoire', 'Gregoire', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'B-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('MEF2', 'MEF2', 'NN', 'I-NP', 'B-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('transcription', 'transcription', 'NN', 'B-NP', 'B-protein'), ('factors', 'factor', 'NNS', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('efficiently', 'efficiently', 'RB', 'I-VP', 'O'), ('sumoylated', 'sumoylate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Previous reports have described the mono- and diphosphorylated state of annexin II [ CIT ] , and our data are consistent with existence of annexin II in these different phosphorylation states .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mono-', 'mono-', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('diphosphorylated', 'diphosphorylate', 'VBN', 'B-VP', 'O'), ('state', 'state', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('annexin', 'annexin', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('existence', 'existence', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('annexin', 'annexin', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('states', 'state', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The appearance of phosphorylated annexin II in the nucleus mimics the annexin II RNA levels during the HeLa cell cycle previously reported [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('appearance', 'appearance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'B-NP', 'B-protein'), ('annexin', 'annexin', 'NN', 'I-NP', 'I-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nucleus', 'nucleus', 'NN', 'I-NP', 'O'), ('mimics', 'mimic', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('annexin', 'annexin', 'NN', 'I-NP', 'O'), ('II', 'II', 'CD', 'I-NP', 'O'), ('RNA', 'RNA', 'NN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HeLa', 'HeLa', 'NN', 'I-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('cycle', 'cycle', 'NN', 'I-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These results are in agreement with data from K562 cells ( Figure 2 ) , as well as previously published literature [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('data', 'data', 'NN', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('K562', 'K562', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('literature', 'literature', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These observations are similar to the finding that the expression of human Cdc6 mutant , HsCdc6E1E2E3 , which is exclusively nuclear , inhibits initiation of DNA replication [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-protein'), ('Cdc6', 'Cdc6', 'NN', 'I-NP', 'I-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('HsCdc6E1E2E3', 'HsCdc6E1E2E3', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('exclusively', 'exclusively', 'RB', 'B-ADJP', 'O'), ('nuclear', 'nuclear', 'JJ', 'I-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('inhibits', 'inhibit', 'VBZ', 'B-VP', 'O'), ('initiation', 'initiation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('DNA', 'DNA', 'NN', 'B-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	These results strictly reproduce the data obtained with similar experiments in myogenic cells , showing that Myf5 is strongly destabilized in mitosis , and is stabilized by proteasome inhibitors as a phosphorylated form [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('strictly', 'strictly', 'RB', 'B-VP', 'O'), ('reproduce', 'reproduce', 'VBP', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('myogenic', 'myogenic', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Myf5', 'Myf5', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('strongly', 'strongly', 'RB', 'I-VP', 'O'), ('destabilized', 'destabilize', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mitosis', 'mitosis', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('stabilized', 'stabilize', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('proteasome', 'proteasome', 'NN', 'B-NP', 'B-protein'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('phosphorylated', 'phosphorylated', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	Since in cells , the pathway responsible for Myf5 degradation in interphase is seemingly different from the pathway operating in mitosis [ CIT ] , one likely explanation is that only the mitotic pathway is active in Xenopus extracts .	[('Since', 'Since', 'IN', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('responsible', 'responsible', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('Myf5', 'Myf5', 'NN', 'B-NP', 'B-protein'), ('degradation', 'degradation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('interphase', 'interphase', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('seemingly', 'seemingly', 'RB', 'B-ADJP', 'O'), ('different', 'different', 'JJ', 'I-ADJP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('operating', 'operate', 'VBG', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mitosis', 'mitosis', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('likely', 'likely', 'JJ', 'I-NP', 'O'), ('explanation', 'explanation', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('the', 'the', 'DT', 'I-NP', 'O'), ('mitotic', 'mitotic', 'JJ', 'I-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('active', 'active', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
3	That is , in a process analogous to that reported for the CDK inhibitor Sic1 in budding yeast [ CIT ] , it would be the number of phosphorylated residues rather than their identity that controls Myf5 stability .	[('That', 'That', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), ('analogous', 'analogous', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CDK', 'CDK', 'NN', 'I-NP', 'B-protein'), ('inhibitor', 'inhibitor', 'NN', 'I-NP', 'I-protein'), ('Sic1', 'Sic1', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('budding', 'bud', 'VBG', 'B-VP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('rather', 'rather', 'RB', 'B-PP', 'O'), ('than', 'than', 'IN', 'I-PP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('controls', 'control', 'VBZ', 'B-VP', 'O'), ('Myf5', 'Myf5', 'NN', 'B-NP', 'B-protein'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , the degradation pathway of Myf5 in mitotic cells appears different with respect of both timing and mechanism from that of known substrates of the APC / C [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('degradation', 'degradation', 'NN', 'I-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Myf5', 'Myf5', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mitotic', 'mitotic', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('appears', 'appear', 'VBZ', 'B-VP', 'O'), ('different', 'different', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('respect', 'respect', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('timing', 'timing', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('mechanism', 'mechanism', 'NN', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('known', 'known', 'JJ', 'B-NP', 'O'), ('substrates', 'substrate', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('APC', 'APC', 'NN', 'I-NP', 'B-cell_type'), ('/', '/', 'SYM', 'O', 'O'), ('C', 'C', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We first used Xenopus interphase extracts in which APC / C is specifically activated by translation in the extract of the APC / C regulator Cdh1 ( Fizzy-related in Xenopus ) , as these extracts have been shown to be able to efficiently degrade most known APC / C substrates in a Cdh1-dependent manner [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('first', 'first', 'RB', 'B-ADVP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('interphase', 'interphase', 'NN', 'I-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('APC', 'APC', 'NN', 'B-NP', 'B-cell_type'), ('/', '/', 'SYM', 'I-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('specifically', 'specifically', 'RB', 'I-VP', 'O'), ('activated', 'activate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('translation', 'translation', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('extract', 'extract', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('APC', 'APC', 'NN', 'I-NP', 'B-cell_type'), ('/', '/', 'SYM', 'B-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'O'), ('regulator', 'regulator', 'NN', 'I-NP', 'O'), ('Cdh1', 'Cdh1', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fizzy-related', 'Fizzy-related', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('efficiently', 'efficiently', 'RB', 'I-VP', 'O'), ('degrade', 'degrade', 'VB', 'I-VP', 'O'), ('most', 'most', 'RBS', 'B-NP', 'O'), ('known', 'know', 'VBN', 'I-NP', 'O'), ('APC', 'APC', 'NN', 'I-NP', 'B-cell_type'), ('/', '/', 'SYM', 'B-NP', 'O'), ('C', 'C', 'NN', 'B-NP', 'B-protein'), ('substrates', 'substrate', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Cdh1-dependent', 'Cdh1-dependent', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	An in vitro assay using dideoxy terminated primer annealed with the template which allows the next correct dNTP to bind in the ternary complex without actual DNA synthesis has recently been reported [ CIT ] .	[('An', 'An', 'DT', 'B-NP', 'O'), ('in', 'in', 'FW', 'I-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('dideoxy', 'dideoxy', 'NN', 'B-NP', 'O'), ('terminated', 'terminate', 'VBN', 'I-NP', 'O'), ('primer', 'primer', 'NN', 'I-NP', 'O'), ('annealed', 'anneal', 'VBD', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('template', 'template', 'NN', 'I-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('allows', 'allow', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('next', 'next', 'JJ', 'I-NP', 'O'), ('correct', 'correct', 'JJ', 'I-NP', 'O'), ('dNTP', 'dNTP', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ternary', 'ternary', 'JJ', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('without', 'without', 'IN', 'B-PP', 'O'), ('actual', 'actual', 'JJ', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	We identified amino acids responsible for binding of arginine to vertebrate-like NAGS based on the information from three dimensional structure of Thermotoga maritima N-acetylglutamate kinase ( NAGK ) protein liganded with L-arginine [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('amino', 'amino', 'JJ', 'B-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('responsible', 'responsible', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('arginine', 'arginine', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('vertebrate-like', 'vertebrate-like', 'JJ', 'B-NP', 'B-protein'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'I-protein'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('information', 'information', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('dimensional', 'dimensional', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Thermotoga', 'Thermotoga', 'NNP', 'B-NP', 'O'), ('maritima', 'maritima', 'NN', 'I-NP', 'B-protein'), ('N-acetylglutamate', 'N-acetylglutamate', 'NN', 'I-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('NAGK', 'NAGK', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('liganded', 'ligande', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('L-arginine', 'L-arginine', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The four conserved residues important for arginine binding were also found previously by our group to be mutated in arginine insensitive NAGS from E. coli [ CIT ] ; they are labeled with asterisks in Figure 2 .	[('The', 'The', 'DT', 'B-NP', 'O'), ('four', 'four', 'CD', 'I-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('arginine', 'arginine', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('mutated', 'mutate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('arginine', 'arginine', 'NN', 'B-NP', 'B-protein'), ('insensitive', 'insensitive', 'JJ', 'I-NP', 'I-protein'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('labeled', 'label', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('asterisks', 'asterisk', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Although homologs of four urea cycle genes ( CPSI , ornithine transcarbamylase , argininosuccinate synthase and argininosuccinate lyase ) were previously identified in the chicken [ CIT ] ; sequences similar to human NAGS and arginase I were absent from the chicken genome .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('homologs', 'homolog', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('four', 'four', 'CD', 'B-NP', 'O'), ('urea', 'urea', 'NN', 'I-NP', 'B-DNA'), ('cycle', 'cycle', 'NN', 'I-NP', 'I-DNA'), ('genes', 'gene', 'NNS', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('CPSI', 'CPSI', 'NN', 'B-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('ornithine', 'ornithine', 'NN', 'B-NP', 'B-protein'), ('transcarbamylase', 'transcarbamylase', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('argininosuccinate', 'argininosuccinate', 'NN', 'B-NP', 'B-protein'), ('synthase', 'synthase', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('argininosuccinate', 'argininosuccinate', 'NN', 'B-NP', 'B-protein'), ('lyase', 'lyase', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('chicken', 'chicken', 'NN', 'I-NP', 'B-DNA'), ('[', '[', '(', 'O', 'I-DNA'), ('CIT', 'CIT', 'NN', 'B-NP', 'I-DNA'), (']', ']', ')', 'O', 'I-DNA'), (';', ';', ':', 'O', 'I-DNA'), ('sequences', 'sequence', 'NNS', 'B-NP', 'I-DNA'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-protein'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('arginase', 'arginase', 'NN', 'I-NP', 'B-protein'), ('I', 'I', 'PRP', 'B-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('absent', 'absent', 'JJ', 'B-ADJP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('chicken', 'chicken', 'NN', 'I-NP', 'B-DNA'), ('genome', 'genome', 'NN', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
1	Figure 4 also indicates that invertebrates and fish have CPSIII , while tetrapods have CPSI , suggesting that the transition from CPSIII to CPSI coincided with the conquest of land by tetrapods , as noted previously [ CIT ] .	[('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('indicates', 'indicate', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('invertebrates', 'invertebrate', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('fish', 'fish', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('CPSIII', 'CPSIII', 'NNP', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('tetrapods', 'tetrapod', 'NNS', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('CPSI', 'CPSI', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('transition', 'transition', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('CPSIII', 'CPSIII', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('CPSI', 'CPSI', 'NN', 'B-NP', 'B-protein'), ('coincided', 'coincide', 'VBD', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conquest', 'conquest', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('land', 'land', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('tetrapods', 'tetrapod', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('noted', 'note', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It was reported previously that NAGS from E. coli enzyme had 15 % residual enzymatic activity in the presence of 1 mM arginine [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('NAGS', 'NAGS', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('residual', 'residual', 'JJ', 'I-NP', 'O'), ('enzymatic', 'enzymatic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('mM', 'mM', 'NN', 'I-NP', 'O'), ('arginine', 'arginine', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Inhibition of X. campestris NAGS-K and E. coli NAGS by arginine , as well as activation of mammalian NAGS by arginine , have been shown previously [ CIT ] .	[('Inhibition', 'Inhibition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('X.', 'X.', 'NN', 'B-NP', 'B-protein'), ('campestris', 'campestris', 'NN', 'I-NP', 'I-protein'), ('NAGS-K', 'NAGS-K', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('arginine', 'arginine', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('activation', 'activation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mammalian', 'mammalian', 'JJ', 'B-NP', 'B-protein'), ('NAGS', 'NAGS', 'NN', 'I-NP', 'I-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('arginine', 'arginine', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The data obtained with L-AFC did indeed demonstrate precisely this [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('L-AFC', 'L-AFC', 'NN', 'B-NP', 'B-protein'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('indeed', 'indeed', 'RB', 'B-ADVP', 'O'), ('demonstrate', 'demonstrate', 'VBP', 'B-VP', 'O'), ('precisely', 'precisely', 'RB', 'B-ADVP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'O', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This is in striking contrast to what was reported previously for this enzyme , in which Ni2+ inhibited activity [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('striking', 'striking', 'JJ', 'B-NP', 'O'), ('contrast', 'contrast', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('what', 'what', 'WP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('Ni2+', 'Ni2+', 'NN', 'B-NP', 'O'), ('inhibited', 'inhibit', 'VBD', 'B-VP', 'O'), ('activity', 'activity', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As previously reported [ CIT ] , the H. pylori arginase in the E. coli model ( pBS-rocF ) displayed optimal catalysis with cobalt at pH 6.0 .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('H.', 'H.', 'NN', 'I-NP', 'B-protein'), ('pylori', 'pylori', 'NN', 'I-NP', 'I-protein'), ('arginase', 'arginase', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('pBS-rocF', 'pBS-rocF', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('displayed', 'display', 'VBD', 'B-VP', 'O'), ('optimal', 'optimal', 'JJ', 'B-NP', 'O'), ('catalysis', 'catalysis', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('cobalt', 'cobalt', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('pH', 'pH', 'NN', 'B-NP', 'O'), ('6.0', '6.0', 'CD', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous results indicated that the six histidine tag did not interfere with arginase activity [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('six', 'six', 'CD', 'I-NP', 'O'), ('histidine', 'histidine', 'NN', 'I-NP', 'O'), ('tag', 'tag', 'NN', 'I-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('interfere', 'interfere', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('arginase', 'arginase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	This was achieved using the suicide plasmid complementation system developed previously [ CIT ] , but with an improved vector backbone , pLSU0005 ( see Methods ) .	[('This', 'This', 'DT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('achieved', 'achieve', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('suicide', 'suicide', 'NN', 'I-NP', 'O'), ('plasmid', 'plasmid', 'NN', 'I-NP', 'O'), ('complementation', 'complementation', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('developed', 'develop', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('improved', 'improve', 'VBN', 'I-NP', 'O'), ('vector', 'vector', 'NN', 'I-NP', 'O'), ('backbone', 'backbone', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('pLSU0005', 'pLSU0005', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('Methods', 'Method', 'NNS', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Transformation of the 26695 rocF mutant with the empty vector control was previously shown not to complement arginase activity , as expected [ CIT ] .	[('Transformation', 'Transformation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('26695', '26695', 'CD', 'I-NP', 'B-protein'), ('rocF', 'rocF', 'NN', 'I-NP', 'I-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('empty', 'empty', 'JJ', 'I-NP', 'O'), ('vector', 'vector', 'NN', 'I-NP', 'O'), ('control', 'control', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('complement', 'complement', 'VB', 'I-VP', 'O'), ('arginase', 'arginase', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('expected', 'expect', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The EC50 for S1P stimulation of the HA-S1P4-Gαi1 fusion protein ( 355 ± 155 nM ) was not statistically significantly different from that obtained using the unfused HA-S1P4 receptor ( 439 ± 187 nM , Figure 2B ) and compared favourably with published values for this receptor in HEK293T cells from two different research groups of 270 nM [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('EC50', 'EC50', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('S1P', 'S1P', 'NN', 'B-NP', 'B-protein'), ('stimulation', 'stimulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HA-S1P4-Gαi1', 'HA-S1P4-Gαi1', 'NN', 'I-NP', 'B-protein'), ('fusion', 'fusion', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('355', '355', 'CD', 'B-NP', 'O'), ('±', '±', 'SYM', 'O', 'O'), ('155', '155', 'CD', 'B-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('statistically', 'statistically', 'RB', 'B-ADJP', 'O'), ('significantly', 'significantly', 'RB', 'I-ADJP', 'O'), ('different', 'different', 'JJ', 'I-ADJP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('unfused', 'unfused', 'JJ', 'I-NP', 'O'), ('HA-S1P4', 'HA-S1P4', 'NN', 'I-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('439', '439', 'CD', 'B-NP', 'O'), ('±', '±', 'SYM', 'O', 'O'), ('187', '187', 'CD', 'B-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2B', '2B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('compared', 'compare', 'VBN', 'B-VP', 'O'), ('favourably', 'favourably', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('HEK293T', 'HEK293T', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('from', 'from', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('research', 'research', 'NN', 'I-NP', 'O'), ('groups', 'group', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('270', '270', 'CD', 'B-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These data are in agreement with previous reports that indicated a preferential binding of the different chaperones to aggregates with different degree of complexity [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('preferential', 'preferential', 'JJ', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('chaperones', 'chaperone', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('aggregates', 'aggregate', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('degree', 'degree', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('complexity', 'complexity', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The role of chaperones in limiting the protein aggregation has been widely demonstrated and DnaK has a key role in the chaperone network [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('chaperones', 'chaperone', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('limiting', 'limit', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('aggregation', 'aggregation', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('widely', 'widely', 'RB', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('DnaK', 'DnaK', 'NNP', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('key', 'key', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('chaperone', 'chaperone', 'NN', 'I-NP', 'O'), ('network', 'network', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in agreement with the report that part of the protein present in the inclusion bodies conserves its secondary structure [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('part', 'part', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inclusion', 'inclusion', 'NN', 'I-NP', 'O'), ('bodies', 'body', 'NNS', 'I-NP', 'O'), ('conserves', 'conserve', 'VBZ', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('secondary', 'secondary', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	First , the GFP-GST proteins affinity purified from the four sucrose gradient fractions were dialysed and analysed in the fluorimeter according to the method proposed by Nominé et al. [ CIT ] , namely the absorbance at 280 and 340 nm was measured and the ratio calculated .	[('First', 'First', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GFP-GST', 'GFP-GST', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('purified', 'purify', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('four', 'four', 'CD', 'I-NP', 'O'), ('sucrose', 'sucrose', 'NN', 'I-NP', 'O'), ('gradient', 'gradient', 'NN', 'I-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('dialysed', 'dialyse', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('analysed', 'analyse', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fluorimeter', 'fluorimeter', 'NN', 'I-NP', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('proposed', 'propose', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Nominé', 'Nominé', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('namely', 'namely', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absorbance', 'absorbance', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('280', '280', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('340', '340', 'CD', 'I-NP', 'O'), ('nm', 'nm', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('measured', 'measure', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ratio', 'ratio', 'NN', 'I-NP', 'O'), ('calculated', 'calculate', 'VBN', 'B-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	In a recent paper it was claimed that bacterial chaperones play an active role in the formation of the aggregates [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('paper', 'paper', 'NN', 'I-NP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('claimed', 'claim', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('bacterial', 'bacterial', 'JJ', 'B-NP', 'O'), ('chaperones', 'chaperone', 'NNS', 'I-NP', 'O'), ('play', 'play', 'VBP', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('active', 'active', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('aggregates', 'aggregate', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The preferential disaggregation of subclasses of aggregates with lower complexity observed in vitro is reminiscent of previous works indicating that specific subclasses of the proteins trapped in the inclusion bodies are preferentially refolded under physiological conditions [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('preferential', 'preferential', 'JJ', 'I-NP', 'O'), ('disaggregation', 'disaggregation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('subclasses', 'subclass', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('aggregates', 'aggregate', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('complexity', 'complexity', 'NN', 'I-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'FW', 'B-PP', 'O'), ('vitro', 'vitro', 'FW', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reminiscent', 'reminiscent', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('works', 'work', 'NNS', 'I-NP', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('specific', 'specific', 'JJ', 'B-NP', 'O'), ('subclasses', 'subclass', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('trapped', 'trap', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('inclusion', 'inclusion', 'NN', 'I-NP', 'O'), ('bodies', 'body', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('preferentially', 'preferentially', 'RB', 'I-VP', 'O'), ('refolded', 'refolde', 'VBN', 'I-VP', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('physiological', 'physiological', 'JJ', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Indeed , a decrease of activity due to the higher purification of the enzyme was previously described [ CIT ] .	[('Indeed', 'Indeed', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('activity', 'activity', 'NN', 'B-NP', 'O'), ('due', 'due', 'IN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('higher', 'high', 'JJR', 'I-NP', 'O'), ('purification', 'purification', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The comparison of kinetic values between baculovirus recombinant Ap-B [ CIT ] and E. coli recombinant protein shows that this latter constitutes a reliable tool to study the enzymatic mechanism of Ap-B , avoiding long procedures of purification ( Table 1 ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('comparison', 'comparison', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('kinetic', 'kinetic', 'JJ', 'B-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('baculovirus', 'baculovirus', 'NN', 'B-NP', 'O'), ('recombinant', 'recombinant', 'JJ', 'I-NP', 'O'), ('Ap-B', 'Ap-B', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('recombinant', 'recombinant', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('shows', 'show', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('latter', 'latter', 'JJ', 'I-NP', 'O'), ('constitutes', 'constitute', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('reliable', 'reliable', 'JJ', 'I-NP', 'O'), ('tool', 'tool', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('study', 'study', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzymatic', 'enzymatic', 'JJ', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ap-B', 'Ap-B', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('avoiding', 'avoid', 'VBG', 'B-VP', 'O'), ('long', 'long', 'JJ', 'B-NP', 'O'), ('procedures', 'procedure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('purification', 'purification', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In order to probe the functional roles of several amino acids previously identified in other members of the M1 family ( For review , see in [ CIT ] ) , an investigation of the conserved HEXXHX18E motif was conducted by site-directed mutagenesis ( Table 3 ) .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('probe', 'probe', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('functional', 'functional', 'JJ', 'I-NP', 'O'), ('roles', 'role', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('members', 'member', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('M1', 'M1', 'NN', 'I-NP', 'B-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('For', 'For', 'IN', 'B-PP', 'O'), ('review', 'review', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('see', 'see', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('investigation', 'investigation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'B-DNA'), ('HEXXHX18E', 'HEXXHX18E', 'NN', 'I-NP', 'I-DNA'), ('motif', 'motif', 'NN', 'I-NP', 'I-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('conducted', 'conduct', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('site-directed', 'site-directed', 'JJ', 'B-NP', 'O'), ('mutagenesis', 'mutagenesis', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('3', '3', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have demonstrated previously [ CIT ] that this region of PDE4D5 is necessary and sufficient for it to bind to RACK1 , thus explaining why PDE4D5 uniquely amongst the PDE4D isoforms is able to interact with RACK1 .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('necessary', 'necessary', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'I-ADJP', 'O'), ('sufficient', 'sufficient', 'JJ', 'I-ADJP', 'O'), ('for', 'for', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('thus', 'thus', 'RB', 'B-ADVP', 'O'), ('explaining', 'explain', 'VBG', 'B-VP', 'O'), ('why', 'why', 'WRB', 'B-ADVP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'B-NP', 'O'), ('uniquely', 'uniquely', 'RB', 'B-ADVP', 'O'), ('amongst', 'amongst', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PDE4D', 'PDE4D', 'NN', 'I-NP', 'B-protein'), ('isoforms', 'isoform', 'NNS', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('able', 'able', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
5	Using an ELISA assay , we confirmed previous observations [ CIT ] , that PDE4D5 interacted with RACK1 with a Ka of 4 - 12 nM ( range ; n = 5 separate experiments ) .	[('Using', 'Use', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('ELISA', 'ELISA', 'NN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('confirmed', 'confirm', 'VBD', 'B-VP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'I-NP', 'O'), ('interacted', 'interact', 'VBD', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('Ka', 'Ka', 'NNP', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('4', '4', 'CD', 'B-NP', 'O'), ('-', '-', 'HYPH', 'I-NP', 'O'), ('12', '12', 'CD', 'I-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('range', 'range', 'NN', 'B-NP', 'O'), (';', ';', ':', 'O', 'O'), ('n', 'n', 'NN', 'B-NP', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('separate', 'separate', 'JJ', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	We have previously confirmed [ CIT ] the fidelity of such an approach by using a variety of independent biochemical analyses , including co-immunoprecipitation , pull down assays with GST-RACK1 and the binding of purified components .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fidelity', 'fidelity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('an', 'an', 'DT', 'I-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('variety', 'variety', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('independent', 'independent', 'JJ', 'B-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('analyses', 'analysis', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('co-immunoprecipitation', 'co-immunoprecipitation', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('pull', 'pull', 'VB', 'B-VP', 'O'), ('down', 'down', 'RP', 'B-PRT', 'O'), ('assays', 'assay', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('GST-RACK1', 'GST-RACK1', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('purified', 'purify', 'VBN', 'B-NP', 'O'), ('components', 'component', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previously we have shown [ CIT ] that Glu-27 was not involved in RACK1 interaction .	[('Previously', 'Previously', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Glu-27', 'Glu-27', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('involved', 'involve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Extracts from these cells were then subjected to a pull-down assay with GST-RACK1 as done before by us [ CIT ] .	[('Extracts', 'Extract', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('then', 'then', 'RB', 'I-VP', 'O'), ('subjected', 'subject', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('pull-down', 'pull-down', 'JJ', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('GST-RACK1', 'GST-RACK1', 'NN', 'B-NP', 'B-protein'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('done', 'do', 'VBN', 'B-VP', 'O'), ('before', 'before', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('us', 'us', 'PRP', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A 38-mer peptide , comprising residues 12-49 of PDE4D5 , contains both the previously identified Asn-22 / Pro-23 / Trp-24 / Asn-26 grouping [ CIT ] and also the novel leucine repeat unit shown also to be crucial for RACK1 to bind to PDE4D5 .	[('A', 'A', 'DT', 'B-NP', 'O'), ('38-mer', '38-mer', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('comprising', 'comprise', 'VBG', 'B-VP', 'O'), ('residues', 'residue', 'NNS', 'B-NP', 'O'), ('12-49', '12-49', 'CD', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('identified', 'identify', 'VBN', 'I-NP', 'O'), ('Asn-22', 'Asn-22', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('Pro-23', 'Pro-23', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'I-NP', 'O'), ('Trp-24', 'Trp-24', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'O', 'O'), ('Asn-26', 'Asn-26', 'NN', 'B-NP', 'O'), ('grouping', 'grouping', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('novel', 'novel', 'JJ', 'I-NP', 'O'), ('leucine', 'leucine', 'NN', 'I-NP', 'O'), ('repeat', 'repeat', 'NN', 'I-NP', 'O'), ('unit', 'unit', 'NN', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('crucial', 'crucial', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), ('to', 'to', 'TO', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
5	This peptide bound to RACK1 with similar affinity1 ( Ka of 6.4 ± 1.2 nM ( Mean ± SD ; n = 3 separate experiments ) to that reported for PDE4D5 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('bound', 'bind', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('RACK1', 'RACK1', 'NN', 'B-NP', 'B-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('similar', 'similar', 'JJ', 'B-NP', 'O'), ('affinity1', 'affinity1', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Ka', 'Ka', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('6.4', '6.4', 'CD', 'B-NP', 'O'), ('±', '±', 'HYPH', 'I-NP', 'O'), ('1.2', '1.2', 'CD', 'I-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Mean', 'Mean', 'NNP', 'B-NP', 'O'), ('±', '±', 'NNP', 'I-NP', 'O'), ('SD', 'SD', 'NNP', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('n', 'n', 'NN', 'B-NP', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('separate', 'separate', 'JJ', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('PDE4D5', 'PDE4D5', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The putative TM domains of the IP and TP receptors are based on the hydropathy analysis described in the original cloning papers [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'B-protein'), ('TM', 'TM', 'NN', 'I-NP', 'I-protein'), ('domains', 'domain', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('IP', 'IP', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('TP', 'TP', 'NN', 'I-NP', 'B-protein'), ('receptors', 'receptor', 'NNS', 'I-NP', 'I-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydropathy', 'hydropathy', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('original', 'original', 'JJ', 'I-NP', 'O'), ('cloning', 'cloning', 'NN', 'I-NP', 'O'), ('papers', 'paper', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The detailed steps have been described previously [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('detailed', 'detailed', 'JJ', 'I-NP', 'O'), ('steps', 'step', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	The constrained eLP2 peptide was likely able to adopt an active conformation , which was evidenced by the binding of the peptide to the receptor ligand using fluorescence and CD spectroscopic studies [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('constrained', 'constrain', 'VBN', 'I-NP', 'O'), ('eLP2', 'eLP2', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('likely', 'likely', 'RB', 'B-ADJP', 'O'), ('able', 'able', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('adopt', 'adopt', 'VB', 'I-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('active', 'active', 'JJ', 'I-NP', 'O'), ('conformation', 'conformation', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('evidenced', 'evidence', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('ligand', 'ligand', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('CD', 'CD', 'NN', 'I-NP', 'O'), ('spectroscopic', 'spectroscopic', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The eLP domains of the IP and TP receptors were identified from the hydropathy analysis described by the original cloning papers [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('eLP', 'eLP', 'NN', 'I-NP', 'B-protein'), ('domains', 'domain', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('IP', 'IP', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('TP', 'TP', 'NN', 'I-NP', 'B-protein'), ('receptors', 'receptor', 'NNS', 'I-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydropathy', 'hydropathy', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('original', 'original', 'JJ', 'I-NP', 'O'), ('cloning', 'cloning', 'NN', 'I-NP', 'O'), ('papers', 'paper', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Dynamic studies for the parent NMR structures of the TP eLPs have been described in our recent publication [ CIT ] , in which 20 structural conformations have been generated and used to evaluate the loop folding .	[('Dynamic', 'Dynamic', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('parent', 'parent', 'NN', 'I-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TP', 'TP', 'NN', 'I-NP', 'O'), ('eLPs', 'eLP', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('publication', 'publication', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('20', '20', 'CD', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('conformations', 'conformation', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('generated', 'generate', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('evaluate', 'evaluate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('folding', 'folding', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Limited conformational changes ( rmsd = 1.2 Å ) were observed [ CIT ] .	[('Limited', 'Limit', 'VBN', 'B-NP', 'O'), ('conformational', 'conformational', 'JJ', 'I-NP', 'O'), ('changes', 'change', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('rmsd', 'rmsd', 'NN', 'B-NP', 'O'), ('=', '=', 'SYM', 'B-VP', 'O'), ('1.2', '1.2', 'CD', 'B-NP', 'O'), ('Å', 'Å', 'SYM', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This hypothesis has been supported by our recent NMR spectroscopic studies using a synthetic eLP2 fragment [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('hypothesis', 'hypothesis', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('supported', 'support', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'O'), ('spectroscopic', 'spectroscopic', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('synthetic', 'synthetic', 'JJ', 'I-NP', 'B-DNA'), ('eLP2', 'eLP2', 'NN', 'I-NP', 'I-DNA'), ('fragment', 'fragment', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The NMR structure of iloprost was docked into the pocket of the IP model corresponding to the ligand recognition pocket of the TP receptor as identified by NMR and mutagenesis studies [ CIT ] using Insight II and Discover computation procedures .	[('The', 'The', 'DT', 'B-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('iloprost', 'iloprost', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('docked', 'dock', 'VBN', 'I-VP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pocket', 'pocket', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('IP', 'IP', 'NN', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ligand', 'ligand', 'NN', 'I-NP', 'O'), ('recognition', 'recognition', 'NN', 'I-NP', 'O'), ('pocket', 'pocket', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TP', 'TP', 'NN', 'I-NP', 'B-protein'), ('receptor', 'receptor', 'NN', 'I-NP', 'I-protein'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('identified', 'identify', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('NMR', 'NMR', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('mutagenesis', 'mutagenesis', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('Insight', 'Insight', 'NN', 'B-NP', 'B-protein'), ('II', 'II', 'CD', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('Discover', 'Discover', 'NNP', 'B-NP', 'O'), ('computation', 'computation', 'NN', 'I-NP', 'O'), ('procedures', 'procedure', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	In addition , it has been found that the residues Ala177 and Gln178 in the IP eLP2 fragment could interact with iloprost by our NMR spectroscopic studies [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('Ala177', 'Ala177', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Gln178', 'Gln178', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('IP', 'IP', 'NN', 'I-NP', 'B-DNA'), ('eLP2', 'eLP2', 'NN', 'I-NP', 'I-DNA'), ('fragment', 'fragment', 'NN', 'I-NP', 'I-DNA'), ('could', 'could', 'MD', 'B-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('iloprost', 'iloprost', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'B-protein'), ('spectroscopic', 'spectroscopic', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The secondary structures of this stretch were predicted using a variety of algorithms , including the Chou-Fasman algorithm [ CIT ] , and the SPDBV modality of Deep View .	[('The', 'The', 'DT', 'B-NP', 'O'), ('secondary', 'secondary', 'JJ', 'I-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('stretch', 'stretch', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('predicted', 'predict', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('variety', 'variety', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('algorithms', 'algorithm', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Chou-Fasman', 'Chou-Fasman', 'NN', 'I-NP', 'O'), ('algorithm', 'algorithm', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SPDBV', 'SPDBV', 'NN', 'I-NP', 'O'), ('modality', 'modality', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Deep', 'Deep', 'NNP', 'B-NP', 'O'), ('View', 'View', 'NNP', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	It should be noted here that a well-ordered structure is to be expected in this stretch owing to the fact that earlier biophysical studies suggested the presence of secondary structural elements that can not be accounted for by what is reported in the crystal structure of LV only [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('should', 'should', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('noted', 'note', 'VBN', 'I-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('well-ordered', 'well-ordered', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('expected', 'expect', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('stretch', 'stretch', 'NN', 'I-NP', 'O'), ('owing', 'owe', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('earlier', 'early', 'JJR', 'B-NP', 'O'), ('biophysical', 'biophysical', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('suggested', 'suggest', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('secondary', 'secondary', 'JJ', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('elements', 'element', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('accounted', 'account', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('what', 'what', 'WP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crystal', 'crystal', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LV', 'LV', 'NN', 'B-NP', 'O'), ('only', 'only', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Moreover , the solvent accessibility analysis illustrates that the involved side chains are well shielded form the aqueous medium and can therefore account for an extra stability in the α-domain of B17 that has been previously reported [ CIT ] .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('solvent', 'solvent', 'JJ', 'I-NP', 'O'), ('accessibility', 'accessibility', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('illustrates', 'illustrate', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('involved', 'involve', 'VBN', 'I-NP', 'O'), ('side', 'side', 'NN', 'I-NP', 'O'), ('chains', 'chain', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('well', 'well', 'RB', 'I-VP', 'O'), ('shielded', 'shield', 'VBN', 'B-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('aqueous', 'aqueous', 'JJ', 'I-NP', 'O'), ('medium', 'medium', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('therefore', 'therefore', 'RB', 'I-VP', 'O'), ('account', 'account', 'VB', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('extra', 'extra', 'JJ', 'I-NP', 'O'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α-domain', 'α-domain', 'NN', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('B17', 'B17', 'NN', 'B-NP', 'B-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Electron microscopy studies of intact LDL particles [ CIT ] showed that the N-terminus of apo B has a knob-shaped electron density with dimensions 30 - 45 Å .	[('Electron', 'Electron', 'NN', 'B-NP', 'O'), ('microscopy', 'microscopy', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('intact', 'intact', 'JJ', 'B-NP', 'O'), ('LDL', 'LDL', 'NN', 'I-NP', 'O'), ('particles', 'particle', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-terminus', 'N-terminus', 'NN', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('apo', 'apo', 'NN', 'B-NP', 'B-DNA'), ('B', 'B', 'NN', 'I-NP', 'I-DNA'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('knob-shaped', 'knob-shaped', 'JJ', 'I-NP', 'O'), ('electron', 'electron', 'NN', 'I-NP', 'O'), ('density', 'density', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('dimensions', 'dimension', 'NNS', 'B-NP', 'B-protein'), ('30', '30', 'CD', 'B-NP', 'I-protein'), ('-', '-', 'HYPH', 'I-NP', 'I-protein'), ('45', '45', 'CD', 'I-NP', 'I-protein'), ('Å', 'Å', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
3	Bond angles were found to deviate normally from the reported mean standard values [ CIT ] .	[('Bond', 'Bond', 'NN', 'B-NP', 'O'), ('angles', 'angle', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('deviate', 'deviate', 'VB', 'I-VP', 'O'), ('normally', 'normally', 'RB', 'B-ADVP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('mean', 'mean', 'JJ', 'I-NP', 'O'), ('standard', 'standard', 'JJ', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently , it has been demonstrated in vitro using a crude kinase fraction , that hisactophilin is phosphorylated on threonine ( 95 % ) and on serine residue ( s ) ( 5 % ) [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('crude', 'crude', 'JJ', 'I-NP', 'O'), ('kinase', 'kinase', 'NN', 'I-NP', 'O'), ('fraction', 'fraction', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('hisactophilin', 'hisactophilin', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('threonine', 'threonine', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('95', '95', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('serine', 'serine', 'NN', 'B-NP', 'O'), ('residue', 'residue', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'I-NP', 'O'), ('s', 's', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Three general types of calcium binding sides ( class I to III ) have been described , depending on the positioning of the ligands in the amino acid chain [ CIT ] .	[('Three', 'Three', 'CD', 'B-NP', 'O'), ('general', 'general', 'JJ', 'I-NP', 'O'), ('types', 'type', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('calcium', 'calcium', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('sides', 'side', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('class', 'class', 'NN', 'B-NP', 'O'), ('I', 'I', 'CD', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('III', 'III', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), (',', ',', ',', 'O', 'O'), ('depending', 'depend', 'VBG', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('positioning', 'positioning', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ligands', 'ligand', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'B-protein'), ('acid', 'acid', 'NN', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Recently , the calcium coordination of a soluble form of the ecto-nucleoside triphosphate diphosphorylase I ( CD39 ) , a typical membrane anchored apyrase [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('calcium', 'calcium', 'NN', 'I-NP', 'O'), ('coordination', 'coordination', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('soluble', 'soluble', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ecto-nucleoside', 'ecto-nucleoside', 'JJ', 'I-NP', 'O'), ('triphosphate', 'triphosphate', 'NN', 'I-NP', 'O'), ('diphosphorylase', 'diphosphorylase', 'NN', 'I-NP', 'O'), ('I', 'I', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('CD39', 'CD39', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('typical', 'typical', 'JJ', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('anchored', 'anchor', 'VBD', 'B-VP', 'O'), ('apyrase', 'apyrase', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	At least for lower calcium concentrations it is unlikely that magnesium is substituted by calcium according to the model proposed by Chen and Guidotti [ CIT ] .	[('At', 'At', 'IN', 'B-ADVP', 'O'), ('least', 'least', 'JJS', 'I-ADVP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('calcium', 'calcium', 'NN', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('unlikely', 'unlikely', 'JJ', 'B-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('magnesium', 'magnesium', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('substituted', 'substitute', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('calcium', 'calcium', 'NN', 'B-NP', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('proposed', 'propose', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Chen', 'Chen', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Guidotti', 'Guidotti', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , deletions or mutations of the sequence outside the ACRs 1 and 4 were found to influence the substrate specificity , even if the mutated part of the protein belongs to a membrane spanning region [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('deletions', 'deletion', 'NNS', 'B-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('mutations', 'mutation', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('outside', 'outside', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ACRs', 'ACR', 'NNS', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('influence', 'influence', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('specificity', 'specificity', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('even', 'even', 'RB', 'B-SBAR', 'O'), ('if', 'if', 'IN', 'I-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutated', 'mutate', 'VBN', 'I-NP', 'O'), ('part', 'part', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('belongs', 'belong', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'B-DNA'), ('spanning', 'spanning', 'NN', 'I-NP', 'I-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Further , a parallel kinase reaction was used for phosphoamino acid analyses which confirmed that 124-v-Mos auto-phosphorylation occurred predominantly on serine residues ( fig. 1C ) and a two-dimensional resolution of a tryptic digest of auto-phosphorylated 124-v-Mos showed that three tryptic peptides include auto-phosphorylation target sites ( fig. 1D ) , demonstrating that auto-phosphorylation occurs on multiple sites of the Mos protein [ CIT ] .	[('Further', 'Further', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('parallel', 'parallel', 'JJ', 'I-NP', 'O'), ('kinase', 'kinase', 'NN', 'I-NP', 'O'), ('reaction', 'reaction', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('phosphoamino', 'phosphoamino', 'NN', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('analyses', 'analysis', 'NNS', 'I-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('confirmed', 'confirm', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('124-v-Mos', '124-v-Mos', 'NN', 'B-NP', 'O'), ('auto-phosphorylation', 'auto-phosphorylation', 'NN', 'I-NP', 'O'), ('occurred', 'occur', 'VBD', 'B-VP', 'O'), ('predominantly', 'predominantly', 'RB', 'B-ADVP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('serine', 'serine', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('fig.', 'fig.', 'NN', 'B-NP', 'O'), ('1C', '1C', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('two-dimensional', 'two-dimensional', 'JJ', 'I-NP', 'O'), ('resolution', 'resolution', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('tryptic', 'tryptic', 'JJ', 'I-NP', 'O'), ('digest', 'digest', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('auto-phosphorylated', 'auto-phosphorylated', 'JJ', 'B-NP', 'B-protein'), ('124-v-Mos', '124-v-Mo', 'NNS', 'I-NP', 'I-protein'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('tryptic', 'tryptic', 'JJ', 'I-NP', 'O'), ('peptides', 'peptide', 'NNS', 'I-NP', 'O'), ('include', 'include', 'VBP', 'B-VP', 'O'), ('auto-phosphorylation', 'auto-phosphorylation', 'NN', 'B-NP', 'B-DNA'), ('target', 'target', 'NN', 'I-NP', 'I-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('fig.', 'fig.', 'NN', 'B-NP', 'O'), ('1D', '1D', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('auto-phosphorylation', 'auto-phosphorylation', 'NN', 'B-NP', 'O'), ('occurs', 'occur', 'VBZ', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('multiple', 'multiple', 'JJ', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Mos', 'Mos', 'NNP', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown that 124-v-Mos , derived from mos-transformed fibroblasts , phosphorylates vimentin in vitro [ CIT ] and as presented here in figure 2C , in vitro kinase assays using immunopurified 124-v-mos from Sf9 insect cells showed strong vimentin phosphorylation .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('124-v-Mos', '124-v-Mos', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('derived', 'derive', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('mos-transformed', 'mos-transformed', 'JJ', 'B-NP', 'B-cell_type'), ('fibroblasts', 'fibroblast', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('phosphorylates', 'phosphorylate', 'VBZ', 'B-VP', 'O'), ('vimentin', 'vimentin', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('presented', 'present', 'VBN', 'B-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('figure', 'figure', 'NN', 'B-NP', 'O'), ('2C', '2C', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'FW', 'B-NP', 'O'), ('vitro', 'vitro', 'FW', 'I-NP', 'O'), ('kinase', 'kinase', 'NN', 'I-NP', 'O'), ('assays', 'assay', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('immunopurified', 'immunopurifie', 'VBN', 'B-NP', 'O'), ('124-v-mos', '124-v-mo', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Sf9', 'Sf9', 'NN', 'B-NP', 'B-cell_line'), ('insect', 'insect', 'NN', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('strong', 'strong', 'JJ', 'B-NP', 'O'), ('vimentin', 'vimentin', 'NN', 'I-NP', 'B-protein'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast , tubulin which has been shown to be phosphorylated in vivo and in vitro by Xenopus c-Mos [ CIT ] was not a substrate for 124-v-Mos in vitro ( fig. 2A ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('tubulin', 'tubulin', 'NN', 'B-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('c-Mos', 'c-Mos', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('124-v-Mos', '124-v-Mos', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('fig.', 'fig.', 'FW', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	PTP-1B has been demonstrated to be phosphorylated on multiple sites in a cell cycle specific manner whereby mitotic hyper-phosphorylation occurs , reflected by a protein mobility shift in SDS-PAGE analyses [ CIT ] .	[('PTP-1B', 'PTP-1B', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('phosphorylated', 'phosphorylate', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('multiple', 'multiple', 'JJ', 'B-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('cycle', 'cycle', 'NN', 'I-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('manner', 'manner', 'NN', 'I-NP', 'O'), ('whereby', 'whereby', 'IN', 'B-PP', 'O'), ('mitotic', 'mitotic', 'JJ', 'B-NP', 'O'), ('hyper-phosphorylation', 'hyper-phosphorylation', 'NN', 'I-NP', 'O'), ('occurs', 'occur', 'VBZ', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('reflected', 'reflect', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('mobility', 'mobility', 'NN', 'I-NP', 'O'), ('shift', 'shift', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('SDS-PAGE', 'SDS-PAGE', 'NN', 'B-NP', 'O'), ('analyses', 'analysis', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	We first sought to confirm the findings of Hofmann et al. [ CIT ] in a phospholipid vesicle system that is closer to physiological conditions .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('first', 'first', 'RB', 'B-ADVP', 'O'), ('sought', 'seek', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('confirm', 'confirm', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Hofmann', 'Hofmann', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('phospholipid', 'phospholipid', 'NN', 'I-NP', 'O'), ('vesicle', 'vesicle', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('closer', 'close', 'JJR', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('physiological', 'physiological', 'JJ', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Jurkat T leukemia cells provide a good model system , as they normally have a significant resting membrane potential of about -60 mV ( i.e. , outside positive and inside negative ) [ CIT ] .	[('Jurkat', 'Jurkat', 'NN', 'B-NP', 'B-cell_line'), ('T', 'T', 'NN', 'I-NP', 'I-cell_line'), ('leukemia', 'leukemia', 'NN', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('provide', 'provide', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('good', 'good', 'JJ', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('normally', 'normally', 'RB', 'B-ADVP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('resting', 'rest', 'VBG', 'I-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('about', 'about', 'RB', 'B-NP', 'O'), ('-60', '-60', 'CD', 'I-NP', 'O'), ('mV', 'mV', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('i.e.', 'i.e.', 'FW', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('outside', 'outside', 'IN', 'B-PP', 'O'), ('positive', 'positive', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('inside', 'inside', 'IN', 'B-PP', 'O'), ('negative', 'negative', 'JJ', 'B-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We also considered data from previous structural studies of HHR23A , which showed that UBL-UBA binding is mediated mainly by hydrophobic interactions and that specificity is conferred by the topology of the binding surfaces [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('considered', 'consider', 'VBD', 'B-VP', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HHR23A', 'HHR23A', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('UBL-UBA', 'UBL-UBA', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('mediated', 'mediate', 'VBN', 'I-VP', 'O'), ('mainly', 'mainly', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('specificity', 'specificity', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('conferred', 'confer', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('topology', 'topology', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('surfaces', 'surface', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This result is consistent with previous findings that HHR23A lacking the UBL domain exhibits higher affinity for polyubiquitin chains compared to the full-length protein [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('HHR23A', 'HHR23A', 'NN', 'B-NP', 'B-protein'), ('lacking', 'lack', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('UBL', 'UBL', 'NN', 'I-NP', 'B-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('exhibits', 'exhibit', 'VBZ', 'B-VP', 'O'), ('higher', 'high', 'JJR', 'B-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polyubiquitin', 'polyubiquitin', 'NN', 'B-NP', 'B-protein'), ('chains', 'chain', 'NNS', 'I-NP', 'I-protein'), ('compared', 'compare', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('full-length', 'full-length', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	1-ribosylimidazole-4-acetic acid ( IAA-R ) and 3- ( 3-aminocarboxypropyl ) -uridine ( acp3U ) were previously identified by our research group in human urine with combined LC-IT MS and ESI-TOF MS measurements [ CIT ] .	[('1-ribosylimidazole-4-acetic', '1-ribosylimidazole-4-acetic', 'JJ', 'B-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('IAA-R', 'IAA-R', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('3-', '3-', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('3-aminocarboxypropyl', '3-aminocarboxypropyl', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('-uridine', '-uridine', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('acp3U', 'acp3U', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('research', 'research', 'NN', 'I-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('urine', 'urine', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('combined', 'combine', 'VBN', 'B-NP', 'O'), ('LC-IT', 'LC-IT', 'JJ', 'I-NP', 'O'), ('MS', 'MS', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('ESI-TOF', 'ESI-TOF', 'NN', 'I-NP', 'O'), ('MS', 'MS', 'NN', 'I-NP', 'O'), ('measurements', 'measurement', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	1-ribosyl-pyridin-2-one-5-carboxamide ( 2 , 5-PCNR ) was identified by MALDI-TOF MS analysis [ CIT ] .	[('1-ribosyl-pyridin-2-one-5-carboxamide', '1-ribosyl-pyridin-2-one-5-carboxamide', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('5-PCNR', '5-PCNR', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('MALDI-TOF', 'MALDI-TOF', 'NN', 'B-NP', 'O'), ('MS', 'MS', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The covalent fatty acylation of several signalling proteins with palmitate results promotes their targeting to lipid rafts , plasma membrane microdomains enriched in cholesterol and glycosphingolipids ( reviewed in [ CIT ] ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('covalent', 'covalent', 'JJ', 'I-NP', 'O'), ('fatty', 'fatty', 'JJ', 'I-NP', 'O'), ('acylation', 'acylation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('signalling', 'signalling', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('palmitate', 'palmitate', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('promotes', 'promote', 'VBZ', 'B-VP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('targeting', 'targeting', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('lipid', 'lipid', 'NN', 'B-NP', 'O'), ('rafts', 'raft', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('plasma', 'plasma', 'NN', 'B-NP', 'B-protein'), ('membrane', 'membrane', 'NN', 'I-NP', 'I-protein'), ('microdomains', 'microdomain', 'NNS', 'I-NP', 'I-protein'), ('enriched', 'enrich', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cholesterol', 'cholesterol', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('glycosphingolipids', 'glycosphingolipid', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('reviewed', 'review', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Protein subunits encoding the Gβ5 / R7-RGS / R7BP complex components are expressed in PC12 cells but not in non-neuronal HeLa ( Fig. 1A ) or HEK-293 cells ( not shown ) consistent with previous results [ CIT ] .	[('Protein', 'Protein', 'NN', 'B-NP', 'B-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('encoding', 'encode', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Gβ5', 'Gβ5', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('R7-RGS', 'R7-RGS', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'I-NP', 'O'), ('R7BP', 'R7BP', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('components', 'component', 'NNS', 'I-NP', 'I-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('PC12', 'PC12', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('but', 'but', 'CC', 'B-PP', 'O'), ('not', 'not', 'RB', 'B-PP', 'O'), ('in', 'in', 'IN', 'I-PP', 'O'), ('non-neuronal', 'non-neuronal', 'JJ', 'B-NP', 'O'), ('HeLa', 'HeLa', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('HEK-293', 'HEK-293', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Immunoprecipitation of the transfected epitope-tagged R7BP constructs demonstrated their tight binding to , and co-immunoprecipitation with , endogenous Gβ5 and RGS7 ( Fig. 2A , lower ) , consistent with previous reports employing non-palmitoylated R7BP mutants [ CIT ] .	[('Immunoprecipitation', 'Immunoprecipitation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('transfected', 'transfecte', 'VBN', 'I-NP', 'O'), ('epitope-tagged', 'epitope-tagged', 'JJ', 'I-NP', 'B-DNA'), ('R7BP', 'R7BP', 'NN', 'I-NP', 'I-DNA'), ('constructs', 'construct', 'NNS', 'I-NP', 'I-DNA'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('tight', 'tight', 'JJ', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('co-immunoprecipitation', 'co-immunoprecipitation', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), (',', ',', ',', 'O', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'O'), ('Gβ5', 'Gβ5', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('RGS7', 'RGS7', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lower', 'low', 'JJR', 'B-ADVP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('employing', 'employ', 'VBG', 'B-VP', 'O'), ('non-palmitoylated', 'non-palmitoylated', 'JJ', 'B-NP', 'B-protein'), ('R7BP', 'R7BP', 'NN', 'I-NP', 'I-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These findings are consistent with the previously described subcellular localization of wild-type and non-palmitoylated R7BP mutant proteins expressed in cultured cells and neurons [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('subcellular', 'subcellular', 'JJ', 'I-NP', 'O'), ('localization', 'localization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild-type', 'wild-type', 'JJ', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'I-protein'), ('non-palmitoylated', 'non-palmitoylated', 'JJ', 'I-NP', 'I-protein'), ('R7BP', 'R7BP', 'NN', 'I-NP', 'I-protein'), ('mutant', 'mutant', 'JJ', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('expressed', 'express', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('cultured', 'culture', 'VBN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('and', 'and', 'CC', 'O', 'O'), ('neurons', 'neuron', 'NNS', 'B-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Because the insolubility of dually palmitoylated lipid raft-associated proteins in ice-cold Triton X-100 has been used previously in PC12 cells to define and isolate lipid rafts [ CIT ] , we tested whether transfected R7BP could influence the distribution of endogenous Gβ5 / R7-RGS proteins to these membrane microdomains .	[('Because', 'Because', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('insolubility', 'insolubility', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('dually', 'dually', 'RB', 'B-NP', 'O'), ('palmitoylated', 'palmitoylate', 'VBN', 'I-NP', 'B-protein'), ('lipid', 'lipid', 'NN', 'I-NP', 'I-protein'), ('raft-associated', 'raft-associated', 'JJ', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('ice-cold', 'ice-cold', 'JJ', 'B-NP', 'O'), ('Triton', 'Triton', 'NN', 'I-NP', 'O'), ('X-100', 'X-100', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('PC12', 'PC12', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('to', 'to', 'TO', 'B-VP', 'O'), ('define', 'define', 'VB', 'I-VP', 'O'), ('and', 'and', 'CC', 'I-VP', 'O'), ('isolate', 'isolate', 'VB', 'I-VP', 'O'), ('lipid', 'lipid', 'NN', 'B-NP', 'O'), ('rafts', 'raft', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('tested', 'test', 'VBD', 'B-VP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('transfected', 'transfecte', 'VBN', 'B-NP', 'O'), ('R7BP', 'R7BP', 'NN', 'I-NP', 'B-protein'), ('could', 'could', 'MD', 'B-VP', 'O'), ('influence', 'influence', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('distribution', 'distribution', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('endogenous', 'endogenous', 'JJ', 'B-NP', 'B-protein'), ('Gβ5', 'Gβ5', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('R7-RGS', 'R7-RGS', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'B-protein'), ('microdomains', 'microdomain', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	HEK-293 cells were shown previously to lack significant expression of Gβ5 mRNA and protein [ CIT ] .	[('HEK-293', 'HEK-293', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('lack', 'lack', 'VB', 'I-VP', 'O'), ('significant', 'significant', 'JJ', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Gβ5', 'Gβ5', 'NN', 'B-NP', 'B-RNA'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA'), ('and', 'and', 'CC', 'O', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	ER is known to be permeable to the oxalate anion , commonly employed in studies of 45Ca2+ uptake into the ER in order to increase the 45Ca2+ sequestering capacity of the vesicles and to prolong the linear course of 45Ca2+ accumulation [ CIT ] .	[('ER', 'ER', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('permeable', 'permeable', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('oxalate', 'oxalate', 'NN', 'I-NP', 'O'), ('anion', 'anion', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('commonly', 'commonly', 'RB', 'B-VP', 'O'), ('employed', 'employ', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('studies', 'study', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'B-NP', 'O'), ('uptake', 'uptake', 'NN', 'I-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ER', 'ER', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('increase', 'increase', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'I-NP', 'O'), ('sequestering', 'sequestering', 'NN', 'I-NP', 'O'), ('capacity', 'capacity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('vesicles', 'vesicle', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('prolong', 'prolong', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('linear', 'linear', 'JJ', 'I-NP', 'O'), ('course', 'course', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'B-NP', 'O'), ('accumulation', 'accumulation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In addition , the following consideration argues strongly for the amounts of 45Ca2+ retained in the vesicles reflecting almost exclusively the formation of the insoluble precipitate , with no possibility of passive leak : given the solubility product of Ca2+-oxalate of approximately 2 × 10-9 M [ CIT ] , already at 10 mM lumenal oxalate one would reach a maximal concentration of free 45Ca2+ in the lumen equal to the employed extravesicular free 45Ca2+ ( 0.2 μM ) , with no 45Ca2+ gradient available for a leak pathway .	[('In', 'In', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('following', 'following', 'JJ', 'I-NP', 'O'), ('consideration', 'consideration', 'NN', 'I-NP', 'O'), ('argues', 'argue', 'VBZ', 'B-VP', 'O'), ('strongly', 'strongly', 'RB', 'B-ADVP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amounts', 'amount', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'B-NP', 'O'), ('retained', 'retain', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('vesicles', 'vesicle', 'NNS', 'I-NP', 'O'), ('reflecting', 'reflect', 'VBG', 'B-VP', 'O'), ('almost', 'almost', 'RB', 'B-ADVP', 'O'), ('exclusively', 'exclusively', 'RB', 'I-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('insoluble', 'insoluble', 'JJ', 'I-NP', 'O'), ('precipitate', 'precipitate', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('passive', 'passive', 'JJ', 'B-NP', 'O'), ('leak', 'leak', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('given', 'give', 'VBN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('solubility', 'solubility', 'NN', 'I-NP', 'B-protein'), ('product', 'product', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ca2+-oxalate', 'Ca2+-oxalate', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('×', '×', 'IN', 'I-NP', 'O'), ('10-9', '10-9', 'CD', 'I-NP', 'O'), ('M', 'M', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('already', 'already', 'RB', 'B-ADVP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('10', '10', 'CD', 'B-NP', 'O'), ('mM', 'mM', 'NN', 'I-NP', 'O'), ('lumenal', 'lumenal', 'JJ', 'I-NP', 'O'), ('oxalate', 'oxalate', 'NN', 'I-NP', 'O'), ('one', 'one', 'PRP', 'B-NP', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('reach', 'reach', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('maximal', 'maximal', 'JJ', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('free', 'free', 'JJ', 'B-NP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lumen', 'lumen', 'NN', 'I-NP', 'O'), ('equal', 'equal', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('employed', 'employ', 'VBN', 'I-NP', 'O'), ('extravesicular', 'extravesicular', 'JJ', 'I-NP', 'O'), ('free', 'free', 'JJ', 'I-NP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('0.2', '0.2', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('45Ca2+', '45Ca2+', 'NN', 'I-NP', 'O'), ('gradient', 'gradient', 'NN', 'I-NP', 'O'), ('available', 'available', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('leak', 'leak', 'NN', 'I-NP', 'O'), ('pathway', 'pathway', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Recently we have confirmed this UPR-inducing effect of EGTA in PC12 cells by demonstrating an increase in GRP78 ( BiP ) mRNA [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('UPR-inducing', 'UPR-inducing', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EGTA', 'EGTA', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('PC12', 'PC12', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('by', 'by', 'IN', 'B-PP', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('GRP78', 'GRP78', 'NN', 'B-NP', 'B-RNA'), ('(', '(', '(', 'O', 'I-RNA'), ('BiP', 'BiP', 'NN', 'B-NP', 'I-RNA'), (')', ')', ')', 'O', 'I-RNA'), ('mRNA', 'mRNA', 'NN', 'B-NP', 'I-RNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Indeed , some studies have routinely included DTT in SERCA isolation buffers to prevent such loss of activity [ CIT ] .	[('Indeed', 'Indeed', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('routinely', 'routinely', 'RB', 'I-VP', 'O'), ('included', 'include', 'VBN', 'I-VP', 'O'), ('DTT', 'DTT', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('SERCA', 'SERCA', 'NN', 'B-NP', 'B-protein'), ('isolation', 'isolation', 'NN', 'I-NP', 'O'), ('buffers', 'buffer', 'VBZ', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('prevent', 'prevent', 'VB', 'I-VP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('loss', 'loss', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('activity', 'activity', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This result is consistent with the DTT-mediated induction of SERCA mRNA increase in the treated cells within the first 4 hours , similar to the known time course of the induction of mRNA for some of the ER stress proteins [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DTT-mediated', 'DTT-mediated', 'JJ', 'I-NP', 'O'), ('induction', 'induction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('SERCA', 'SERCA', 'NN', 'B-NP', 'B-RNA'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('treated', 'treat', 'VBN', 'I-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('hours', 'hour', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('time', 'time', 'NN', 'I-NP', 'O'), ('course', 'course', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('induction', 'induction', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mRNA', 'mRNA', 'NN', 'B-NP', 'B-RNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ER', 'ER', 'NN', 'I-NP', 'B-protein'), ('stress', 'stress', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	The NIPP1 peptide ( RPKRKRKNSRVTFSEDDEII ) readily displaced PP1 regulatory subunits ( data not shown ) , yet we chose to continue working with the ZAP peptide ( GKKRVRWADLE , later also referred to as RVRW peptide ) because it is small , readily soluble and an excellent match to the optimal PP1 binding peptide discovered through panning a random peptide library [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('NIPP1', 'NIPP1', 'NN', 'I-NP', 'B-protein'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('RPKRKRKNSRVTFSEDDEII', 'RPKRKRKNSRVTFSEDDEII', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('readily', 'readily', 'RB', 'B-ADVP', 'O'), ('displaced', 'displace', 'VBD', 'B-VP', 'O'), ('PP1', 'PP1', 'NN', 'B-NP', 'B-protein'), ('regulatory', 'regulatory', 'JJ', 'I-NP', 'I-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('yet', 'yet', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('chose', 'choose', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('continue', 'continue', 'VB', 'I-VP', 'O'), ('working', 'work', 'VBG', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ZAP', 'ZAP', 'NN', 'I-NP', 'B-protein'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('GKKRVRWADLE', 'GKKRVRWADLE', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('later', 'later', 'RB', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('referred', 'refer', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('RVRW', 'RVRW', 'NN', 'B-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('small', 'small', 'JJ', 'B-ADJP', 'O'), (',', ',', ',', 'O', 'O'), ('readily', 'readily', 'RB', 'B-ADJP', 'O'), ('soluble', 'soluble', 'JJ', 'I-ADJP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('excellent', 'excellent', 'JJ', 'I-NP', 'O'), ('match', 'match', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('optimal', 'optimal', 'JJ', 'I-NP', 'O'), ('PP1', 'PP1', 'NN', 'I-NP', 'B-protein'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('discovered', 'discover', 'VBN', 'B-VP', 'O'), ('through', 'through', 'IN', 'B-PP', 'O'), ('panning', 'pan', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('random', 'random', 'JJ', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('library', 'library', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Analysis of the sequences using the program NetOGlyc 2.0 ( ) [ CIT ] to reveal potential GalNAc O-glycosylation sites found 5 sites in EAA08760.1 , 7 sites in EAA08763.1 , and 6 sites in EAA08929.1 .	[('Analysis', 'Analysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ('NetOGlyc', 'NetOGlyc', 'NN', 'I-NP', 'O'), ('2.0', '2.0', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('reveal', 'reveal', 'VB', 'I-VP', 'O'), ('potential', 'potential', 'JJ', 'B-NP', 'O'), ('GalNAc', 'GalNAc', 'NN', 'I-NP', 'B-DNA'), ('O-glycosylation', 'O-glycosylation', 'NN', 'I-NP', 'I-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('5', '5', 'CD', 'B-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08760.1', 'EAA08760.1', 'NN', 'B-NP', 'B-cell_line'), (',', ',', ',', 'O', 'O'), ('7', '7', 'CD', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08763.1', 'EAA08763.1', 'NN', 'B-NP', 'B-cell_line'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('6', '6', 'CD', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08929.1', 'EAA08929.1', 'NN', 'B-NP', 'B-cell_line'), ('.', '.', '.', 'O', 'O')]
1	Analysis of the sequences using NetNGlyc 1.0 ( ) [ CIT ] to reveal potential N-glycosylation sites found 2 sites in EAA08760.1 , 8 sites in EAA08763.1 , and 3 sites in EAA08929.1 .	[('Analysis', 'Analysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('NetNGlyc', 'NetNGlyc', 'NN', 'B-NP', 'O'), ('1.0', '1.0', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('reveal', 'reveal', 'VB', 'I-VP', 'O'), ('potential', 'potential', 'JJ', 'B-NP', 'O'), ('N-glycosylation', 'N-glycosylation', 'NN', 'I-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('2', '2', 'CD', 'B-NP', 'B-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08760.1', 'EAA08760.1', 'NN', 'B-NP', 'B-cell_line'), (',', ',', ',', 'O', 'O'), ('8', '8', 'CD', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08763.1', 'EAA08763.1', 'NN', 'B-NP', 'B-cell_line'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('EAA08929.1', 'EAA08929.1', 'NN', 'B-NP', 'B-cell_line'), ('.', '.', '.', 'O', 'O')]
1	Another protein BLAST search was performed using the sequence of a known conserved region for aminopeptidases ( MAAVPDFSAGAMENWGLL ) [ CIT ] , which yielded 16 homologous proteins from the An. gambiae genomic database ( Table 2 ) .	[('Another', 'Another', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('BLAST', 'BLAST', 'NN', 'I-NP', 'O'), ('search', 'search', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('known', 'know', 'VBN', 'I-NP', 'O'), ('conserved', 'conserve', 'VBN', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('aminopeptidases', 'aminopeptidas', 'NNS', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('MAAVPDFSAGAMENWGLL', 'MAAVPDFSAGAMENWGLL', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('yielded', 'yield', 'VBD', 'B-VP', 'B-protein'), ('16', '16', 'CD', 'B-NP', 'I-protein'), ('homologous', 'homologous', 'JJ', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('An.', 'An.', 'NNP', 'I-NP', 'O'), ('gambiae', 'gambiae', 'VB', 'B-VP', 'O'), ('genomic', 'genomic', 'JJ', 'B-NP', 'O'), ('database', 'database', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have already demonstrated that these regions are not essential for the catalytic activity [ CIT ] , which retain their catalytic activity upon modification .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('already', 'already', 'RB', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('regions', 'region', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('essential', 'essential', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('retain', 'retain', 'VBP', 'B-VP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('modification', 'modification', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	In some FTFs it has been demonstrated the C-terminal region is responsible for anchoring the enzyme to the cell by means of the LPXTG motif [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('FTFs', 'FTF', 'NNS', 'I-NP', 'B-protein'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C-terminal', 'C-terminal', 'JJ', 'I-NP', 'B-protein'), ('region', 'region', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('responsible', 'responsible', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('anchoring', 'anchor', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('means', 'mean', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('LPXTG', 'LPXTG', 'NN', 'I-NP', 'B-DNA'), ('motif', 'motif', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Through deletions within the C terminus of this enzyme , Rathsam and Jacques [ CIT ] , implicated both the hydrophobic and the PGST-rich wall-associated domains in stabilizing the enzyme on the cell surface .	[('Through', 'Through', 'IN', 'B-PP', 'O'), ('deletions', 'deletion', 'NNS', 'B-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'B-protein'), ('terminus', 'terminus', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'I-NP', 'O'), ('Rathsam', 'Rathsam', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Jacques', 'Jacque', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('implicated', 'implicate', 'VBD', 'B-VP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrophobic', 'hydrophobic', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PGST-rich', 'PGST-rich', 'JJ', 'I-NP', 'B-protein'), ('wall-associated', 'wall-associated', 'JJ', 'I-NP', 'I-protein'), ('domains', 'domain', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('stabilizing', 'stabilize', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	The kinase responsible for this phosphorylation during splicing catalysis has not been characterised to date , but Seghezzi et al. [ CIT ] have identified SF3b1 as a potential target of cyclin E / CDK2 complexes .	[('The', 'The', 'DT', 'B-NP', 'O'), ('kinase', 'kinase', 'NN', 'I-NP', 'B-protein'), ('responsible', 'responsible', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('during', 'during', 'IN', 'B-PP', 'O'), ('splicing', 'splicing', 'NN', 'B-NP', 'O'), ('catalysis', 'catalysis', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('characterised', 'characterise', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('date', 'date', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('Seghezzi', 'Seghezzi', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('SF3b1', 'SF3b1', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('potential', 'potential', 'JJ', 'I-NP', 'O'), ('target', 'target', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cyclin', 'cyclin', 'NN', 'B-NP', 'B-protein'), ('E', 'E', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('CDK2', 'CDK2', 'NN', 'I-NP', 'I-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	Previous work [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('work', 'work', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Salzer et al. recently reported the presence of the 47 kDa isoform of annexin A7 and its partner sorcin in micro- and nanovesicles derived from red blood cells where they are located in the lumen and are also enriched in membrane rafts [ CIT ] .	[('Salzer', 'Salzer', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('recently', 'recently', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('47', '47', 'CD', 'I-NP', 'B-protein'), ('kDa', 'kDa', 'NN', 'I-NP', 'I-protein'), ('isoform', 'isoform', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('annexin', 'annexin', 'NN', 'B-NP', 'B-protein'), ('A7', 'A7', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('partner', 'partner', 'NN', 'I-NP', 'O'), ('sorcin', 'sorcin', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('micro-', 'micro-', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('nanovesicles', 'nanovesicle', 'NNS', 'I-NP', 'O'), ('derived', 'derive', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('red', 'red', 'JJ', 'B-NP', 'B-cell_type'), ('blood', 'blood', 'NN', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('located', 'located', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lumen', 'lumen', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('enriched', 'enrich', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('membrane', 'membrane', 'NN', 'B-NP', 'O'), ('rafts', 'raft', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	This could reflect the binding of annexin A7 to membrane subdomains that have different lipid or lipid / protein composition as discussed by Salzer et al. [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('reflect', 'reflect', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('annexin', 'annexin', 'NN', 'B-NP', 'B-protein'), ('A7', 'A7', 'NN', 'I-NP', 'I-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('membrane', 'membrane', 'NN', 'B-NP', 'B-protein'), ('subdomains', 'subdomain', 'NNS', 'I-NP', 'I-protein'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('lipid', 'lipid', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('lipid', 'lipid', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('composition', 'composition', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('discussed', 'discuss', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Salzer', 'Salzer', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Furthermore we found that murine platelets responded immediately to the initiating chemical whereas human platelets have a lag phase [ CIT ] .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('murine', 'murine', 'JJ', 'B-NP', 'B-cell_type'), ('platelets', 'platelet', 'NNS', 'I-NP', 'I-cell_type'), ('responded', 'respond', 'VBD', 'B-VP', 'O'), ('immediately', 'immediately', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('initiating', 'initiate', 'VBG', 'I-NP', 'O'), ('chemical', 'chemical', 'NN', 'I-NP', 'O'), ('whereas', 'whereas', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-cell_type'), ('platelets', 'platelet', 'NNS', 'I-NP', 'I-cell_type'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('lag', 'lag', 'NN', 'I-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	A comparison of the putative extra exon in the mouse CD147 gene against the genomic sequence of human CD147 using pairwise BLAST [ CIT ] revealed a corresponding region .	[('A', 'A', 'DT', 'B-NP', 'O'), ('comparison', 'comparison', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('extra', 'extra', 'JJ', 'I-NP', 'O'), ('exon', 'exon', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mouse', 'mouse', 'NN', 'I-NP', 'B-DNA'), ('CD147', 'CD147', 'NN', 'I-NP', 'I-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('against', 'against', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('genomic', 'genomic', 'JJ', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-protein'), ('CD147', 'CD147', 'NN', 'I-NP', 'I-protein'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('pairwise', 'pairwise', 'JJ', 'B-NP', 'O'), ('BLAST', 'BLAST', 'NN', 'I-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('corresponding', 'corresponding', 'JJ', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently Ochrietor et al. [ CIT ] have shown that this three domain form is present in mouse , rat , human , chicken and zebrafish retina pointing to the importance of this isoform .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), ('Ochrietor', 'Ochrietor', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('domain', 'domain', 'NN', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('present', 'present', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('chicken', 'chicken', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('zebrafish', 'zebrafish', 'NN', 'I-NP', 'O'), ('retina', 'retina', 'NN', 'I-NP', 'O'), ('pointing', 'point', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('importance', 'importance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('isoform', 'isoform', 'NN', 'I-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
2	As the three domain form of neuroplastin np65 but not the two domain form , had been shown to interact homophilically [ CIT ] we tested to see if the three domain form of CD147 interacted homophilically by surface plasmon resonance using a BIAcore .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('domain', 'domain', 'NN', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('neuroplastin', 'neuroplastin', 'NN', 'B-NP', 'B-protein'), ('np65', 'np65', 'NN', 'I-NP', 'I-protein'), ('but', 'but', 'CC', 'B-NP', 'O'), ('not', 'not', 'RB', 'I-NP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('two', 'two', 'CD', 'I-NP', 'O'), ('domain', 'domain', 'NN', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('interact', 'interact', 'VB', 'I-VP', 'O'), ('homophilically', 'homophilically', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('tested', 'test', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('see', 'see', 'VB', 'I-VP', 'O'), ('if', 'if', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('domain', 'domain', 'NN', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CD147', 'CD147', 'NN', 'B-NP', 'B-protein'), ('interacted', 'interact', 'VBD', 'B-VP', 'O'), ('homophilically', 'homophilically', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('surface', 'surface', 'NN', 'B-NP', 'O'), ('plasmon', 'plasmon', 'NN', 'I-NP', 'O'), ('resonance', 'resonance', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('BIAcore', 'BIAcore', 'NN', 'I-NP', 'B-DNA'), ('.', '.', '.', 'O', 'O')]
2	Previous analysis on the CD150 homophilic interaction had established methods to do this taking the fluid phase and immobilized interactions into account [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CD150', 'CD150', 'NN', 'I-NP', 'B-protein'), ('homophilic', 'homophilic', 'JJ', 'I-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('established', 'establish', 'VBN', 'I-VP', 'O'), ('methods', 'method', 'NNS', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('do', 'do', 'VB', 'I-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('taking', 'take', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fluid', 'fluid', 'NN', 'I-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('immobilized', 'immobilize', 'VBN', 'B-VP', 'O'), ('interactions', 'interaction', 'NNS', 'B-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('account', 'account', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The resultant concentration of immobilized CD147 Af is slightly higher than that calculated ( 121 μM ) using equation 14 [ CIT ] and an experimentally determined value for P of 5.8 .	[('The', 'The', 'DT', 'B-NP', 'O'), ('resultant', 'resultant', 'JJ', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('immobilized', 'immobilize', 'VBN', 'B-NP', 'O'), ('CD147', 'CD147', 'NN', 'I-NP', 'B-protein'), ('Af', 'Af', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('slightly', 'slightly', 'RB', 'B-ADJP', 'O'), ('higher', 'high', 'JJR', 'I-ADJP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('calculated', 'calculate', 'VBN', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('121', '121', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('equation', 'equation', 'NN', 'B-NP', 'O'), ('14', '14', 'CD', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('experimentally', 'experimentally', 'RB', 'I-NP', 'O'), ('determined', 'determine', 'VBN', 'I-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('P', 'P', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('5.8', '5.8', 'CD', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	A substitution mutation in Myc Box II , W135E , which was previously shown to have diminished interaction with TRRAP and diminished transformation activity [ CIT ] , has a robust response to increasing TBP .	[('A', 'A', 'DT', 'B-NP', 'O'), ('substitution', 'substitution', 'NN', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Myc', 'Myc', 'NNP', 'B-NP', 'B-protein'), ('Box', 'Box', 'NNP', 'I-NP', 'O'), ('II', 'II', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('W135E', 'W135E', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('have', 'have', 'VB', 'I-VP', 'O'), ('diminished', 'diminish', 'VBN', 'I-VP', 'O'), ('interaction', 'interaction', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('TRRAP', 'TRRAP', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('diminished', 'diminish', 'VBD', 'B-VP', 'O'), ('transformation', 'transformation', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('robust', 'robust', 'JJ', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('increasing', 'increase', 'VBG', 'B-NP', 'O'), ('TBP', 'TBP', 'NN', 'I-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
2	Since TBP was shown to be limiting for TATA-dependent but not InR-dependent transcription [ CIT ] , we sought to determine whether GAL4-Myc cooperation with TBP requires the TATA element .	[('Since', 'Since', 'IN', 'B-SBAR', 'O'), ('TBP', 'TBP', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('limiting', 'limit', 'VBG', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('TATA-dependent', 'TATA-dependent', 'JJ', 'B-ADJP', 'O'), ('but', 'but', 'CC', 'B-CONJP', 'O'), ('not', 'not', 'RB', 'I-CONJP', 'O'), ('InR-dependent', 'InR-dependent', 'JJ', 'B-NP', 'O'), ('transcription', 'transcription', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('sought', 'seek', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('whether', 'whether', 'IN', 'B-SBAR', 'O'), ('GAL4-Myc', 'GAL4-Myc', 'NN', 'B-NP', 'O'), ('cooperation', 'cooperation', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('TBP', 'TBP', 'NN', 'B-NP', 'B-protein'), ('requires', 'require', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TATA', 'TATA', 'NN', 'I-NP', 'B-DNA'), ('element', 'element', 'NN', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
2	Others and we have shown that c-Myc regulation of the AdML is biphasic with transactivation followed by transrepression at high levels of input Myc plasmids [ CIT ] .	[('Others', 'Other', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('c-Myc', 'c-Myc', 'NN', 'B-NP', 'B-protein'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('AdML', 'AdML', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('biphasic', 'biphasic', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('transactivation', 'transactivation', 'NN', 'B-NP', 'O'), ('followed', 'follow', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('transrepression', 'transrepression', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('input', 'input', 'NN', 'B-NP', 'B-DNA'), ('Myc', 'Myc', 'NN', 'I-NP', 'I-DNA'), ('plasmids', 'plasmid', 'NNS', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This result confirmed previous observations indicating that Hat1p is localized to both the cytoplasm and the nucleus [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('confirmed', 'confirm', 'VBD', 'B-VP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Hat1p', 'Hat1p', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('localized', 'localized', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytoplasm', 'cytoplasm', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nucleus', 'nucleus', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	More recently , the complete genome sequences of T. acidophilum [ CIT ] have been reported .	[('More', 'More', 'RBR', 'B-ADVP', 'O'), ('recently', 'recently', 'RB', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('complete', 'complete', 'JJ', 'I-NP', 'O'), ('genome', 'genome', 'NN', 'I-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('T.', 'T.', 'NN', 'B-NP', 'O'), ('acidophilum', 'acidophilum', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
7	Using PSI-BLAST [ CIT ] with different inteins as seeds , divergent inteins with less than ten percent sequence identity as compared to the query sequence are recovered ( data not shown ) ; however , using this approach we did not discover any additional intein or homing endonuclease encoding genes in T. acidophilum .	[('Using', 'Use', 'VBG', 'B-VP', 'O'), ('PSI-BLAST', 'PSI-BLAST', 'NN', 'B-NP', 'B-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('different', 'different', 'JJ', 'B-NP', 'O'), ('inteins', 'intein', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('seeds', 'seed', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('divergent', 'divergent', 'JJ', 'B-NP', 'O'), ('inteins', 'intein', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('less', 'less', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('ten', 'ten', 'CD', 'I-NP', 'O'), ('percent', 'percent', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('compared', 'compare', 'VBN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('query', 'query', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('recovered', 'recover', 'VBN', 'I-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('data', 'datum', 'NNS', 'B-NP', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('discover', 'discover', 'VB', 'I-VP', 'O'), ('any', 'any', 'DT', 'B-NP', 'O'), ('additional', 'additional', 'JJ', 'I-NP', 'O'), ('intein', 'intein', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('homing', 'homing', 'JJ', 'B-NP', 'O'), ('endonuclease', 'endonuclease', 'NN', 'I-NP', 'B-protein'), ('encoding', 'encode', 'VBG', 'B-VP', 'O'), ('genes', 'gene', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('T.', 'T.', 'NN', 'B-NP', 'O'), ('acidophilum', 'acidophilum', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The significance of the match between the T. acidophilum and the three pyrococcal ATPase inteins was assessed using PRSS at [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('significance', 'significance', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('match', 'match', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('T.', 'T.', 'NNP', 'I-NP', 'O'), ('acidophilum', 'acidophilum', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('pyrococcal', 'pyrococcal', 'JJ', 'I-NP', 'B-protein'), ('ATPase', 'ATPase', 'NN', 'I-NP', 'I-protein'), ('inteins', 'intein', 'NNS', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('assessed', 'assess', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('PRSS', 'PRSS', 'NN', 'B-NP', 'B-DNA'), ('at', 'at', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The structure of the bovine mitochondrial F1-ATPase has been determined by X-ray crystallography [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('bovine', 'bovine', 'JJ', 'I-NP', 'B-protein'), ('mitochondrial', 'mitochondrial', 'JJ', 'I-NP', 'I-protein'), ('F1-ATPase', 'F1-ATPase', 'NN', 'I-NP', 'I-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('X-ray', 'X-ray', 'NN', 'B-NP', 'O'), ('crystallography', 'crystallography', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	So far , most consistent data are available for rat brain [ CIT ] , while less is known about the subcellular localization in rat liver .	[('So', 'So', 'RB', 'B-ADVP', 'O'), ('far', 'far', 'RB', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('most', 'most', 'RBS', 'B-NP', 'O'), ('consistent', 'consistent', 'JJ', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('available', 'available', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('brain', 'brain', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('less', 'less', 'JJR', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('about', 'about', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('subcellular', 'subcellular', 'JJ', 'I-NP', 'O'), ('localization', 'localization', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('liver', 'liver', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	With regard to TPP , its content in rat brain is reported to be highest in mitochondrial and synaptosomal fractions [ CIT ] most TPP is reported as cytosolic .	[('With', 'With', 'IN', 'B-PP', 'O'), ('regard', 'regard', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('TPP', 'TPP', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('content', 'content', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('brain', 'brain', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('highest', 'high', 'JJS', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mitochondrial', 'mitochondrial', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('synaptosomal', 'synaptosomal', 'JJ', 'I-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('most', 'most', 'JJS', 'B-NP', 'O'), ('TPP', 'TPP', 'NN', 'I-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('cytosolic', 'cytosolic', 'JJ', 'B-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
3	The latter value is comparable with previously published data [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('latter', 'latter', 'JJ', 'I-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('comparable', 'comparable', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	When analyzing subcellular fractions of rat liver , about 50 % of the TPP was recovered in the cytosol ( Figure 2A ) , which is also in agreement with previous data [ CIT ] .	[('When', 'When', 'WRB', 'B-ADVP', 'O'), ('analyzing', 'analyze', 'VBG', 'B-VP', 'O'), ('subcellular', 'subcellular', 'JJ', 'B-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('rat', 'rat', 'NN', 'B-NP', 'O'), ('liver', 'liver', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('about', 'about', 'RB', 'B-NP', 'O'), ('50', '50', 'CD', 'I-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('TPP', 'TPP', 'NN', 'I-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('recovered', 'recover', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytosol', 'cytosol', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('2A', '2A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	As expected [ CIT ] , HACL1 was also recovered in the peroxisomal fractions ( Figure 3B ) .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('expected', 'expect', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('HACL1', 'HACL1', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('recovered', 'recover', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('peroxisomal', 'peroxisomal', 'JJ', 'I-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3B', '3B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is in accordance with previous results [ CIT ] and with computer-based prediction studies , which show no peroxisome targeting signal in the primary amino acid sequence of mammalian TPK .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('accordance', 'accordance', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('computer-based', 'computer-based', 'JJ', 'B-NP', 'O'), ('prediction', 'prediction', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('show', 'show', 'VBP', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('peroxisome', 'peroxisome', 'NN', 'I-NP', 'O'), ('targeting', 'target', 'VBG', 'B-VP', 'O'), ('signal', 'signal', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('primary', 'primary', 'JJ', 'I-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mammalian', 'mammalian', 'JJ', 'B-NP', 'B-protein'), ('TPK', 'TPK', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
2	In human mitochondria , Song and Singleton [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Song', 'Song', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Singleton', 'Singleton', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
8	So far , evidence for functional transporters in mammalian peroxisomes is limited to ATP [ CIT ] .	[('So', 'So', 'RB', 'B-ADVP', 'O'), ('far', 'far', 'RB', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('evidence', 'evidence', 'NN', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('functional', 'functional', 'JJ', 'B-NP', 'O'), ('transporters', 'transporter', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mammalian', 'mammalian', 'JJ', 'B-NP', 'B-protein'), ('peroxisomes', 'peroxisome', 'NNS', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('limited', 'limit', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('ATP', 'ATP', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	It follows that the enzyme is homotrimer like the riboflavin synthases of B. subtilis and E. coli [ CIT ] and that the quaternary structure is not affected by binding of the substrate analog .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('follows', 'follow', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('homotrimer', 'homotrimer', 'NN', 'B-NP', 'O'), ('like', 'like', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('riboflavin', 'riboflavin', 'NN', 'I-NP', 'B-protein'), ('synthases', 'synthas', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('B.', 'B.', 'NNP', 'B-NP', 'O'), ('subtilis', 'subtilis', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('quaternary', 'quaternary', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('affected', 'affect', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('binding', 'binding', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('analog', 'analog', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Protein perturbation studies monitored by 19F NMR had been performed earlier with riboflavin synthases from B. subtilis and E. coli and had shown surprising multiplicities of signals for enzyme-bound ligands [ CIT ] .	[('Protein', 'Protein', 'NN', 'B-NP', 'O'), ('perturbation', 'perturbation', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('monitored', 'monitor', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('19F', '19F', 'NN', 'B-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('earlier', 'earlier', 'RBR', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('riboflavin', 'riboflavin', 'NN', 'B-NP', 'B-protein'), ('synthases', 'synthas', 'NNS', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('B.', 'B.', 'NNP', 'B-NP', 'O'), ('subtilis', 'subtilis', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('surprising', 'surprising', 'JJ', 'B-NP', 'O'), ('multiplicities', 'multiplicity', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('signals', 'signal', 'NNS', 'B-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('enzyme-bound', 'enzyme-bound', 'JJ', 'B-NP', 'O'), ('ligands', 'ligand', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similarly , an artificial N-terminal domain of E. coli riboflavin synthase which forms a c2 symmetric homodimer showed single lines for each trifluoromethyl group of trifluoromethylsubstituted lumazine derivatives [ CIT ] .	[('Similarly', 'Similarly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('artificial', 'artificial', 'JJ', 'I-NP', 'B-protein'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'FW', 'B-NP', 'B-protein'), ('coli', 'coli', 'FW', 'I-NP', 'I-protein'), ('riboflavin', 'riboflavin', 'NN', 'I-NP', 'I-protein'), ('synthase', 'synthase', 'NN', 'I-NP', 'I-protein'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('forms', 'form', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('c2', 'c2', 'NN', 'I-NP', 'B-protein'), ('symmetric', 'symmetric', 'JJ', 'I-NP', 'I-protein'), ('homodimer', 'homodimer', 'NN', 'I-NP', 'I-protein'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('single', 'single', 'JJ', 'B-NP', 'O'), ('lines', 'line', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('trifluoromethyl', 'trifluoromethyl', 'NN', 'I-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('trifluoromethylsubstituted', 'trifluoromethylsubstitute', 'VBN', 'B-NP', 'O'), ('lumazine', 'lumazine', 'NN', 'I-NP', 'O'), ('derivatives', 'derivative', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The physiological NADH oxidase activity of the parental strain was inhibited by 52 % by annonin VI , which selectively blocks complex I ( Table 1 ) , as observed with other E. coli strains [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('physiological', 'physiological', 'JJ', 'I-NP', 'O'), ('NADH', 'NADH', 'NN', 'I-NP', 'O'), ('oxidase', 'oxidase', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('parental', 'parental', 'JJ', 'I-NP', 'O'), ('strain', 'strain', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('inhibited', 'inhibit', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('52', '52', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('annonin', 'annonin', 'NN', 'B-NP', 'O'), ('VI', 'VI', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('selectively', 'selectively', 'RB', 'B-ADVP', 'O'), ('blocks', 'block', 'VBZ', 'B-VP', 'O'), ('complex', 'complex', 'NN', 'B-NP', 'B-protein'), ('I', 'I', 'CD', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('strains', 'strain', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	No NADH / ferricyanide oxidoreductase activity was detected in fractions 7 to 10 corresponding to the position of a soluble fragment of the complex [ CIT ] , indicating that the complex from the deletion strain did not disintegrate .	[('No', 'No', 'DT', 'B-NP', 'O'), ('NADH', 'NADH', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('ferricyanide', 'ferricyanide', 'NN', 'I-NP', 'B-protein'), ('oxidoreductase', 'oxidoreductase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('detected', 'detect', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('fractions', 'fraction', 'NNS', 'B-NP', 'O'), ('7', '7', 'CD', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('10', '10', 'CD', 'B-NP', 'O'), ('corresponding', 'correspond', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('position', 'position', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('soluble', 'soluble', 'JJ', 'I-NP', 'O'), ('fragment', 'fragment', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('complex', 'complex', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('complex', 'complex', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('deletion', 'deletion', 'NN', 'I-NP', 'O'), ('strain', 'strain', 'NN', 'I-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('disintegrate', 'disintegrate', 'VB', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Complex I isolated from the parental and the deletion strain was reactivated by addition of phospholipids as described [ CIT ] .	[('Complex', 'Complex', 'NN', 'B-NP', 'B-protein'), ('I', 'I', 'PRP', 'B-NP', 'I-protein'), ('isolated', 'isolate', 'VBD', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('parental', 'parental', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('deletion', 'deletion', 'NN', 'I-NP', 'O'), ('strain', 'strain', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reactivated', 'reactivate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('phospholipids', 'phospholipid', 'NNS', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is similar to the rate obtained with the complex from other E. coli strains [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rate', 'rate', 'NN', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('complex', 'complex', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('strains', 'strain', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The subunits NuoE and J were not separated by SDS-PAGE as reported previously [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('subunits', 'subunit', 'NNS', 'I-NP', 'O'), ('NuoE', 'NuoE', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('J', 'J', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('separated', 'separate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('SDS-PAGE', 'SDS-PAGE', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown that recombinant CyaY can bind eight Fe3+ [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('recombinant', 'recombinant', 'JJ', 'B-NP', 'O'), ('CyaY', 'CyaY', 'NN', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('eight', 'eight', 'CD', 'B-NP', 'O'), ('Fe3+', 'Fe3+', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	Fortunately , Kao and Davis ( 1994 ) [ CIT ] had previously purified and characterised the porcine L-threonine dehydrogenase protein , that they had isolated from liver mitochondria and partially peptide , sequenced .	[('Fortunately', 'Fortunately', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Kao', 'Kao', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Davis', 'Davis', 'NNP', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('1994', '1994', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('purified', 'purify', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('characterised', 'characterise', 'VBN', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('porcine', 'porcine', 'JJ', 'I-NP', 'B-protein'), ('L-threonine', 'L-threonine', 'NN', 'I-NP', 'I-protein'), ('dehydrogenase', 'dehydrogenase', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('isolated', 'isolate', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('liver', 'liver', 'NN', 'B-NP', 'O'), ('mitochondria', 'mitochondrion', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('partially', 'partially', 'RB', 'B-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('sequenced', 'sequence', 'VBN', 'B-VP', 'O'), ('.', '.', '.', 'O', 'O')]
1	The program ESTblast [ CIT ] was used to construct a tentative mouse contiguous sequence from EST sequences .	[('The', 'The', 'DT', 'B-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ('ESTblast', 'ESTblast', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('construct', 'construct', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('tentative', 'tentative', 'JJ', 'I-NP', 'B-DNA'), ('mouse', 'mouse', 'NN', 'I-NP', 'I-DNA'), ('contiguous', 'contiguous', 'JJ', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('from', 'from', 'IN', 'B-PP', 'O'), ('EST', 'EST', 'NN', 'B-NP', 'B-DNA'), ('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
2	Previous studies using mitogenic stimuli showed that the levels of several initiation factor proteins increase later ( > 16 h ) following T cell activation and probably contribute to the increase in protein synthesis [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('mitogenic', 'mitogenic', 'JJ', 'B-NP', 'O'), ('stimuli', 'stimulus', 'NNS', 'I-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('initiation', 'initiation', 'NN', 'I-NP', 'B-protein'), ('factor', 'factor', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('increase', 'increase', 'VBP', 'B-VP', 'O'), ('later', 'later', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('>', '>', 'JJR', 'B-NP', 'O'), ('16', '16', 'CD', 'I-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('following', 'follow', 'VBG', 'B-PP', 'O'), ('T', 'T', 'NN', 'B-NP', 'O'), ('cell', 'cell', 'NN', 'I-NP', 'O'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('probably', 'probably', 'RB', 'B-ADVP', 'O'), ('contribute', 'contribute', 'VBP', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Furthermore , the phosphorylation of eIF4E has been reported to be increased in response to several different treatments of primary T lymphocytes [ CIT ] .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('phosphorylation', 'phosphorylation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('eIF4E', 'eIF4E', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('increased', 'increase', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('response', 'response', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('treatments', 'treatment', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('primary', 'primary', 'JJ', 'B-NP', 'B-cell_type'), ('T', 'T', 'NN', 'I-NP', 'I-cell_type'), ('lymphocytes', 'lymphocyte', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In resting T-cells , 4E-BP1 was mainly present in the unphosphorylated form ( α-form ) as reported before [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('resting', 'rest', 'VBG', 'B-NP', 'B-cell_type'), ('T-cells', 'T-cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('4E-BP1', '4E-BP1', 'NN', 'B-NP', 'B-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('mainly', 'mainly', 'RB', 'B-ADJP', 'O'), ('present', 'present', 'JJ', 'I-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('unphosphorylated', 'unphosphorylated', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('α-form', 'α-form', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	An increase in eIF2B activity after stimulation of primary T-cells with PMA / ionomycin has been reported before [ CIT ] .	[('An', 'An', 'DT', 'B-NP', 'O'), ('increase', 'increase', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('eIF2B', 'eIF2B', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('stimulation', 'stimulation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('primary', 'primary', 'JJ', 'B-NP', 'B-cell_type'), ('T-cells', 'T-cell', 'NNS', 'I-NP', 'I-cell_type'), ('with', 'with', 'IN', 'B-PP', 'O'), ('PMA', 'PMA', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('ionomycin', 'ionomycin', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('before', 'before', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been suggested that GSK-3 may be an important regulator of eIF2B activity , i.e. in response to insulin [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('suggested', 'suggest', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('GSK-3', 'GSK-3', 'NN', 'B-NP', 'B-protein'), ('may', 'may', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('important', 'important', 'JJ', 'I-NP', 'O'), ('regulator', 'regulator', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('eIF2B', 'eIF2B', 'NN', 'B-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('i.e.', 'i.e.', 'FW', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('response', 'response', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('insulin', 'insulin', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	These protein bands have previously been shown to be Cα1 ( 40 kDa ) and Cβ2 ( 47 kDa ) [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('Cα1', 'Cα1', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('40', '40', 'CD', 'B-NP', 'B-protein'), ('kDa', 'kDa', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Cβ2', 'Cβ2', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('47', '47', 'CD', 'B-NP', 'O'), ('kDa', 'kDa', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	To further investigate the identity of the 40 and 47 kDa protein bands , we analysed C subunit expression and PKA kinase activity in mice lacking the Cβ1 splice variant ( Cβ1 -/- ) [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('further', 'further', 'RB', 'I-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('40', '40', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('47', '47', 'CD', 'I-NP', 'O'), ('kDa', 'kDa', 'NN', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('analysed', 'analyse', 'VBD', 'B-VP', 'O'), ('C', 'C', 'NN', 'B-NP', 'B-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('PKA', 'PKA', 'NN', 'B-NP', 'B-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('mice', 'mouse', 'NNS', 'B-NP', 'O'), ('lacking', 'lack', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Cβ1', 'Cβ1', 'NN', 'I-NP', 'B-DNA'), ('splice', 'splice', 'NN', 'I-NP', 'I-DNA'), ('variant', 'variant', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('Cβ1', 'Cβ1', 'NN', 'B-NP', 'O'), ('-/-', '-/-', 'JJ', 'B-ADJP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	We identified a region with high sequence similarity to the human exon 1-2 sequence in the published mouse genome [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('similarity', 'similarity', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('human', 'human', 'JJ', 'I-NP', 'B-DNA'), ('exon', 'exon', 'NN', 'I-NP', 'I-DNA'), ('1-2', '1-2', 'CD', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('mouse', 'mouse', 'NN', 'I-NP', 'B-DNA'), ('genome', 'genome', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Based on this information and the fact that all C subunits identified so far only differ in the domain encoded by alternative use of exon 1 , we postulated a hypothetical cDNA sequence using this mouse exon 1-2 sequence and the known murine Cβ cDNA sequence [ CIT ] ( Figure 2A , bottom ) .	[('Based', 'Base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('information', 'information', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fact', 'fact', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('C', 'C', 'NN', 'I-NP', 'B-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('identified', 'identify', 'VBN', 'B-VP', 'O'), ('so', 'so', 'RB', 'B-ADVP', 'O'), ('far', 'far', 'RB', 'I-ADVP', 'O'), ('only', 'only', 'RB', 'I-VP', 'O'), ('differ', 'differ', 'VB', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('domain', 'domain', 'NN', 'I-NP', 'O'), ('encoded', 'encode', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('alternative', 'alternative', 'JJ', 'B-NP', 'O'), ('use', 'use', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('1', '1', 'CD', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('postulated', 'postulate', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('hypothetical', 'hypothetical', 'JJ', 'I-NP', 'B-DNA'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('mouse', 'mouse', 'NN', 'I-NP', 'B-DNA'), ('exon', 'exon', 'NN', 'I-NP', 'I-DNA'), ('1-2', '1-2', 'CD', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('murine', 'murine', 'JJ', 'I-NP', 'B-DNA'), ('Cβ', 'Cβ', 'NN', 'I-NP', 'I-DNA'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('bottom', 'bottom', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has previously been demonstrated that a cDNA encoding the bovine Cβ2 was not active when transfected into CHO cells [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'B-DNA'), ('encoding', 'encode', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('bovine', 'bovine', 'JJ', 'I-NP', 'B-protein'), ('Cβ2', 'Cβ2', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('active', 'active', 'JJ', 'B-ADJP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('transfected', 'transfecte', 'VBN', 'B-VP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('CHO', 'CHO', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	First , unlike the situation reported for other proteins [ CIT ] , no bands were observed for trimeric , pentameric , etc. ( i.e. ( 2n+1 ) × Mr ) forms of MBP-ZP-N-6his ( Fig. 2B ) .	[('First', 'First', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('unlike', 'unlike', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('situation', 'situation', 'NN', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('bands', 'band', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('trimeric', 'trimeric', 'JJ', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('pentameric', 'pentameric', 'JJ', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('etc.', 'etc.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('i.e.', 'i.e.', 'FW', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2n+1', '2n+1', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('×', '×', 'NN', 'B-NP', 'O'), ('Mr', 'Mr', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('forms', 'form', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MBP-ZP-N-6his', 'MBP-ZP-N-6his', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('2B', '2B', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	However , the determination of the solution structure of the ChBDchiA1 by Ikegami et al. [ CIT ] identified only Trp687 as a putative chitin binding residue , in addition to His681 , Thr682 , Pro689 , and Pro693 .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('determination', 'determination', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('solution', 'solution', 'NN', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ChBDchiA1', 'ChBDchiA1', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Ikegami', 'Ikegami', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('only', 'only', 'RB', 'B-NP', 'O'), ('Trp687', 'Trp687', 'NN', 'I-NP', 'B-protein'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('putative', 'putative', 'JJ', 'I-NP', 'O'), ('chitin', 'chitin', 'NN', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('residue', 'residue', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('His681', 'His681', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Thr682', 'Thr682', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Pro689', 'Pro689', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Pro693', 'Pro693', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Like most carbamates , the four diastereomers of 1 are characterized as the pseudo substrate inhibitors of CEase ( Figures 3 and 4 ) and meet some of the criteria proposed by Abeles and Maycock [ CIT ] .	[('Like', 'Like', 'IN', 'B-PP', 'O'), ('most', 'most', 'JJS', 'B-NP', 'O'), ('carbamates', 'carbamate', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('four', 'four', 'CD', 'I-NP', 'O'), ('diastereomers', 'diastereomer', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('characterized', 'characterize', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pseudo', 'pseudo', 'NN', 'I-NP', 'O'), ('substrate', 'substrate', 'NN', 'I-NP', 'O'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CEase', 'CEase', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Figures', 'Figure', 'NNS', 'B-NP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('meet', 'meet', 'VB', 'B-VP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('criteria', 'criterion', 'NNS', 'I-NP', 'O'), ('proposed', 'propose', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Abeles', 'Abeles', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('Maycock', 'Maycock', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	When CEase is incubated with a carbamate in the presence of TFA ( 2 μM ) , a known competitive inhibitor of CEase [ CIT ] ( Figure 4B ) .	[('When', 'When', 'WRB', 'B-ADVP', 'O'), ('CEase', 'CEase', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('incubated', 'incubate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('carbamate', 'carbamate', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('TFA', 'TFA', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('known', 'known', 'JJ', 'I-NP', 'O'), ('competitive', 'competitive', 'JJ', 'I-NP', 'O'), ('inhibitor', 'inhibitor', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CEase', 'CEase', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('4B', '4B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In this study , and also as done previously [ CIT ] , we focused on the characterization of three fractions of MCR1 ( referred to as Fractions A , B , and C ) that were pooled after the preparative SEC gel filtration step ( Figure 1 ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('done', 'do', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('focused', 'focus', 'VBD', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('characterization', 'characterization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MCR1', 'MCR1', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('referred', 'refer', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('Fractions', 'Fraction', 'NNS', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('B', 'B', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('C', 'C', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('pooled', 'pool', 'VBN', 'I-VP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('preparative', 'preparative', 'JJ', 'I-NP', 'O'), ('SEC', 'SEC', 'NNP', 'I-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('filtration', 'filtration', 'NN', 'I-NP', 'O'), ('step', 'step', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Consistent with our previous results [ CIT ] , MCR1 self-associated as tetrameric and octameric forms , in addition to the dimeric form .	[('Consistent', 'Consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('MCR1', 'MCR1', 'NN', 'B-NP', 'B-protein'), ('self-associated', 'self-associated', 'JJ', 'B-ADJP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('tetrameric', 'tetrameric', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('octameric', 'octameric', 'JJ', 'I-NP', 'B-protein'), ('forms', 'form', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('addition', 'addition', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dimeric', 'dimeric', 'JJ', 'I-NP', 'B-protein'), ('form', 'form', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
7	Our findings of the three distinct oligomeric forms of RAG1 coupled with the contradictory reports of RAG1 stoichiometry in catalytically-active complexes [ CIT ] led us to further investigate the self-association properties of this protein .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('distinct', 'distinct', 'JJ', 'I-NP', 'O'), ('oligomeric', 'oligomeric', 'JJ', 'I-NP', 'B-protein'), ('forms', 'form', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('RAG1', 'RAG1', 'NN', 'B-NP', 'B-protein'), ('coupled', 'couple', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('contradictory', 'contradictory', 'JJ', 'I-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('RAG1', 'RAG1', 'NN', 'B-NP', 'B-protein'), ('stoichiometry', 'stoichiometry', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('catalytically-active', 'catalytically-active', 'JJ', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('led', 'lead', 'VBD', 'B-VP', 'O'), ('us', 'us', 'PRP', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('further', 'further', 'RBR', 'I-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('self-association', 'self-association', 'NN', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	In this study we examined how the self-association properties of MCR1 varied with temperature ( previous studies were performed at a single temperature with MCR1 samples incubated at 4°C prior to SEC [ CIT ] ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('how', 'how', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('self-association', 'self-association', 'NN', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MCR1', 'MCR1', 'NN', 'B-NP', 'B-protein'), ('varied', 'vary', 'VBD', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('temperature', 'temperature', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('performed', 'perform', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('MCR1', 'MCR1', 'NN', 'B-NP', 'B-protein'), ('samples', 'sample', 'NNS', 'I-NP', 'O'), ('incubated', 'incubate', 'VBN', 'B-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('4°C', '4°C', 'NN', 'B-NP', 'O'), ('prior', 'prior', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('SEC', 'SEC', 'NNP', 'B-NP', 'B-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Fraction A ( containing dimeric MCR1 ) formed multiple complexes with the RSS at protein concentrations of less than 0.2 μM ( Figure 4A ) , consistent with our previous results in which we showed that MCR1 can form two major complexes with a single 12-RSS prior to saturation of the DNA [ CIT ] .	[('Fraction', 'Fraction', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('containing', 'contain', 'VBG', 'B-VP', 'O'), ('dimeric', 'dimeric', 'JJ', 'B-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('formed', 'form', 'VBD', 'B-VP', 'O'), ('multiple', 'multiple', 'JJ', 'B-NP', 'O'), ('complexes', 'complex', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RSS', 'RSS', 'NN', 'I-NP', 'B-protein'), ('at', 'at', 'IN', 'B-PP', 'I-protein'), ('protein', 'protein', 'NN', 'B-NP', 'I-protein'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('less', 'less', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('0.2', '0.2', 'CD', 'I-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'B-protein'), ('4A', '4A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('MCR1', 'MCR1', 'NN', 'B-NP', 'B-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('major', 'major', 'JJ', 'I-NP', 'O'), ('complexes', 'complex', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('12-RSS', '12-RSS', 'NN', 'I-NP', 'O'), ('prior', 'prior', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('saturation', 'saturation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In previous studies it was determined that the fastest migrating MCR1 : RSS complex in the nondenaturing gel contained a single MCR1 dimer [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fastest', 'fast', 'JJS', 'I-NP', 'O'), ('migrating', 'migrating', 'JJ', 'I-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'B-protein'), (':', ':', ':', 'O', 'O'), ('RSS', 'RSS', 'NN', 'B-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('nondenaturing', 'nondenaturing', 'JJ', 'I-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('contained', 'contain', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'O'), ('dimer', 'dimer', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	While there is some evidence that this complex may contain pre-formed tetramer [ CIT ] , it is more likely that it is due to the binding of two separate dimers to the RSS , since ( as shown in Figure 3 ) the pre-formed tetramer is less evident at 25°C ( the typical incubation temperature used in the mobility shift experiments ) .	[('While', 'While', 'IN', 'B-SBAR', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('evidence', 'evidence', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('complex', 'complex', 'NN', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('contain', 'contain', 'VB', 'I-VP', 'O'), ('pre-formed', 'pre-formed', 'JJ', 'B-NP', 'O'), ('tetramer', 'tetramer', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('more', 'more', 'RBR', 'B-ADJP', 'O'), ('likely', 'likely', 'JJ', 'I-ADJP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('due', 'due', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('separate', 'separate', 'JJ', 'I-NP', 'O'), ('dimers', 'dimer', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RSS', 'RSS', 'NN', 'I-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('since', 'since', 'IN', 'B-SBAR', 'O'), ('(', '(', '(', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pre-formed', 'pre-formed', 'JJ', 'I-NP', 'O'), ('tetramer', 'tetramer', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('evident', 'evident', 'JJ', 'I-ADJP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('25°C', '25°C', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('typical', 'typical', 'JJ', 'I-NP', 'O'), ('incubation', 'incubation', 'NN', 'I-NP', 'O'), ('temperature', 'temperature', 'NN', 'I-NP', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mobility', 'mobility', 'NN', 'I-NP', 'O'), ('shift', 'shift', 'NN', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	In previous studies it was shown that RAG2 could bind to both the 2-subunit MCR1 : 12-RSS and the 4-subunit MCR1 : 12-RSS complexes following incubation at 25°C [ CIT ] .	[('In', 'In', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('RAG2', 'RAG2', 'NN', 'B-NP', 'B-protein'), ('could', 'could', 'MD', 'B-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('2-subunit', '2-subunit', 'NN', 'I-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('12-RSS', '12-RSS', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('4-subunit', '4-subunit', 'NN', 'I-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('12-RSS', '12-RSS', 'NN', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('following', 'follow', 'VBG', 'B-PP', 'O'), ('incubation', 'incubation', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('25°C', '25°C', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Upon incubation at 10 and 25°C , two complexes were formed ( Figure 7A , lane 3 ) , as has been previously observed under these conditions [ CIT ] .	[('Upon', 'Upon', 'IN', 'B-PP', 'O'), ('incubation', 'incubation', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('10', '10', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('25°C', '25°C', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('complexes', 'complex', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('formed', 'form', 'VBN', 'I-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NNP', 'B-NP', 'O'), ('7A', '7A', 'NNP', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lane', 'lane', 'NN', 'B-NP', 'B-protein'), ('3', '3', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('under', 'under', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	There is a possibility that complex 2 could be due to the binding of additional GST-core RAG2 subunits to the 2-subunit MCR1 : 12-RSS complex , which would correspond to the previously reported complexes " SC1 " and " SC2 " that contain 1 and 2 subunits of RAG2 bound to the RAG1 dimer : RSS complex , respectively [ CIT ] .	[('There', 'There', 'EX', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('complex', 'complex', 'NN', 'B-NP', 'B-protein'), ('2', '2', 'CD', 'I-NP', 'I-protein'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('due', 'due', 'JJ', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('additional', 'additional', 'JJ', 'B-NP', 'O'), ('GST-core', 'GST-core', 'NN', 'I-NP', 'B-protein'), ('RAG2', 'RAG2', 'NN', 'I-NP', 'I-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('2-subunit', '2-subunit', 'NN', 'I-NP', 'O'), ('MCR1', 'MCR1', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('12-RSS', '12-RSS', 'NN', 'B-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('would', 'would', 'MD', 'B-VP', 'O'), ('correspond', 'correspond', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('reported', 'report', 'VBN', 'I-NP', 'O'), ('complexes', 'complex', 'NNS', 'I-NP', 'O'), ('``', '``', '``', 'O', 'O'), ('SC1', 'SC1', 'NN', 'B-NP', 'B-protein'), ('``', '``', '``', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('``', '``', '``', 'O', 'O'), ('SC2', 'SC2', 'NN', 'B-NP', 'B-protein'), ('``', '``', '``', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('contain', 'contain', 'VBP', 'B-VP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('subunits', 'subunit', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('RAG2', 'RAG2', 'NN', 'B-NP', 'B-protein'), ('bound', 'bind', 'VBD', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RAG1', 'RAG1', 'NN', 'I-NP', 'B-protein'), ('dimer', 'dimer', 'NN', 'I-NP', 'I-protein'), (':', ':', ':', 'O', 'O'), ('RSS', 'RSS', 'NN', 'B-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	These results are consistent with previous studies , which showed that dimeric GST unfolds in a two-state mechanism to denatured monomers , indicating that a monomeric folded form of GST is highly unstable [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('dimeric', 'dimeric', 'JJ', 'B-NP', 'O'), ('GST', 'GST', 'NN', 'I-NP', 'O'), ('unfolds', 'unfold', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('two-state', 'two-state', 'JJ', 'I-NP', 'O'), ('mechanism', 'mechanism', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('denatured', 'denature', 'VBN', 'B-NP', 'O'), ('monomers', 'monomer', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('monomeric', 'monomeric', 'JJ', 'I-NP', 'O'), ('folded', 'folded', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('GST', 'GST', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('highly', 'highly', 'RB', 'B-ADJP', 'O'), ('unstable', 'unstable', 'JJ', 'I-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To investigate the binding specificity of the POB1 EH domain , we expressed it as a fusion to glutathione S-transferase ( GST ) and used it to screen a random nonapeptide phage-display library as previously described [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('specificity', 'specificity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('POB1', 'POB1', 'NN', 'I-NP', 'B-protein'), ('EH', 'EH', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('expressed', 'express', 'VBD', 'B-VP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('fusion', 'fusion', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('glutathione', 'glutathione', 'NN', 'B-NP', 'B-protein'), ('S-transferase', 'S-transferase', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('GST', 'GST', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('screen', 'screen', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('random', 'random', 'JJ', 'I-NP', 'B-DNA'), ('nonapeptide', 'nonapeptide', 'NN', 'I-NP', 'I-DNA'), ('phage-display', 'phage-display', 'JJ', 'I-NP', 'I-DNA'), ('library', 'library', 'NN', 'I-NP', 'I-DNA'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In order to confirm the EH targets inferred by the pull down experiment , we synthesized the full-length human Eps15 protein as 15 amino acid long peptides , overlapping by 12 amino acids , using the SPOT synthesis method [ CIT ] .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('confirm', 'confirm', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('EH', 'EH', 'NN', 'I-NP', 'O'), ('targets', 'target', 'NNS', 'I-NP', 'O'), ('inferred', 'infer', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pull', 'pull', 'NN', 'I-NP', 'O'), ('down', 'down', 'RP', 'B-PRT', 'O'), ('experiment', 'experiment', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('synthesized', 'synthesize', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('full-length', 'full-length', 'JJ', 'I-NP', 'B-protein'), ('human', 'human', 'JJ', 'I-NP', 'I-protein'), ('Eps15', 'Eps15', 'NN', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('as', 'as', 'IN', 'B-PP', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('long', 'long', 'JJ', 'I-NP', 'O'), ('peptides', 'peptide', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('overlapping', 'overlap', 'VBG', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('12', '12', 'CD', 'B-NP', 'O'), ('amino', 'amino', 'NN', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SPOT', 'SPOT', 'NN', 'I-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Cupers and collaborators proposed that Eps15 forms a head to head dimer and that two dimers further associate head to tail to form a tetramer [ CIT ] .	[('Cupers', 'Cuper', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('collaborators', 'collaborator', 'NNS', 'I-NP', 'O'), ('proposed', 'propose', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Eps15', 'Eps15', 'NN', 'B-NP', 'B-protein'), ('forms', 'form', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('head', 'head', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('head', 'head', 'VB', 'I-VP', 'O'), ('dimer', 'dimer', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('dimers', 'dimer', 'NNS', 'I-NP', 'O'), ('further', 'further', 'JJ', 'I-NP', 'O'), ('associate', 'associate', 'JJ', 'I-NP', 'O'), ('head', 'head', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('tail', 'tail', 'VB', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('tetramer', 'tetramer', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	Although these experiments don't definitively prove a direct DPF / EH interaction in Eps15 , as we can not exclude the involvement of accessory proteins , they confirm a plausible role of EH-DPF interaction in the stabilization of Eps15 tetramers , as suggested by other authors [ CIT ] .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('do', 'do', 'VBP', 'B-VP', 'O'), ("n't", "n't", 'RB', 'I-VP', 'O'), ('definitively', 'definitively', 'RB', 'I-VP', 'O'), ('prove', 'prove', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('direct', 'direct', 'JJ', 'I-NP', 'O'), ('DPF', 'DPF', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('EH', 'EH', 'NN', 'I-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Eps15', 'Eps15', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('exclude', 'exclude', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('involvement', 'involvement', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('accessory', 'accessory', 'JJ', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('confirm', 'confirm', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('plausible', 'plausible', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EH-DPF', 'EH-DPF', 'NN', 'B-NP', 'B-protein'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('stabilization', 'stabilization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Eps15', 'Eps15', 'NN', 'B-NP', 'B-protein'), ('tetramers', 'tetramer', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('suggested', 'suggest', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('authors', 'author', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Interestingly , Whitehead and collaborators [ CIT ] assert that the mutation of the three tyrosine residues Tyr19 , Tyr22 , and Tyr23 of mEH1 in Eps15 abolishes its mono-ubiquitination upon stimulation of the cells with EGF , indicating a clear functional role of this region in the regulation of Eps15 .	[('Interestingly', 'Interestingly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Whitehead', 'Whitehead', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('collaborators', 'collaborator', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('assert', 'assert', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('tyrosine', 'tyrosine', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('Tyr19', 'Tyr19', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Tyr22', 'Tyr22', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Tyr23', 'Tyr23', 'NN', 'B-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('mEH1', 'mEH1', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Eps15', 'Eps15', 'NN', 'B-NP', 'B-protein'), ('abolishes', 'abolish', 'VBZ', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('mono-ubiquitination', 'mono-ubiquitination', 'NN', 'I-NP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('stimulation', 'stimulation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('EGF', 'EGF', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('clear', 'clear', 'JJ', 'I-NP', 'O'), ('functional', 'functional', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Eps15', 'Eps15', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
2	Bioinformatics analysis of the E. faecalis V583 genome [ CIT ] demonstrated the presence of a gene locus coding for putative SUF proteins ( Fig. 1A ) .	[('Bioinformatics', 'Bioinformatic', 'NNS', 'B-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'NNP', 'I-NP', 'B-DNA'), ('faecalis', 'faecalis', 'NN', 'I-NP', 'I-DNA'), ('V583', 'V583', 'NN', 'I-NP', 'I-DNA'), ('genome', 'genome', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), ('locus', 'locus', 'NN', 'I-NP', 'O'), ('coding', 'cod', 'VBG', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('putative', 'putative', 'JJ', 'B-NP', 'B-protein'), ('SUF', 'SUF', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1A', '1A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	ORFs possibly related to [ CIT ] cluster formation ; EF3293 and EF2394 encoding SufD and SufC orthologue proteins , which presented 22 % and 52 % identity with the E. coli proteins , respectively .	[('ORFs', 'ORF', 'NNS', 'B-NP', 'B-DNA'), ('possibly', 'possibly', 'RB', 'B-ADJP', 'O'), ('related', 'related', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'O'), (']', ']', ')', 'I-NP', 'O'), ('cluster', 'cluster', 'NN', 'I-NP', 'O'), ('formation', 'formation', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('EF3293', 'EF3293', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('EF2394', 'EF2394', 'NN', 'I-NP', 'O'), ('encoding', 'encode', 'VBG', 'B-VP', 'O'), ('SufD', 'SufD', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('SufC', 'SufC', 'NN', 'I-NP', 'B-protein'), ('orthologue', 'orthologue', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('presented', 'present', 'VBD', 'B-VP', 'O'), ('22', '22', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('52', '52', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'B-protein'), ('coli', 'coli', 'FW', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Furthermore , cyanobacteria were found to contain the sufR gene , which encodes a protein that functions as a transcriptional repressor of the suf regulon [ CIT ] , but it was not found in the Firmicutes genomes .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('cyanobacteria', 'cyanobacteria', 'NNS', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('contain', 'contain', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sufR', 'sufR', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('encodes', 'encode', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('functions', 'function', 'VBZ', 'B-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('transcriptional', 'transcriptional', 'JJ', 'I-NP', 'B-protein'), ('repressor', 'repressor', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('suf', 'suf', 'NN', 'I-NP', 'O'), ('regulon', 'regulon', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Firmicutes', 'Firmicute', 'NNPS', 'I-NP', 'B-DNA'), ('genomes', 'genome', 'NNS', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
1	In order to characterize the structure and conformation of the SufU key protein observed in E. faecalis comparative modeling was carried out [ CIT ] .	[('In', 'In', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('characterize', 'characterize', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('conformation', 'conformation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SufU', 'SufU', 'NN', 'I-NP', 'B-protein'), ('key', 'key', 'JJ', 'I-NP', 'I-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('E.', 'E.', 'NNP', 'B-NP', 'O'), ('faecalis', 'faecalis', 'NN', 'I-NP', 'O'), ('comparative', 'comparative', 'JJ', 'I-NP', 'O'), ('modeling', 'modeling', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('carried', 'carry', 'VBN', 'I-VP', 'O'), ('out', 'out', 'RP', 'B-PRT', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Neither the primary composition nor the three-dimensional structure seen in the scaffold protein SufU matches SufA , the scaffold-function protein found in the E. coli SUF system , but it does match the Proteobacteria IscU structure [ CIT ] .	[('Neither', 'Neither', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('primary', 'primary', 'JJ', 'I-NP', 'O'), ('composition', 'composition', 'NN', 'I-NP', 'O'), ('nor', 'nor', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('seen', 'see', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('scaffold', 'scaffold', 'JJ', 'I-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('SufU', 'SufU', 'NN', 'I-NP', 'O'), ('matches', 'match', 'VBZ', 'B-VP', 'O'), ('SufA', 'SufA', 'NNP', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('scaffold-function', 'scaffold-function', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('E.', 'E.', 'FW', 'I-NP', 'O'), ('coli', 'coli', 'FW', 'I-NP', 'O'), ('SUF', 'SUF', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('match', 'match', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Proteobacteria', 'Proteobacteria', 'NNP', 'I-NP', 'O'), ('IscU', 'IscU', 'NN', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	However , according to Liu et al. ( 2005 ) [ CIT ] , although sharing < 10 % sequence identity , the similarity of the three-dimensional structure suggests that IscU / SufU and SufE are homologous desulfurase enhancers .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('according', 'accord', 'VBG', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('Liu', 'Liu', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2005', '2005', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('sharing', 'share', 'VBG', 'B-VP', 'O'), ('<', '<', 'SYM', 'B-NP', 'O'), ('10', '10', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('similarity', 'similarity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('suggests', 'suggest', 'VBZ', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('IscU', 'IscU', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('SufU', 'SufU', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('SufE', 'SufE', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('homologous', 'homologous', 'JJ', 'B-NP', 'O'), ('desulfurase', 'desulfurase', 'NN', 'I-NP', 'O'), ('enhancers', 'enhancer', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	As reported [ CIT ] , crystallographic structures may retain non-biological conformations as due to forces occurring in the crystal environment .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('crystallographic', 'crystallographic', 'JJ', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('retain', 'retain', 'VB', 'I-VP', 'O'), ('non-biological', 'non-biological', 'JJ', 'B-NP', 'O'), ('conformations', 'conformation', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('due', 'due', 'JJ', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('forces', 'force', 'NNS', 'B-NP', 'O'), ('occurring', 'occur', 'VBG', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('crystal', 'crystal', 'JJ', 'I-NP', 'O'), ('environment', 'environment', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Indeed , such strategy has already been employed with success to refine comparative models of proteins , allowing the observation of modifications on secondary structure elements of the interest protein towards the NMR observed structure [ CIT ] .	[('Indeed', 'Indeed', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('strategy', 'strategy', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('already', 'already', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('employed', 'employ', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('success', 'success', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('refine', 'refine', 'VB', 'I-VP', 'O'), ('comparative', 'comparative', 'JJ', 'B-NP', 'O'), ('models', 'model', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('proteins', 'protein', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('allowing', 'allow', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('modifications', 'modification', 'NNS', 'B-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('secondary', 'secondary', 'JJ', 'B-NP', 'B-DNA'), ('structure', 'structure', 'NN', 'I-NP', 'I-DNA'), ('elements', 'element', 'NNS', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interest', 'interest', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('towards', 'towards', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('NMR', 'NMR', 'NN', 'I-NP', 'B-protein'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('structure', 'structure', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	So , in order to gain further insights into the conformational behavior of the simulated proteins , we employed a strategy that describes the structural fluctuation of a protein structure as a function of both time and residue number [ CIT ] .	[('So', 'So', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-SBAR', 'O'), ('order', 'order', 'NN', 'O', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('gain', 'gain', 'VB', 'I-VP', 'O'), ('further', 'further', 'JJ', 'B-NP', 'O'), ('insights', 'insight', 'NNS', 'I-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('conformational', 'conformational', 'JJ', 'I-NP', 'O'), ('behavior', 'behavior', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('simulated', 'simulated', 'JJ', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('employed', 'employ', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('strategy', 'strategy', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('describes', 'describe', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('fluctuation', 'fluctuation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('protein', 'protein', 'NN', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('time', 'time', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('residue', 'residue', 'NN', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The suitability of yeast two-hybrid system to study mycobacterial protein-protein interaction has been well demonstrated [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('suitability', 'suitability', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('two-hybrid', 'two-hybrid', 'JJ', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('study', 'study', 'VB', 'I-VP', 'O'), ('mycobacterial', 'mycobacterial', 'JJ', 'B-NP', 'O'), ('protein-protein', 'protein-protein', 'JJ', 'I-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('well', 'well', 'RB', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Based upon our earlier report [ CIT ] and the present mass spectrometry data , we propose that an intra-molecular disulfide bond is formed between C193 and C617 .	[('Based', 'Base', 'VBN', 'B-VP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('mass', 'mass', 'NN', 'I-NP', 'O'), ('spectrometry', 'spectrometry', 'NN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('propose', 'propose', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('intra-molecular', 'intra-molecular', 'JJ', 'I-NP', 'O'), ('disulfide', 'disulfide', 'NN', 'I-NP', 'O'), ('bond', 'bond', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('formed', 'form', 'VBN', 'I-VP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('C193', 'C193', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('C617', 'C617', 'NN', 'I-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
1	To prove the hypothesis that interaction of WhiB1 with GlgB may involve exchange of thiol-disulfide , the Trx affinity chromatography method , originally developed by Motohashi et al. ( 2001 ) [ CIT ] was employed .	[('To', 'To', 'TO', 'B-VP', 'O'), ('prove', 'prove', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hypothesis', 'hypothesis', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('interaction', 'interaction', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('WhiB1', 'WhiB1', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('GlgB', 'GlgB', 'NN', 'B-NP', 'B-protein'), ('may', 'may', 'MD', 'B-VP', 'O'), ('involve', 'involve', 'VB', 'I-VP', 'O'), ('exchange', 'exchange', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('thiol-disulfide', 'thiol-disulfide', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Trx', 'Trx', 'NN', 'I-NP', 'B-protein'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('chromatography', 'chromatography', 'NN', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('originally', 'originally', 'RB', 'B-VP', 'O'), ('developed', 'develop', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Motohashi', 'Motohashi', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2001', '2001', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('employed', 'employ', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	The glycogen synthesis in S. coelicolor A3 ( 2 ) has been shown to be associated with sporulation which represent stationary phase of the growth [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('glycogen', 'glycogen', 'NN', 'I-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('S.', 'S.', 'NNP', 'B-NP', 'O'), ('coelicolor', 'coelicolor', 'NN', 'I-NP', 'O'), ('A3', 'A3', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('associated', 'associate', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('sporulation', 'sporulation', 'NN', 'B-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('represent', 'represent', 'VBP', 'B-VP', 'O'), ('stationary', 'stationary', 'JJ', 'B-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('growth', 'growth', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Increased level of whiB1 transcripts in stationary phase has also been demonstrated by RT-PCR [ CIT ] .	[('Increased', 'Increase', 'VBN', 'B-NP', 'O'), ('level', 'level', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('whiB1', 'whiB1', 'NN', 'B-NP', 'B-RNA'), ('transcripts', 'transcript', 'NNS', 'I-NP', 'I-RNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('stationary', 'stationary', 'JJ', 'B-NP', 'O'), ('phase', 'phase', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('RT-PCR', 'RT-PCR', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently , WhiB1 has been demonstrated to co-ordinate an oxidation labile iron-sulfur cluster [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('WhiB1', 'WhiB1', 'NN', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('co-ordinate', 'co-ordinate', 'VB', 'I-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('oxidation', 'oxidation', 'NN', 'I-NP', 'O'), ('labile', 'labile', 'JJ', 'I-NP', 'O'), ('iron-sulfur', 'iron-sulfur', 'NN', 'I-NP', 'O'), ('cluster', 'cluster', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Host expression profiling in a sufficiently large and diverse set of profiles could allow additional hypotheses to be drawn regarding the function of genes based on the regulatory characteristics of their own transcripts [ CIT ] .	[('Host', 'Host', 'NN', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('profiling', 'profiling', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('sufficiently', 'sufficiently', 'RB', 'I-NP', 'O'), ('large', 'large', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('diverse', 'diverse', 'JJ', 'I-NP', 'O'), ('set', 'set', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('profiles', 'profile', 'NNS', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('allow', 'allow', 'VB', 'I-VP', 'O'), ('additional', 'additional', 'JJ', 'B-NP', 'O'), ('hypotheses', 'hypothesis', 'NNS', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('drawn', 'draw', 'VBN', 'I-VP', 'O'), ('regarding', 'regard', 'VBG', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('genes', 'gene', 'NNS', 'B-NP', 'O'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('regulatory', 'regulatory', 'JJ', 'I-NP', 'O'), ('characteristics', 'characteristic', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('own', 'own', 'JJ', 'I-NP', 'B-RNA'), ('transcripts', 'transcript', 'NNS', 'I-NP', 'I-RNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This is in sharp contrast to latent HTLV-1 infected Tax expressing cells , where more than two-thirds of the same set of genes were activated and scored above one [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('sharp', 'sharp', 'JJ', 'B-NP', 'O'), ('contrast', 'contrast', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('latent', 'latent', 'JJ', 'B-NP', 'B-cell_type'), ('HTLV-1', 'HTLV-1', 'NN', 'I-NP', 'I-cell_type'), ('infected', 'infected', 'JJ', 'I-NP', 'I-cell_type'), ('Tax', 'Tax', 'NN', 'I-NP', 'I-cell_type'), ('expressing', 'expressing', 'NN', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), (',', ',', ',', 'O', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('more', 'more', 'JJR', 'B-NP', 'O'), ('than', 'than', 'IN', 'I-NP', 'O'), ('two-thirds', 'two-third', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('set', 'set', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('genes', 'gene', 'NNS', 'B-NP', 'B-DNA'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('activated', 'activate', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('scored', 'score', 'VBN', 'B-VP', 'O'), ('above', 'above', 'IN', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	As can be seen in Figure 1C , and consistent with previously published reports , p21 / Waf1 [ CIT ] was down-regulated and C-myc and pro-thymosin-α were up-regulated in HIV-1 latent cells .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('seen', 'see', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('1C', '1C', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('p21', 'p21', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'O', 'O'), ('Waf1', 'Waf1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('down-regulated', 'down-regulate', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('C-myc', 'C-myc', 'NN', 'B-NP', 'B-DNA'), ('and', 'and', 'CC', 'I-NP', 'O'), ('pro-thymosin-α', 'pro-thymosin-α', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('up-regulated', 'up-regulate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'B-cell_type'), ('latent', 'latent', 'JJ', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('.', '.', '.', 'O', 'O')]
5	The sizes of the isotope shifts for C-2 and C-3 ( 50.9 ppb and 37.6 ppb , respectively ) as well as the 13C15N coupling constant of 3.7 Hz ( 1JCN ) were in accordance with published values [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('sizes', 'size', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('isotope', 'isotope', 'NN', 'I-NP', 'O'), ('shifts', 'shift', 'NNS', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('C-2', 'C-2', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('C-3', 'C-3', 'NN', 'I-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('50.9', '50.9', 'CD', 'B-NP', 'O'), ('ppb', 'ppb', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('37.6', '37.6', 'CD', 'B-NP', 'O'), ('ppb', 'ppb', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('13C15N', '13C15N', 'NN', 'I-NP', 'O'), ('coupling', 'coupling', 'NN', 'I-NP', 'O'), ('constant', 'constant', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('3.7', '3.7', 'CD', 'B-NP', 'O'), ('Hz', 'Hz', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('1JCN', '1JCN', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('accordance', 'accordance', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
6	This value was confirmed by GC / MS of the N-trifluoroacetyl-n-butylester of phenylalanine [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('value', 'value', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('GC', 'GC', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('MS', 'MS', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('N-trifluoroacetyl-n-butylester', 'N-trifluoroacetyl-n-butylester', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('phenylalanine', 'phenylalanine', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This result is consistent with AMPPNP binding strongly to a single site on sCD39 in the presence of metal [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('AMPPNP', 'AMPPNP', 'NN', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('strongly', 'strongly', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('site', 'site', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('sCD39', 'sCD39', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('metal', 'metal', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Recently , another shikimate pathway enzyme from M. tuberculosis , 3-Deoxy-D-arabino-heptulosonate 7-phosphate ( DAHP ) synthase , was reported to be expressed only in the absence of IPTG [ CIT ] .	[('Recently', 'Recently', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('another', 'another', 'DT', 'B-NP', 'O'), ('shikimate', 'shikimate', 'JJ', 'I-NP', 'B-protein'), ('pathway', 'pathway', 'NN', 'I-NP', 'I-protein'), ('enzyme', 'enzyme', 'NN', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('M.', 'M.', 'NN', 'B-NP', 'O'), ('tuberculosis', 'tuberculosis', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('3-Deoxy-D-arabino-heptulosonate', '3-Deoxy-D-arabino-heptulosonate', 'NN', 'B-NP', 'B-protein'), ('7-phosphate', '7-phosphate', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'I-protein'), ('DAHP', 'DAHP', 'NN', 'B-NP', 'I-protein'), (')', ')', ')', 'O', 'I-protein'), ('synthase', 'synthase', 'NN', 'B-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('expressed', 'express', 'VBN', 'I-VP', 'O'), ('only', 'only', 'RB', 'B-ADVP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('IPTG', 'IPTG', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Analytical gel filtration chromatography revealed a single peak of approximately 104 kDa , suggesting that MtCS is a dimer in solution , which is in agreement with the hydrodynamic properties of the recombinant protein assessed by sedimentation velocity and sedimentation equilibrium [ CIT ] .	[('Analytical', 'Analytical', 'JJ', 'B-NP', 'O'), ('gel', 'gel', 'NN', 'I-NP', 'O'), ('filtration', 'filtration', 'NN', 'I-NP', 'O'), ('chromatography', 'chromatography', 'NN', 'I-NP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('peak', 'peak', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('approximately', 'approximately', 'RB', 'B-NP', 'O'), ('104', '104', 'CD', 'I-NP', 'O'), ('kDa', 'kDa', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('MtCS', 'MtCS', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('dimer', 'dimer', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('solution', 'solution', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('hydrodynamic', 'hydrodynamic', 'JJ', 'I-NP', 'O'), ('properties', 'property', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('recombinant', 'recombinant', 'JJ', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('assessed', 'assess', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('sedimentation', 'sedimentation', 'NN', 'B-NP', 'O'), ('velocity', 'velocity', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('sedimentation', 'sedimentation', 'NN', 'B-NP', 'O'), ('equilibrium', 'equilibrium', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Moreover , the structures of CS complexed with FMN from Helicobacter pylori [ CIT ] have shown that there are a number of positively charged amino acids in the FMN binding pocket , which could increase the reduction potential of FMNox / FMNred couple , likely permitting the decrease of the rate of reoxidation .	[('Moreover', 'Moreover', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('structures', 'structure', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CS', 'CS', 'NN', 'B-NP', 'B-protein'), ('complexed', 'complexe', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('FMN', 'FMN', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Helicobacter', 'Helicobacter', 'NN', 'B-NP', 'O'), ('pylori', 'pylori', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('positively', 'positively', 'RB', 'B-NP', 'O'), ('charged', 'charge', 'VBN', 'I-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'O'), ('acids', 'acid', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('FMN', 'FMN', 'NN', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('pocket', 'pocket', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('increase', 'increase', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reduction', 'reduction', 'NN', 'I-NP', 'O'), ('potential', 'potential', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('FMNox', 'FMNox', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('FMNred', 'FMNred', 'JJ', 'I-NP', 'O'), ('couple', 'couple', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('likely', 'likely', 'RB', 'B-VP', 'O'), ('permitting', 'permit', 'VBG', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rate', 'rate', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('reoxidation', 'reoxidation', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	The KNADH observed for MtCS is similar to the KNADPH determined for NcCS [ CIT ] ( 43 μM and 70 μM , respectively ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('KNADH', 'KNADH', 'NN', 'I-NP', 'B-protein'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('MtCS', 'MtCS', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('KNADPH', 'KNADPH', 'NN', 'I-NP', 'O'), ('determined', 'determine', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('NcCS', 'NcCS', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('43', '43', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('70', '70', 'CD', 'B-NP', 'O'), ('μM', 'μM', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The binding of FMNox to MtCS was assessed by UV-visible difference spectra as described by Kitzing et al. [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('FMNox', 'FMNox', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('MtCS', 'MtCS', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('assessed', 'assess', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('UV-visible', 'UV-visible', 'JJ', 'B-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('spectra', 'spectrum', 'NNS', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Kitzing', 'Kitze', 'VBG', 'B-VP', 'O'), ('et', 'et', 'FW', 'B-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We have also tried to determine the dissociation constant of FMNox from protein fluorescence titration as recently described by Broco et al [ CIT ] , which could allow reliable measurement of oxidized FMN binding to MtCS at low concentrations of FMNox .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('tried', 'try', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('determine', 'determine', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('dissociation', 'dissociation', 'NN', 'I-NP', 'O'), ('constant', 'constant', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('FMNox', 'FMNox', 'NN', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'O'), ('fluorescence', 'fluorescence', 'NN', 'I-NP', 'O'), ('titration', 'titration', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('recently', 'recently', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Broco', 'Broco', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al', 'al', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('allow', 'allow', 'VB', 'I-VP', 'O'), ('reliable', 'reliable', 'JJ', 'B-NP', 'O'), ('measurement', 'measurement', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('oxidized', 'oxidize', 'VBN', 'B-NP', 'O'), ('FMN', 'FMN', 'NN', 'I-NP', 'O'), ('binding', 'bind', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('MtCS', 'MtCS', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('FMNox', 'FMNox', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies of the structure of ARS1 in both plasmid and chromosome contexts have shown that it contains one essential DNA element , A , that includes a perfect ( 11 / 11 ) match to the ARS consensus sequence ( ACS , Fig. 7A ) , and three additional elements , B1 , B2 , and B3 , with 9 out of 11 bases match to the ACS that are also important for ARS function [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ARS1', 'ARS1', 'NN', 'B-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('plasmid', 'plasmid', 'NN', 'B-NP', 'B-DNA'), ('and', 'and', 'CC', 'I-NP', 'O'), ('chromosome', 'chromosome', 'NN', 'I-NP', 'O'), ('contexts', 'context', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('contains', 'contain', 'VBZ', 'B-VP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('essential', 'essential', 'JJ', 'I-NP', 'B-DNA'), ('DNA', 'DNA', 'NN', 'I-NP', 'I-DNA'), ('element', 'element', 'NN', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('A', 'A', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('includes', 'include', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('perfect', 'perfect', 'JJ', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('11', '11', 'CD', 'O', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('11', '11', 'CD', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('match', 'match', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ARS', 'ARS', 'NN', 'I-NP', 'B-DNA'), ('consensus', 'consensus', 'NN', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('ACS', 'ACS', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('7A', '7A', 'NNP', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('additional', 'additional', 'JJ', 'I-NP', 'O'), ('elements', 'element', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('B1', 'B1', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('B2', 'B2', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('B3', 'B3', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('9', '9', 'CD', 'B-NP', 'O'), ('out', 'out', 'IN', 'B-PP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('11', '11', 'CD', 'B-NP', 'O'), ('bases', 'base', 'NNS', 'I-NP', 'O'), ('match', 'match', 'VBP', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ACS', 'ACS', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('important', 'important', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('ARS', 'ARS', 'NN', 'B-NP', 'B-protein'), ('function', 'function', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	An origin of replication was mapped previously by nascent strand abundance analysis within 2.0 kb zone immediately upstream of c-myc gene [ CIT ] .	[('An', 'An', 'DT', 'B-NP', 'O'), ('origin', 'origin', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('replication', 'replication', 'NN', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('mapped', 'map', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('nascent', 'nascent', 'JJ', 'B-NP', 'O'), ('strand', 'strand', 'NN', 'I-NP', 'O'), ('abundance', 'abundance', 'NN', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('2.0', '2.0', 'CD', 'B-NP', 'O'), ('kb', 'kb', 'NN', 'I-NP', 'O'), ('zone', 'zone', 'NN', 'I-NP', 'O'), ('immediately', 'immediately', 'RB', 'B-ADVP', 'O'), ('upstream', 'upstream', 'RB', 'I-ADVP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('c-myc', 'c-myc', 'NN', 'B-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Interestingly , analysis of Lamin beta 2 origin of replication region also revealed the presence of two ACS ( 9 / 11 match ) like elements [ CIT ] .	[('Interestingly', 'Interestingly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('analysis', 'analysis', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Lamin', 'Lamin', 'NN', 'B-NP', 'B-protein'), ('beta', 'beta', 'SYM', 'O', 'I-protein'), ('2', '2', 'CD', 'B-NP', 'I-protein'), ('origin', 'origin', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('replication', 'replication', 'NN', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('ACS', 'ACS', 'NN', 'I-NP', 'B-DNA'), ('(', '(', '(', 'O', 'I-DNA'), ('9', '9', 'CD', 'B-NP', 'I-DNA'), ('/', '/', 'SYM', 'O', 'I-DNA'), ('11', '11', 'CD', 'B-NP', 'I-DNA'), ('match', 'match', 'NN', 'I-NP', 'I-DNA'), (')', ')', ')', 'O', 'I-DNA'), ('like', 'like', 'IN', 'B-PP', 'I-DNA'), ('elements', 'element', 'NNS', 'B-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To isolate CSN1-NTD interacting proteins , we took a biochemical approach previously described by Lyapina et al. [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('isolate', 'isolate', 'VB', 'I-VP', 'O'), ('CSN1-NTD', 'CSN1-NTD', 'NN', 'B-NP', 'B-protein'), ('interacting', 'interacting', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('took', 'take', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Lyapina', 'Lyapina', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	We are particularly interested in SAP130 because it is highly homologous to DDB1 [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('particularly', 'particularly', 'RB', 'B-ADJP', 'O'), ('interested', 'interested', 'JJ', 'I-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('SAP130', 'SAP130', 'NN', 'B-NP', 'B-protein'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('highly', 'highly', 'RB', 'B-ADJP', 'O'), ('homologous', 'homologous', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('DDB1', 'DDB1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown that CAND1 ( also known as TIP120A ) specifically binds un-neddylated cullins forming stable CAND1-cullin complexes in the cells [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('CAND1', 'CAND1', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('also', 'also', 'RB', 'B-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('TIP120A', 'TIP120A', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('specifically', 'specifically', 'RB', 'B-VP', 'O'), ('binds', 'bind', 'VBZ', 'I-VP', 'O'), ('un-neddylated', 'un-neddylated', 'JJ', 'B-NP', 'B-protein'), ('cullins', 'cullin', 'NNS', 'I-NP', 'I-protein'), ('forming', 'form', 'VBG', 'B-VP', 'I-protein'), ('stable', 'stable', 'JJ', 'B-NP', 'I-protein'), ('CAND1-cullin', 'CAND1-cullin', 'NN', 'I-NP', 'I-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We previously reported that the de-neddylation activity of CSN could be blocked by anti-CSN2 antibody [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('de-neddylation', 'de-neddylation', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CSN', 'CSN', 'NN', 'B-NP', 'B-protein'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('blocked', 'block', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('anti-CSN2', 'anti-CSN2', 'JJ', 'B-NP', 'B-protein'), ('antibody', 'antibody', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with the genetic analysis in Arabidopsis that CSN1-NTD is not required for CSN mediated de-neddylation of Cul1 [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('genetic', 'genetic', 'JJ', 'I-NP', 'O'), ('analysis', 'analysis', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Arabidopsis', 'Arabidopsis', 'NN', 'B-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('CSN1-NTD', 'CSN1-NTD', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('required', 'require', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('CSN', 'CSN', 'NN', 'B-NP', 'B-protein'), ('mediated', 'mediate', 'VBN', 'I-NP', 'O'), ('de-neddylation', 'de-neddylation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Cul1', 'Cul1', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The inhibition constants of two Kazal domains of EPI1 against subtilisin A were predicted using the Laskowski algorithm [ CIT ] based on the sequence of their 10 hypervariable contact residues ( Fig. 1 ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('constants', 'constant', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('Kazal', 'Kazal', 'NNP', 'I-NP', 'O'), ('domains', 'domain', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('EPI1', 'EPI1', 'NN', 'B-NP', 'B-protein'), ('against', 'against', 'IN', 'B-PP', 'O'), ('subtilisin', 'subtilisin', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('predicted', 'predict', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Laskowski', 'Laskowski', 'NNP', 'I-NP', 'O'), ('algorithm', 'algorithm', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('based', 'base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('10', '10', 'CD', 'I-NP', 'O'), ('hypervariable', 'hypervariable', 'JJ', 'I-NP', 'O'), ('contact', 'contact', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We previously showed that rEPI1 interacts with P69B [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('rEPI1', 'rEPI1', 'NN', 'B-NP', 'B-protein'), ('interacts', 'interact', 'VBZ', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('P69B', 'P69B', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	These results are in sharp contrast with those reported for domain LD-6 of LEKTI , which lost 50 % of inhibitory activity after 1 hour of incubation with trypsin and lost all inhibitory effect after 3-4 hours [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('sharp', 'sharp', 'JJ', 'B-NP', 'O'), ('contrast', 'contrast', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('LD-6', 'LD-6', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('LEKTI', 'LEKTI', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('lost', 'lose', 'VBD', 'B-VP', 'O'), ('50', '50', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('inhibitory', 'inhibitory', 'JJ', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('hour', 'hour', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('incubation', 'incubation', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('trypsin', 'trypsin', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('lost', 'lose', 'VBD', 'B-VP', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('inhibitory', 'inhibitory', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('3-4', '3-4', 'CD', 'B-NP', 'O'), ('hours', 'hour', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have demonstrated previously that biologically active 125I-PEDF binds specifically , competitively and with high affinity to cell-surface receptors of Y-79 cells [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('biologically', 'biologically', 'RB', 'B-NP', 'O'), ('active', 'active', 'JJ', 'I-NP', 'O'), ('125I-PEDF', '125I-PEDF', 'NN', 'I-NP', 'O'), ('binds', 'bind', 'VBZ', 'B-VP', 'O'), ('specifically', 'specifically', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('competitively', 'competitively', 'RB', 'B-ADVP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('high', 'high', 'JJ', 'B-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('cell-surface', 'cell-surface', 'JJ', 'B-NP', 'B-protein'), ('receptors', 'receptor', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Y-79', 'Y-79', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Note that with the binding method used , the amount of 125I-PEDF retained in CM without cells is the same to the amount of non-specific 125I-PEDF binding ( reactions with cells and in the presence of 50-fold molar excess of unlabeled PEDF ) [ CIT ] , indicating retention by PEI-treated glass-fiber filters of PEDF-receptor or GAG-PEDF-receptor complexes rather than PEDF-GAG .	[('Note', 'Note', 'VB', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('method', 'method', 'NN', 'I-NP', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amount', 'amount', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('125I-PEDF', '125I-PEDF', 'NN', 'B-NP', 'O'), ('retained', 'retain', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('CM', 'CM', 'NN', 'B-NP', 'B-cell_line'), ('without', 'without', 'IN', 'B-PP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'B-NP', 'I-cell_line'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('amount', 'amount', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('non-specific', 'non-specific', 'JJ', 'B-NP', 'O'), ('125I-PEDF', '125I-PEDF', 'NN', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('reactions', 'reaction', 'NNS', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('50-fold', '50-fold', 'JJ', 'B-NP', 'O'), ('molar', 'molar', 'JJ', 'I-NP', 'O'), ('excess', 'excess', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('unlabeled', 'unlabeled', 'JJ', 'B-NP', 'O'), ('PEDF', 'PEDF', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('indicating', 'indicate', 'VBG', 'B-VP', 'O'), ('retention', 'retention', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('PEI-treated', 'PEI-treated', 'JJ', 'B-NP', 'O'), ('glass-fiber', 'glass-fiber', 'NN', 'I-NP', 'O'), ('filters', 'filter', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('PEDF-receptor', 'PEDF-receptor', 'NN', 'B-NP', 'B-protein'), ('or', 'or', 'CC', 'I-NP', 'O'), ('GAG-PEDF-receptor', 'GAG-PEDF-receptor', 'NN', 'I-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('rather', 'rather', 'RB', 'B-PP', 'O'), ('than', 'than', 'IN', 'I-PP', 'O'), ('PEDF-GAG', 'PEDF-GAG', 'NN', 'B-NP', 'B-protein'), ('.', '.', '.', 'O', 'O')]
2	The collagen and gelation binding domain is reported to localize between R259 / A260 and R1005 / G1006 [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('collagen', 'collagen', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'I-protein'), ('gelation', 'gelation', 'NN', 'I-NP', 'I-protein'), ('binding', 'binding', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('localize', 'localize', 'VB', 'I-VP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('R259', 'R259', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'O'), ('A260', 'A260', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('R1005', 'R1005', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('G1006', 'G1006', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	From a previous study [ CIT ] , 39 carboxyl residues found within protein active sites were selected .	[('From', 'From', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('39', '39', 'CD', 'B-NP', 'O'), ('carboxyl', 'carboxyl', 'NN', 'I-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('found', 'find', 'VBN', 'B-VP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'B-DNA'), ('active', 'active', 'JJ', 'I-NP', 'I-DNA'), ('sites', 'site', 'NNS', 'I-NP', 'I-DNA'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('selected', 'select', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	These are shown in Table 6 [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('6', '6', 'CD', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	The accuracy values obtained for MCCE were also comparable with those that recently appeared on the program 's website , which show an RMSD of 0.77 and an accuracy range of 98 % within the < 2 pH unit range and 84 % accuracy within the < 1 pH unit range [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('accuracy', 'accuracy', 'NN', 'I-NP', 'O'), ('values', 'value', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('MCCE', 'MCCE', 'NN', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('comparable', 'comparable', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('recently', 'recently', 'RB', 'B-ADVP', 'O'), ('appeared', 'appear', 'VBD', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('program', 'program', 'NN', 'I-NP', 'O'), ("'s", "'s", 'POS', 'B-NP', 'O'), ('website', 'website', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('show', 'show', 'VBP', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('RMSD', 'RMSD', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('0.77', '0.77', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('accuracy', 'accuracy', 'NN', 'I-NP', 'O'), ('range', 'range', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('98', '98', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('<', '<', 'SYM', 'I-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('unit', 'unit', 'NN', 'I-NP', 'O'), ('range', 'range', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('84', '84', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('accuracy', 'accuracy', 'NN', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('<', '<', 'SYM', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('pH', 'pH', 'NN', 'I-NP', 'O'), ('unit', 'unit', 'NN', 'I-NP', 'O'), ('range', 'range', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	MEAD , UHBD and MCCE are all based upon an electrostatic continuum model that solves the linearised Poisson-Boltzmann equation numerically [ CIT ] .	[('MEAD', 'MEAD', 'NN', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('UHBD', 'UHBD', 'NN', 'I-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('MCCE', 'MCCE', 'NN', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('all', 'all', 'DT', 'O', 'O'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('upon', 'upon', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('electrostatic', 'electrostatic', 'JJ', 'I-NP', 'O'), ('continuum', 'continuum', 'NN', 'I-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('solves', 'solve', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('linearised', 'linearised', 'JJ', 'I-NP', 'O'), ('Poisson-Boltzmann', 'Poisson-Boltzmann', 'NNP', 'I-NP', 'O'), ('equation', 'equation', 'NN', 'I-NP', 'O'), ('numerically', 'numerically', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
4	PROPKA [ CIT ] takes a different approach to the other three programs , calculating the pKa shift by using empirical rules that incorporate effects from hydrogen bonds , desolvation and Coulombic interactions .	[('PROPKA', 'PROPKA', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('takes', 'take', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('approach', 'approach', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('three', 'three', 'CD', 'I-NP', 'O'), ('programs', 'program', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('calculating', 'calculate', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('pKa', 'pKa', 'NN', 'I-NP', 'O'), ('shift', 'shift', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('empirical', 'empirical', 'JJ', 'B-NP', 'O'), ('rules', 'rule', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('incorporate', 'incorporate', 'VBP', 'B-VP', 'O'), ('effects', 'effect', 'NNS', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('hydrogen', 'hydrogen', 'NN', 'B-NP', 'O'), ('bonds', 'bond', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('desolvation', 'desolvation', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Coulombic', 'Coulombic', 'JJ', 'B-NP', 'O'), ('interactions', 'interaction', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	A previous study reported cloning of a partial cDNA for the catalytic subunit ( p260 ) of Xenopus Pol ε ( xPol ε ) [ CIT ] , and in this report , the corresponding full-length cDNA was cloned by 5 ' Rapid amplification of cDNA ends ( 5 ' Race ) ( see Additional file 1 ) .	[('A', 'A', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('reported', 'report', 'VBD', 'B-VP', 'O'), ('cloning', 'cloning', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('partial', 'partial', 'JJ', 'I-NP', 'O'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'B-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('catalytic', 'catalytic', 'JJ', 'I-NP', 'B-protein'), ('subunit', 'subunit', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('p260', 'p260', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('Pol', 'Pol', 'NN', 'I-NP', 'O'), ('ε', 'ε', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('xPol', 'xPol', 'NN', 'B-NP', 'O'), ('ε', 'ε', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('corresponding', 'correspond', 'VBG', 'I-NP', 'O'), ('full-length', 'full-length', 'JJ', 'I-NP', 'O'), ('cDNA', 'cDNA', 'NN', 'I-NP', 'B-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('cloned', 'clone', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ("'", "'", 'SYM', 'I-NP', 'O'), ('Rapid', 'Rapid', 'JJ', 'I-NP', 'O'), ('amplification', 'amplification', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cDNA', 'cDNA', 'NN', 'B-NP', 'B-DNA'), ('ends', 'end', 'VBZ', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ("'", "'", 'SYM', 'I-NP', 'O'), ('Race', 'Race', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('Additional', 'Additional', 'JJ', 'B-NP', 'O'), ('file', 'file', 'NN', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The predicted amino acid sequences of p12 and p17 showed very high similarity to p12 and p17 of human Pol ε , respectively [ CIT ] ( see Additional file 4 ) , confirming the identity of the cloned cDNAs .	[('The', 'The', 'DT', 'B-NP', 'O'), ('predicted', 'predict', 'VBN', 'I-NP', 'O'), ('amino', 'amino', 'JJ', 'I-NP', 'O'), ('acid', 'acid', 'NN', 'I-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('p12', 'p12', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('p17', 'p17', 'NN', 'I-NP', 'B-protein'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('very', 'very', 'RB', 'B-NP', 'O'), ('high', 'high', 'JJ', 'I-NP', 'O'), ('similarity', 'similarity', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('p12', 'p12', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('p17', 'p17', 'NN', 'I-NP', 'B-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('Pol', 'Pol', 'NN', 'I-NP', 'O'), ('ε', 'ε', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('respectively', 'respectively', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('Additional', 'Additional', 'JJ', 'B-NP', 'O'), ('file', 'file', 'NN', 'I-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('confirming', 'confirm', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cloned', 'clone', 'VBN', 'I-NP', 'B-DNA'), ('cDNAs', 'cDNA', 'NNS', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
3	For these experiments , p260 deletion mutants were fused to the FLAG epitope tag ( Fig. 1A ) and the following mutants were generated : ( a ) FLAG-p260full , ( b ) FLAG-p260ΔC2157 , ( c ) FLAG-p260ΔC1054 , ( d ) FLAG-p260D860N , and ( e ) FLAG-p260ΔCat ( equivalent to yeast Pol2-16p [ CIT ] ) .	[('For', 'For', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('p260', 'p260', 'NN', 'B-NP', 'B-protein'), ('deletion', 'deletion', 'NN', 'I-NP', 'I-protein'), ('mutants', 'mutant', 'NNS', 'I-NP', 'I-protein'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('fused', 'fuse', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('FLAG', 'FLAG', 'NN', 'I-NP', 'O'), ('epitope', 'epitope', 'NN', 'I-NP', 'O'), ('tag', 'tag', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('1A', '1A', 'NN', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('following', 'follow', 'VBG', 'I-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('generated', 'generate', 'VBN', 'I-VP', 'O'), (':', ':', ':', 'O', 'O'), ('(', '(', '(', 'B-LST', 'O'), ('a', 'a', 'LS', 'I-LST', 'O'), (')', ')', ')', 'O', 'O'), ('FLAG-p260full', 'FLAG-p260full', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('b', 'b', 'NN', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('FLAG-p260ΔC2157', 'FLAG-p260ΔC2157', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('c', 'c', 'NN', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('FLAG-p260ΔC1054', 'FLAG-p260ΔC1054', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('(', '(', '(', 'B-LST', 'O'), ('d', 'd', 'LS', 'I-LST', 'O'), (')', ')', ')', 'O', 'O'), ('FLAG-p260D860N', 'FLAG-p260D860N', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('(', '(', '(', 'B-LST', 'O'), ('e', 'e', 'LS', 'I-LST', 'O'), (')', ')', ')', 'O', 'O'), ('FLAG-p260ΔCat', 'FLAG-p260ΔCat', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('equivalent', 'equivalent', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('Pol2-16p', 'Pol2-16p', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies suggested that Cdc45p , Cut5p , and GINS are critical for loading Pol α and Pol ε onto DNA replication origins and for initiating chromosomal DNA replication in yeast and Xenopus egg extracts [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('suggested', 'suggest', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Cdc45p', 'Cdc45p', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Cut5p', 'Cut5p', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('GINS', 'GINS', 'NN', 'B-NP', 'B-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('critical', 'critical', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('loading', 'load', 'VBG', 'B-VP', 'O'), ('Pol', 'Pol', 'NN', 'B-NP', 'B-protein'), ('α', 'α', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('Pol', 'Pol', 'NN', 'B-NP', 'B-protein'), ('ε', 'ε', 'NN', 'I-NP', 'I-protein'), ('onto', 'onto', 'IN', 'B-PP', 'O'), ('DNA', 'DNA', 'NN', 'B-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('origins', 'origin', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'B-PP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('initiating', 'initiate', 'VBG', 'B-VP', 'O'), ('chromosomal', 'chromosomal', 'JJ', 'B-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Xenopus', 'Xenopus', 'NN', 'B-NP', 'O'), ('egg', 'egg', 'NN', 'I-NP', 'O'), ('extracts', 'extract', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies demonstrated a direct interaction between yeast GINS and yeast Pol ε holoenzyme and that this interaction stimulates the rate and processivity of DNA synthesis by Pol ε holoenzyme [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('demonstrated', 'demonstrate', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('direct', 'direct', 'JJ', 'I-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('GINS', 'GINS', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-protein'), ('Pol', 'Pol', 'NN', 'I-NP', 'I-protein'), ('ε', 'ε', 'NN', 'I-NP', 'I-protein'), ('holoenzyme', 'holoenzyme', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('stimulates', 'stimulate', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rate', 'rate', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('processivity', 'processivity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('DNA', 'DNA', 'NN', 'B-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Pol', 'Pol', 'NN', 'B-NP', 'B-protein'), ('ε', 'ε', 'NN', 'I-NP', 'I-protein'), ('holoenzyme', 'holoenzyme', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	A similar result was obtained using r-xPol ε and r-xGINS [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('similar', 'similar', 'JJ', 'I-NP', 'O'), ('result', 'result', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('r-xPol', 'r-xPol', 'NN', 'B-NP', 'B-protein'), ('ε', 'ε', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('r-xGINS', 'r-xGINS', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Of these , one recognized CD63 as reported previously [ CIT ] , and three ( including mAb 6B12 ) recognized a disulfide-linked cell surface heterodimer consisting of an 85 kD heavy chain and a 35 kD light chain .	[('Of', 'Of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('recognized', 'recognize', 'VBD', 'B-VP', 'O'), ('CD63', 'CD63', 'NN', 'B-NP', 'B-protein'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('three', 'three', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('including', 'include', 'VBG', 'B-PP', 'O'), ('mAb', 'mAb', 'NN', 'B-NP', 'O'), ('6B12', '6B12', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('recognized', 'recognize', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('disulfide-linked', 'disulfide-linked', 'JJ', 'I-NP', 'B-protein'), ('cell', 'cell', 'NN', 'I-NP', 'I-protein'), ('surface', 'surface', 'NN', 'I-NP', 'I-protein'), ('heterodimer', 'heterodimer', 'NN', 'I-NP', 'I-protein'), ('consisting', 'consist', 'VBG', 'B-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('85', '85', 'CD', 'I-NP', 'B-protein'), ('kD', 'kD', 'NN', 'I-NP', 'I-protein'), ('heavy', 'heavy', 'JJ', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('35', '35', 'CD', 'I-NP', 'B-protein'), ('kD', 'kD', 'NN', 'I-NP', 'I-protein'), ('light', 'light', 'JJ', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
3	Because the proteins recognized by 6B12 resembled the disulfide-linked 85 and 35 kD subunits of CD98 [ CIT ] , they were compared to authentic CD98 as precipitated using mAb 4F2 .	[('Because', 'Because', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('recognized', 'recognize', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('6B12', '6B12', 'NN', 'B-NP', 'B-protein'), ('resembled', 'resemble', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('disulfide-linked', 'disulfide-linked', 'JJ', 'I-NP', 'B-protein'), ('85', '85', 'CD', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'I-NP', 'I-protein'), ('35', '35', 'CD', 'I-NP', 'I-protein'), ('kD', 'kD', 'NN', 'I-NP', 'I-protein'), ('subunits', 'subunit', 'NNS', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CD98', 'CD98', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('compared', 'compare', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('authentic', 'authentic', 'JJ', 'B-NP', 'O'), ('CD98', 'CD98', 'NN', 'I-NP', 'B-protein'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('precipitated', 'precipitate', 'VBN', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('mAb', 'mAb', 'NN', 'B-NP', 'B-protein'), ('4F2', '4F2', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
7	Thus , although manganese is well known to " activate " β1 integrins [ CIT ] , this activation may not be relevant to α4β1-CD98 association .	[('Thus', 'Thus', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('manganese', 'manganese', 'NN', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('well', 'well', 'RB', 'I-VP', 'O'), ('known', 'know', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('``', '``', '``', 'O', 'O'), ('activate', 'activate', 'VB', 'B-VP', 'O'), ('``', '``', '``', 'O', 'O'), ('β1', 'β1', 'NN', 'B-NP', 'B-protein'), ('integrins', 'integrin', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('relevant', 'relevant', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('α4β1-CD98', 'α4β1-CD98', 'NN', 'B-NP', 'B-protein'), ('association', 'association', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	Results in Fig. 2A and 2B indicate that CD98-integrin complexes are distinct from previously described integrin-CD81 [ CIT ] complexes .	[('Results', 'Result', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('2B', '2B', 'NN', 'I-NP', 'O'), ('indicate', 'indicate', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('CD98-integrin', 'CD98-integrin', 'NN', 'B-NP', 'B-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('distinct', 'distinct', 'JJ', 'B-ADJP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('integrin-CD81', 'integrin-CD81', 'NN', 'I-NP', 'B-protein'), ('[', '[', '(', 'I-NP', 'I-protein'), ('CIT', 'CIT', 'NN', 'I-NP', 'I-protein'), (']', ']', ')', 'I-NP', 'I-protein'), ('complexes', 'complex', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
5	Notably , association of CD98 heavy chain with CD98 light chain was maintained for the C330S mutant , but was lost for the C109S mutant ( not shown ) , in agreement with previously published results suggesting that Cysteine 109 is required for disulfide linkage to the light chain [ CIT ] .	[('Notably', 'Notably', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('association', 'association', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CD98', 'CD98', 'NN', 'B-NP', 'B-protein'), ('heavy', 'heavy', 'JJ', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('with', 'with', 'IN', 'B-PP', 'O'), ('CD98', 'CD98', 'NN', 'B-NP', 'B-protein'), ('light', 'light', 'JJ', 'I-NP', 'O'), ('chain', 'chain', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('maintained', 'maintain', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C330S', 'C330S', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('lost', 'lose', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('C109S', 'C109S', 'NN', 'I-NP', 'B-protein'), ('mutant', 'mutant', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('suggesting', 'suggest', 'VBG', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('Cysteine', 'Cysteine', 'NN', 'B-NP', 'B-protein'), ('109', '109', 'CD', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('required', 'require', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('disulfide', 'disulfide', 'NN', 'B-NP', 'O'), ('linkage', 'linkage', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('light', 'light', 'JJ', 'I-NP', 'O'), ('chain', 'chain', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Similarly , GPI-linked proteins such as CD 109 , TM4SF proteins such as CD81 , and other transmembrane proteins such as CD147 / EMMPRIN can be found at substantial levels in light membrane fractions [ CIT ] , and our unpublished results ) , and these also did not co-immunoprecipitate with CD98 ( Fig. 2A , 2B ) .	[('Similarly', 'Similarly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('GPI-linked', 'GPI-linked', 'JJ', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('CD', 'CD', 'NNP', 'B-NP', 'B-protein'), ('109', '109', 'CD', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('TM4SF', 'TM4SF', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('CD81', 'CD81', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('transmembrane', 'transmembrane', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('CD147', 'CD147', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('EMMPRIN', 'EMMPRIN', 'NN', 'I-NP', 'I-protein'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('substantial', 'substantial', 'JJ', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('light', 'light', 'JJ', 'B-NP', 'O'), ('membrane', 'membrane', 'NN', 'I-NP', 'O'), ('fractions', 'fraction', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('unpublished', 'unpublished', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('co-immunoprecipitate', 'co-immunoprecipitate', 'VB', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('CD98', 'CD98', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('2A', '2A', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('2B', '2B', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The CD98 protein was recently shown to associate specifically with integrin β chain cytoplasmic tail fusion proteins [ CIT ] in 0.05 % Triton X-100 detergent conditions .	[('The', 'The', 'DT', 'B-NP', 'O'), ('CD98', 'CD98', 'NN', 'I-NP', 'B-protein'), ('protein', 'protein', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('associate', 'associate', 'VB', 'I-VP', 'O'), ('specifically', 'specifically', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('integrin', 'integrin', 'NN', 'B-NP', 'B-protein'), ('β', 'β', 'NN', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('cytoplasmic', 'cytoplasmic', 'JJ', 'I-NP', 'I-protein'), ('tail', 'tail', 'NN', 'I-NP', 'I-protein'), ('fusion', 'fusion', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('0.05', '0.05', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('Triton', 'Triton', 'NN', 'I-NP', 'O'), ('X-100', 'X-100', 'NN', 'I-NP', 'O'), ('detergent', 'detergent', 'NN', 'I-NP', 'O'), ('conditions', 'condition', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	Although the role of the CD98 light chain was not addressed in the earlier study [ CIT ] , we assume that it may have played a key role .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('CD98', 'CD98', 'NN', 'I-NP', 'B-protein'), ('light', 'light', 'JJ', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('addressed', 'address', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('earlier', 'early', 'JJR', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('assume', 'assume', 'VBP', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('may', 'may', 'MD', 'B-VP', 'O'), ('have', 'have', 'VB', 'I-VP', 'O'), ('played', 'play', 'VBN', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('key', 'key', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	Furthermore , CD98 interaction with recombinant β chain cytoplasmic tail fusion proteins , in the absence of the α chain [ CIT ] , is consistent with our observation that the α chain cytoplasmic tail is not needed for integrin-CD98 association .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('CD98', 'CD98', 'NN', 'B-NP', 'B-protein'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('recombinant', 'recombinant', 'JJ', 'B-NP', 'B-protein'), ('β', 'β', 'NN', 'I-NP', 'I-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('cytoplasmic', 'cytoplasmic', 'JJ', 'I-NP', 'I-protein'), ('tail', 'tail', 'NN', 'I-NP', 'I-protein'), ('fusion', 'fusion', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('absence', 'absence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α', 'α', 'NN', 'I-NP', 'B-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('observation', 'observation', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('α', 'α', 'NN', 'I-NP', 'B-protein'), ('chain', 'chain', 'NN', 'I-NP', 'I-protein'), ('cytoplasmic', 'cytoplasmic', 'JJ', 'I-NP', 'I-protein'), ('tail', 'tail', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('needed', 'need', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('integrin-CD98', 'integrin-CD98', 'NN', 'B-NP', 'B-protein'), ('association', 'association', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
1	To compare quantitatively the relative affinity of SET / TAF-Iβ for histones H3 and H2B , we performed fluorescence-based titration experiments [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('compare', 'compare', 'VB', 'I-VP', 'O'), ('quantitatively', 'quantitatively', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('relative', 'relative', 'JJ', 'I-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('SET', 'SET', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'I-NP', 'B-protein'), ('for', 'for', 'IN', 'B-PP', 'O'), ('histones', 'histone', 'NNS', 'B-NP', 'B-protein'), ('H3', 'H3', 'NN', 'I-NP', 'I-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('H2B', 'H2B', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('performed', 'perform', 'VBD', 'B-VP', 'O'), ('fluorescence-based', 'fluorescence-based', 'JJ', 'B-NP', 'O'), ('titration', 'titration', 'NN', 'I-NP', 'O'), ('experiments', 'experiment', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	In this sense , SET / TAF-Iβ behaves similarly to NAP1 from yeast , Drosophila and humans which have been shown to preferentially bind the ( H3 / H4 ) 2 tetramer in vitro [ CIT ] , although NAP family members have generally been described as H2A / H2B chaperones .	[('In', 'In', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('sense', 'sense', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('SET', 'SET', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'I-NP', 'B-protein'), ('behaves', 'behave', 'VBZ', 'B-VP', 'O'), ('similarly', 'similarly', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('NAP1', 'NAP1', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('Drosophila', 'Drosophila', 'FW', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('humans', 'human', 'NNS', 'B-NP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('preferentially', 'preferentially', 'RB', 'I-VP', 'O'), ('bind', 'bind', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('H3', 'H3', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('H4', 'H4', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), ('tetramer', 'tetramer', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('although', 'although', 'IN', 'B-SBAR', 'O'), ('NAP', 'NAP', 'NN', 'B-NP', 'B-protein'), ('family', 'family', 'NN', 'I-NP', 'I-protein'), ('members', 'member', 'NNS', 'I-NP', 'I-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('generally', 'generally', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('H2A', 'H2A', 'NN', 'B-NP', 'B-protein'), ('/', '/', 'SYM', 'B-VP', 'O'), ('H2B', 'H2B', 'NN', 'B-NP', 'O'), ('chaperones', 'chaperone', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	On the contrary , yeast NAP1 is capable of binding to linker histone H1 [ CIT ] , while our data rule out such a possibility for SET / TAF-Iβ ( Fig. 1A , lane 2 ) .	[('On', 'On', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('contrary', 'contrary', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-protein'), ('NAP1', 'NAP1', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('capable', 'capable', 'JJ', 'B-ADJP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('binding', 'bind', 'VBG', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('linker', 'linker', 'NN', 'B-NP', 'B-protein'), ('histone', 'histone', 'NN', 'I-NP', 'I-protein'), ('H1', 'H1', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('rule', 'rule', 'VBP', 'B-VP', 'O'), ('out', 'out', 'RP', 'B-PRT', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('a', 'a', 'DT', 'I-NP', 'O'), ('possibility', 'possibility', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('SET', 'SET', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'B-NP', 'B-protein'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('lane', 'lane', 'NN', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	NAP1 from yeast and humans has also been shown to facilitate the removal of H2A-H2B dimers from a folded nucleosome [ CIT ] .	[('NAP1', 'NAP1', 'NN', 'B-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('humans', 'human', 'NNS', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('facilitate', 'facilitate', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('removal', 'removal', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('H2A-H2B', 'H2A-H2B', 'NN', 'B-NP', 'B-protein'), ('dimers', 'dimer', 'NNS', 'I-NP', 'I-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('folded', 'fold', 'VBN', 'I-NP', 'O'), ('nucleosome', 'nucleosome', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Based on sequence comparisons between human SET / TAF-Iβ and members of the Nucleosome Assembly Protein ( NAP ) family , in particular NAP-1 from yeast , whose three-dimensional structure was recently solved [ CIT ] ( PDB ID : 2AYU ) , we designed several deletion mutants of SET / TAF-Iβ , shown in Fig. 2A .	[('Based', 'Base', 'VBN', 'B-PP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('sequence', 'sequence', 'NN', 'B-NP', 'O'), ('comparisons', 'comparison', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('SET', 'SET', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'I-NP', 'O'), ('members', 'member', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Nucleosome', 'Nucleosome', 'NN', 'I-NP', 'B-protein'), ('Assembly', 'Assembly', 'NN', 'I-NP', 'I-protein'), ('Protein', 'Protein', 'NN', 'I-NP', 'I-protein'), ('(', '(', '(', 'O', 'O'), ('NAP', 'NAP', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('family', 'family', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('particular', 'particular', 'JJ', 'B-NP', 'O'), ('NAP-1', 'NAP-1', 'NN', 'I-NP', 'B-protein'), ('from', 'from', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('whose', 'whose', 'WP$', 'B-NP', 'O'), ('three-dimensional', 'three-dimensional', 'JJ', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('solved', 'solve', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('PDB', 'PDB', 'NN', 'B-NP', 'O'), ('ID', 'ID', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('2AYU', '2AYU', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('designed', 'design', 'VBD', 'B-VP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('deletion', 'deletion', 'NN', 'I-NP', 'O'), ('mutants', 'mutant', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('SET', 'SET', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'I-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('2A', '2A', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous structural and biochemical studies have underlined the essential role of the central region of NAP1 proteins in the interaction with histones ; the β-sheet subdomain , which is part of this region , is structurally conserved in otherwise unrelated in sequence and structure histone chaperones and is believed to form a scaffold onto which histone binding elements are built [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('structural', 'structural', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('biochemical', 'biochemical', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('underlined', 'underline', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('essential', 'essential', 'JJ', 'I-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('central', 'central', 'JJ', 'I-NP', 'B-protein'), ('region', 'region', 'NN', 'I-NP', 'I-protein'), ('of', 'of', 'IN', 'B-PP', 'O'), ('NAP1', 'NAP1', 'NN', 'B-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('histones', 'histone', 'NNS', 'B-NP', 'B-protein'), (';', ';', ':', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('β-sheet', 'β-sheet', 'JJ', 'I-NP', 'B-protein'), ('subdomain', 'subdomain', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('part', 'part', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('structurally', 'structurally', 'RB', 'I-VP', 'O'), ('conserved', 'conserve', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('otherwise', 'otherwise', 'RB', 'B-ADJP', 'O'), ('unrelated', 'unrelated', 'JJ', 'I-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('sequence', 'sequence', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('histone', 'histone', 'NN', 'I-NP', 'O'), ('chaperones', 'chaperone', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('believed', 'believe', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('form', 'form', 'VB', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('scaffold', 'scaffold', 'NN', 'I-NP', 'O'), ('onto', 'onto', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('histone', 'histone', 'NN', 'B-NP', 'B-DNA'), ('binding', 'binding', 'NN', 'I-NP', 'I-DNA'), ('elements', 'element', 'NNS', 'I-NP', 'I-DNA'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('built', 'build', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	The homologous region of yeast NAP1 has been shown to be crucial for the interaction with histones and has been termed " protein interaction domain " [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('homologous', 'homologous', 'JJ', 'I-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-protein'), ('NAP1', 'NAP1', 'NN', 'I-NP', 'I-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('crucial', 'crucial', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('histones', 'histone', 'NNS', 'B-NP', 'B-protein'), ('and', 'and', 'CC', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('termed', 'term', 'VBN', 'I-VP', 'O'), ('``', '``', '``', 'O', 'O'), ('protein', 'protein', 'NN', 'B-NP', 'B-protein'), ('interaction', 'interaction', 'NN', 'I-NP', 'I-protein'), ('domain', 'domain', 'NN', 'I-NP', 'I-protein'), ('``', '``', '``', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Our data are in agreement with previous observations on the 1 : 1 stoichiometry for yeast NAP1 / H3 interaction [ CIT ] .	[('Our', 'Our', 'PRP$', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (':', ':', 'SYM', 'I-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), ('stoichiometry', 'stoichiometry', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('yeast', 'yeast', 'NN', 'B-NP', 'B-protein'), ('NAP1', 'NAP1', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-VP', 'O'), ('H3', 'H3', 'NN', 'B-NP', 'O'), ('interaction', 'interaction', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This finding contradicts a previous study showing direct binding of SET / TAF-Iβ to the H3 N-terminal tail , which is disrupted when the tail is modified [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('finding', 'finding', 'NN', 'I-NP', 'O'), ('contradicts', 'contradict', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('showing', 'show', 'VBG', 'B-VP', 'O'), ('direct', 'direct', 'JJ', 'B-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('SET', 'SET', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('TAF-Iβ', 'TAF-Iβ', 'NN', 'I-NP', 'B-protein'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('H3', 'H3', 'NN', 'I-NP', 'B-protein'), ('N-terminal', 'N-terminal', 'JJ', 'I-NP', 'I-protein'), ('tail', 'tail', 'NN', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('disrupted', 'disrupt', 'VBN', 'I-VP', 'O'), ('when', 'when', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('tail', 'tail', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('modified', 'modify', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Overall , Drosophila PCNA is > 70 % identical to that from mammals ( e.g. , humans ; see [ CIT ] ) .	[('Overall', 'Overall', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('Drosophila', 'Drosophila', 'FW', 'B-NP', 'B-protein'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'I-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('>', '>', 'JJR', 'B-NP', 'O'), ('70', '70', 'CD', 'I-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('identical', 'identical', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('mammals', 'mammal', 'NNS', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('e.g.', 'e.g.', 'FW', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('humans', 'human', 'NNS', 'B-NP', 'O'), (';', ';', ':', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Others showed that PCNA residues 123 , 126 , 127 and 128 were essential for interaction with pol δ [ CIT ] .	[('Others', 'Other', 'NNS', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('PCNA', 'PCNA', 'NN', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('123', '123', 'CD', 'B-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('126', '126', 'CD', 'I-NP', 'O'), (',', ',', ',', 'I-NP', 'O'), ('127', '127', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('128', '128', 'CD', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('essential', 'essential', 'JJ', 'B-ADJP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('interaction', 'interaction', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('pol', 'pol', 'NN', 'B-NP', 'B-protein'), ('δ', 'δ', 'NN', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The identity of wild-type human PCNA was confirmed using mouse monoclonal anti-mammalian PCNA antibody PC10 ; the identity of wild-type Drosophila PCNA was confirmed using affinity purified polyclonal anti-Drosophila PCNA antibodies prepared in rabbits [ CIT ] ( not shown ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild-type', 'wild-type', 'JJ', 'B-NP', 'B-protein'), ('human', 'human', 'JJ', 'I-NP', 'I-protein'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('mouse', 'mouse', 'NN', 'B-NP', 'O'), ('monoclonal', 'monoclonal', 'JJ', 'I-NP', 'O'), ('anti-mammalian', 'anti-mammalian', 'JJ', 'I-NP', 'O'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'O'), ('antibody', 'antibody', 'NN', 'I-NP', 'O'), ('PC10', 'PC10', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('identity', 'identity', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('wild-type', 'wild-type', 'JJ', 'B-NP', 'B-protein'), ('Drosophila', 'Drosophila', 'FW', 'I-NP', 'I-protein'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'I-protein'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('confirmed', 'confirm', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('affinity', 'affinity', 'NN', 'B-NP', 'O'), ('purified', 'purify', 'VBN', 'B-VP', 'O'), ('polyclonal', 'polyclonal', 'JJ', 'B-NP', 'O'), ('anti-Drosophila', 'anti-Drosophila', 'JJ', 'I-NP', 'B-protein'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'I-protein'), ('antibodies', 'antibody', 'NNS', 'I-NP', 'I-protein'), ('prepared', 'prepare', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('rabbits', 'rabbit', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('not', 'not', 'RB', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Calf thymus pol δ ( apparently homogeneous two-subunit form ; see [ CIT ] ) was purified and assayed for polymerase activity in the presence of varying concentrations of both highly purified wild-type and specific mutant PCNA molecules .	[('Calf', 'Calf', 'NN', 'B-NP', 'O'), ('thymus', 'thymus', 'NN', 'I-NP', 'O'), ('pol', 'pol', 'NN', 'I-NP', 'O'), ('δ', 'δ', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('apparently', 'apparently', 'RB', 'B-NP', 'O'), ('homogeneous', 'homogeneous', 'JJ', 'I-NP', 'O'), ('two-subunit', 'two-subunit', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('[', '[', '(', 'B-NP', 'O'), ('CIT', 'CIT', 'NN', 'I-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('purified', 'purify', 'VBN', 'I-VP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('assayed', 'assay', 'VBN', 'B-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('polymerase', 'polymerase', 'NN', 'B-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('presence', 'presence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('varying', 'vary', 'VBG', 'B-VP', 'O'), ('concentrations', 'concentration', 'NNS', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'B-NP', 'O'), ('highly', 'highly', 'RB', 'I-NP', 'O'), ('purified', 'purify', 'VBN', 'I-NP', 'O'), ('wild-type', 'wild-type', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('specific', 'specific', 'JJ', 'I-NP', 'O'), ('mutant', 'mutant', 'JJ', 'I-NP', 'B-protein'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'I-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
1	We showed previously that either calf thymus or human PCNA could be used interchangeably as stimulatory co-factors for calf thymus pol δ [ CIT ] ) .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('either', 'either', 'CC', 'O', 'O'), ('calf', 'calf', 'NN', 'B-NP', 'O'), ('thymus', 'thymus', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('PCNA', 'PCNA', 'NN', 'I-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('interchangeably', 'interchangeably', 'RB', 'B-ADVP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('stimulatory', 'stimulatory', 'JJ', 'B-NP', 'B-protein'), ('co-factors', 'co-factor', 'NNS', 'I-NP', 'I-protein'), ('for', 'for', 'IN', 'B-PP', 'O'), ('calf', 'calf', 'NN', 'B-NP', 'O'), ('thymus', 'thymus', 'NN', 'I-NP', 'O'), ('pol', 'pol', 'NN', 'I-NP', 'O'), ('δ', 'δ', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is also consistent with activity data presented herein ( Fig. 3 ) as well as with results reported previously [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('activity', 'activity', 'NN', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('presented', 'present', 'VBN', 'B-VP', 'O'), ('herein', 'herein', 'RB', 'B-ADVP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'B-protein'), ('3', '3', 'CD', 'I-NP', 'I-protein'), (')', ')', ')', 'O', 'O'), ('as', 'as', 'RB', 'B-CONJP', 'O'), ('well', 'well', 'RB', 'I-CONJP', 'O'), ('as', 'as', 'IN', 'I-CONJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('results', 'result', 'NNS', 'B-NP', 'O'), ('reported', 'report', 'VBN', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	PCNA-dependent TLS by pol δ was first reported by O'Day et al. [ CIT ] .	[('PCNA-dependent', 'PCNA-dependent', 'JJ', 'B-NP', 'O'), ('TLS', 'TLS', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('pol', 'pol', 'NN', 'B-NP', 'O'), ('δ', 'δ', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('first', 'first', 'RB', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ("O'Day", "O'Day", 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	For the data shown ( Fig. 6B ) , X represents the model abasic site ( hereafter termed the abasic site [ CIT ] ) .	[('For', 'For', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NNP', 'B-NP', 'O'), ('6B', '6B', 'NN', 'I-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('X', 'X', 'NN', 'B-NP', 'B-DNA'), ('represents', 'represent', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('model', 'model', 'JJ', 'I-NP', 'O'), ('abasic', 'abasic', 'JJ', 'I-NP', 'O'), ('site', 'site', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('hereafter', 'hereafter', 'RB', 'B-VP', 'O'), ('termed', 'term', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('abasic', 'abasic', 'JJ', 'I-NP', 'O'), ('site', 'site', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Such isozymes have been reported previously [ CIT ] .	[('Such', 'Such', 'JJ', 'B-NP', 'O'), ('isozymes', 'isozyme', 'NNS', 'I-NP', 'B-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It was shown previously that APN may be purified with intact GPI-anchors if PIPLC is omitted from the preparation buffer [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('APN', 'APN', 'NN', 'B-NP', 'B-protein'), ('may', 'may', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('purified', 'purify', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('intact', 'intact', 'JJ', 'B-NP', 'O'), ('GPI-anchors', 'GPI-anchor', 'NNS', 'I-NP', 'O'), ('if', 'if', 'IN', 'B-SBAR', 'O'), ('PIPLC', 'PIPLC', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('omitted', 'omit', 'VBN', 'I-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('preparation', 'preparation', 'NN', 'I-NP', 'O'), ('buffer', 'buffer', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The overall affinity determined in the present study for Cry1Aa to BtR175 ( 2.6 nM ) agrees well with the findings of Ihara et al. [ CIT ] by a different assay ( 0.8 nM ) .	[('The', 'The', 'DT', 'B-NP', 'O'), ('overall', 'overall', 'JJ', 'I-NP', 'O'), ('affinity', 'affinity', 'NN', 'I-NP', 'O'), ('determined', 'determine', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('present', 'present', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('Cry1Aa', 'Cry1Aa', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('BtR175', 'BtR175', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('2.6', '2.6', 'CD', 'B-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('agrees', 'agree', 'VBZ', 'B-VP', 'O'), ('well', 'well', 'RB', 'B-ADVP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Ihara', 'Ihara', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('0.8', '0.8', 'CD', 'B-NP', 'O'), ('nM', 'nM', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	Hybrid toxin 4109 is particular useful in this context , because it is comprised of domains I and II from Cry1Aa and domain III from Cry1Ac ( Aa / Aa / Ac ) [ CIT ] .	[('Hybrid', 'Hybrid', 'JJ', 'B-NP', 'O'), ('toxin', 'toxin', 'NN', 'I-NP', 'O'), ('4109', '4109', 'CD', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('particular', 'particular', 'JJ', 'B-ADJP', 'O'), ('useful', 'useful', 'JJ', 'B-ADJP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('context', 'context', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('it', 'it', 'PRP', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('comprised', 'comprise', 'VBN', 'I-VP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('domains', 'domain', 'NNS', 'B-NP', 'O'), ('I', 'I', 'CD', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('II', 'II', 'CD', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Cry1Aa', 'Cry1Aa', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('domain', 'domain', 'NN', 'B-NP', 'O'), ('III', 'III', 'CD', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('Cry1Ac', 'Cry1Ac', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Aa', 'Aa', 'NN', 'B-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('Aa', 'Aa', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('Ac', 'Ac', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The starting structure is planar and undulations form in the first 1.5 ns of the simulation ( Fig. 1A , 1B ) , which has also been observed in an equilibrium simulation of a bilayer half this size [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('starting', 'start', 'VBG', 'I-NP', 'O'), ('structure', 'structure', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('planar', 'planar', 'JJ', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('undulations', 'undulations', 'JJ', 'I-NP', 'O'), ('form', 'form', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('first', 'first', 'JJ', 'I-NP', 'O'), ('1.5', '1.5', 'CD', 'I-NP', 'O'), ('ns', 'n', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('simulation', 'simulation', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('1A', '1A', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('1B', '1B', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('equilibrium', 'equilibrium', 'NN', 'I-NP', 'O'), ('simulation', 'simulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('bilayer', 'bilayer', 'NN', 'I-NP', 'O'), ('half', 'half', 'NN', 'I-NP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('size', 'size', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Lewis and coworkers mapped the RRE within HIV-2 env [ CIT ] and showed that the RRE activity was localized within a 1045 bp fragment .	[('Lewis', 'Lewis', 'NNP', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('coworkers', 'coworker', 'NNS', 'I-NP', 'O'), ('mapped', 'map', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RRE', 'RRE', 'NN', 'I-NP', 'B-DNA'), ('within', 'within', 'IN', 'B-PP', 'O'), ('HIV-2', 'HIV-2', 'NN', 'B-NP', 'O'), ('env', 'env', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RRE', 'RRE', 'NN', 'I-NP', 'O'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('localized', 'localize', 'VBN', 'I-VP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('1045', '1045', 'CD', 'I-NP', 'B-DNA'), ('bp', 'bp', 'NN', 'I-NP', 'I-DNA'), ('fragment', 'fragment', 'NN', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
5	The results , demonstrating the non-reciprocal nature of interaction of HIV-1 and HIV-2 or SIV Revs with the homologous and heterologous RREs , are consistent with the previous observations of Lewis , et al. [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('demonstrating', 'demonstrate', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('non-reciprocal', 'non-reciprocal', 'JJ', 'I-NP', 'O'), ('nature', 'nature', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('interaction', 'interaction', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('HIV-2', 'HIV-2', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'I-NP', 'O'), ('SIV', 'SIV', 'NN', 'I-NP', 'O'), ('Revs', 'Rev', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('homologous', 'homologous', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('heterologous', 'heterologous', 'JJ', 'I-NP', 'B-DNA'), ('RREs', 'RRE', 'NNS', 'I-NP', 'I-DNA'), (',', ',', ',', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Lewis', 'Lewis', 'NNP', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('et', 'et', 'FW', 'B-ADVP', 'O'), ('al.', 'al.', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	A previous study [ CIT ] , using a luciferase-based reporter system , showed that the SIV RRE rendered the reporter less susceptible to inhibition by Rev M10 .	[('A', 'A', 'DT', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('luciferase-based', 'luciferase-based', 'JJ', 'I-NP', 'B-cell_line'), ('reporter', 'reporter', 'NN', 'I-NP', 'I-cell_line'), ('system', 'system', 'NN', 'I-NP', 'I-cell_line'), (',', ',', ',', 'O', 'O'), ('showed', 'show', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('SIV', 'SIV', 'NN', 'I-NP', 'O'), ('RRE', 'RRE', 'NN', 'I-NP', 'O'), ('rendered', 'render', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('reporter', 'reporter', 'NN', 'I-NP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('susceptible', 'susceptible', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('inhibition', 'inhibition', 'NN', 'B-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Rev', 'Rev', 'NN', 'B-NP', 'B-protein'), ('M10', 'M10', 'NN', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
1	This occurred despite the use of lower amounts of pCI-HIV Rev. A second experiment , using a different HIV-1 vector ( pN-GIT72 ) [ CIT ] with the control HIV-1 RRE-based packaging system , provided comparable results ( see Additional File 2 ) .	[('This', 'This', 'DT', 'B-NP', 'O'), ('occurred', 'occur', 'VBD', 'B-VP', 'O'), ('despite', 'despite', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('use', 'use', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('lower', 'low', 'JJR', 'B-NP', 'O'), ('amounts', 'amount', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('pCI-HIV', 'pCI-HIV', 'NN', 'B-NP', 'O'), ('Rev.', 'Rev.', 'NNP', 'I-NP', 'O'), ('A', 'A', 'NNP', 'I-NP', 'O'), ('second', 'second', 'JJ', 'I-NP', 'O'), ('experiment', 'experiment', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('vector', 'vector', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('pN-GIT72', 'pN-GIT72', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('control', 'control', 'NN', 'I-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('RRE-based', 'RRE-based', 'JJ', 'I-NP', 'O'), ('packaging', 'packaging', 'NN', 'I-NP', 'O'), ('system', 'system', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('provided', 'provide', 'VBN', 'B-NP', 'O'), ('comparable', 'comparable', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('see', 'see', 'VB', 'B-VP', 'O'), ('Additional', 'Additional', 'JJ', 'B-NP', 'O'), ('File', 'File', 'NN', 'I-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have demonstrated effective inhibition of HIV and SHIV-RT viral replication in aptamer-transduced cells [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('effective', 'effective', 'JJ', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV', 'HIV', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('SHIV-RT', 'SHIV-RT', 'JJ', 'B-NP', 'O'), ('viral', 'viral', 'JJ', 'I-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('aptamer-transduced', 'aptamer-transduced', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast to previous results that used a single round of packaging and pools of individual CD4+ clones after limiting dilution plating [ CIT ] , we did not find any significant inhibition of viral replication in the heterogeneous populations of aptamer-transduced CEMx174 cells ( Figure 2b ) .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('round', 'round', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('packaging', 'packaging', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('pools', 'pool', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('individual', 'individual', 'JJ', 'B-NP', 'O'), ('CD4+', 'CD4+', 'JJ', 'I-NP', 'B-cell_line'), ('clones', 'clone', 'NNS', 'I-NP', 'I-cell_line'), ('after', 'after', 'IN', 'B-PP', 'O'), ('limiting', 'limit', 'VBG', 'B-VP', 'O'), ('dilution', 'dilution', 'NN', 'B-NP', 'O'), ('plating', 'plating', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('find', 'find', 'VB', 'I-VP', 'O'), ('any', 'any', 'DT', 'B-NP', 'O'), ('significant', 'significant', 'JJ', 'I-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('viral', 'viral', 'JJ', 'B-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('heterogeneous', 'heterogeneous', 'JJ', 'I-NP', 'B-cell_type'), ('populations', 'population', 'NNS', 'I-NP', 'I-cell_type'), ('of', 'of', 'IN', 'B-PP', 'O'), ('aptamer-transduced', 'aptamer-transduced', 'JJ', 'B-NP', 'B-cell_line'), ('CEMx174', 'CEMx174', 'NN', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2b', '2b', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As shown in Figure 5a , the GU and AG at the ends of most introns , along with the internal stretch of pyrimidines and other frequently occurring nucleotides , define the consensus sequences for splice donor and splice acceptor sites ( reviewed in [ CIT ] ) .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('5a', '5a', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('GU', 'GU', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('AG', 'AG', 'NN', 'I-NP', 'B-protein'), ('at', 'at', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ends', 'end', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('most', 'most', 'JJS', 'B-NP', 'O'), ('introns', 'intron', 'NNS', 'I-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('along', 'along', 'IN', 'B-PP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('internal', 'internal', 'JJ', 'I-NP', 'O'), ('stretch', 'stretch', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('pyrimidines', 'pyrimidine', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('frequently', 'frequently', 'RB', 'B-ADVP', 'O'), ('occurring', 'occur', 'VBG', 'B-VP', 'O'), ('nucleotides', 'nucleotide', 'NNS', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('define', 'define', 'VBP', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('consensus', 'consensus', 'NN', 'I-NP', 'B-DNA'), ('sequences', 'sequence', 'NNS', 'I-NP', 'I-DNA'), ('for', 'for', 'IN', 'B-PP', 'O'), ('splice', 'splice', 'NN', 'B-NP', 'O'), ('donor', 'donor', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('splice', 'splice', 'NN', 'I-NP', 'O'), ('acceptor', 'acceptor', 'NN', 'I-NP', 'O'), ('sites', 'site', 'NNS', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('reviewed', 'review', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have shown that the promoter is transcriptionally active with limited distance between the PSE and the upstream enhancer elements [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('promoter', 'promoter', 'NN', 'I-NP', 'B-DNA'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('transcriptionally', 'transcriptionally', 'RB', 'B-ADJP', 'O'), ('active', 'active', 'JJ', 'I-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('limited', 'limited', 'JJ', 'B-NP', 'O'), ('distance', 'distance', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('PSE', 'PSE', 'NN', 'I-NP', 'B-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('upstream', 'upstream', 'JJ', 'I-NP', 'B-DNA'), ('enhancer', 'enhancer', 'NN', 'I-NP', 'I-DNA'), ('elements', 'element', 'NNS', 'I-NP', 'I-DNA'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	In vivo , macrophages , DC and CD4 T cells are described to be major reservoir of HIV-1 [ CIT ] .	[('In', 'In', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('macrophages', 'macrophage', 'NNS', 'B-NP', 'B-cell_type'), (',', ',', ',', 'O', 'O'), ('DC', 'DC', 'NN', 'B-NP', 'B-cell_type'), ('and', 'and', 'CC', 'I-NP', 'O'), ('CD4', 'CD4', 'NN', 'I-NP', 'B-cell_type'), ('T', 'T', 'NN', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('major', 'major', 'JJ', 'B-NP', 'O'), ('reservoir', 'reservoir', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The EC50 in TZM-bl cells was determined after 24 h incubation by measuring the luciferase activity as previously described [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('EC50', 'EC50', 'NN', 'I-NP', 'B-protein'), ('in', 'in', 'IN', 'B-PP', 'O'), ('TZM-bl', 'TZM-bl', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('determined', 'determine', 'VBN', 'I-VP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('24', '24', 'CD', 'B-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('incubation', 'incubation', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('measuring', 'measure', 'VBG', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('luciferase', 'luciferase', 'NN', 'I-NP', 'B-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	EC50s 4'-Ed4T , D4T , AZT , and NVP have been previously published [ CIT ] ; they were included in Table 1 for comparison .	[('EC50s', 'EC50', 'NNS', 'B-NP', 'O'), ("4'-Ed4T", "4'-Ed4T", 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('D4T', 'D4T', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('AZT', 'AZT', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('NVP', 'NVP', 'NN', 'B-NP', 'B-protein'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('published', 'publish', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (';', ';', ':', 'O', 'O'), ('they', 'they', 'PRP', 'B-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('included', 'include', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Table', 'Table', 'JJ', 'B-NP', 'B-protein'), ('1', '1', 'CD', 'I-NP', 'I-protein'), ('for', 'for', 'IN', 'B-PP', 'O'), ('comparison', 'comparison', 'NN', 'B-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	The EC50s obtained with pre-incubation of cells in our assay were more consistent with published potencies of these analogs based on multiple HIV replication cycles [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('EC50s', 'EC50', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('pre-incubation', 'pre-incubation', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('cells', 'cell', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('more', 'more', 'RBR', 'B-ADJP', 'O'), ('consistent', 'consistent', 'JJ', 'I-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('published', 'publish', 'VBN', 'B-NP', 'O'), ('potencies', 'potency', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('analogs', 'analog', 'NNS', 'I-NP', 'O'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('multiple', 'multiple', 'JJ', 'B-NP', 'O'), ('HIV', 'HIV', 'NN', 'I-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('cycles', 'cycle', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	TZM-bl cells were pre-incubated with inhibitors to ensure that all inhibitors have reached their peak intracellular concentrations prior to HIV infection ; this is based on our previous report that AZT reached its peak concentration at 2 h while d4T and 4'-Ed4T reached peak concentrations at 12 h and other published studies [ CIT ] .	[('TZM-bl', 'TZM-bl', 'NN', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('pre-incubated', 'pre-incubated', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('inhibitors', 'inhibitor', 'NNS', 'B-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('ensure', 'ensure', 'VB', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('all', 'all', 'DT', 'B-NP', 'O'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('reached', 'reach', 'VBN', 'I-VP', 'O'), ('their', 'their', 'PRP$', 'B-NP', 'O'), ('peak', 'peak', 'JJ', 'I-NP', 'O'), ('intracellular', 'intracellular', 'JJ', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('prior', 'prior', 'RB', 'B-ADVP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('HIV', 'HIV', 'NN', 'B-NP', 'O'), ('infection', 'infection', 'NN', 'I-NP', 'O'), (';', ';', ':', 'O', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('based', 'base', 'VBN', 'I-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('AZT', 'AZT', 'NNP', 'B-NP', 'O'), ('reached', 'reach', 'VBD', 'B-VP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('peak', 'peak', 'JJ', 'I-NP', 'O'), ('concentration', 'concentration', 'NN', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('d4T', 'd4T', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ("4'-Ed4T", "4'-Ed4T", 'NN', 'I-NP', 'O'), ('reached', 'reach', 'VBD', 'B-VP', 'O'), ('peak', 'peak', 'NN', 'B-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('12', '12', 'CD', 'B-NP', 'O'), ('h', 'h', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('other', 'other', 'JJ', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The composite ranking was obtained using previously published data on 4'-Ed4T , D4T , AZT , and NVP [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('composite', 'composite', 'JJ', 'I-NP', 'O'), ('ranking', 'ranking', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'B-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ("4'-Ed4T", "4'-Ed4T", 'NN', 'B-NP', 'B-DNA'), (',', ',', ',', 'O', 'O'), ('D4T', 'D4T', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('AZT', 'AZT', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('NVP', 'NVP', 'NN', 'B-NP', 'B-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We had previously observed a decrease in weight gain in female LDL-R null mice receiving ritonavir in the drinking water as compared to males [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('observed', 'observe', 'VBN', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('decrease', 'decrease', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('weight', 'weight', 'NN', 'B-NP', 'O'), ('gain', 'gain', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('female', 'female', 'JJ', 'B-NP', 'O'), ('LDL-R', 'LDL-R', 'NN', 'I-NP', 'O'), ('null', 'null', 'JJ', 'I-NP', 'O'), ('mice', 'mouse', 'NNS', 'I-NP', 'O'), ('receiving', 'receive', 'VBG', 'B-VP', 'O'), ('ritonavir', 'ritonavir', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('drinking', 'drinking', 'NN', 'I-NP', 'O'), ('water', 'water', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('compared', 'compare', 'VBN', 'B-PP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('males', 'male', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	One group received vehicle ( 0.01 % ethanol ) , while the other received ritonavir ( 15 μg / day ) in the drinking water as previously described [ CIT ] .	[('One', 'One', 'CD', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('received', 'receive', 'VBD', 'B-VP', 'O'), ('vehicle', 'vehicle', 'NN', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('0.01', '0.01', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('ethanol', 'ethanol', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('while', 'while', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('received', 'receive', 'VBN', 'I-NP', 'O'), ('ritonavir', 'ritonavir', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('15', '15', 'CD', 'B-NP', 'O'), ('μg', 'μg', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('day', 'day', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('drinking', 'drinking', 'NN', 'I-NP', 'O'), ('water', 'water', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Additionally we isolated white adipose tissue from the gonadal fat pad in the abdomen as previously described [ CIT ] ( Figure 2B ) .	[('Additionally', 'Additionally', 'RB', 'B-ADVP', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('isolated', 'isolate', 'VBD', 'B-VP', 'O'), ('white', 'white', 'JJ', 'B-NP', 'O'), ('adipose', 'adipose', 'NN', 'I-NP', 'O'), ('tissue', 'tissue', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('gonadal', 'gonadal', 'JJ', 'I-NP', 'O'), ('fat', 'fat', 'JJ', 'I-NP', 'O'), ('pad', 'pad', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('abdomen', 'abdomen', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('2B', '2B', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous findings revealed that HAART resulted in a drop in RNA and plasma infectivity in one day [ CIT ] , however , the efficacy of ARV treatment can be affected by factors such as drug concentrations , compliance , potency , and selection of ARV resistant quasispecies .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('revealed', 'reveal', 'VBD', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('HAART', 'HAART', 'NN', 'B-NP', 'B-protein'), ('resulted', 'result', 'VBD', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('drop', 'drop', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('RNA', 'RNA', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('plasma', 'plasma', 'NN', 'I-NP', 'O'), ('infectivity', 'infectivity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('one', 'one', 'CD', 'B-NP', 'O'), ('day', 'day', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('efficacy', 'efficacy', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ARV', 'ARV', 'NN', 'B-NP', 'O'), ('treatment', 'treatment', 'NN', 'I-NP', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('affected', 'affect', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('factors', 'factor', 'NNS', 'B-NP', 'O'), ('such', 'such', 'JJ', 'B-PP', 'O'), ('as', 'as', 'IN', 'I-PP', 'O'), ('drug', 'drug', 'NN', 'B-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('compliance', 'compliance', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('potency', 'potency', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('selection', 'selection', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('ARV', 'ARV', 'NN', 'B-NP', 'B-protein'), ('resistant', 'resistant', 'JJ', 'I-NP', 'I-protein'), ('quasispecies', 'quasispecy', 'NNS', 'I-NP', 'I-protein'), ('.', '.', '.', 'O', 'O')]
5	Three [ CIT ] met our inclusion for pre-term delivery .	[('Three', 'Three', 'CD', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('met', 'meet', 'VBD', 'B-VP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('inclusion', 'inclusion', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('pre-term', 'pre-term', 'JJ', 'B-NP', 'O'), ('delivery', 'delivery', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Three studies examined the role of vitamin A for prevention of MTCT [ CIT ] examined the role of both vitamin A and a multivitamin using a 2 × 2 factorial design .	[('Three', 'Three', 'CD', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('vitamin', 'vitamin', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('prevention', 'prevention', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MTCT', 'MTCT', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('role', 'role', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('both', 'both', 'CC', 'O', 'O'), ('vitamin', 'vitamin', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('multivitamin', 'multivitamin', 'NN', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('×', '×', 'NN', 'I-NP', 'O'), ('2', '2', 'CD', 'B-NP', 'O'), ('factorial', 'factorial', 'JJ', 'I-NP', 'O'), ('design', 'design', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	We identified 1 unpublished and unreported study [ CIT ] , from which however no results could be obtained .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('identified', 'identify', 'VBD', 'B-VP', 'O'), ('1', '1', 'CD', 'B-NP', 'O'), ('unpublished', 'unpublished', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('unreported', 'unreported', 'JJ', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('obtained', 'obtain', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	However , recent data had shown that in some circumstances , certain siRNAs might induce variable levels of interferon activation [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('recent', 'recent', 'JJ', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('had', 'have', 'VBD', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('circumstances', 'circumstance', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('certain', 'certain', 'JJ', 'B-NP', 'O'), ('siRNAs', 'siRNA', 'NNS', 'I-NP', 'O'), ('might', 'might', 'MD', 'B-VP', 'O'), ('induce', 'induce', 'VB', 'I-VP', 'O'), ('variable', 'variable', 'JJ', 'B-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('interferon', 'interferon', 'NN', 'B-NP', 'B-protein'), ('activation', 'activation', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	The observed levels of viral inhibition in primary PBMC are similar to those observed in a recent report [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'I-NP', 'O'), ('levels', 'level', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('viral', 'viral', 'JJ', 'B-NP', 'O'), ('inhibition', 'inhibition', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('primary', 'primary', 'JJ', 'B-NP', 'B-cell_type'), ('PBMC', 'PBMC', 'NNS', 'I-NP', 'I-cell_type'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('recent', 'recent', 'JJ', 'I-NP', 'O'), ('report', 'report', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	We previously have introduced a monospecific siRNA targeted to HIV-1 rev into CD34 hematopoietic progenitor cells via lentiviral vectors and derived transgenic macrophages in vitro and T cells in vivo [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('introduced', 'introduce', 'VBN', 'I-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('monospecific', 'monospecific', 'JJ', 'I-NP', 'O'), ('siRNA', 'siRNA', 'NN', 'I-NP', 'O'), ('targeted', 'target', 'VBN', 'B-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('rev', 'rev', 'NN', 'I-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('CD34', 'CD34', 'NN', 'B-NP', 'B-protein'), ('hematopoietic', 'hematopoietic', 'JJ', 'I-NP', 'O'), ('progenitor', 'progenitor', 'NN', 'I-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('via', 'via', 'IN', 'B-PP', 'O'), ('lentiviral', 'lentiviral', 'JJ', 'B-NP', 'O'), ('vectors', 'vector', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('derived', 'derive', 'VBN', 'B-VP', 'O'), ('transgenic', 'transgenic', 'JJ', 'B-NP', 'O'), ('macrophages', 'macrophage', 'NNS', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vitro', 'vitro', 'FW', 'I-ADVP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('T', 'T', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Additionally , recent gene expression profiling studies indicated some off-target effects by siRNAs [ CIT ] .	[('Additionally', 'Additionally', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('recent', 'recent', 'JJ', 'B-NP', 'O'), ('gene', 'gene', 'NN', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('profiling', 'profiling', 'NN', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('indicated', 'indicate', 'VBD', 'B-VP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('off-target', 'off-target', 'JJ', 'I-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('siRNAs', 'siRNA', 'NNS', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Nucleolar expression of the Rev Binding Element ( RBE ) was achieved by substitution of the apical loop of the U16 small nucleolar RNA ( snoRNA ) with the RBE sequence as previously described [ CIT ] .	[('Nucleolar', 'Nucleolar', 'JJ', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Rev', 'Rev', 'NN', 'I-NP', 'B-DNA'), ('Binding', 'Binding', 'NN', 'I-NP', 'I-DNA'), ('Element', 'Element', 'NN', 'I-NP', 'I-DNA'), ('(', '(', '(', 'O', 'O'), ('RBE', 'RBE', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('achieved', 'achieve', 'VBN', 'I-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('substitution', 'substitution', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('apical', 'apical', 'JJ', 'I-NP', 'O'), ('loop', 'loop', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('U16', 'U16', 'NN', 'I-NP', 'B-DNA'), ('small', 'small', 'JJ', 'I-NP', 'O'), ('nucleolar', 'nucleolar', 'JJ', 'I-NP', 'O'), ('RNA', 'RNA', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('snoRNA', 'snoRNA', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('RBE', 'RBE', 'NN', 'I-NP', 'B-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Intracellular expression and nucleolar compartmentalization of the U16RBE RNA in 293 cells has been previously demonstrated [ CIT ] .	[('Intracellular', 'Intracellular', 'JJ', 'B-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('nucleolar', 'nucleolar', 'JJ', 'B-NP', 'O'), ('compartmentalization', 'compartmentalization', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('U16RBE', 'U16RBE', 'NN', 'I-NP', 'B-RNA'), ('RNA', 'RNA', 'NN', 'I-NP', 'I-RNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('293', '293', 'CD', 'B-NP', 'B-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	The 6 patients with immunological failure were switched to a LPV / r based regimen as recommended by the Kenyan national guidelines [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('6', '6', 'CD', 'I-NP', 'O'), ('patients', 'patient', 'NNS', 'I-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('immunological', 'immunological', 'JJ', 'B-NP', 'O'), ('failure', 'failure', 'NN', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('switched', 'switch', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('LPV', 'LPV', 'NN', 'I-NP', 'B-protein'), ('/', '/', 'SYM', 'B-NP', 'I-protein'), ('r', 'r', 'NN', 'I-NP', 'I-protein'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('regimen', 'regimen', 'NN', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('recommended', 'recommend', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Kenyan', 'Kenyan', 'NNP', 'I-NP', 'O'), ('national', 'national', 'JJ', 'I-NP', 'O'), ('guidelines', 'guideline', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	All sequences and positions were referenced with the wild-type HLA-G sequence of Geragthy et al. , [ CIT ] .	[('All', 'All', 'DT', 'B-NP', 'O'), ('sequences', 'sequence', 'NNS', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('positions', 'position', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('referenced', 'reference', 'VBN', 'I-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('wild-type', 'wild-type', 'JJ', 'I-NP', 'B-DNA'), ('HLA-G', 'HLA-G', 'NN', 'I-NP', 'I-DNA'), ('sequence', 'sequence', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Geragthy', 'Geragthy', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Seven out of 21 ( 33 % ) of the observed variants were previously described [ CIT ] .	[('Seven', 'Seven', 'CD', 'B-NP', 'O'), ('out', 'out', 'IN', 'B-PP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('21', '21', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('33', '33', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('observed', 'observe', 'VBN', 'I-NP', 'O'), ('variants', 'variant', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Although , the mutation in exon 2 region was considered as a silent mutation , a study by Duan et al. , [ CIT ] has demonstrated that a silent mutation effects human dopamine receptor D2 stability and synthesis of the receptor .	[('Although', 'Although', 'IN', 'B-SBAR', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('2', '2', 'CD', 'I-NP', 'I-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('considered', 'consider', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('silent', 'silent', 'JJ', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Duan', 'Duan', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('silent', 'silent', 'JJ', 'I-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'O'), ('dopamine', 'dopamine', 'NN', 'I-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('D2', 'D2', 'NN', 'I-NP', 'O'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('synthesis', 'synthesis', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('receptor', 'receptor', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	In contrast , a study by Matte et al. , [ CIT ] that investigated HLA-G gene concordance / discordance in African population of MTCT found no association of the mutation in exon 2 region at codon 57 with perinatal HIV-1 transmission .	[('In', 'In', 'IN', 'B-PP', 'O'), ('contrast', 'contrast', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Matte', 'Matte', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('investigated', 'investigate', 'VBD', 'B-VP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'B-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('concordance', 'concordance', 'NN', 'I-NP', 'O'), ('/', '/', 'SYM', 'B-NP', 'O'), ('discordance', 'discordance', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('African', 'African', 'JJ', 'B-NP', 'O'), ('population', 'population', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('MTCT', 'MTCT', 'NN', 'B-NP', 'B-protein'), ('found', 'find', 'VBD', 'B-VP', 'O'), ('no', 'no', 'DT', 'B-NP', 'O'), ('association', 'association', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mutation', 'mutation', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('2', '2', 'CD', 'I-NP', 'I-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('at', 'at', 'IN', 'B-PP', 'O'), ('codon', 'codon', 'NN', 'B-NP', 'B-DNA'), ('57', '57', 'CD', 'I-NP', 'I-DNA'), ('with', 'with', 'IN', 'B-PP', 'O'), ('perinatal', 'perinatal', 'JJ', 'B-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('transmission', 'transmission', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
7	Furthermore , the apparent discrepancies between Matte et al. , [ CIT ] study and our previous results could be further attributed to the definition of concordance and discordance .	[('Furthermore', 'Furthermore', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('apparent', 'apparent', 'JJ', 'I-NP', 'O'), ('discrepancies', 'discrepancy', 'NNS', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('Matte', 'Matte', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'I-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('could', 'could', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('further', 'further', 'RBR', 'B-ADJP', 'O'), ('attributed', 'attribute', 'VBN', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('definition', 'definition', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('concordance', 'concordance', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('discordance', 'discordance', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
2	A study has demonstrated that 14-bp deletion-insertion polymorphisms in the 3 ' UT region of the HLA-G gene influences HLA-G mRNA stability [ CIT ] .	[('A', 'A', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('demonstrated', 'demonstrate', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('14-bp', '14-bp', 'JJ', 'B-NP', 'B-DNA'), ('deletion-insertion', 'deletion-insertion', 'NN', 'I-NP', 'I-DNA'), ('polymorphisms', 'polymorphism', 'NNS', 'I-NP', 'I-DNA'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'B-DNA'), ("'", "'", 'SYM', 'I-NP', 'I-DNA'), ('UT', 'UT', 'NN', 'I-NP', 'I-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('influences', 'influence', 'VBZ', 'B-VP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'B-NP', 'B-RNA'), ('mRNA', 'mRNA', 'NN', 'I-NP', 'I-RNA'), ('stability', 'stability', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Other studies have shown that down regulation of the surface expression of HLA-G gene by viral immunoevasion of the placental MHC class I molecules like herpes simplex and cytomegalovirus results in viral replication and infection [ CIT ] .	[('Other', 'Other', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('down', 'down', 'JJ', 'B-NP', 'O'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('surface', 'surface', 'NN', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'B-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('by', 'by', 'IN', 'B-PP', 'O'), ('viral', 'viral', 'JJ', 'B-NP', 'O'), ('immunoevasion', 'immunoevasion', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('placental', 'placental', 'JJ', 'I-NP', 'B-protein'), ('MHC', 'MHC', 'NN', 'I-NP', 'I-protein'), ('class', 'class', 'NN', 'I-NP', 'I-protein'), ('I', 'I', 'CD', 'B-NP', 'I-protein'), ('molecules', 'molecule', 'NNS', 'I-NP', 'I-protein'), ('like', 'like', 'IN', 'B-PP', 'O'), ('herpes', 'herpes', 'NN', 'B-NP', 'O'), ('simplex', 'simplex', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('cytomegalovirus', 'cytomegalovirus', 'NN', 'I-NP', 'O'), ('results', 'result', 'VBZ', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('viral', 'viral', 'JJ', 'B-NP', 'O'), ('replication', 'replication', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('infection', 'infection', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	Surprisingly , we did not observe any previously described polymorphisms by Ober [ CIT ] at 714insG in the portion of the studied sequence of the untranslated regulatory and full length of exon 1 regions of the HLA-G gene .	[('Surprisingly', 'Surprisingly', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('did', 'do', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('observe', 'observe', 'VB', 'I-VP', 'O'), ('any', 'any', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'I-NP', 'O'), ('polymorphisms', 'polymorphism', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Ober', 'Ober', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('714insG', '714insG', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('portion', 'portion', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('studied', 'study', 'VBN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('untranslated', 'untranslated', 'JJ', 'I-NP', 'O'), ('regulatory', 'regulatory', 'JJ', 'I-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('full', 'full', 'JJ', 'I-NP', 'O'), ('length', 'length', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('1', '1', 'CD', 'I-NP', 'I-DNA'), ('regions', 'region', 'NNS', 'I-NP', 'I-DNA'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'I-NP', 'B-DNA'), ('gene', 'gene', 'NN', 'I-NP', 'I-DNA'), ('.', '.', '.', 'O', 'O')]
5	Nevertheless , 98-99 % of the same regions in our study matched with the previously published sequence of that region by Geraghty et al. , [ CIT ] .	[('Nevertheless', 'Nevertheless', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('98-99', '98-99', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('same', 'same', 'JJ', 'I-NP', 'O'), ('regions', 'region', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('matched', 'match', 'VBD', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('published', 'publish', 'VBN', 'I-NP', 'O'), ('sequence', 'sequence', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('that', 'that', 'DT', 'B-NP', 'O'), ('region', 'region', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Geraghty', 'Geraghty', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	This is a striking difference between this study and previously reported 31 variations in exon 3 by van der Ven et al. , [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('striking', 'striking', 'JJ', 'I-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('31', '31', 'CD', 'B-NP', 'O'), ('variations', 'variation', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('3', '3', 'CD', 'I-NP', 'I-DNA'), ('by', 'by', 'IN', 'B-PP', 'O'), ('van', 'van', 'NNP', 'B-NP', 'O'), ('der', 'der', 'NNP', 'I-NP', 'O'), ('Ven', 'Ven', 'NNP', 'I-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	However , the number of variations in exon 3 region was similar to those reports by Ishitani et al. , [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('number', 'number', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('variations', 'variation', 'NNS', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('exon', 'exon', 'NN', 'B-NP', 'B-DNA'), ('3', '3', 'CD', 'I-NP', 'I-DNA'), ('region', 'region', 'NN', 'I-NP', 'I-DNA'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('reports', 'report', 'NNS', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Ishitani', 'Ishitani', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
3	Taken together , the data from this study fits the " Trojan exosome hypothesis " to some degree , which predicts relatively efficient retroviral transmission between individuals who are histocompatible and relatively inefficient retroviral transmission between individuals who are histoincompatible [ CIT ] .	[('Taken', 'Take', 'VBN', 'B-VP', 'O'), ('together', 'together', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('study', 'study', 'NN', 'I-NP', 'O'), ('fits', 'fit', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('``', '``', '``', 'I-NP', 'O'), ('Trojan', 'Trojan', 'NN', 'I-NP', 'O'), ('exosome', 'exosome', 'NN', 'I-NP', 'O'), ('hypothesis', 'hypothesis', 'NN', 'I-NP', 'O'), ('``', '``', '``', 'O', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('some', 'some', 'DT', 'B-NP', 'O'), ('degree', 'degree', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('which', 'which', 'WDT', 'B-NP', 'O'), ('predicts', 'predict', 'VBZ', 'B-VP', 'O'), ('relatively', 'relatively', 'RB', 'B-NP', 'O'), ('efficient', 'efficient', 'JJ', 'I-NP', 'O'), ('retroviral', 'retroviral', 'JJ', 'I-NP', 'O'), ('transmission', 'transmission', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('individuals', 'individual', 'NNS', 'B-NP', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('histocompatible', 'histocompatible', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'B-NP', 'O'), ('relatively', 'relatively', 'RB', 'I-NP', 'O'), ('inefficient', 'inefficient', 'JJ', 'I-NP', 'O'), ('retroviral', 'retroviral', 'JJ', 'I-NP', 'O'), ('transmission', 'transmission', 'NN', 'I-NP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('individuals', 'individual', 'NNS', 'B-NP', 'O'), ('who', 'who', 'WP', 'B-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('histoincompatible', 'histoincompatible', 'JJ', 'B-ADJP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This deduced scenario is similar to the previously hypothesized scenario by van der Ven and Ober regarding HLA-G allogenic response [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('deduced', 'deduce', 'VBN', 'I-NP', 'O'), ('scenario', 'scenario', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('similar', 'similar', 'JJ', 'B-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'I-NP', 'O'), ('hypothesized', 'hypothesize', 'VBN', 'I-NP', 'O'), ('scenario', 'scenario', 'NN', 'I-NP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('van', 'van', 'NNP', 'B-NP', 'O'), ('der', 'der', 'NNP', 'I-NP', 'O'), ('Ven', 'Ven', 'NNP', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('Ober', 'Ober', 'NNP', 'B-NP', 'O'), ('regarding', 'regard', 'VBG', 'B-PP', 'O'), ('HLA-G', 'HLA-G', 'NN', 'B-NP', 'B-protein'), ('allogenic', 'allogenic', 'JJ', 'I-NP', 'O'), ('response', 'response', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	As observed in previous studies , average MPA AUC measured at week 4 was 19.40 ( range 18.79-19.90 ) regardless of antiretroviral regimen [ CIT ] .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('observed', 'observe', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('previous', 'previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('average', 'average', 'JJ', 'B-NP', 'O'), ('MPA', 'MPA', 'NN', 'I-NP', 'O'), ('AUC', 'AUC', 'NN', 'I-NP', 'O'), ('measured', 'measure', 'VBN', 'B-VP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('week', 'week', 'NN', 'B-NP', 'O'), ('4', '4', 'CD', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('19.40', '19.40', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('range', 'range', 'NN', 'B-NP', 'O'), ('18.79-19.90', '18.79-19.90', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('regardless', 'regardless', 'RB', 'B-ADVP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('antiretroviral', 'antiretroviral', 'JJ', 'B-NP', 'O'), ('regimen', 'regimen', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	However , MMF has also been reported to induce apoptosis in the setting of HIV infection [ CIT ] .	[('However', 'However', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('MMF', 'MMF', 'NN', 'B-NP', 'B-protein'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('also', 'also', 'RB', 'I-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('reported', 'report', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('induce', 'induce', 'VB', 'I-VP', 'O'), ('apoptosis', 'apoptosis', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('setting', 'setting', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV', 'HIV', 'NN', 'B-NP', 'O'), ('infection', 'infection', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	RT1t49 and 5 other DNA aptamers representing each of the six classes of DNA aptamers described by Schneider et al. [ CIT ] and a single RNA aptamer 1.1 ( termed Rknot 1.1 here ) were selected .	[('RT1t49', 'RT1t49', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('other', 'other', 'JJ', 'I-NP', 'O'), ('DNA', 'DNA', 'NN', 'I-NP', 'O'), ('aptamers', 'aptamer', 'NNS', 'I-NP', 'O'), ('representing', 'represent', 'VBG', 'B-VP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('six', 'six', 'CD', 'I-NP', 'O'), ('classes', 'class', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('DNA', 'DNA', 'NN', 'B-NP', 'O'), ('aptamers', 'aptamer', 'NNS', 'I-NP', 'O'), ('described', 'describe', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('Schneider', 'Schneider', 'NNP', 'B-NP', 'O'), ('et', 'et', 'FW', 'I-NP', 'O'), ('al.', 'al.', 'FW', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('single', 'single', 'JJ', 'I-NP', 'O'), ('RNA', 'RNA', 'NN', 'I-NP', 'O'), ('aptamer', 'aptamer', 'NN', 'I-NP', 'O'), ('1.1', '1.1', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('termed', 'term', 'VBN', 'B-VP', 'O'), ('Rknot', 'Rknot', 'NN', 'B-NP', 'B-protein'), ('1.1', '1.1', 'CD', 'I-NP', 'I-protein'), ('here', 'here', 'RB', 'B-ADVP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('selected', 'select', 'VBN', 'I-VP', 'O'), ('.', '.', '.', 'O', 'O')]
2	Previous studies have shown that alanine substitutions at several residues within the minor groove binding track ( MGBT ) [ CIT ] .	[('Previous', 'Previous', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('alanine', 'alanine', 'NN', 'B-NP', 'O'), ('substitutions', 'substitution', 'NNS', 'I-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('several', 'several', 'JJ', 'B-NP', 'O'), ('residues', 'residue', 'NNS', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('minor', 'minor', 'JJ', 'I-NP', 'O'), ('groove', 'groove', 'NN', 'I-NP', 'O'), ('binding', 'binding', 'NN', 'I-NP', 'O'), ('track', 'track', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('MGBT', 'MGBT', 'NN', 'B-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	We previously constructed a MLV / HIV-1 producer cell line based on FLY cells [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('constructed', 'construct', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('MLV', 'MLV', 'NN', 'I-NP', 'B-cell_line'), ('/', '/', 'SYM', 'B-NP', 'I-cell_line'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'I-cell_line'), ('producer', 'producer', 'NN', 'I-NP', 'I-cell_line'), ('cell', 'cell', 'NN', 'I-NP', 'I-cell_line'), ('line', 'line', 'NN', 'I-NP', 'I-cell_line'), ('based', 'base', 'VBN', 'B-VP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('FLY', 'FLY', 'NN', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
7	The inhibitor concentrations used in these studies were higher than those previously published because C-terminally truncated Envs have a fast fusion kinetic and are thus less sensitive to entry inhibitors [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('inhibitor', 'inhibitor', 'NN', 'I-NP', 'O'), ('concentrations', 'concentration', 'NNS', 'I-NP', 'O'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('higher', 'high', 'JJR', 'B-ADJP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('previously', 'previously', 'RB', 'B-VP', 'O'), ('published', 'publish', 'VBN', 'I-VP', 'O'), ('because', 'because', 'IN', 'B-SBAR', 'O'), ('C-terminally', 'C-terminally', 'RB', 'B-NP', 'O'), ('truncated', 'truncate', 'VBN', 'I-NP', 'O'), ('Envs', 'Env', 'NNS', 'I-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('fast', 'fast', 'JJ', 'I-NP', 'O'), ('fusion', 'fusion', 'NN', 'I-NP', 'O'), ('kinetic', 'kinetic', 'JJ', 'B-ADJP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('thus', 'thus', 'RB', 'B-ADVP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('sensitive', 'sensitive', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('entry', 'entry', 'NN', 'B-NP', 'O'), ('inhibitors', 'inhibitor', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	It has been shown that the cytoplasmic tail slows the folding of HIV-1 Env from a late prebundle configuration into the six-helix bundle , and thereby also slows down the fusion process [ CIT ] .	[('It', 'It', 'PRP', 'B-NP', 'O'), ('has', 'have', 'VBZ', 'B-VP', 'O'), ('been', 'be', 'VBN', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('cytoplasmic', 'cytoplasmic', 'JJ', 'I-NP', 'B-protein'), ('tail', 'tail', 'NN', 'I-NP', 'I-protein'), ('slows', 'slow', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('folding', 'folding', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('Env', 'Env', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('late', 'late', 'JJ', 'I-NP', 'O'), ('prebundle', 'prebundle', 'JJ', 'I-NP', 'O'), ('configuration', 'configuration', 'NN', 'I-NP', 'O'), ('into', 'into', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('six-helix', 'six-helix', 'JJ', 'I-NP', 'O'), ('bundle', 'bundle', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('thereby', 'thereby', 'RB', 'B-ADVP', 'O'), ('also', 'also', 'RB', 'B-ADVP', 'O'), ('slows', 'slow', 'VBZ', 'B-VP', 'O'), ('down', 'down', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('fusion', 'fusion', 'NN', 'I-NP', 'O'), ('process', 'process', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	ICS is generally considered less sensitive than ELISPOT in detecting low magnitude responses [ CIT ] .	[('ICS', 'ICS', 'NN', 'B-NP', 'B-protein'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('generally', 'generally', 'RB', 'I-VP', 'O'), ('considered', 'consider', 'VBN', 'I-VP', 'O'), ('less', 'less', 'RBR', 'B-ADJP', 'O'), ('sensitive', 'sensitive', 'JJ', 'I-ADJP', 'O'), ('than', 'than', 'IN', 'B-PP', 'O'), ('ELISPOT', 'ELISPOT', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('detecting', 'detect', 'VBG', 'B-VP', 'O'), ('low', 'low', 'JJ', 'B-NP', 'O'), ('magnitude', 'magnitude', 'NN', 'I-NP', 'O'), ('responses', 'response', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Laboratory 2 analyzed 29 samples obtained from 3 HIV-1 infected subjects stimulated with 18 different peptide formulations derived from 5 HIV-1 proteins using an ELISPOT assay approved by the Cancer Vaccine Consortium [ CIT ] .	[('Laboratory', 'Laboratory', 'NN', 'B-NP', 'O'), ('2', '2', 'CD', 'I-NP', 'O'), ('analyzed', 'analyze', 'VBD', 'B-VP', 'O'), ('29', '29', 'CD', 'B-NP', 'O'), ('samples', 'sample', 'NNS', 'I-NP', 'O'), ('obtained', 'obtain', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('3', '3', 'CD', 'B-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('infected', 'infected', 'JJ', 'I-NP', 'O'), ('subjects', 'subject', 'NNS', 'I-NP', 'O'), ('stimulated', 'stimulate', 'VBN', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('18', '18', 'CD', 'B-NP', 'O'), ('different', 'different', 'JJ', 'I-NP', 'O'), ('peptide', 'peptide', 'NN', 'I-NP', 'O'), ('formulations', 'formulation', 'NNS', 'I-NP', 'O'), ('derived', 'derive', 'VBN', 'B-VP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('5', '5', 'CD', 'B-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('an', 'an', 'DT', 'B-NP', 'O'), ('ELISPOT', 'ELISPOT', 'NN', 'I-NP', 'O'), ('assay', 'assay', 'NN', 'I-NP', 'O'), ('approved', 'approve', 'VBN', 'B-VP', 'O'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Cancer', 'Cancer', 'NNP', 'I-NP', 'O'), ('Vaccine', 'Vaccine', 'NNP', 'I-NP', 'O'), ('Consortium', 'Consortium', 'NNP', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	We have previously shown that cyclin E / CDK2 kinase activity is de-regulated in HTLV-1 infected cells and these cells are especially susceptible to Purvalanol A treatment [ CIT ] .	[('We', 'We', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('cyclin', 'cyclin', 'NN', 'B-NP', 'B-protein'), ('E', 'E', 'NN', 'I-NP', 'I-protein'), ('/', '/', 'SYM', 'B-VP', 'I-protein'), ('CDK2', 'CDK2', 'NN', 'B-NP', 'I-protein'), ('kinase', 'kinase', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('de-regulated', 'de-regulate', 'VBN', 'I-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('HTLV-1', 'HTLV-1', 'NN', 'B-NP', 'B-cell_type'), ('infected', 'infected', 'JJ', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('and', 'and', 'CC', 'O', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('cells', 'cell', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('especially', 'especially', 'RB', 'B-ADJP', 'O'), ('susceptible', 'susceptible', 'JJ', 'I-ADJP', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('Purvalanol', 'Purvalanol', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('treatment', 'treatment', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with our previous results where Purvalanol A treatment of infected cells inhibited cyclin E / CDK2 complex activity in HTLV-1 infected cells , inhibited transcription of the LTR promoter and promoted apoptosis [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('results', 'result', 'NNS', 'I-NP', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('Purvalanol', 'Purvalanol', 'NN', 'B-NP', 'O'), ('A', 'A', 'NN', 'I-NP', 'O'), ('treatment', 'treatment', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('infected', 'infected', 'JJ', 'B-NP', 'B-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('inhibited', 'inhibit', 'VBD', 'B-VP', 'O'), ('cyclin', 'cyclin', 'NN', 'B-NP', 'B-DNA'), ('E', 'E', 'NN', 'I-NP', 'I-DNA'), ('/', '/', 'SYM', 'B-NP', 'O'), ('CDK2', 'CDK2', 'NN', 'I-NP', 'B-protein'), ('complex', 'complex', 'NN', 'I-NP', 'I-protein'), ('activity', 'activity', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('HTLV-1', 'HTLV-1', 'NN', 'B-NP', 'B-cell_line'), ('infected', 'infected', 'JJ', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), (',', ',', ',', 'O', 'O'), ('inhibited', 'inhibit', 'VBD', 'B-VP', 'O'), ('transcription', 'transcription', 'NN', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('LTR', 'LTR', 'NN', 'I-NP', 'B-DNA'), ('promoter', 'promoter', 'NN', 'I-NP', 'I-DNA'), ('and', 'and', 'CC', 'O', 'O'), ('promoted', 'promote', 'VBD', 'B-VP', 'O'), ('apoptosis', 'apoptosis', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	When the mean microflora scores of the Lactobacillus morphotypes were evaluated as per the Nugent 's criteria [ CIT ] , there was reduction in the normal flora from 30 / 42 ( 71 % ) to 18 / 42 ( 46 % ) participants after 14 days of product use however , the difference was not statistically significant .	[('When', 'When', 'WRB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('mean', 'mean', 'JJ', 'I-NP', 'O'), ('microflora', 'microflora', 'NN', 'I-NP', 'O'), ('scores', 'score', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Lactobacillus', 'Lactobacillus', 'NN', 'I-NP', 'O'), ('morphotypes', 'morphotype', 'NNS', 'I-NP', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('evaluated', 'evaluate', 'VBN', 'I-VP', 'O'), ('as', 'as', 'IN', 'B-PP', 'O'), ('per', 'per', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('Nugent', 'Nugent', 'NNP', 'I-NP', 'O'), ("'s", "'s", 'POS', 'B-NP', 'O'), ('criteria', 'criterion', 'NNS', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('there', 'there', 'EX', 'B-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('reduction', 'reduction', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('normal', 'normal', 'JJ', 'I-NP', 'O'), ('flora', 'flora', 'NN', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('30', '30', 'CD', 'B-NP', 'O'), ('/', '/', 'SYM', 'I-NP', 'O'), ('42', '42', 'CD', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('71', '71', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('to', 'to', 'TO', 'B-PP', 'O'), ('18', '18', 'CD', 'B-NP', 'O'), ('/', '/', 'SYM', 'O', 'O'), ('42', '42', 'CD', 'B-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('46', '46', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('participants', 'participant', 'NNS', 'B-NP', 'O'), ('after', 'after', 'IN', 'B-PP', 'O'), ('14', '14', 'CD', 'B-NP', 'O'), ('days', 'day', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('product', 'product', 'NN', 'B-NP', 'O'), ('use', 'use', 'NN', 'I-NP', 'O'), ('however', 'however', 'RB', 'B-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('difference', 'difference', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('not', 'not', 'RB', 'O', 'O'), ('statistically', 'statistically', 'RB', 'B-ADJP', 'O'), ('significant', 'significant', 'JJ', 'I-ADJP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with our previous findings that HIV-1 transgenic expression dampens the immune functions of the resident alveolar macrophage [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('our', 'our', 'PRP$', 'B-NP', 'O'), ('previous', 'previous', 'JJ', 'I-NP', 'O'), ('findings', 'finding', 'NNS', 'I-NP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('transgenic', 'transgenic', 'JJ', 'I-NP', 'O'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('dampens', 'dampen', 'VBZ', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('immune', 'immune', 'JJ', 'I-NP', 'O'), ('functions', 'function', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('resident', 'resident', 'JJ', 'I-NP', 'O'), ('alveolar', 'alveolar', 'JJ', 'I-NP', 'O'), ('macrophage', 'macrophage', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To investigate epithelial barrier function in vivo , we examined lung liquid clearance following intra-tracheal saline challenge as we have previously described [ CIT ] .	[('To', 'To', 'TO', 'B-VP', 'O'), ('investigate', 'investigate', 'VB', 'I-VP', 'O'), ('epithelial', 'epithelial', 'JJ', 'B-NP', 'O'), ('barrier', 'barrier', 'NN', 'I-NP', 'O'), ('function', 'function', 'NN', 'I-NP', 'O'), ('in', 'in', 'FW', 'B-ADVP', 'O'), ('vivo', 'vivo', 'FW', 'I-ADVP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('lung', 'lung', 'NN', 'B-NP', 'O'), ('liquid', 'liquid', 'JJ', 'I-NP', 'O'), ('clearance', 'clearance', 'NN', 'I-NP', 'O'), ('following', 'follow', 'VBG', 'B-PP', 'O'), ('intra-tracheal', 'intra-tracheal', 'JJ', 'B-NP', 'O'), ('saline', 'saline', 'NN', 'I-NP', 'O'), ('challenge', 'challenge', 'NN', 'I-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('previously', 'previously', 'RB', 'I-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Note that the baseline wet : dry ratio of the rat lung is 4.7 as we have published previously [ CIT ] , and therefore the data are plotted to reflect the relative increases from this baseline in each group .	[('Note', 'Note', 'VB', 'B-VP', 'O'), ('that', 'that', 'IN', 'B-SBAR', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('baseline', 'baseline', 'NN', 'I-NP', 'O'), ('wet', 'wet', 'NN', 'I-NP', 'O'), (':', ':', ':', 'O', 'O'), ('dry', 'dry', 'JJ', 'B-NP', 'O'), ('ratio', 'ratio', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('rat', 'rat', 'NN', 'I-NP', 'O'), ('lung', 'lung', 'NN', 'I-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('4.7', '4.7', 'CD', 'B-NP', 'O'), ('as', 'as', 'IN', 'B-SBAR', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('published', 'publish', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('therefore', 'therefore', 'RB', 'B-ADVP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('data', 'datum', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('plotted', 'plot', 'VBN', 'I-VP', 'O'), ('to', 'to', 'TO', 'I-VP', 'O'), ('reflect', 'reflect', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('relative', 'relative', 'JJ', 'I-NP', 'O'), ('increases', 'increase', 'NNS', 'I-NP', 'O'), ('from', 'from', 'IN', 'B-PP', 'O'), ('this', 'this', 'DT', 'B-NP', 'O'), ('baseline', 'baseline', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('each', 'each', 'DT', 'B-NP', 'O'), ('group', 'group', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	This is consistent with the clinical scenario , where HIV does not infect the lung epithelium but can be found along with its related proteins within the alveolar space [ CIT ] .	[('This', 'This', 'DT', 'B-NP', 'O'), ('is', 'be', 'VBZ', 'B-VP', 'O'), ('consistent', 'consistent', 'JJ', 'B-ADJP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('clinical', 'clinical', 'JJ', 'I-NP', 'O'), ('scenario', 'scenario', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('where', 'where', 'WRB', 'B-ADVP', 'O'), ('HIV', 'HIV', 'NN', 'B-NP', 'O'), ('does', 'do', 'VBZ', 'B-VP', 'O'), ('not', 'not', 'RB', 'I-VP', 'O'), ('infect', 'infect', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('lung', 'lung', 'NN', 'I-NP', 'O'), ('epithelium', 'epithelium', 'NN', 'I-NP', 'O'), ('but', 'but', 'CC', 'O', 'O'), ('can', 'can', 'MD', 'B-VP', 'O'), ('be', 'be', 'VB', 'I-VP', 'O'), ('found', 'find', 'VBN', 'I-VP', 'O'), ('along', 'along', 'IN', 'B-PP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('related', 'related', 'JJ', 'I-NP', 'O'), ('proteins', 'protein', 'NNS', 'I-NP', 'O'), ('within', 'within', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('alveolar', 'alveolar', 'JJ', 'I-NP', 'O'), ('space', 'space', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
5	As tight junction proteins mediate the ability of alveolar epithelial cells to regulate paracellular permeability [ CIT ] , we extended the physiological studies shown in Figure 3 and examined the effects of HIV-1 transgene expression on two key tight junction proteins , namely zonula occludens-1 ( ZO-1 ) and occludin , in the alveolar epithelium .	[('As', 'As', 'IN', 'B-SBAR', 'O'), ('tight', 'tight', 'JJ', 'B-NP', 'B-protein'), ('junction', 'junction', 'NN', 'I-NP', 'I-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), ('mediate', 'mediate', 'VBP', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ability', 'ability', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('alveolar', 'alveolar', 'JJ', 'B-NP', 'B-cell_type'), ('epithelial', 'epithelial', 'JJ', 'I-NP', 'I-cell_type'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type'), ('to', 'to', 'TO', 'B-VP', 'O'), ('regulate', 'regulate', 'VB', 'I-VP', 'O'), ('paracellular', 'paracellular', 'JJ', 'B-NP', 'O'), ('permeability', 'permeability', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('extended', 'extend', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('physiological', 'physiological', 'JJ', 'I-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('shown', 'show', 'VBN', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('Figure', 'Figure', 'NN', 'B-NP', 'O'), ('3', '3', 'CD', 'I-NP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('examined', 'examine', 'VBD', 'B-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('effects', 'effect', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'B-DNA'), ('transgene', 'transgene', 'NN', 'I-NP', 'I-DNA'), ('expression', 'expression', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('two', 'two', 'CD', 'B-NP', 'O'), ('key', 'key', 'JJ', 'I-NP', 'O'), ('tight', 'tight', 'JJ', 'I-NP', 'O'), ('junction', 'junction', 'NN', 'I-NP', 'B-protein'), ('proteins', 'protein', 'NNS', 'I-NP', 'I-protein'), (',', ',', ',', 'O', 'O'), ('namely', 'namely', 'RB', 'B-ADVP', 'O'), ('zonula', 'zonula', 'NN', 'B-NP', 'O'), ('occludens-1', 'occludens-1', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('ZO-1', 'ZO-1', 'NN', 'B-NP', 'B-protein'), (')', ')', ')', 'O', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('occludin', 'occludin', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('alveolar', 'alveolar', 'JJ', 'I-NP', 'O'), ('epithelium', 'epithelium', 'NN', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	The outcome of interest , ' late presentation ' ( disease stage B or C at HIV-diagnosis [ CIT ] .	[('The', 'The', 'DT', 'B-NP', 'O'), ('outcome', 'outcome', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('interest', 'interest', 'NN', 'B-NP', 'O'), (',', ',', ',', 'O', 'O'), ("'", "'", '``', 'O', 'O'), ('late', 'late', 'JJ', 'B-NP', 'O'), ('presentation', 'presentation', 'NN', 'I-NP', 'O'), ("'", "'", "''", 'O', 'O'), ('(', '(', '(', 'O', 'O'), ('disease', 'disease', 'NN', 'B-NP', 'O'), ('stage', 'stage', 'NN', 'I-NP', 'O'), ('B', 'B', 'NN', 'I-NP', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('C', 'C', 'NN', 'B-NP', 'O'), ('at', 'at', 'IN', 'B-PP', 'O'), ('HIV-diagnosis', 'HIV-diagnosis', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
2	Early studies using MuLV based retrovirus vectors have shown the efficacy of aptamers and ribozymes against Tat , Rev , or envelope in interfering with HIV-1 infection [ CIT ] .	[('Early', 'Early', 'JJ', 'B-NP', 'O'), ('studies', 'study', 'NNS', 'I-NP', 'O'), ('using', 'use', 'VBG', 'B-VP', 'O'), ('MuLV', 'MuLV', 'NN', 'B-NP', 'B-DNA'), ('based', 'based', 'JJ', 'I-NP', 'I-DNA'), ('retrovirus', 'retrovirus', 'NN', 'I-NP', 'I-DNA'), ('vectors', 'vector', 'NNS', 'I-NP', 'I-DNA'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('shown', 'show', 'VBN', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('efficacy', 'efficacy', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('aptamers', 'aptamer', 'NNS', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('ribozymes', 'ribozyme', 'NNS', 'I-NP', 'O'), ('against', 'against', 'IN', 'B-PP', 'O'), ('Tat', 'Tat', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('Rev', 'Rev', 'NN', 'B-NP', 'B-protein'), (',', ',', ',', 'O', 'O'), ('or', 'or', 'CC', 'O', 'O'), ('envelope', 'envelope', 'NN', 'B-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('interfering', 'interfere', 'VBG', 'B-VP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('infection', 'infection', 'NN', 'I-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Down regulation of CCR5 by the ribozyme used here and its corresponding inhibitory effect on HIV-1 infection was described previously [ CIT ] .	[('Down', 'Down', 'JJ', 'B-NP', 'O'), ('regulation', 'regulation', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('CCR5', 'CCR5', 'NN', 'B-NP', 'B-protein'), ('by', 'by', 'IN', 'B-PP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('ribozyme', 'ribozyme', 'NN', 'I-NP', 'B-protein'), ('used', 'use', 'VBN', 'B-VP', 'O'), ('here', 'here', 'RB', 'B-ADVP', 'O'), ('and', 'and', 'CC', 'O', 'O'), ('its', 'its', 'PRP$', 'B-NP', 'O'), ('corresponding', 'correspond', 'VBG', 'I-NP', 'O'), ('inhibitory', 'inhibitory', 'JJ', 'I-NP', 'O'), ('effect', 'effect', 'NN', 'I-NP', 'O'), ('on', 'on', 'IN', 'B-PP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('infection', 'infection', 'NN', 'I-NP', 'O'), ('was', 'be', 'VBD', 'B-VP', 'O'), ('described', 'describe', 'VBN', 'I-VP', 'O'), ('previously', 'previously', 'RB', 'B-ADVP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	To further expand the utility of such inhibitory RNAs , we used a third generation HIV-1 based self-inactivating vector ( Fig. 1 ) [ CIT ] A highly enriched population of human CD34+ cells ( > 90 % pure ) were used for vector transductions .	[('To', 'To', 'TO', 'B-VP', 'O'), ('further', 'further', 'RB', 'I-VP', 'O'), ('expand', 'expand', 'VB', 'I-VP', 'O'), ('the', 'the', 'DT', 'B-NP', 'O'), ('utility', 'utility', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('such', 'such', 'JJ', 'B-NP', 'O'), ('inhibitory', 'inhibitory', 'JJ', 'I-NP', 'O'), ('RNAs', 'RNA', 'NNS', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('used', 'use', 'VBD', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('third', 'third', 'JJ', 'I-NP', 'O'), ('generation', 'generation', 'NN', 'I-NP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'I-NP', 'O'), ('based', 'based', 'JJ', 'I-NP', 'O'), ('self-inactivating', 'self-inactivating', 'JJ', 'I-NP', 'O'), ('vector', 'vector', 'NN', 'I-NP', 'O'), ('(', '(', '(', 'O', 'O'), ('Fig.', 'Fig.', 'NN', 'B-NP', 'O'), ('1', '1', 'CD', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'B-protein'), (']', ']', ')', 'I-NP', 'I-protein'), ('A', 'A', 'NN', 'I-NP', 'I-protein'), ('highly', 'highly', 'RB', 'B-NP', 'O'), ('enriched', 'enrich', 'VBN', 'I-NP', 'O'), ('population', 'population', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('human', 'human', 'JJ', 'B-NP', 'B-cell_line'), ('CD34+', 'CD34+', 'JJ', 'I-NP', 'I-cell_line'), ('cells', 'cell', 'NNS', 'I-NP', 'I-cell_line'), ('(', '(', '(', 'O', 'O'), ('>', '>', 'SYM', 'B-NP', 'O'), ('90', '90', 'CD', 'B-NP', 'O'), ('%', '%', 'NN', 'I-NP', 'O'), ('pure', 'pure', 'NN', 'I-NP', 'O'), (')', ')', ')', 'O', 'O'), ('were', 'be', 'VBD', 'B-VP', 'O'), ('used', 'use', 'VBN', 'I-VP', 'O'), ('for', 'for', 'IN', 'B-PP', 'O'), ('vector', 'vector', 'NN', 'B-NP', 'O'), ('transductions', 'transduction', 'NNS', 'I-NP', 'O'), ('.', '.', '.', 'O', 'O')]
5	These initial observations are in agreement with those of Reid and colleagues that suggested HIV-1 associated complications in these transgenic rats manifest between 5-9 months of age [ CIT ] .	[('These', 'These', 'DT', 'B-NP', 'O'), ('initial', 'initial', 'JJ', 'I-NP', 'O'), ('observations', 'observation', 'NNS', 'I-NP', 'O'), ('are', 'be', 'VBP', 'B-VP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('agreement', 'agreement', 'NN', 'B-NP', 'O'), ('with', 'with', 'IN', 'B-PP', 'O'), ('those', 'those', 'DT', 'B-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('Reid', 'Reid', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('colleagues', 'colleague', 'NNS', 'I-NP', 'O'), ('that', 'that', 'WDT', 'B-NP', 'O'), ('suggested', 'suggest', 'VBD', 'B-VP', 'O'), ('HIV-1', 'HIV-1', 'NN', 'B-NP', 'O'), ('associated', 'associated', 'JJ', 'I-NP', 'O'), ('complications', 'complication', 'NNS', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('these', 'these', 'DT', 'B-NP', 'O'), ('transgenic', 'transgenic', 'JJ', 'I-NP', 'O'), ('rats', 'rat', 'NNS', 'I-NP', 'O'), ('manifest', 'manifest', 'VBP', 'B-VP', 'O'), ('between', 'between', 'IN', 'B-PP', 'O'), ('5-9', '5-9', 'CD', 'B-NP', 'O'), ('months', 'month', 'NNS', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('age', 'age', 'NN', 'B-NP', 'O'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
1	Using a model of chronic alcohol ingestion to induce oxidative stress in skeletal muscle , we have recently identified atrogin-1 and TGFβ1 as redox-sensitive catabolic factors [ CIT ] .	[('Using', 'Use', 'VBG', 'B-VP', 'O'), ('a', 'a', 'DT', 'B-NP', 'O'), ('model', 'model', 'NN', 'I-NP', 'O'), ('of', 'of', 'IN', 'B-PP', 'O'), ('chronic', 'chronic', 'JJ', 'B-NP', 'O'), ('alcohol', 'alcohol', 'NN', 'I-NP', 'O'), ('ingestion', 'ingestion', 'NN', 'I-NP', 'O'), ('to', 'to', 'TO', 'B-VP', 'O'), ('induce', 'induce', 'VB', 'I-VP', 'O'), ('oxidative', 'oxidative', 'JJ', 'B-NP', 'O'), ('stress', 'stress', 'NN', 'I-NP', 'O'), ('in', 'in', 'IN', 'B-PP', 'O'), ('skeletal', 'skeletal', 'JJ', 'B-NP', 'O'), ('muscle', 'muscle', 'NN', 'I-NP', 'O'), (',', ',', ',', 'O', 'O'), ('we', 'we', 'PRP', 'B-NP', 'O'), ('have', 'have', 'VBP', 'B-VP', 'O'), ('recently', 'recently', 'RB', 'I-VP', 'O'), ('identified', 'identify', 'VBN', 'I-VP', 'O'), ('atrogin-1', 'atrogin-1', 'NN', 'B-NP', 'O'), ('and', 'and', 'CC', 'I-NP', 'O'), ('TGFβ1', 'TGFβ1', 'NN', 'I-NP', 'B-protein'), ('as', 'as', 'IN', 'B-PP', 'O'), ('redox-sensitive', 'redox-sensitive', 'JJ', 'B-NP', 'B-protein'), ('catabolic', 'catabolic', 'JJ', 'I-NP', 'I-protein'), ('factors', 'factor', 'NNS', 'I-NP', 'I-protein'), ('[', '[', '(', 'O', 'O'), ('CIT', 'CIT', 'NN', 'B-NP', 'O'), (']', ']', ')', 'O', 'O'), ('.', '.', '.', 'O', 'O')]
